{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "0058d880",
   "metadata": {},
   "source": [
    "# Read libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "aeaaaee0",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-08T23:08:57.516419Z",
     "start_time": "2024-01-08T23:08:57.106497Z"
    }
   },
   "outputs": [],
   "source": [
    "%load_ext autoreload\n",
    "%autoreload 2\n",
    "%matplotlib inline\n",
    "\n",
    "from copy import copy, deepcopy\n",
    "from pathlib import Path\n",
    "from sys import path\n",
    "\n",
    "path.append( str(Path.cwd().parent) )\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "0e7f0558",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-08T23:08:59.392666Z",
     "start_time": "2024-01-08T23:08:58.288449Z"
    }
   },
   "outputs": [],
   "source": [
    "import json\n",
    "import re\n",
    "\n",
    "import matplotlib.pyplot as plt\n",
    "import pandas as pd\n",
    "\n",
    "from collections import Counter\n",
    "from string import punctuation, whitespace\n",
    "\n",
    "from Project_libraries.pubmed import ( concatenate_lines, \n",
    "                                       extract_publication_date, \n",
    "                                       get_article_data )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "3a3a021f",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-08T23:24:21.561967Z",
     "start_time": "2024-01-08T23:24:21.526320Z"
    }
   },
   "outputs": [],
   "source": [
    "csv_file = Path.cwd() / 'csv-brca2-set.csv'\n",
    "abstracts_file = Path.cwd() / 'abstract-brca2-set.txt'"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f4a354eb",
   "metadata": {},
   "source": [
    "# Import CSV file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 205,
   "id": "ed3f8e4e",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:26:53.960774Z",
     "start_time": "2024-01-10T16:26:53.898910Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>PMID</th>\n",
       "      <th>Title</th>\n",
       "      <th>Authors</th>\n",
       "      <th>Citation</th>\n",
       "      <th>First Author</th>\n",
       "      <th>Journal/Book</th>\n",
       "      <th>Publication Year</th>\n",
       "      <th>Create Date</th>\n",
       "      <th>PMCID</th>\n",
       "      <th>NIHMS ID</th>\n",
       "      <th>DOI</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>29687286</td>\n",
       "      <td>The BRCA1 and BRCA2 Genes in Early-Onset Breas...</td>\n",
       "      <td>Saleem M, Ghazali MB, Wahab MAMA, Yusoff NM, M...</td>\n",
       "      <td>Adv Exp Med Biol. 2020;1292:1-12. doi: 10.1007...</td>\n",
       "      <td>Saleem M</td>\n",
       "      <td>Adv Exp Med Biol</td>\n",
       "      <td>2020</td>\n",
       "      <td>2018/04/25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.1007/5584_2018_147</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>23747889</td>\n",
       "      <td>Breast cancer genes: beyond BRCA1 and BRCA2</td>\n",
       "      <td>Filippini SE, Vega A.</td>\n",
       "      <td>Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1...</td>\n",
       "      <td>Filippini SE</td>\n",
       "      <td>Front Biosci (Landmark Ed)</td>\n",
       "      <td>2013</td>\n",
       "      <td>2013/06/11</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.2741/4185</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>26187060</td>\n",
       "      <td>Comprehensive spectrum of BRCA1 and BRCA2 dele...</td>\n",
       "      <td>Kwong A, Shin VY, Ho JC, Kang E, Nakamura S, T...</td>\n",
       "      <td>J Med Genet. 2016 Jan;53(1):15-23. doi: 10.113...</td>\n",
       "      <td>Kwong A</td>\n",
       "      <td>J Med Genet</td>\n",
       "      <td>2016</td>\n",
       "      <td>2015/07/19</td>\n",
       "      <td>PMC4681590</td>\n",
       "      <td>NIHMS721868</td>\n",
       "      <td>10.1136/jmedgenet-2015-103132</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>31915789</td>\n",
       "      <td>BRCA2 gene mutation and prostate cancer risk. ...</td>\n",
       "      <td>Junejo NN, AlKhateeb SS.</td>\n",
       "      <td>Saudi Med J. 2020 Jan;41(1):9-17. doi: 10.1553...</td>\n",
       "      <td>Junejo NN</td>\n",
       "      <td>Saudi Med J</td>\n",
       "      <td>2020</td>\n",
       "      <td>2020/01/10</td>\n",
       "      <td>PMC7001059</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.15537/smj.2020.1.24759</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>32005245</td>\n",
       "      <td>Mutations of BRCA2 in canine mammary tumors an...</td>\n",
       "      <td>Thumser-Henner P, Nytko KJ, Rohrer Bley C.</td>\n",
       "      <td>BMC Vet Res. 2020 Jan 31;16(1):30. doi: 10.118...</td>\n",
       "      <td>Thumser-Henner P</td>\n",
       "      <td>BMC Vet Res</td>\n",
       "      <td>2020</td>\n",
       "      <td>2020/02/02</td>\n",
       "      <td>PMC6995156</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.1186/s12917-020-2247-4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9987</th>\n",
       "      <td>33112397</td>\n",
       "      <td>Activity of Platinum-Based Chemotherapy in Pat...</td>\n",
       "      <td>Schmid S, Omlin A, Higano C, Sweeney C, Martin...</td>\n",
       "      <td>JAMA Netw Open. 2020 Oct 1;3(10):e2021692. doi...</td>\n",
       "      <td>Schmid S</td>\n",
       "      <td>JAMA Netw Open</td>\n",
       "      <td>2020</td>\n",
       "      <td>2020/10/28</td>\n",
       "      <td>PMC7593810</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.1001/jamanetworkopen.2020.21692</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9988</th>\n",
       "      <td>27197191</td>\n",
       "      <td>Cross-Cancer Genome-Wide Analysis of Lung, Ova...</td>\n",
       "      <td>Fehringer G, Kraft P, Pharoah PD, Eeles RA, Ch...</td>\n",
       "      <td>Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10...</td>\n",
       "      <td>Fehringer G</td>\n",
       "      <td>Cancer Res</td>\n",
       "      <td>2016</td>\n",
       "      <td>2016/05/20</td>\n",
       "      <td>PMC5010493</td>\n",
       "      <td>NIHMS780930</td>\n",
       "      <td>10.1158/0008-5472.CAN-15-2980</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9989</th>\n",
       "      <td>23535731</td>\n",
       "      <td>Multiple independent variants at the TERT locu...</td>\n",
       "      <td>Bojesen SE, Pooley KA, Johnatty SE, Beesley J,...</td>\n",
       "      <td>Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi...</td>\n",
       "      <td>Bojesen SE</td>\n",
       "      <td>Nat Genet</td>\n",
       "      <td>2013</td>\n",
       "      <td>2013/03/29</td>\n",
       "      <td>PMC3670748</td>\n",
       "      <td>NIHMS467552</td>\n",
       "      <td>10.1038/ng.2566</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9990</th>\n",
       "      <td>33990587</td>\n",
       "      <td>Author Correction: A case-only study to identi...</td>\n",
       "      <td>Coignard J, Lush M, Beesley J, O'Mara TA, Denn...</td>\n",
       "      <td>Nat Commun. 2021 May 14;12(1):2986. doi: 10.10...</td>\n",
       "      <td>Coignard J</td>\n",
       "      <td>Nat Commun</td>\n",
       "      <td>2021</td>\n",
       "      <td>2021/05/15</td>\n",
       "      <td>PMC8121813</td>\n",
       "      <td>NaN</td>\n",
       "      <td>10.1038/s41467-021-23162-4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9991</th>\n",
       "      <td>26921362</td>\n",
       "      <td>No evidence that protein truncating variants i...</td>\n",
       "      <td>Easton DF, Lesueur F, Decker B, Michailidou K,...</td>\n",
       "      <td>J Med Genet. 2016 May;53(5):298-309. doi: 10.1...</td>\n",
       "      <td>Easton DF</td>\n",
       "      <td>J Med Genet</td>\n",
       "      <td>2016</td>\n",
       "      <td>2016/02/28</td>\n",
       "      <td>PMC4938802</td>\n",
       "      <td>NIHMS783860</td>\n",
       "      <td>10.1136/jmedgenet-2015-103529</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>9992 rows × 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          PMID                                              Title  \\\n",
       "0     29687286  The BRCA1 and BRCA2 Genes in Early-Onset Breas...   \n",
       "1     23747889        Breast cancer genes: beyond BRCA1 and BRCA2   \n",
       "2     26187060  Comprehensive spectrum of BRCA1 and BRCA2 dele...   \n",
       "3     31915789  BRCA2 gene mutation and prostate cancer risk. ...   \n",
       "4     32005245  Mutations of BRCA2 in canine mammary tumors an...   \n",
       "...        ...                                                ...   \n",
       "9987  33112397  Activity of Platinum-Based Chemotherapy in Pat...   \n",
       "9988  27197191  Cross-Cancer Genome-Wide Analysis of Lung, Ova...   \n",
       "9989  23535731  Multiple independent variants at the TERT locu...   \n",
       "9990  33990587  Author Correction: A case-only study to identi...   \n",
       "9991  26921362  No evidence that protein truncating variants i...   \n",
       "\n",
       "                                                Authors  \\\n",
       "0     Saleem M, Ghazali MB, Wahab MAMA, Yusoff NM, M...   \n",
       "1                                 Filippini SE, Vega A.   \n",
       "2     Kwong A, Shin VY, Ho JC, Kang E, Nakamura S, T...   \n",
       "3                              Junejo NN, AlKhateeb SS.   \n",
       "4            Thumser-Henner P, Nytko KJ, Rohrer Bley C.   \n",
       "...                                                 ...   \n",
       "9987  Schmid S, Omlin A, Higano C, Sweeney C, Martin...   \n",
       "9988  Fehringer G, Kraft P, Pharoah PD, Eeles RA, Ch...   \n",
       "9989  Bojesen SE, Pooley KA, Johnatty SE, Beesley J,...   \n",
       "9990  Coignard J, Lush M, Beesley J, O'Mara TA, Denn...   \n",
       "9991  Easton DF, Lesueur F, Decker B, Michailidou K,...   \n",
       "\n",
       "                                               Citation      First Author  \\\n",
       "0     Adv Exp Med Biol. 2020;1292:1-12. doi: 10.1007...          Saleem M   \n",
       "1     Front Biosci (Landmark Ed). 2013 Jun 1;18(4):1...      Filippini SE   \n",
       "2     J Med Genet. 2016 Jan;53(1):15-23. doi: 10.113...           Kwong A   \n",
       "3     Saudi Med J. 2020 Jan;41(1):9-17. doi: 10.1553...         Junejo NN   \n",
       "4     BMC Vet Res. 2020 Jan 31;16(1):30. doi: 10.118...  Thumser-Henner P   \n",
       "...                                                 ...               ...   \n",
       "9987  JAMA Netw Open. 2020 Oct 1;3(10):e2021692. doi...          Schmid S   \n",
       "9988  Cancer Res. 2016 Sep 1;76(17):5103-14. doi: 10...       Fehringer G   \n",
       "9989  Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. doi...        Bojesen SE   \n",
       "9990  Nat Commun. 2021 May 14;12(1):2986. doi: 10.10...        Coignard J   \n",
       "9991  J Med Genet. 2016 May;53(5):298-309. doi: 10.1...         Easton DF   \n",
       "\n",
       "                    Journal/Book  Publication Year Create Date       PMCID  \\\n",
       "0               Adv Exp Med Biol              2020  2018/04/25         NaN   \n",
       "1     Front Biosci (Landmark Ed)              2013  2013/06/11         NaN   \n",
       "2                    J Med Genet              2016  2015/07/19  PMC4681590   \n",
       "3                    Saudi Med J              2020  2020/01/10  PMC7001059   \n",
       "4                    BMC Vet Res              2020  2020/02/02  PMC6995156   \n",
       "...                          ...               ...         ...         ...   \n",
       "9987              JAMA Netw Open              2020  2020/10/28  PMC7593810   \n",
       "9988                  Cancer Res              2016  2016/05/20  PMC5010493   \n",
       "9989                   Nat Genet              2013  2013/03/29  PMC3670748   \n",
       "9990                  Nat Commun              2021  2021/05/15  PMC8121813   \n",
       "9991                 J Med Genet              2016  2016/02/28  PMC4938802   \n",
       "\n",
       "         NIHMS ID                                 DOI  \n",
       "0             NaN               10.1007/5584_2018_147  \n",
       "1             NaN                        10.2741/4185  \n",
       "2     NIHMS721868       10.1136/jmedgenet-2015-103132  \n",
       "3             NaN           10.15537/smj.2020.1.24759  \n",
       "4             NaN           10.1186/s12917-020-2247-4  \n",
       "...           ...                                 ...  \n",
       "9987          NaN  10.1001/jamanetworkopen.2020.21692  \n",
       "9988  NIHMS780930       10.1158/0008-5472.CAN-15-2980  \n",
       "9989  NIHMS467552                     10.1038/ng.2566  \n",
       "9990          NaN          10.1038/s41467-021-23162-4  \n",
       "9991  NIHMS783860       10.1136/jmedgenet-2015-103529  \n",
       "\n",
       "[9992 rows x 11 columns]"
      ]
     },
     "execution_count": 205,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(csv_file)\n",
    "df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 206,
   "id": "a47d5c2a",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:26:58.399012Z",
     "start_time": "2024-01-10T16:26:58.372068Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 9992 published in 1454 unique journals.\n"
     ]
    }
   ],
   "source": [
    "n_papers = len(df)\n",
    "n_journals = len(set(df['Journal/Book']))\n",
    "\n",
    "print(f\"There are {n_papers} published in {n_journals} unique journals.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 207,
   "id": "66d6c938",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:26:58.846097Z",
     "start_time": "2024-01-10T16:26:58.836414Z"
    }
   },
   "outputs": [],
   "source": [
    "journals = Counter(df['Journal/Book'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 208,
   "id": "fe751816",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:26:59.897705Z",
     "start_time": "2024-01-10T16:26:59.875131Z"
    }
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('Breast Cancer Res Treat', 456),\n",
       " ('Fam Cancer', 227),\n",
       " ('Gynecol Oncol', 209),\n",
       " ('J Clin Oncol', 197),\n",
       " ('Clin Cancer Res', 151),\n",
       " ('BMC Cancer', 146),\n",
       " ('PLoS One', 143),\n",
       " ('J Genet Couns', 121),\n",
       " ('Cancer', 116),\n",
       " ('Breast Cancer Res', 114),\n",
       " ('Br J Cancer', 110),\n",
       " ('Cancers (Basel)', 109),\n",
       " ('Clin Genet', 106),\n",
       " ('Genet Med', 105),\n",
       " ('Oncotarget', 105),\n",
       " ('Int J Cancer', 104),\n",
       " ('Ann Oncol', 101),\n",
       " ('Cancer Res', 98),\n",
       " ('J Med Genet', 92),\n",
       " ('J Natl Cancer Inst', 91)]"
      ]
     },
     "execution_count": 208,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "journals.most_common(20)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "007e81ff",
   "metadata": {},
   "source": [
    "# Import abstract file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 209,
   "id": "d4bc9266",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:01.733999Z",
     "start_time": "2024-01-10T16:27:01.504111Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "There are 9992 articles in file.\n"
     ]
    }
   ],
   "source": [
    "with open(abstracts_file, 'r', encoding = 'utf-8') as f_abs:\n",
    "    data = f_abs.readlines()\n",
    "\n",
    "# Identify starting line of each article\n",
    "#\n",
    "pattern = '\\d{1,4}[.] '\n",
    "\n",
    "articles_start = []\n",
    "k = 0\n",
    "while True:\n",
    "    \n",
    "    # Start of record  \n",
    "    #\n",
    "    potential_match = re.match(pattern, data[k])\n",
    "    if potential_match:\n",
    "        potential_index = int( data[k][potential_match.start(): \n",
    "                                       potential_match.end()-2] )\n",
    "        \n",
    "        if potential_index - 1 == len(articles_start):\n",
    "            articles_start.append( k )\n",
    "        \n",
    "    k += 1\n",
    "    if k == len(data):\n",
    "        break\n",
    "\n",
    "print(f\"There are {len(articles_start)} articles in file.\" )\n",
    "\n",
    "# Need to add last line of file so all articles are checked later\n",
    "articles_start.append( len(data) )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 210,
   "id": "45ae9bcc",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:02.730427Z",
     "start_time": "2024-01-10T16:27:02.443943Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1 -- Article 172, lines 5493 to 5503 failed to process\n",
      "2 -- Article 248, lines 7768 to 7777 failed to process\n",
      "3 -- Article 462, lines 12742 to 12753 failed to process\n",
      "4 -- Article 486, lines 13086 to 13096 failed to process\n",
      "5 -- Article 490, lines 13135 to 13144 failed to process\n",
      "6 -- Article 494, lines 13185 to 13194 failed to process\n",
      "7 -- Article 497, lines 13220 to 13231 failed to process\n",
      "8 -- Article 499, lines 13245 to 13255 failed to process\n",
      "9 -- Article 505, lines 13385 to 13397 failed to process\n",
      "10 -- Article 579, lines 15725 to 15735 failed to process\n",
      "11 -- Article 590, lines 15979 to 15989 failed to process\n",
      "12 -- Article 762, lines 21970 to 21980 failed to process\n",
      "13 -- Article 801, lines 23427 to 23437 failed to process\n",
      "14 -- Article 1131, lines 35444 to 35454 failed to process\n",
      "15 -- Article 1209, lines 38443 to 38455 failed to process\n",
      "16 -- Article 1365, lines 45017 to 45028 failed to process\n",
      "-----> 2151. RETRACTED ARTICLE\n",
      "\n",
      "1 -- Article 3546, lines 146933 to 147010 lacks year.\n",
      "-----> 4114. RETRACTED ARTICLE\n",
      "\n",
      "2 -- Article 5018, lines 216536 to 216646 lacks year.\n",
      "3 -- Article 6121, lines 275019 to 275094 lacks year.\n",
      "17 -- Article 6144, lines 276535 to 276546 failed to process\n",
      "18 -- Article 6192, lines 278140 to 278150 failed to process\n",
      "19 -- Article 6329, lines 282952 to 282961 failed to process\n",
      "20 -- Article 6397, lines 285344 to 285355 failed to process\n",
      "21 -- Article 6548, lines 290408 to 290418 failed to process\n",
      "22 -- Article 6685, lines 296015 to 296024 failed to process\n",
      "23 -- Article 6794, lines 299949 to 299960 failed to process\n",
      "-----> 6809. RETRACTED ARTICLE\n",
      "\n",
      "-----> 6871. RETRACTED ARTICLE\n",
      "\n",
      "-----> 8818. RETRACTED ARTICLE\n",
      "\n",
      "4 -- Article 9165, lines 413689 to 413725 lacks year.\n",
      "5 -- Article 9219, lines 416100 to 416140 lacks year.\n",
      "6 -- Article 9445, lines 427227 to 427311 lacks year.\n"
     ]
    }
   ],
   "source": [
    "articles = []\n",
    "retracted_articles = []\n",
    "\n",
    "count1 = 0\n",
    "count2 = 0\n",
    "for i in range(0, len(articles_start) - 1):\n",
    "#     print(articles_start[i],articles_start[i+1])\n",
    "    info = copy( data[articles_start[i]:articles_start[i+1]])\n",
    "    \n",
    "    try:\n",
    "        flag, article = get_article_data(info)\n",
    "        \n",
    "        if flag:\n",
    "            retracted_articles.append( article )\n",
    "    \n",
    "        articles.append( article )\n",
    "\n",
    "    except IndexError:\n",
    "        count1 += 1\n",
    "        print( f\"{count1} -- Article {i+1}, lines {articles_start[i]} to \"\n",
    "               f\"{articles_start[i+1]} failed to process\" )\n",
    "        articles.append( None )\n",
    "        \n",
    "    except ValueError:\n",
    "        count2 += 1\n",
    "        print( f\"{count2} -- Article {i+1}, lines {articles_start[i]} to \"\n",
    "               f\"{articles_start[i+1]} lacks year.\" )\n",
    "        articles.append( None )\n",
    "        \n",
    "    except:\n",
    "        print( f\"Article {i+1}, lines {articles_start[i]} to \"\n",
    "               f\"{articles_start[i+1]}.\" )\n",
    "        flag, article = get_article_data(info)\n",
    "        \n",
    "    \n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "id": "49e128f6",
   "metadata": {},
   "source": [
    "## Manual corrections"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 211,
   "id": "35c01a7f",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:05.935004Z",
     "start_time": "2024-01-10T16:27:05.914353Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'BMJ', 'year': 2007, 'date': ' Mar 3', 'volume': '334(7591)', 'pages': '437-8', 'doi': '10.1136/bmj.39114.354248.80', 'title': 'Management of breast cancer in women with BRCA gene mutation.', 'authors': 'Kell MR, Burke JP', 'affiliations': None, 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'Breast conservation surgery is safe in selected women when combined with adjuvant therapy'} \n",
      "\n",
      "{'retraction': None, 'journal': 'BMJ', 'year': 2007, 'date': ' Mar 3', 'volume': '334(7591)', 'pages': '437-8', 'doi': '10.1136/bmj.39114.354248.80', 'title': 'Management of breast cancer in women with BRCA gene mutation.', 'authors': 'Kell MR, Burke JP', 'affiliations': None, 'erratum': None, 'comment': None, 'abstract': 'Breast conservation surgery is safe in selected women when combined with adjuvant therapy', 'copyright': None, 'other_ids': 'DOI: 10.1136/bmj.39114.354248.80 PMCID: PMC1808129 PMID: 17332541 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 265\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = 'Breast conservation surgery is safe in selected women when combined with adjuvant therapy'\n",
    "articles[i]['other_ids'] = 'DOI: 10.1136/bmj.39114.354248.80 PMCID: PMC1808129 PMID: 17332541 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 212,
   "id": "cae72a80",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:07.124558Z",
     "start_time": "2024-01-10T16:27:07.101307Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Biomedica', 'year': 2021, 'date': ' Dec 15', 'volume': '41(4)', 'pages': '773-786', 'doi': '10.7705/biomedica.5663', 'title': 'Correlation between the number of false positive variants and the quality of results using Ion Torrent PGM™ sequencing to screen BRCA genes.', 'authors': 'Gouvêa Moreira TC(1), Da Silva Spínola P(2), Campos Rezende M(3), Moreira de Freitas CS(3), Borges Mury F(4), Rodrigues Bonvicino C(2), De Andrade Agostinho L(5)', 'affiliations': 'Author information: (1)Hospital do Câncer de Muriaé, Fundação Cristiano Varella, Muriaé, Brazil;\\xa0Centro Universitário UNIFAMINAS, Muriaé, Brazil. biomedica@ins.gov.co. (2)Divisão de Genética, Instituto Nacional do Câncer, Rio de Janeiro, Brazil; Programa de Pós-Graduação em Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. biomedica@ins.gov.co. (3)Hospital do Câncer de Muriaé, Fundação Cristiano Varella, Muriaé, Brazil; Instituto de Ensino e Pesquisa Santa Casa BH, Belo Horizonte, Brazil. biomedica@ins.gov.co. (4)Thermo Fisher Scientific, São Paulo, Brazil. biomedica@ins.gov.co. (5)UNIFAMINASHospital do Câncer de Muriaé, Fundação Cristiano Varella, Muriaé, Brazil; Centro Universitário UNIFAMINAS, Muriaé, Brazil; Programa de Pós-Graduação em Neurologia, Universidade Federal do Estado do Rio de Janeiro Rio de Janeiro, Brazil. polucita@yahoo.com.br', 'erratum': None, 'comment': None, 'abstract': 'INTRODUCTION: Next Generation Sequencing (NGS) is cost-effective and a faster method to study genes, but its protocol is challenging. OBJECTIVE: To analyze different adjustments to the protocol for screening the BRCA genes using Ion Torrent PGM sequencing and correlate the results with the number of false positive (FP) variants. MATERIAL AND METHODS: We conducted a library preparation process and analyzed the number of FP InDels, the library concentration, the number of cycles in the target amplification step, the purity of the nucleic acid, the input, and the number of samples/Ion 314 chips in association with the results obtained by NGS. RESULTS: We carried out 51 reactions and nine adjustments of protocols and observed eight FP InDels in homopolymer regions. No FP Single-Nucleotide Polymorphism variant was observed; 67.5% of protocol variables were jointly associated with the quality of the results obtained (p<0.05). The number of FP InDels decreased when the quality of results increased. CONCLUSION: The Ion AmpliSeq BRCA1/BRCA2 Community Panel had a better performance using four samples per Ion-314 chip instead of eight and the optimum number of cycles in the amplification step, even when using high-quality DNA, was 23. We observed better results with the manual equalization process and not using the Ion Library Equalizer kit. These adjustments provided a higher coverage of the variants and fewer artifacts (6.7-fold). Laboratories must perform internal validation because FP InDel variants can vary according to the quality of results while the NGS assay should be validated with Sanger. Publisher: Introducción. La secuenciación de nueva generación es un método rentable y rápido para el estudio de los genes, pero su protocolo entraña desafíos. Objetivo. Investigar diferentes ajustes del protocolo de selección de los genes BRCA mediante secuenciación de Ion Torrent PGM™ y correlacionar los resultados con el número de variantes de falso positivo. Materiales y métodos. El proceso de preparación de la biblioteca, el número de falsos positivos InDels, la concentración de la biblioteca, el número de ciclos en el paso de amplificación de objetivos, la pureza del ácido nucleico, la entrada y el número de muestras por chip del Ion-314 se analizaron en asociación con los resultados obtenidos por secuenciación de nueva generación secuenciación de nueva generación. Resultados. Se hicieron 51 reacciones y nueve ajustes de los protocolos, y se observaron ocho falsos positivos InDels en las regiones de homopolímeros. No se observó ninguna variante de polimorfismo de nucleótido simple falso positivo. En 67,5 % de los casos, las variables de protocolo en su conjunto se asociaron con la calidad de los resultados obtenidos (p<0,05). El número de falsos positivos InDels disminuyó al aumentar la calidad de los resultados. Conclusiones. El panel comunitario Ion AmpliSeq BRCA1/BRCA2 tuvo un mejor rendimiento, con cuatro muestras por chip Ion-314 en lugar de ocho, y el número de ciclos en el paso de amplificación, incluso con ADN de alta calidad, fue mejor con 23. Se observaron mejores resultados con el proceso de ecualización manual y sin el uso del kit Ion Library Equalizer. Estos ajustes proporcionaron una mayor cobertura de las variantes y menos artefactos. Los laboratorios deben realizar la validación interna porque las variantes de falsos positivos InDel pueden variar según la calidad de los resultados. La secuenciación de próxima generación debe validarse con Sanger.', 'copyright': None, 'other_ids': 'INTRODUCCIÓN. La secuenciación de nueva generación es un método rentable y rápido para el estudio de los genes, pero su protocolo entraña desafíos. OBJETIVO. Investigar diferentes ajustes del protocolo de selección de los genes BRCA mediante secuenciación de Ion Torrent PGM™ y correlacionar los resultados con el número de variantes de falso positivo. MATERIALES Y MÉTODOS. El proceso de preparación de la biblioteca, el número de falsos positivos InDels, la concentración de la biblioteca, el número de ciclos en el paso de amplificación de objetivos, la pureza del ácido nucleico, la entrada y el número de muestras por chip del Ion-314 se analizaron en asociación con los resultados obtenidos por secuenciación de nueva generación secuenciación de nueva generación. RESULTADOS. Se hicieron 51 reacciones y nueve ajustes de los protocolos, y se observaron ocho falsos positivos InDels en las regiones de homopolímeros. No se observó ninguna variante de polimorfismo de nucleótido simple falso positivo. En 67,5 % de los casos, las variables de protocolo en su conjunto se asociaron con la calidad de los resultados obtenidos (p<0,05). El número de falsos positivos InDels disminuyó al aumentar la calidad de los resultados. CONCLUSIONES. El panel comunitario Ion AmpliSeq BRCA1/BRCA2 tuvo un mejor rendimiento, con cuatro muestras por chip Ion-314 en lugar de ocho, y el número de ciclos en el paso de amplificación, incluso con ADN de alta calidad, fue mejor con 23. Se observaron mejores resultados con el proceso de ecualización manual y sin el uso del kit Ion Library Equalizer. Estos ajustes proporcionaron una mayor cobertura de las variantes y menos artefactos. Los laboratorios deben realizar la validación interna porque las variantes de falsos positivos InDel pueden variar según la calidad de los resultados. La secuenciación de próxima generación debe validarse con Sanger.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Biomedica', 'year': 2021, 'date': ' Dec 15', 'volume': '41(4)', 'pages': '773-786', 'doi': '10.7705/biomedica.5663', 'title': 'Correlation between the number of false positive variants and the quality of results using Ion Torrent PGM™ sequencing to screen BRCA genes.', 'authors': 'Gouvêa Moreira TC(1), Da Silva Spínola P(2), Campos Rezende M(3), Moreira de Freitas CS(3), Borges Mury F(4), Rodrigues Bonvicino C(2), De Andrade Agostinho L(5)', 'affiliations': 'Author information: (1)Hospital do Câncer de Muriaé, Fundação Cristiano Varella, Muriaé, Brazil;\\xa0Centro Universitário UNIFAMINAS, Muriaé, Brazil. biomedica@ins.gov.co. (2)Divisão de Genética, Instituto Nacional do Câncer, Rio de Janeiro, Brazil; Programa de Pós-Graduação em Genética, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. biomedica@ins.gov.co. (3)Hospital do Câncer de Muriaé, Fundação Cristiano Varella, Muriaé, Brazil; Instituto de Ensino e Pesquisa Santa Casa BH, Belo Horizonte, Brazil. biomedica@ins.gov.co. (4)Thermo Fisher Scientific, São Paulo, Brazil. biomedica@ins.gov.co. (5)UNIFAMINASHospital do Câncer de Muriaé, Fundação Cristiano Varella, Muriaé, Brazil; Centro Universitário UNIFAMINAS, Muriaé, Brazil; Programa de Pós-Graduação em Neurologia, Universidade Federal do Estado do Rio de Janeiro Rio de Janeiro, Brazil. polucita@yahoo.com.br', 'erratum': None, 'comment': None, 'abstract': 'INTRODUCTION: Next Generation Sequencing (NGS) is cost-effective and a faster method to study genes, but its protocol is challenging. OBJECTIVE: To analyze different adjustments to the protocol for screening the BRCA genes using Ion Torrent PGM sequencing and correlate the results with the number of false positive (FP) variants. MATERIAL AND METHODS: We conducted a library preparation process and analyzed the number of FP InDels, the library concentration, the number of cycles in the target amplification step, the purity of the nucleic acid, the input, and the number of samples/Ion 314 chips in association with the results obtained by NGS. RESULTS: We carried out 51 reactions and nine adjustments of protocols and observed eight FP InDels in homopolymer regions. No FP Single-Nucleotide Polymorphism variant was observed; 67.5% of protocol variables were jointly associated with the quality of the results obtained (p<0.05). The number of FP InDels decreased when the quality of results increased. CONCLUSION: The Ion AmpliSeq BRCA1/BRCA2 Community Panel had a better performance using four samples per Ion-314 chip instead of eight and the optimum number of cycles in the amplification step, even when using high-quality DNA, was 23. We observed better results with the manual equalization process and not using the Ion Library Equalizer kit. These adjustments provided a higher coverage of the variants and fewer artifacts (6.7-fold). Laboratories must perform internal validation because FP InDel variants can vary according to the quality of results while the NGS assay should be validated with Sanger. Publisher: Introducción. La secuenciación de nueva generación es un método rentable y rápido para el estudio de los genes, pero su protocolo entraña desafíos. Objetivo. Investigar diferentes ajustes del protocolo de selección de los genes BRCA mediante secuenciación de Ion Torrent PGM™ y correlacionar los resultados con el número de variantes de falso positivo. Materiales y métodos. El proceso de preparación de la biblioteca, el número de falsos positivos InDels, la concentración de la biblioteca, el número de ciclos en el paso de amplificación de objetivos, la pureza del ácido nucleico, la entrada y el número de muestras por chip del Ion-314 se analizaron en asociación con los resultados obtenidos por secuenciación de nueva generación secuenciación de nueva generación. Resultados. Se hicieron 51 reacciones y nueve ajustes de los protocolos, y se observaron ocho falsos positivos InDels en las regiones de homopolímeros. No se observó ninguna variante de polimorfismo de nucleótido simple falso positivo. En 67,5 % de los casos, las variables de protocolo en su conjunto se asociaron con la calidad de los resultados obtenidos (p<0,05). El número de falsos positivos InDels disminuyó al aumentar la calidad de los resultados. Conclusiones. El panel comunitario Ion AmpliSeq BRCA1/BRCA2 tuvo un mejor rendimiento, con cuatro muestras por chip Ion-314 en lugar de ocho, y el número de ciclos en el paso de amplificación, incluso con ADN de alta calidad, fue mejor con 23. Se observaron mejores resultados con el proceso de ecualización manual y sin el uso del kit Ion Library Equalizer. Estos ajustes proporcionaron una mayor cobertura de las variantes y menos artefactos. Los laboratorios deben realizar la validación interna porque las variantes de falsos positivos InDel pueden variar según la calidad de los resultados. La secuenciación de próxima generación debe validarse con Sanger.', 'copyright': None, 'other_ids': 'DOI: 10.7705/biomedica.5663 PMCID: PMC8768485 PMID: 34936260 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 364\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'DOI: 10.7705/biomedica.5663 PMCID: PMC8768485 PMID: 34936260 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 213,
   "id": "5c66b5ab",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:08.500296Z",
     "start_time": "2024-01-10T16:27:08.479029Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Am J Nurs', 'year': 2016, 'date': ' Nov', 'volume': '116(11)', 'pages': '17', 'doi': '10.1097/01.NAJ.0000505576.27516.9d', 'title': 'New Advisory on Contralateral Prophylactic Mastectomy.', 'authors': 'Zolot J(1)', 'affiliations': 'Author information: (1)Joan Zolot, PA', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'Breast surgeons recommend against the procedure unless cancer risk is increased.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Am J Nurs', 'year': 2016, 'date': ' Nov', 'volume': '116(11)', 'pages': '17', 'doi': '10.1097/01.NAJ.0000505576.27516.9d', 'title': 'New Advisory on Contralateral Prophylactic Mastectomy.', 'authors': 'Zolot J(1)', 'affiliations': 'Author information: (1)Joan Zolot, PA', 'erratum': None, 'comment': None, 'abstract': 'Breast surgeons recommend against the procedure unless cancer risk is increased.', 'copyright': None, 'other_ids': 'DOI: 10.1097/01.NAJ.0000505576.27516.9d PMID: 27787313 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 442\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = 'Breast surgeons recommend against the procedure unless cancer risk is increased.'\n",
    "articles[i]['other_ids'] = 'DOI: 10.1097/01.NAJ.0000505576.27516.9d PMID: 27787313 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 214,
   "id": "e291ecbf",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:09.623364Z",
     "start_time": "2024-01-10T16:27:09.599457Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'J Fam Pract', 'year': 2020, 'date': ' Jun', 'volume': '69(5)', 'pages': '237-243', 'doi': None, 'title': 'Managing a woman with BRCA mutations? Shared decision-making is key.', 'authors': 'Schrager S(1), Torell E(2), Ledford K(3), Elezaby M(4), Barroleit L(5), Sadowski E(4)', 'affiliations': 'Author information: (1)University of Wisconsin Department of Family Medicine and Community Health, Madison, USA. Email: sbschrag@wisc.edu. (2)Indian Health Board, Minneapolis, MN, USA. (3)Group Health of Wisconsin, Madison, USA. (4)University of Wisconsin Department of Radiology, Madison, USA. (5)University of Wisconsin Department of Obstetrics and Gynecology, Madison, USA', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'A collaborative assessment of options and trade-offs-perhaps using visual decision aids-can help.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'J Fam Pract', 'year': 2020, 'date': ' Jun', 'volume': '69(5)', 'pages': '237-243', 'doi': None, 'title': 'Managing a woman with BRCA mutations? Shared decision-making is key.', 'authors': 'Schrager S(1), Torell E(2), Ledford K(3), Elezaby M(4), Barroleit L(5), Sadowski E(4)', 'affiliations': 'Author information: (1)University of Wisconsin Department of Family Medicine and Community Health, Madison, USA. Email: sbschrag@wisc.edu. (2)Indian Health Board, Minneapolis, MN, USA. (3)Group Health of Wisconsin, Madison, USA. (4)University of Wisconsin Department of Radiology, Madison, USA. (5)University of Wisconsin Department of Obstetrics and Gynecology, Madison, USA', 'erratum': None, 'comment': None, 'abstract': 'A collaborative assessment of options and trade-offs-perhaps using visual decision aids-can help.', 'copyright': None, 'other_ids': 'PMID: 32555753 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 1662\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = 'A collaborative assessment of options and trade-offs-perhaps using visual decision aids-can help.'\n",
    "articles[i]['other_ids'] = 'PMID: 32555753 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 215,
   "id": "f4541ca2",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:10.518829Z",
     "start_time": "2024-01-10T16:27:10.496229Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Probl Radiac Med Radiobiol', 'year': 2013, 'date': '', 'volume': '(18)', 'pages': '253-60', 'doi': None, 'title': 'Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer. [Article in English, Ukrainian; Abstract available in Ukrainian from the publisher]', 'authors': 'Rybchenko LA, Bychkova AM, Skyban GV, Klymenko SV', 'affiliations': None, 'erratum': None, 'comment': None, 'abstract': \"Burdened family history of breast and/or ovarian cancer may indicate the mutations carriage in the BRCA1 and BRCA2 genes. OBJECTIVE: Estimation and compare of the Manchester Scoring system, Penn II and Myriad algorithm in an ability to distinguish the cases with BRCA1/2 mutation those and no mutant alleles at the individual level among the Ukrainian women with early onset of a breast cancer and/or compromised family history with breast cancer and/or ovarian cancer. MATERIAL AND METHODS: Results of genealogy, molecular genetic and morphological study from 44 females with breast cancer, with early development of the disease or family history of a breast cancer and/or ovarian cancer were the material of research. Determination of carriers BRCA1 and BRCA2 mutations among women was performed by Manchester Scoring system and Penn II and Myriad algorithm. RESULTS AND CONCLUSIONS: Manchester Scoring system has better capacity to distinguish patients with and without mutant alleles at the individual level. The area under the curve of Manchester Scoring system is 0.84, Penn II - 0.66, Myriad - 0.68. Publisher: Obtjazhenist' simejnogo anamnezu shhodo raku molochnoi' zalozy ta/abo raku jajechnykiv mozhe svidchyty pro nosijstvo mutacii' v BRCA1 ta BRCA2 genah. Meta: ocinyty ta porivnjaty mozhlyvosti Manchesters'koi' bal'noi' systemy, algorytmu Penn II ta Myriad na indyvidual'nomu rivni vidriznjaty pacijentiv z mutacijeju BRCA1/2 ta osib bez mutantnyh alelej sered ukrai'ns'kyh zhinok z rannim rozvytkom raku molochnoi' zalozy ta/abo obtjazhenym simejnym anamnezom shhodo raku molochnoi' zalozy ta/abo raku jajechnykiv. Material ta metody doslidzhennja. Materialom doslidzhennja sluguvaly rezul'taty genealogichnogo, molekuljarno-genetychnogo ta kliniko-morfologichnogo obstezhennja 44 osib, hvoryh na rak molochnoi' zalozy, z rannim rozvytkom zahvorjuvannja abo z obtjazhenym simejnym anamnezom shhodo onkologichnoi' patologii' molochnoi' zalozy ta/abo jajechnykiv. Vyznachennja najbil'sh imovirnyh nosii'v mutacij BRCA1 i BRCA2 sered obstezhenyh zhinok provodyly za dopomogoju tr'oh vyshhezgadanyh algorytmiv. Rezul'taty ta vysnovky. Manchesters'ka bal'na systema maje krashhu zdatnist' na indyvidual'nomu rivni vidriznjaty pacijentiv z mutacijeju ta osib bez mutantnyh alelej. Ploshha pid kryvoju Manchesters'koi' bal'noi' systemy skladaje 0,84, Penn II – 0,66, Myriad – 0,68.\", 'copyright': None, 'other_ids': 'Rybchenko L. A., Bychkova G. M., Skyban G. V., Klymenko S. V., 2013.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Probl Radiac Med Radiobiol', 'year': 2013, 'date': '', 'volume': '(18)', 'pages': '253-60', 'doi': None, 'title': 'Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer. [Article in English, Ukrainian; Abstract available in Ukrainian from the publisher]', 'authors': 'Rybchenko LA, Bychkova AM, Skyban GV, Klymenko SV', 'affiliations': None, 'erratum': None, 'comment': None, 'abstract': \"Burdened family history of breast and/or ovarian cancer may indicate the mutations carriage in the BRCA1 and BRCA2 genes. OBJECTIVE: Estimation and compare of the Manchester Scoring system, Penn II and Myriad algorithm in an ability to distinguish the cases with BRCA1/2 mutation those and no mutant alleles at the individual level among the Ukrainian women with early onset of a breast cancer and/or compromised family history with breast cancer and/or ovarian cancer. MATERIAL AND METHODS: Results of genealogy, molecular genetic and morphological study from 44 females with breast cancer, with early development of the disease or family history of a breast cancer and/or ovarian cancer were the material of research. Determination of carriers BRCA1 and BRCA2 mutations among women was performed by Manchester Scoring system and Penn II and Myriad algorithm. RESULTS AND CONCLUSIONS: Manchester Scoring system has better capacity to distinguish patients with and without mutant alleles at the individual level. The area under the curve of Manchester Scoring system is 0.84, Penn II - 0.66, Myriad - 0.68. Publisher: Obtjazhenist' simejnogo anamnezu shhodo raku molochnoi' zalozy ta/abo raku jajechnykiv mozhe svidchyty pro nosijstvo mutacii' v BRCA1 ta BRCA2 genah. Meta: ocinyty ta porivnjaty mozhlyvosti Manchesters'koi' bal'noi' systemy, algorytmu Penn II ta Myriad na indyvidual'nomu rivni vidriznjaty pacijentiv z mutacijeju BRCA1/2 ta osib bez mutantnyh alelej sered ukrai'ns'kyh zhinok z rannim rozvytkom raku molochnoi' zalozy ta/abo obtjazhenym simejnym anamnezom shhodo raku molochnoi' zalozy ta/abo raku jajechnykiv. Material ta metody doslidzhennja. Materialom doslidzhennja sluguvaly rezul'taty genealogichnogo, molekuljarno-genetychnogo ta kliniko-morfologichnogo obstezhennja 44 osib, hvoryh na rak molochnoi' zalozy, z rannim rozvytkom zahvorjuvannja abo z obtjazhenym simejnym anamnezom shhodo onkologichnoi' patologii' molochnoi' zalozy ta/abo jajechnykiv. Vyznachennja najbil'sh imovirnyh nosii'v mutacij BRCA1 i BRCA2 sered obstezhenyh zhinok provodyly za dopomogoju tr'oh vyshhezgadanyh algorytmiv. Rezul'taty ta vysnovky. Manchesters'ka bal'na systema maje krashhu zdatnist' na indyvidual'nomu rivni vidriznjaty pacijentiv z mutacijeju ta osib bez mutantnyh alelej. Ploshha pid kryvoju Manchesters'koi' bal'noi' systemy skladaje 0,84, Penn II – 0,66, Myriad – 0,68.\", 'copyright': None, 'other_ids': 'PMID: 25191729 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 2453\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'PMID: 25191729 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 216,
   "id": "93d58711",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:11.448802Z",
     "start_time": "2024-01-10T16:27:11.425483Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Probl Radiac Med Radiobiol', 'year': 2019, 'date': ' Dec', 'volume': '24', 'pages': '455-464', 'doi': '10.33145/2304-8336-2019-24-455-464', 'title': 'MUTATIONS OF GENES BRCA1 AND BRCA2 IN WOMEN WITH OVARIAN CANCER EXPOSED TO FACTORS OF CHORNOBYL NUCLEAR ACCIDENT. [Article in English, Ukrainian; Abstract available in Ukrainian from the publisher]', 'authors': 'Rybchenko LA(1), Poluben LO(1), Bychkova GM(1), Stephanovych GV(1), Klymenko SV(1)', 'affiliations': 'Author information: (1)State Institution «National Research Center for Radiation Medicine of the National Academy of MedicalSciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine', 'erratum': None, 'comment': None, 'abstract': \"OBJECTIVE: to determine a frequency of germline mutations 185delAG, 5382insC in BRCA1 gene and 6174delT in BRCA2 gene in Ukrainian patients with OC including women who were exposed to the factors of Chornobyl nuclear accident. MATERIAL AND METHODS: In the study we enrolled 306 OC patients of different age who were tested for the presence of the major BRCA1 and BRCA2 gene mutations using allele specific multiplex polymerase chain reaction. RESULTS: The mutation frequency in patients exposed to IR with OC (main group) was 5.3 % (2 from 38). Among unexposed patients (control group) 11,2 % (30 from 268) of cases with mutation were identified. However, the dif- ference between the groups was not significant (p = 0.39). It was shown that the BRCA1/2 mutations frequency in the patient of both groups was 10,4 % (32 from 306). The mutation BRCA1 5382insC was positive in 87.5 % (28 from 32) of cases, nevertheless nobody was identified with the allelic variant BRCA2 6174delT among both groups. There was a tendency toward an earlier age of the OC manifestation in the patients exposed to IR due to Chornobyl nuclear accident compared to BRCA-positive women of the control group (р = 0.06). When comparing BRCA-positive and BRCA-negative patients with OC of the main group, there was a statistical significance regarding the earlier age of the disease manifestation in the patients with mutations (р = 0.04). However, such difference was not observed in the control group (р = 0.22). CONCLUSIONS: The frequency of the mutations in exposed to IR and unexposed patients with OC does not differ and depends on a spectrum of studied BRCA1/2 gene mutations, level of DNA amplification and sample number. The allel- ic variant BRCA1 5382insC is dominant and accounts for 87.5 % of the total number of the found mutations. Due to the radiation factor the OC in the BRCA1-positive individuals is realized at the earlier age than in patients negative for these mutations. The incidence of OC after the Chornobyl accident was observed 27-38 years later in a cohort of women who were from 4 to 40 years old at the moment of the nuclear explosion. Publisher: Meta: vstanovyty chastotu germinal'nykh mutatsiy̆ 185delAG, 5382insC gena BRCA1 i 6174delT gena BRCA2 u khvorykh na rak iaiechnykiv (RIa) v Ukraïni, zokrema u zhinok, iaki zaznaly vplyvu chynnykiv Chornobyl's'koï katastrofy. Materialy i metody. U doslidzhennia vkliucheno 306 khvorykh na RIa riznogo viku, iakym bulo provedeno molekuliar- no-genetychne vyznachennia mazhornykh mutatsiy̆ v genakh BRCA1 i BRCA2 za dopomogoiu alel'-spetsyfichnoï mul'typle- ksnoï polimeraznoï reaktsiï.Rezul'taty. Chastota mutatsiy̆ u khvorykh na RIa z radiatsiy̆nym anamnezom (osnovna grupa) sklala 5,3 % (2 z 38). U khvorykh bez radiatsiy̆nogo anamnezu (kontrol'na grupa) vyiavleno 11,2 % (30 z 268) vypadkiv z mutatsiieiu. Prote znachushchoï riznytsi v chastoti mutatsiy̆ mizh grupamy khvorykh vyiavleno ne bulo (p = 0,39). Vstanovleno, shcho chastota mu- tatsiy̆ BRCA1/2 u patsiientiv obokh grup sklala 10,4 % (32 iz 306). Na doliu mutatsiï 5382insC u geni BRCA1 prypadaie 87,5 % (28 z 32) vypadkiv z mutatsiieiu, natomist' alel'nyy̆ variant 6174delT gena BRCA2 ne vyiavleno u zhodnoï patsiientky obokh grup. Vyiavleno tendentsiiu do bil'sh rann'ogo viku zakhvoriuvannia na RIa u postrazhdalykh vnaslidok avariï na ChAES z mutatsiiamy porivniano z BRCA-pozytyvnymy osobamy kontrol'noï grupy (r = 0,06). Pry porivnianni khvorykh z BRCA-pozytyvnym RIa ta BRCA-negatyvnym RIa osnovnoï kogorty vstanovleno statystychnu zna- chushchist' shchodo manifestatsiï zakhvoriuvannia u patsiientiv z mutatsiiamy v bil'sh rann'omu vitsi (r = 0,04). Odnak takykh vidminnostey̆ ne sposterigalosia v kontrol'niy̆ grupi (r = 0,22).Vysnovky. Chastota mutatsiy̆ u khvorykh na RIa z radiatsiy̆nym anamnezom i bez takogo ne vidrizniaiet'sia ta zalezhyt' vid spektru doslidzhuvanykh mutatsiy̆ u genakh BRCA1/2, vid stupenia amplifikatsiï DNK i chysel'nosti vybirky. Alel'- nyy̆ variant 5382insC u geni BRCA1 ie dominuiuchym i stanovyt' 87,5 % vid zagal'noï kil'kosti znay̆denykh mutatsiy̆. Cherez diiu radiatsiy̆nogo faktora zakhvoriuvannia na RIa u BRCA1-pozytyvnykh osib realizuiet'sia u bil'sh rann'omu vitsi, nizh u patsiientiv bez mutatsiy̆. Zakhvoriuvanist' na RIa sposterigalas' til'ky cherez 27–38 rokiv pislia Chorno- byl's'koï katastrofy u kogorti zhinok, iakym na moment avariï bulo vid 4 do 40 rokiv.\", 'copyright': None, 'other_ids': 'L. A. Rybchenko, L. O. Poluben, G. M. Bychkova, G. V. Stephanovych, S. V. Klymenko.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Probl Radiac Med Radiobiol', 'year': 2019, 'date': ' Dec', 'volume': '24', 'pages': '455-464', 'doi': '10.33145/2304-8336-2019-24-455-464', 'title': 'MUTATIONS OF GENES BRCA1 AND BRCA2 IN WOMEN WITH OVARIAN CANCER EXPOSED TO FACTORS OF CHORNOBYL NUCLEAR ACCIDENT. [Article in English, Ukrainian; Abstract available in Ukrainian from the publisher]', 'authors': 'Rybchenko LA(1), Poluben LO(1), Bychkova GM(1), Stephanovych GV(1), Klymenko SV(1)', 'affiliations': 'Author information: (1)State Institution «National Research Center for Radiation Medicine of the National Academy of MedicalSciences of Ukraine», 53 Yuriia Illienka St., Kyiv, 04050, Ukraine', 'erratum': None, 'comment': None, 'abstract': \"OBJECTIVE: to determine a frequency of germline mutations 185delAG, 5382insC in BRCA1 gene and 6174delT in BRCA2 gene in Ukrainian patients with OC including women who were exposed to the factors of Chornobyl nuclear accident. MATERIAL AND METHODS: In the study we enrolled 306 OC patients of different age who were tested for the presence of the major BRCA1 and BRCA2 gene mutations using allele specific multiplex polymerase chain reaction. RESULTS: The mutation frequency in patients exposed to IR with OC (main group) was 5.3 % (2 from 38). Among unexposed patients (control group) 11,2 % (30 from 268) of cases with mutation were identified. However, the dif- ference between the groups was not significant (p = 0.39). It was shown that the BRCA1/2 mutations frequency in the patient of both groups was 10,4 % (32 from 306). The mutation BRCA1 5382insC was positive in 87.5 % (28 from 32) of cases, nevertheless nobody was identified with the allelic variant BRCA2 6174delT among both groups. There was a tendency toward an earlier age of the OC manifestation in the patients exposed to IR due to Chornobyl nuclear accident compared to BRCA-positive women of the control group (р = 0.06). When comparing BRCA-positive and BRCA-negative patients with OC of the main group, there was a statistical significance regarding the earlier age of the disease manifestation in the patients with mutations (р = 0.04). However, such difference was not observed in the control group (р = 0.22). CONCLUSIONS: The frequency of the mutations in exposed to IR and unexposed patients with OC does not differ and depends on a spectrum of studied BRCA1/2 gene mutations, level of DNA amplification and sample number. The allel- ic variant BRCA1 5382insC is dominant and accounts for 87.5 % of the total number of the found mutations. Due to the radiation factor the OC in the BRCA1-positive individuals is realized at the earlier age than in patients negative for these mutations. The incidence of OC after the Chornobyl accident was observed 27-38 years later in a cohort of women who were from 4 to 40 years old at the moment of the nuclear explosion. Publisher: Meta: vstanovyty chastotu germinal'nykh mutatsiy̆ 185delAG, 5382insC gena BRCA1 i 6174delT gena BRCA2 u khvorykh na rak iaiechnykiv (RIa) v Ukraïni, zokrema u zhinok, iaki zaznaly vplyvu chynnykiv Chornobyl's'koï katastrofy. Materialy i metody. U doslidzhennia vkliucheno 306 khvorykh na RIa riznogo viku, iakym bulo provedeno molekuliar- no-genetychne vyznachennia mazhornykh mutatsiy̆ v genakh BRCA1 i BRCA2 za dopomogoiu alel'-spetsyfichnoï mul'typle- ksnoï polimeraznoï reaktsiï.Rezul'taty. Chastota mutatsiy̆ u khvorykh na RIa z radiatsiy̆nym anamnezom (osnovna grupa) sklala 5,3 % (2 z 38). U khvorykh bez radiatsiy̆nogo anamnezu (kontrol'na grupa) vyiavleno 11,2 % (30 z 268) vypadkiv z mutatsiieiu. Prote znachushchoï riznytsi v chastoti mutatsiy̆ mizh grupamy khvorykh vyiavleno ne bulo (p = 0,39). Vstanovleno, shcho chastota mu- tatsiy̆ BRCA1/2 u patsiientiv obokh grup sklala 10,4 % (32 iz 306). Na doliu mutatsiï 5382insC u geni BRCA1 prypadaie 87,5 % (28 z 32) vypadkiv z mutatsiieiu, natomist' alel'nyy̆ variant 6174delT gena BRCA2 ne vyiavleno u zhodnoï patsiientky obokh grup. Vyiavleno tendentsiiu do bil'sh rann'ogo viku zakhvoriuvannia na RIa u postrazhdalykh vnaslidok avariï na ChAES z mutatsiiamy porivniano z BRCA-pozytyvnymy osobamy kontrol'noï grupy (r = 0,06). Pry porivnianni khvorykh z BRCA-pozytyvnym RIa ta BRCA-negatyvnym RIa osnovnoï kogorty vstanovleno statystychnu zna- chushchist' shchodo manifestatsiï zakhvoriuvannia u patsiientiv z mutatsiiamy v bil'sh rann'omu vitsi (r = 0,04). Odnak takykh vidminnostey̆ ne sposterigalosia v kontrol'niy̆ grupi (r = 0,22).Vysnovky. Chastota mutatsiy̆ u khvorykh na RIa z radiatsiy̆nym anamnezom i bez takogo ne vidrizniaiet'sia ta zalezhyt' vid spektru doslidzhuvanykh mutatsiy̆ u genakh BRCA1/2, vid stupenia amplifikatsiï DNK i chysel'nosti vybirky. Alel'- nyy̆ variant 5382insC u geni BRCA1 ie dominuiuchym i stanovyt' 87,5 % vid zagal'noï kil'kosti znay̆denykh mutatsiy̆. Cherez diiu radiatsiy̆nogo faktora zakhvoriuvannia na RIa u BRCA1-pozytyvnykh osib realizuiet'sia u bil'sh rann'omu vitsi, nizh u patsiientiv bez mutatsiy̆. Zakhvoriuvanist' na RIa sposterigalas' til'ky cherez 27–38 rokiv pislia Chorno- byl's'koï katastrofy u kogorti zhinok, iakym na moment avariï bulo vid 4 do 40 rokiv.\", 'copyright': None, 'other_ids': 'DOI: 10.33145/2304-8336-2019-24-455-464 PMID: 31841487 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 4116\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'DOI: 10.33145/2304-8336-2019-24-455-464 PMID: 31841487 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 217,
   "id": "a2914334",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:12.592368Z",
     "start_time": "2024-01-10T16:27:12.568372Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Probl Radiac Med Radiobiol', 'year': 2015, 'date': ' Dec', 'volume': '20', 'pages': '12-24', 'doi': None, 'title': 'State Institution \"National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine\" - research activities and scientific advance in 2014. [Article in English, Ukrainian; Abstract available in Ukrainian from the publisher]', 'authors': 'Bazyka D(1), Sushko V(1), Chumak A(1), Buzunov V(1), Talko V(1), Yanovich L(1)', 'affiliations': 'Author information: (1)State Institution National Research Center for Radiation Medicine of the National Academy of MedicalSciences of Ukraine, Melnykov str., 53, Kyiv, 04050, Ukraine', 'erratum': None, 'comment': None, 'abstract': 'Research activities and scientific advance achieved in 2014 at the State Institution \"National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine\" (NRCRM) concerning medical problems of the Chornobyl disaster, radiation medicine, radiobiology, radiation hygiene and epidemiology in collaboration with the WHO network of medical preparedness and assistance in radiation accidents are outlined in the annual report.Epidemiological cohort studies found increased incidence (1990-2012 gg.) of thyroid cancer in victims of Chernobyl accident (liquidators - in 4.6 times, evacuated - in 4.0 times, residents of contaminated areas - in 1.3 times) and increased incidence of breast cancer in female workers of 1986-1987. (in the 1994-2012 biennium. SIR = 160,0%, 95% CI: 142,4-177,6). Retrospective studies of thyroid cancer (\"case control\") in cohorts and 152 thousand of liquidators were continued together with the US National Cancer Institute. Radiation risks of multiple myeloma and chronic lymphocytic leukemia were found.Molecular effects of remote period after radiation exposure include changes in gene expression TERF1, TERF2, CCND1, telomere length, the protein expression of cyclin D1, histone gamma H2AX. An association of molecular changes with cognitive deficits were defined. Genetic polymorphisms of rs2981582 gene FGFR2, rs12443621 gene TNRC9, rs3817198 gene LSP1, rs3803662 gene TNRC9, rs889312 gene MAP3K1 and their association with breast can cer were studied; the expression by tumor cells of estrogen and progesterone receptor, antigens of c kit, cytoker atins 5/6, TP53 and ki67, amplification status of the gene Her2 / neu, mutation status of the genes BRCA1 (muta tions 185delAG and 5382insC) and BRCA2 (mutation 6174delT) were studied. The possibility of persistence of radi ation modified hidden chromosomal instability in consecutive generations of human somatic cells was proven.The status of reproductive function and peculiarities of baby nutrition in population of contaminated areas were studied. In the framework of National social programs for improving safety, occupational health and working envi ronment in 2014 2018 for the first time in Ukraine developed and successfully completed intercalibration of 18 lab oratories for individual monitoring. Studying of medical effects of radiation in interventional cardiologists was started.Experimental studies concerned the impact of radiomodyficans on cell systems. The report also shows the results of scientific organizational and health care work, staff training.The NRCRM Annual Report was approved at the Scientific Council meeting of NAMS on March 17, 2015. Publisher: Shchorichnyy zvit vidobrazhuie osnovni rezul\\'taty diial\\'nosti DerzhavnoI ustanovy „Natsional\\'nyy naukovyy tsentr radiatsiynoI medytsyny Natsional\\'noI akademiI medychnykh nauk UkraIny ” (NNTsRM) z medychnykh problem Chorno byl\\'s\\'koI katastrofy, radiatsiynoI medytsyny, radiobiologiI, radiatsiynoI gigiieny ta epidemiologiI, spivpratsi z VOOZ v merezhi medychnoI gotovnosti ta dopomogy pry radiatsiynykh avariiakh u 2014 r.Epidemiologichnymy kogortnymy doslidzhenniamy vstanovleno zrostannia zakhvoriuvanosti (1990–2012 rr.) na rak shchytopodibnoI zalozy u postrazhdalykh vnaslidok avariI na ChAES (ULNA – u 4,6 raza, evakuyovanykh – u 4,0 ra zy, meshkantsiv zabrudnenykh terytoriy – u 1,3 raza) ta zrostannia chastoty raku molochnoI zalozy u zhinok ULNA 1986–1987 rr. (u 1994–2012 rr. SIR = 160,0%, 95% DI: 142,4–177,6). Spil\\'no z Natsional\\'nym instytutom raku CShA prodovzheno retrospektyvne doslidzhennia raku shchytopodibnoI zalozy „vypadok kontrol\\' ” v kogorti 152 tys. likvidatoriv. Vstanovleno radiatsiyni ryzyky miielomnoI khvoroby ta khronichnoI limfotsytarnoI leykemiI.Molekuliarni efekty viddalenogo periodu pislia oprominennia vkliuchaly zminy ekspresiI geniv TERF1, TERF2, CCND1, dovzhyny telomer, ekspresiI bilka cyclin D1, gistonu gamma H2AX. Vyznacheno asotsiatsiiu molekuliarnykh zmin z kognityvnym defitsytom. Vyvcheno genetychni polimorfizmy rs2981582 gena FGFR2, rs12443621 gena TNRC9, rs3817198 gena LSP1, rs3803662 gena TNRC9 i rs889312 gena MAP3K1 ta Ikh asotsiatsiiu z rakom molochnoI zalozy; ekspresiiu klitynamy pukhlyny retseptoriv estrogenu ta progesteronu, antygeniv c kit, tsytokeratynu 5/6, TP53 ta ki67, amplifikatsiynyy status gena Her2/neu, mutatsiynyy status geniv BRCA1 (mutatsiI 185delAG ta 5382insC) i BRCA2 (mutatsiia 6174delT). Dovedeno mozhlyvist\\' persystentsiI radiatsiyno modyfikovanoI prykhovanoI khromosom noI nestabil\\'nosti u poslidovnykh generatsiiakh somatychnykh klityn liudyny.U naselennia vyvcheno stan reproduktyvnoI funktsiI, osoblyvosti dytiachogo kharchuvannia na radioaktyvno zabrud nenykh terytoriiakh. V ramkakh vykonannia Zagal\\'noderzhavnoI sotsial\\'noI programy polipshennia stanu bezpeky, gigiieny pratsi ta vyrobnychogo seredovyshcha na 2014–2018 roky vpershe v UkraIni rozrobleno y uspishno vykonano interkalibruvannia dlia 18 laboratoriy indyvidual\\'nogo dozymetrychnogo kontroliu. Rozpochato doslidzhennia efektiv medychnogo oprominennia u interventsiynykh kardiologiv.Eksperymental\\'ni doslidzhennia stosuvalysia vplyvu radiomodyfikatoriv na klitynni systemy.V zviti takozh vidobrazheno rezul\\'taty naukovo organizatsiynoI, likuval\\'no profilaktychnoI roboty, pidgotovky kadriv ta vprovadzhennia.Zvit NNTsRM zatverdzheno na zasidanni NaukovoI rady NAMN UkraIny 17.03.2015 r.', 'copyright': None, 'other_ids': 'D. Bazyka, V. Sushko, A. Chumak, V. Buzunov, V. Talko, L. Yanovych.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Probl Radiac Med Radiobiol', 'year': 2015, 'date': ' Dec', 'volume': '20', 'pages': '12-24', 'doi': None, 'title': 'State Institution \"National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine\" - research activities and scientific advance in 2014. [Article in English, Ukrainian; Abstract available in Ukrainian from the publisher]', 'authors': 'Bazyka D(1), Sushko V(1), Chumak A(1), Buzunov V(1), Talko V(1), Yanovich L(1)', 'affiliations': 'Author information: (1)State Institution National Research Center for Radiation Medicine of the National Academy of MedicalSciences of Ukraine, Melnykov str., 53, Kyiv, 04050, Ukraine', 'erratum': None, 'comment': None, 'abstract': 'Research activities and scientific advance achieved in 2014 at the State Institution \"National Research Center for Radiation Medicine of the National Academy of Medical Sciences of Ukraine\" (NRCRM) concerning medical problems of the Chornobyl disaster, radiation medicine, radiobiology, radiation hygiene and epidemiology in collaboration with the WHO network of medical preparedness and assistance in radiation accidents are outlined in the annual report.Epidemiological cohort studies found increased incidence (1990-2012 gg.) of thyroid cancer in victims of Chernobyl accident (liquidators - in 4.6 times, evacuated - in 4.0 times, residents of contaminated areas - in 1.3 times) and increased incidence of breast cancer in female workers of 1986-1987. (in the 1994-2012 biennium. SIR = 160,0%, 95% CI: 142,4-177,6). Retrospective studies of thyroid cancer (\"case control\") in cohorts and 152 thousand of liquidators were continued together with the US National Cancer Institute. Radiation risks of multiple myeloma and chronic lymphocytic leukemia were found.Molecular effects of remote period after radiation exposure include changes in gene expression TERF1, TERF2, CCND1, telomere length, the protein expression of cyclin D1, histone gamma H2AX. An association of molecular changes with cognitive deficits were defined. Genetic polymorphisms of rs2981582 gene FGFR2, rs12443621 gene TNRC9, rs3817198 gene LSP1, rs3803662 gene TNRC9, rs889312 gene MAP3K1 and their association with breast can cer were studied; the expression by tumor cells of estrogen and progesterone receptor, antigens of c kit, cytoker atins 5/6, TP53 and ki67, amplification status of the gene Her2 / neu, mutation status of the genes BRCA1 (muta tions 185delAG and 5382insC) and BRCA2 (mutation 6174delT) were studied. The possibility of persistence of radi ation modified hidden chromosomal instability in consecutive generations of human somatic cells was proven.The status of reproductive function and peculiarities of baby nutrition in population of contaminated areas were studied. In the framework of National social programs for improving safety, occupational health and working envi ronment in 2014 2018 for the first time in Ukraine developed and successfully completed intercalibration of 18 lab oratories for individual monitoring. Studying of medical effects of radiation in interventional cardiologists was started.Experimental studies concerned the impact of radiomodyficans on cell systems. The report also shows the results of scientific organizational and health care work, staff training.The NRCRM Annual Report was approved at the Scientific Council meeting of NAMS on March 17, 2015. Publisher: Shchorichnyy zvit vidobrazhuie osnovni rezul\\'taty diial\\'nosti DerzhavnoI ustanovy „Natsional\\'nyy naukovyy tsentr radiatsiynoI medytsyny Natsional\\'noI akademiI medychnykh nauk UkraIny ” (NNTsRM) z medychnykh problem Chorno byl\\'s\\'koI katastrofy, radiatsiynoI medytsyny, radiobiologiI, radiatsiynoI gigiieny ta epidemiologiI, spivpratsi z VOOZ v merezhi medychnoI gotovnosti ta dopomogy pry radiatsiynykh avariiakh u 2014 r.Epidemiologichnymy kogortnymy doslidzhenniamy vstanovleno zrostannia zakhvoriuvanosti (1990–2012 rr.) na rak shchytopodibnoI zalozy u postrazhdalykh vnaslidok avariI na ChAES (ULNA – u 4,6 raza, evakuyovanykh – u 4,0 ra zy, meshkantsiv zabrudnenykh terytoriy – u 1,3 raza) ta zrostannia chastoty raku molochnoI zalozy u zhinok ULNA 1986–1987 rr. (u 1994–2012 rr. SIR = 160,0%, 95% DI: 142,4–177,6). Spil\\'no z Natsional\\'nym instytutom raku CShA prodovzheno retrospektyvne doslidzhennia raku shchytopodibnoI zalozy „vypadok kontrol\\' ” v kogorti 152 tys. likvidatoriv. Vstanovleno radiatsiyni ryzyky miielomnoI khvoroby ta khronichnoI limfotsytarnoI leykemiI.Molekuliarni efekty viddalenogo periodu pislia oprominennia vkliuchaly zminy ekspresiI geniv TERF1, TERF2, CCND1, dovzhyny telomer, ekspresiI bilka cyclin D1, gistonu gamma H2AX. Vyznacheno asotsiatsiiu molekuliarnykh zmin z kognityvnym defitsytom. Vyvcheno genetychni polimorfizmy rs2981582 gena FGFR2, rs12443621 gena TNRC9, rs3817198 gena LSP1, rs3803662 gena TNRC9 i rs889312 gena MAP3K1 ta Ikh asotsiatsiiu z rakom molochnoI zalozy; ekspresiiu klitynamy pukhlyny retseptoriv estrogenu ta progesteronu, antygeniv c kit, tsytokeratynu 5/6, TP53 ta ki67, amplifikatsiynyy status gena Her2/neu, mutatsiynyy status geniv BRCA1 (mutatsiI 185delAG ta 5382insC) i BRCA2 (mutatsiia 6174delT). Dovedeno mozhlyvist\\' persystentsiI radiatsiyno modyfikovanoI prykhovanoI khromosom noI nestabil\\'nosti u poslidovnykh generatsiiakh somatychnykh klityn liudyny.U naselennia vyvcheno stan reproduktyvnoI funktsiI, osoblyvosti dytiachogo kharchuvannia na radioaktyvno zabrud nenykh terytoriiakh. V ramkakh vykonannia Zagal\\'noderzhavnoI sotsial\\'noI programy polipshennia stanu bezpeky, gigiieny pratsi ta vyrobnychogo seredovyshcha na 2014–2018 roky vpershe v UkraIni rozrobleno y uspishno vykonano interkalibruvannia dlia 18 laboratoriy indyvidual\\'nogo dozymetrychnogo kontroliu. Rozpochato doslidzhennia efektiv medychnogo oprominennia u interventsiynykh kardiologiv.Eksperymental\\'ni doslidzhennia stosuvalysia vplyvu radiomodyfikatoriv na klitynni systemy.V zviti takozh vidobrazheno rezul\\'taty naukovo organizatsiynoI, likuval\\'no profilaktychnoI roboty, pidgotovky kadriv ta vprovadzhennia.Zvit NNTsRM zatverdzheno na zasidanni NaukovoI rady NAMN UkraIny 17.03.2015 r.', 'copyright': None, 'other_ids': 'PMID: 26695891'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 5952\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'PMID: 26695891'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 218,
   "id": "1382027c",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:14.802343Z",
     "start_time": "2024-01-10T16:27:14.781514Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'JAMA Netw Open', 'year': 2021, 'date': ' May 3', 'volume': '4(5)', 'pages': 'e217728', 'doi': '10.1001/jamanetworkopen.2021.7728', 'title': 'Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors.', 'authors': 'Zhou Z(1), Li M(1)', 'affiliations': 'Author information: (1)Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'This cohort study examines the association of BRCA1 and BRCA2 with tumor mutation burden and response to immune checkpoint inhibitors.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'JAMA Netw Open', 'year': 2021, 'date': ' May 3', 'volume': '4(5)', 'pages': 'e217728', 'doi': '10.1001/jamanetworkopen.2021.7728', 'title': 'Evaluation of BRCA1 and BRCA2 as Indicators of Response to Immune Checkpoint Inhibitors.', 'authors': 'Zhou Z(1), Li M(1)', 'affiliations': 'Author information: (1)Department of Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'DOI: 10.1001/jamanetworkopen.2021.7728 PMCID: PMC8105747 PMID: 33961040 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 6389\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'DOI: 10.1001/jamanetworkopen.2021.7728 PMCID: PMC8105747 PMID: 33961040 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 219,
   "id": "8f482975",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:16.268410Z",
     "start_time": "2024-01-10T16:27:16.244050Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Oncogene', 'year': 2006, 'date': ' Feb 23', 'volume': '25(8)', 'pages': '1186-94', 'doi': '10.1038/sj.onc.1209153', 'title': 'DSS1 is required for the stability of BRCA2.', 'authors': 'Li J(1), Zou C, Bai Y, Wazer DE, Band V, Gao Q', 'affiliations': 'Author information: (1)Division of Cancer Biology, Department of Medicine, Evanston Northwestern Healthcare Research Institute, Northwestern University Feinberg School of Medicine, Evanston, IL 60201, USA', 'erratum': None, 'comment': None, 'abstract': 'DSS1 is an evolutionarily conserved acidic protein that binds to BRCA2. However, study of the function of DSS1 in mammalian cells has been hampered because endogenous DSS1 has not been detectable by Western blotting. Here, we developed a modified Western blotting protocol that detects endogenous DSS1 protein, and used it to study the function of DSS1 and its interaction with BRCA2 in mammalian cells. We found that essentially all BRCA2 in human cell lines is associated with DSS1. Importantly, we found that RNAi knockdown of DSS1 in human cell lines led to dramatic loss of BRCA2 protein, mainly due to its increased degradation. Furthermore, the stability of BRCA2 mutant devoid of the DSS1-binding domain is unaffected by the depletion of DSS1. Most notably, like BRCA2 depletion, DSS1 depletion also led to hypersensitivity to DNA damage. These results demonstrated that the stability of BRCA2 protein in mammalian cells depends on the presence of DSS1. Deletion or mutation of DSS1 or suppression of its expression by other mechanisms are therefore potential causative mechanisms for human breast and ovarian cancer. Such mechanisms may be relevant to sporadic as well as familiar breast cancer where BRCA1 and BRCA2 mutations are not present.', 'copyright': None, 'other_ids': 'Oncogene (2006) 25, 1186-1194. doi:10.1038/sj.onc.1209153; published online 3 October 2005.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Oncogene', 'year': 2006, 'date': ' Feb 23', 'volume': '25(8)', 'pages': '1186-94', 'doi': '10.1038/sj.onc.1209153', 'title': 'DSS1 is required for the stability of BRCA2.', 'authors': 'Li J(1), Zou C, Bai Y, Wazer DE, Band V, Gao Q', 'affiliations': 'Author information: (1)Division of Cancer Biology, Department of Medicine, Evanston Northwestern Healthcare Research Institute, Northwestern University Feinberg School of Medicine, Evanston, IL 60201, USA', 'erratum': None, 'comment': None, 'abstract': 'DSS1 is an evolutionarily conserved acidic protein that binds to BRCA2. However, study of the function of DSS1 in mammalian cells has been hampered because endogenous DSS1 has not been detectable by Western blotting. Here, we developed a modified Western blotting protocol that detects endogenous DSS1 protein, and used it to study the function of DSS1 and its interaction with BRCA2 in mammalian cells. We found that essentially all BRCA2 in human cell lines is associated with DSS1. Importantly, we found that RNAi knockdown of DSS1 in human cell lines led to dramatic loss of BRCA2 protein, mainly due to its increased degradation. Furthermore, the stability of BRCA2 mutant devoid of the DSS1-binding domain is unaffected by the depletion of DSS1. Most notably, like BRCA2 depletion, DSS1 depletion also led to hypersensitivity to DNA damage. These results demonstrated that the stability of BRCA2 protein in mammalian cells depends on the presence of DSS1. Deletion or mutation of DSS1 or suppression of its expression by other mechanisms are therefore potential causative mechanisms for human breast and ovarian cancer. Such mechanisms may be relevant to sporadic as well as familiar breast cancer where BRCA1 and BRCA2 mutations are not present.', 'copyright': None, 'other_ids': 'DOI: 10.1038/sj.onc.1209153 PMID: 16205630 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 6567\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'DOI: 10.1038/sj.onc.1209153 PMID: 16205630 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 220,
   "id": "53add556",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:17.256491Z",
     "start_time": "2024-01-10T16:27:17.235563Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'PLoS Biol', 'year': 2013, 'date': ' Sep', 'volume': '11(9)', 'pages': 'e1001663', 'doi': '10.1371/journal.pbio.1001663', 'title': 'The actress, the court, and what needs to be done to guarantee the future of clinical genomics.', 'authors': 'Caplan AL(1)', 'affiliations': 'Author information: (1)Division of Medical Ethics, NYU Langone Medical Center, New York, New York, United States of America', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'Clinical genomics is poised for a rapid expansion but more work must be done to build a supporting ethical infrastructure.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'PLoS Biol', 'year': 2013, 'date': ' Sep', 'volume': '11(9)', 'pages': 'e1001663', 'doi': '10.1371/journal.pbio.1001663', 'title': 'The actress, the court, and what needs to be done to guarantee the future of clinical genomics.', 'authors': 'Caplan AL(1)', 'affiliations': 'Author information: (1)Division of Medical Ethics, NYU Langone Medical Center, New York, New York, United States of America', 'erratum': None, 'comment': None, 'abstract': 'Clinical genomics is poised for a rapid expansion but more work must be done to build a supporting ethical infrastructure.', 'copyright': None, 'other_ids': 'DOI: 10.1371/journal.pbio.1001663 PMCID: PMC3782420 PMID: 24086107 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 6627\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = 'Clinical genomics is poised for a rapid expansion but more work must be done to build a supporting ethical infrastructure.'\n",
    "articles[i]['other_ids'] = 'DOI: 10.1371/journal.pbio.1001663 PMCID: PMC3782420 PMID: 24086107 [Indexed for MEDLINE]'\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 221,
   "id": "64c9fa83",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:18.543465Z",
     "start_time": "2024-01-10T16:27:18.515368Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Laeknabladid', 'year': 2018, 'date': ' Jun', 'volume': '104(6)', 'pages': '281', 'doi': '10.17992/lbl.2018.06.187', 'title': '[To know or not to know, that is the question - screening for BRCA]. [Article in Icelandic]', 'authors': 'Johannsson OT(1)', 'affiliations': 'Author information: (1)MD PhD, Counsulting Specialist and Clinical Professor of Medical Oncology LSH', 'erratum': None, 'comment': 'Comment on Laeknabladid. 2018 Juni;104(6):289-296.', 'abstract': None, 'copyright': None, 'other_ids': 'DOI: 10.17992/lbl.2018.06.187 PMID: 29863479 [Indexed for MEDLINE]'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Laeknabladid', 'year': 2018, 'date': ' Jun', 'volume': '104(6)', 'pages': '281', 'doi': '10.17992/lbl.2018.06.187', 'title': '[To know or not to know, that is the question - screening for BRCA]. [Article in Icelandic]', 'authors': 'Johannsson OT(1)', 'affiliations': 'Author information: (1)MD PhD, Counsulting Specialist and Clinical Professor of Medical Oncology LSH', 'erratum': None, 'comment': 'Comment on Laeknabladid. 2018 Jun;104(6):289-296.', 'abstract': None, 'copyright': None, 'other_ids': 'DOI: 10.17992/lbl.2018.06.187 PMID: 29863479 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 6628\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['comment'] = articles[i]['comment'].replace('Juni', 'Jun')\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 222,
   "id": "2d0b8ad0",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:19.596961Z",
     "start_time": "2024-01-10T16:27:19.571205Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Laeknabladid', 'year': 2018, 'date': ' Juni', 'volume': '104(6)', 'pages': '289-296', 'doi': '10.17992/lbl.2018.06.189', 'title': '[Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations]. [Article in Icelandic]', 'authors': 'Jonsdottir T(1), Valdimarsdottir H(2), Tryggvadottir L(3), Lund SH(1), Thordardottir M(1), Magnusson MK(4), Valdimarsdottir U(1)', 'affiliations': 'Author information: (1)Center of Public Health sciences, Faculty of Medicine, University of Iceland. (2)Reykjavik University. (3)Icelandic Cancer Registry, Icelandic Cancer Society, Skógarhlíð 8. (4)Faculty of Medicine, University of Iceland, Reykjavik', 'erratum': None, 'comment': 'Comment in Laeknabladid. 2018 Juni;104(6):281.', 'abstract': 'Introduction The aim of this study was to explore the attitudes of Icelandic women towards existing genetic information, genetic counseling and genetic testing for BRCA mutations which dramatically increase risk for aggressive cancers. Materials and methods Women attending the cancer prevention clinic in Reykjavik, capital of Iceland, from October 12th until November 20th 2015 received an invitation to participate. Participation involved answering a short online questionnaire about background, family history of cancer as well as attitudes towards genetic counseling, BRCA testing and preventive use of such information. Descriptive statistics and chi-square tests were used to describe differences in attitudes towards those questions between subgroups of women. Results 1129 women (69% response rate) answered the questionnaire. Mean age was 47 years (span 21-76 years). Around half (47%) had heard fairly much about the mutations. Independent of family history of cancer, the majority of women were positive towards receiving genetic counseling (79%) and to undergo genetic testing (83%) for BRCA mutation with younger women being more interested than older women. On the other hand, only 4% of the women had already received genetic counseling and 7% undergone genetic testing. Women with family history of cancer were more knowledgeable about BRCA mutations (p<0.0001) and were less afraid of the consequence of being a mutation carrier (p<0.0001) compared to those with little or no family history. Regardless of family history, half (49%) worried that results from genetic testing could influence their health insurance. Almost all, or 97% of the women, were positive or very positive toward using existing genetic information obtained through scientific work, to inform affected indi-viduals of their mutation status. Conclusion Icelandic women are positive towards genetic counseling and testing for BRCA mutations although half of them worry that a positive result might affect their health insurance. Nevertheless, almost all women believe that existing genetic information should be used to inform carriers for preventive purposes.', 'copyright': None, 'other_ids': 'DOI: 10.17992/lbl.2018.06.189 PMID: 29863481 [Indexed for MEDLINE]'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Laeknabladid', 'year': 2018, 'date': ' Jun', 'volume': '104(6)', 'pages': '289-296', 'doi': '10.17992/lbl.2018.06.189', 'title': '[Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations]. [Article in Icelandic]', 'authors': 'Jonsdottir T(1), Valdimarsdottir H(2), Tryggvadottir L(3), Lund SH(1), Thordardottir M(1), Magnusson MK(4), Valdimarsdottir U(1)', 'affiliations': 'Author information: (1)Center of Public Health sciences, Faculty of Medicine, University of Iceland. (2)Reykjavik University. (3)Icelandic Cancer Registry, Icelandic Cancer Society, Skógarhlíð 8. (4)Faculty of Medicine, University of Iceland, Reykjavik', 'erratum': None, 'comment': 'Comment in Laeknabladid. 2018 Jun;104(6):281.', 'abstract': 'Introduction The aim of this study was to explore the attitudes of Icelandic women towards existing genetic information, genetic counseling and genetic testing for BRCA mutations which dramatically increase risk for aggressive cancers. Materials and methods Women attending the cancer prevention clinic in Reykjavik, capital of Iceland, from October 12th until November 20th 2015 received an invitation to participate. Participation involved answering a short online questionnaire about background, family history of cancer as well as attitudes towards genetic counseling, BRCA testing and preventive use of such information. Descriptive statistics and chi-square tests were used to describe differences in attitudes towards those questions between subgroups of women. Results 1129 women (69% response rate) answered the questionnaire. Mean age was 47 years (span 21-76 years). Around half (47%) had heard fairly much about the mutations. Independent of family history of cancer, the majority of women were positive towards receiving genetic counseling (79%) and to undergo genetic testing (83%) for BRCA mutation with younger women being more interested than older women. On the other hand, only 4% of the women had already received genetic counseling and 7% undergone genetic testing. Women with family history of cancer were more knowledgeable about BRCA mutations (p<0.0001) and were less afraid of the consequence of being a mutation carrier (p<0.0001) compared to those with little or no family history. Regardless of family history, half (49%) worried that results from genetic testing could influence their health insurance. Almost all, or 97% of the women, were positive or very positive toward using existing genetic information obtained through scientific work, to inform affected indi-viduals of their mutation status. Conclusion Icelandic women are positive towards genetic counseling and testing for BRCA mutations although half of them worry that a positive result might affect their health insurance. Nevertheless, almost all women believe that existing genetic information should be used to inform carriers for preventive purposes.', 'copyright': None, 'other_ids': 'DOI: 10.17992/lbl.2018.06.189 PMID: 29863481 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 7382\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['date'] = articles[i]['date'].replace('Juni', 'Jun')\n",
    "articles[i]['comment'] = articles[i]['comment'].replace('Juni', 'Jun')\n",
    "\n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 223,
   "id": "72ea42a4",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:20.852897Z",
     "start_time": "2024-01-10T16:27:20.832182Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Sci Transl Med', 'year': 2012, 'date': ' Oct 24', 'volume': '4(157)', 'pages': '157fs38', 'doi': '10.1126/scitranslmed.3004955', 'title': 'Lupus antibody tops cancer cells.', 'authors': 'Ford JM(1)', 'affiliations': 'Author information: (1)Departments of Medicine and Genetics, Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA. jmf@stanford.edu', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': 'A lupus causing anti-DNA antibody penetrates living cells and targets DNA repair for therapeutic advantage in human cancer cells.'} \n",
      "\n",
      "{'retraction': None, 'journal': 'Sci Transl Med', 'year': 2012, 'date': ' Oct 24', 'volume': '4(157)', 'pages': '157fs38', 'doi': '10.1126/scitranslmed.3004955', 'title': 'Lupus antibody tops cancer cells.', 'authors': 'Ford JM(1)', 'affiliations': 'Author information: (1)Departments of Medicine and Genetics, Division of Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA. jmf@stanford.edu', 'erratum': None, 'comment': None, 'abstract': 'A lupus causing anti-DNA antibody penetrates living cells and targets DNA repair for therapeutic advantage in human cancer cells.', 'copyright': None, 'other_ids': 'DOI: 10.1126/scitranslmed.3004955 PMID: 23100623 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 6875\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = 'A lupus causing anti-DNA antibody penetrates living cells and targets DNA repair for therapeutic advantage in human cancer cells.'\n",
    "articles[i]['other_ids'] = 'DOI: 10.1126/scitranslmed.3004955 PMID: 23100623 [Indexed for MEDLINE]'\n",
    "    \n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 224,
   "id": "6541b72c",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:22.109575Z",
     "start_time": "2024-01-10T16:27:22.090442Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Genome Biol', 'year': 2011, 'date': '', 'volume': '12(4)', 'pages': '304', 'doi': '10.1186/gb-2011-12-4-304', 'title': 'A top-down view on DNA replication and recombination from 9,000 feet above sea level.', 'authors': 'Johansson E(1), Speck C, Chabes A', 'affiliations': 'Author information: (1)Department of Medical Biochemistry and Biophysics, Umeå University, SE 90187 Umeå, Sweden', 'erratum': None, 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': \"A report of the Keystone Symposium 'DNA Replication and Recombination' held in Keystone, USA, 27 February to 4 March 2011.\"} \n",
      "\n"
     ]
    }
   ],
   "source": [
    "i = 7033\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = \"A report of the Keystone Symposium 'DNA Replication and Recombination' held in Keystone, USA, 27 February to 4 March 2011.\"\n",
    "articles[i]['copyright'] = '© 2011 BioMed Central Ltd'\n",
    "articles[i]['other_ids'] = 'DOI: 10.1186/gb-2011-12-4-304 PMCID: PMC3218856 PMID: 21554750 [Indexed for MEDLINE]'\n",
    "    \n",
    "# print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 225,
   "id": "6dfc2451",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:23.461943Z",
     "start_time": "2024-01-10T16:27:23.438836Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'Praxis (Bern 1994)', 'year': 2013, 'date': ' Nov 27', 'volume': '102(24)', 'pages': '1475-82', 'doi': '10.1024/1661-8157/a001489', 'title': '[Genetic diagnostics of cancer diseases]. [Article in German; Abstract available in German from the publisher]', 'authors': 'Cobilanschi J(1)', 'affiliations': 'Author information: (1)Institut für Medizinische Genetik, Universität Zürich, Schlieren', 'erratum': None, 'comment': None, 'abstract': \"Cancer is caused by genetic alterations, but only 10% of the cancer diseases are inherited. The probability for an individual or a family of having inherited cancer, individual consequences of the respective results of genetic testing, as well as its costs and reimbursement by the health insurance must be addressed by expert genetic counseling which at-risk requires special expertise. Identification of a germline mutation which may predispose to a variety of different cancer types allows determination of an individual's specific life time risk in symptomatic as well as in a-symptomatic family members. Identification of the underlying defective gene in heritable cancer disorders also enables optimized preventive and novel therapeutic approaches specifically targeting the underlying molecular pathomechanisms. Publisher: Krebserkrankungen sind genetisch bedingt, aber nur ca. 10% der Krebserkrankungen sind erblich und nur für einen Teil der erblichen Tumorerkrankungen sind die verursachenden Genveränderungen bekannt. Die tumorprädisponierenden Genveränderungen können mittels genetischer Analysen detektiert werden, wobei die Voraussetzungen hierfür, die Kostenübernahme durch die Krankenversicherung und die allfälligen individuellen Konsequenzen, im Rahmen einer ausführlichen genetischen Beratung diskutiert werden müssen. Die prädiktive Diagnostik stellt hierbei eine besondere Situation dar. Die Feststellung einer erblichen Tumorprädisposition erlaubt Aussagen über das spezifische Lebenszeitrisiko für verschiedene Tumorarten sowohl für bereits erkrankte als auch für gesunde Mutationsträger. Ferner ermöglicht der Nachweis eines krankheitsverursachenden Gendefektes eine an das jeweilig mutierte Gen angepasste, optimierte Tumorvorsorge mit allenfalls unmittelbar lebensverlängernder Wirkung. Zunehmend sind auch auf den jeweils gestörten Pathomechanismus individuell zugeschnittene Therapien in Erprobung.\", 'copyright': None, 'other_ids': \"Publisher: Les cancers sont d'origine génétique, mais seulement 10% sont héréditaires, et l'anomalie génétique n'est pas toujours connue. Ces prédispositions peuvent être détectées par des analyses génétiques, à condition que l'assurance maladie prenne en charge les coûts, et que les conséquences individuelles soient discutées en conseil génétique. Le diagnostic prédictif met le patient dans une situation particulière. En effet, la découverte d'une prédisposition héréditaire à un cancer permet d'évaluer l'espérance de vie, aussi bien pour les malades que pour les porteurs sains de la mutation. Par ailleurs, la détection du défaut génétique permet d'optimiser la prise en charge du patient et ainsi prolonger son espérance de vie. Enfin, la connaissance des mécanismes pathogènes sous-jacents ouvre de nouvelles approches thérapeutiques adaptées à chacun.\"} \n",
      "\n",
      "{'retraction': None, 'journal': 'Praxis (Bern 1994)', 'year': 2013, 'date': ' Nov 27', 'volume': '102(24)', 'pages': '1475-82', 'doi': '10.1024/1661-8157/a001489', 'title': '[Genetic diagnostics of cancer diseases]. [Article in German; Abstract available in German from the publisher]', 'authors': 'Cobilanschi J(1)', 'affiliations': 'Author information: (1)Institut für Medizinische Genetik, Universität Zürich, Schlieren', 'erratum': None, 'comment': None, 'abstract': \"Cancer is caused by genetic alterations, but only 10% of the cancer diseases are inherited. The probability for an individual or a family of having inherited cancer, individual consequences of the respective results of genetic testing, as well as its costs and reimbursement by the health insurance must be addressed by expert genetic counseling which at-risk requires special expertise. Identification of a germline mutation which may predispose to a variety of different cancer types allows determination of an individual's specific life time risk in symptomatic as well as in a-symptomatic family members. Identification of the underlying defective gene in heritable cancer disorders also enables optimized preventive and novel therapeutic approaches specifically targeting the underlying molecular pathomechanisms. Publisher: Krebserkrankungen sind genetisch bedingt, aber nur ca. 10% der Krebserkrankungen sind erblich und nur für einen Teil der erblichen Tumorerkrankungen sind die verursachenden Genveränderungen bekannt. Die tumorprädisponierenden Genveränderungen können mittels genetischer Analysen detektiert werden, wobei die Voraussetzungen hierfür, die Kostenübernahme durch die Krankenversicherung und die allfälligen individuellen Konsequenzen, im Rahmen einer ausführlichen genetischen Beratung diskutiert werden müssen. Die prädiktive Diagnostik stellt hierbei eine besondere Situation dar. Die Feststellung einer erblichen Tumorprädisposition erlaubt Aussagen über das spezifische Lebenszeitrisiko für verschiedene Tumorarten sowohl für bereits erkrankte als auch für gesunde Mutationsträger. Ferner ermöglicht der Nachweis eines krankheitsverursachenden Gendefektes eine an das jeweilig mutierte Gen angepasste, optimierte Tumorvorsorge mit allenfalls unmittelbar lebensverlängernder Wirkung. Zunehmend sind auch auf den jeweils gestörten Pathomechanismus individuell zugeschnittene Therapien in Erprobung.\", 'copyright': None, 'other_ids': 'DOI: 10.1024/1661-8157/a001489 PMID: 24280604 [Indexed for MEDLINE]'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 7576\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['other_ids'] = 'DOI: 10.1024/1661-8157/a001489 PMID: 24280604 [Indexed for MEDLINE]' \n",
    "    \n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 226,
   "id": "db7fdd63",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:24.725956Z",
     "start_time": "2024-01-10T16:27:24.698941Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'retraction': None, 'journal': 'EMBO Rep', 'year': 2017, 'date': ' Jul', 'volume': '18(7)', 'pages': '1264', 'doi': '10.15252/embr.201744508', 'title': 'Structural basis for recruitment of BRCA2 by PALB2.', 'authors': 'Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH', 'affiliations': None, 'erratum': 'Erratum for EMBO Rep. 2009 Sep;10(9):990-6.', 'comment': None, 'abstract': None, 'copyright': None, 'other_ids': '[Image: see text]'} \n",
      "\n",
      "{'retraction': None, 'journal': 'EMBO Rep', 'year': 2017, 'date': ' Jul', 'volume': '18(7)', 'pages': '1264', 'doi': '10.15252/embr.201744508', 'title': 'Structural basis for recruitment of BRCA2 by PALB2.', 'authors': 'Oliver AW, Swift S, Lord CJ, Ashworth A, Pearl LH', 'affiliations': None, 'erratum': 'Erratum for EMBO Rep. 2009 Sep;10(9):990-6.', 'comment': None, 'abstract': '[Image: see text]', 'copyright': None, 'other_ids': 'DOI: 10.15252/embr.201744508 PMCID: PMC5494498 PMID: 28673926'} \n",
      "------\n"
     ]
    }
   ],
   "source": [
    "i = 8248\n",
    "print(articles[i], '\\n')\n",
    "articles[i]['abstract'] = '[Image: see text]'\n",
    "articles[i]['other_ids'] = 'DOI: 10.15252/embr.201744508 PMCID: PMC5494498 PMID: 28673926'\n",
    "    \n",
    "print(articles[i], '\\n------')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 200,
   "id": "cea29ef0",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:23:16.769071Z",
     "start_time": "2024-01-10T16:23:16.746784Z"
    },
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1733. Psychooncology. 2011 Dec;20(12):1301-8. doi: 10.1002/pon.1846. Epub 2010 Oct 3.\n",
      "\n",
      "Novel one-stop multidisciplinary follow-up clinic for BRCA1/2 carriers: patient\n",
      "satisfaction and decision making.\n",
      "\n",
      "Firth C(1), Jacobs C, Evison M, Pichert G, Izatt L, Hunter MS.\n",
      "\n",
      "Author information:\n",
      "(1)Clinical Genetics Department, Guy's and St. Thomas' NHS Foundation Trust,\n",
      "London, UK. clare.firth@nhs.net\n",
      "\n",
      "OBJECTIVE: To evaluate patient' satisfaction and cancer risk management decision\n",
      "making, following attendance at a novel multidisciplinary one-stop follow-up\n",
      "clinic (MDOSC) for BRCA1/2 carriers.\n",
      "PATIENTS AND METHODS: 172 patients attended the MDOSC over a 2-year period\n",
      "between 2006 and 2008. A total of 96 and 76 patients were seen in the first and\n",
      "second year, respectively. All patients who attended the MDOSC were sent a\n",
      "17-item Satisfaction Questionnaire (SQ) designed to examine their views about\n",
      "the MDOSC, using rating scales and open questions after the first year. Patients\n",
      "were asked to comment on the most helpful aspects of the MDOSC and on how the\n",
      "service might be improved. Changes were made based on this feedback. During the\n",
      "second year, all patients were given the SQ with three questions about cancer\n",
      "risk management decision making on the day of the MDOSC.\n",
      "RESULTS: In total, 132 (77%) patients responded and overall satisfaction was\n",
      "high with a mean of 8.94 (range 1-10). BRCA1/2 carriers were pleased to see a\n",
      "range of health care professionals on the same day, who they viewed gave\n",
      "consistent information, considered every aspect of care and addressed\n",
      "psychosocial needs. Following improvements, based on patients' feedback,\n",
      "satisfaction significantly increased in year 2. Furthermore, the MDOSC also\n",
      "helped patients to move forward with their cancer risk management decisions.\n",
      "CONCLUSIONS: BRCA1/2 carriers were highly satisfied with the MDOSC, which met\n",
      "their needs and helped them to make informed decisions regarding their cancer\n",
      "risk management.\n",
      "\n",
      "Copyright © 2010 John Wiley & Sons, Ltd.\n",
      "\n",
      "DOI: 10.1002/pon.1846\n",
      "PMID: 22114045 [Indexed for MEDLINE]\n",
      "\n",
      "\n",
      "\n",
      "------\n",
      "(None, {'retraction': None, 'journal': 'Psychooncology', 'year': 2011, 'date': ' Dec', 'volume': '20(12)', 'pages': '1301-8', 'doi': '10.1002/pon.1846', 'title': 'Novel one-stop multidisciplinary follow-up clinic for BRCA1/2 carriers: patient satisfaction and decision making.', 'authors': 'Firth C(1), Jacobs C, Evison M, Pichert G, Izatt L, Hunter MS', 'affiliations': \"Author information: (1)Clinical Genetics Department, Guy's and St. Thomas' NHS Foundation Trust, London, UK. clare.firth@nhs.net\", 'erratum': None, 'comment': \"OBJECTIVE: To evaluate patient' satisfaction and cancer risk management decision making, following attendance at a novel multidisciplinary one-stop follow-up clinic (MDOSC) for BRCA1/2 carriers. PATIENTS AND METHODS: 172 patients attended the MDOSC over a 2-year period between 2006 and 2008. A total of 96 and 76 patients were seen in the first and second year, respectively. All patients who attended the MDOSC were sent a 17-item Satisfaction Questionnaire (SQ) designed to examine their views about the MDOSC, using rating scales and open questions after the first year. Patients were asked to comment on the most helpful aspects of the MDOSC and on how the service might be improved. Changes were made based on this feedback. During the second year, all patients were given the SQ with three questions about cancer risk management decision making on the day of the MDOSC. RESULTS: In total, 132 (77%) patients responded and overall satisfaction was high with a mean of 8.94 (range 1-10). BRCA1/2 carriers were pleased to see a range of health care professionals on the same day, who they viewed gave consistent information, considered every aspect of care and addressed psychosocial needs. Following improvements, based on patients' feedback, satisfaction significantly increased in year 2. Furthermore, the MDOSC also helped patients to move forward with their cancer risk management decisions. CONCLUSIONS: BRCA1/2 carriers were highly satisfied with the MDOSC, which met their needs and helped them to make informed decisions regarding their cancer risk management.\", 'abstract': None, 'copyright': 'Copyright © 2010 John Wiley & Sons, Ltd', 'other_ids': 'DOI: 10.1002/pon.1846 PMID: 22114045 [Indexed for MEDLINE]'})\n"
     ]
    }
   ],
   "source": [
    "i = 1732\n",
    "info = copy(data[articles_start[i]:\n",
    "                 articles_start[i+1]])\n",
    "\n",
    "for line in info:\n",
    "    print(line.strip())\n",
    "print()\n",
    "\n",
    "# for line in concatenate_lines(info):\n",
    "#     print(line.strip())\n",
    "#     print()\n",
    "\n",
    "print('------')\n",
    "print(get_article_data(info))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "06b505d6",
   "metadata": {},
   "source": [
    "# Verify records\n",
    "\n",
    "If this cell print anything, it means that some articles are not processed correctly.\n",
    "\n",
    "This may be fixable within function or require manual correction."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 227,
   "id": "702ddd03",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:27:40.409277Z",
     "start_time": "2024-01-10T16:27:40.382052Z"
    },
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "for i, article in enumerate( articles ):\n",
    "    if article:\n",
    "        if ( article['other_ids'][:3] == 'DOI' \n",
    "             or article['other_ids'][:4] == 'PMID' \n",
    "             or article['other_ids'][:5] == 'PMCID' ):\n",
    "            continue\n",
    "        \n",
    "        print(i, article['other_ids'], '\\n')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5358bbaf",
   "metadata": {},
   "source": [
    "# Classify articles"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 202,
   "id": "5e245fb8",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:23:26.269983Z",
     "start_time": "2024-01-10T16:23:26.199000Z"
    }
   },
   "outputs": [],
   "source": [
    "articles_save = deepcopy( articles )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 230,
   "id": "f5bdad0f",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:28:43.862612Z",
     "start_time": "2024-01-10T16:28:43.838073Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1984 -- Comput Math Methods Med. 2021; 2021 \n",
      "\tDetection of BRCA1/2 Mutation and Analysis of Clinicopathological Characteristics in 141 Cases of Ovarian Cancer.\n",
      "\tRetraction in Comput Math Methods Med. 2023 Dec 6;2023:9825317.\n",
      "\n",
      "3905 -- PLoS Genet. 2009; 5(10) \n",
      "\tp63 and p73 transcriptionally regulate genes involved in DNA repair.\n",
      "\tRetraction in PLoS Genet. 2023 Mar 27;19(3):e1010699.\n",
      "\n",
      "6500 -- Hered Cancer Clin Pract. 2017; 15 \n",
      "\tThe BRCA2 variant c.68-7 T>A is associated with breast cancer.\n",
      "\tRetraction in Hered Cancer Clin Pract. 2018 May 2;16:10.\n",
      "\n",
      "6555 -- J Biol Chem. 2006; 281(31) \n",
      "\tUp-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.\n",
      "\tRetraction in J Biol Chem. 2014 Jun 20;289(25):17424.\n",
      "\n",
      "7750 -- J Biol Chem. 2014; 289(25) \n",
      "\tDown-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation.\n",
      "\tRetraction Notice: Retraction of Moro L, Arbini AA, Marra E, Greco M. J Biol Chem. 2005 Jun 10;280(23):22482-91.\n",
      "\n",
      "[7750]\n",
      "7800 -- J Biol Chem. 2014; 289(25) \n",
      "\tUp-regulation of Skp2 after prostate cancer cell adhesion to basement membranes results in BRCA2 degradation and cell proliferation.\n",
      "\tRetraction Notice: Retraction of Moro L, Arbini AA, Marra E, Greco M. J Biol Chem. 2006 Aug 4;281(31):22100-7.\n",
      "\n",
      "[7750, 7800]\n",
      "8265 -- Hered Cancer Clin Pract. 2018; 16 \n",
      "\tRetraction Note to: The BRCA2 variant c.68-7 T > A is associated with breast cancer.\n",
      "\tRetraction Notice: Retraction of Hered Cancer Clin Pract. 2017 Nov 13;15:20. [This retracts the article DOI: 10.1186/s13053-017-0080-y.].\n",
      "\n",
      "[7750, 7800, 8265]\n",
      "8437 -- Int J Gynecol Cancer. 2013; 23(6) \n",
      "\tRisk factors for ovarian cancers with and without microsatellite instability.\n",
      "\tRetraction in Beller U. Int J Gynecol Cancer. 2014 Sep;24(7):1356.\n",
      "\n",
      "[7750, 7800, 8265]\n"
     ]
    }
   ],
   "source": [
    "to_remove = []\n",
    "for i, article in enumerate( articles ):\n",
    "    if article and article['retraction']:\n",
    "        print( f\"{i} -- {article['journal']}. {article['year']}; {article['volume']} \" \n",
    "               f\"\\n\\t{article['title']}\\n\\t{article['retraction']}\\n\")\n",
    "        if article['retraction'][:19] == 'Retraction Notice: ':\n",
    "            to_remove.append(i)\n",
    "            print(to_remove)\n",
    "\n",
    "print(to_remove)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 231,
   "id": "a0842b84",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:28:50.470753Z",
     "start_time": "2024-01-10T16:28:50.445975Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9584\n"
     ]
    }
   ],
   "source": [
    "for i in reversed(to_remove):\n",
    "    articles.pop(i)\n",
    "\n",
    "print(len(articles))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 232,
   "id": "c9f788bc",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:28:54.097793Z",
     "start_time": "2024-01-10T16:28:54.072727Z"
    },
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "19 -- Clin Transl Oncol. 2021; 23(1) \n",
      "\tComprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer.\n",
      "\tErratum in Clin Transl Oncol. 2021 Oct;23(10):2191.\n",
      "\n",
      "111 -- BMJ. 2021; 375 \n",
      "\tCare of men with cancer-predisposing BRCA variants.\n",
      "\tErratum in BMJ. 2021 Oct 19;375:n2550.\n",
      "\n",
      "146 -- J Hum Genet. 2012; 57(3) \n",
      "\tSpectra of BRCA1 and BRCA2 mutations in Korean patients with breast cancer: the importance of whole-gene sequencing.\n",
      "\tErratum in J Hum Genet. 2012 Mar;57(3):222.\n",
      "\n",
      "155 -- Hum Mutat. 2020; 41(10) \n",
      "\tVariant effect on splicing regulatory elements, branchpoint usage, and pseudoexonization: Strategies to enhance bioinformatic prediction using hereditary cancer genes as exemplars.\n",
      "\tErratum in Hum Mutat. 2022 Dec;43(12):2328.\n",
      "\n",
      "186 -- Breast Cancer Res. 2009; 11(4) \n",
      "\tGenomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes.\n",
      "\tErratum in Breast Cancer Res. 2009;11(5):404.\n",
      "\n",
      "218 -- BMJ. 2013; 346 \n",
      "\tUS Supreme Court hears arguments in case of BRCA1 and BRCA2 [corrected] patents.\n",
      "\tErratum in BMJ. 2013;346:f2543.\n",
      "\n",
      "261 -- Semin Oncol. 2011; 38(4) \n",
      "\tVariants of uncertain significance in breast cancer-related genes: real-world implications for a clinical conundrum. Part one: clinical genetics recommendations.\n",
      "\tErratum in Semin Oncol. 2012 Feb;39(1):123. McDonald, Deborah J [corrected to MacDonald, Deborah J].\n",
      "\n",
      "314 -- Breast. 2006; 15 Suppl 2 \n",
      "\tBest surgical prophylaxis--risk-reducing mastectomy for women at high personal risk of breast cancer.\n",
      "\tErratum in Breast. 2008 Apr;17(2):213.\n",
      "\n",
      "329 -- Science. 2013; 340(6139) \n",
      "\tIntellectual property. Supreme Court rules out patents on 'natural' genes.\n",
      "\tErratum in Science. 2013 Aug 23;341(6148):842.\n",
      "\n",
      "375 -- Nat Biotechnol. 2009; 27(7) \n",
      "\tDiagnostics firms face new patent claim worries.\n",
      "\tErratum in Nat Biotechnol. 2009 Oct;27(10):957.\n",
      "\n",
      "657 -- Cancer. 2009; 115(10) \n",
      "\tBRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer.\n",
      "\tErratum in Cancer. 2009 Jun 15;115(12):2804.\n",
      "\n",
      "717 -- Breast Cancer Res Treat. 2016; 155(1) \n",
      "\tRates of BRCA1/2 mutation testing among young survivors of breast cancer.\n",
      "\tErratum in Breast Cancer Res Treat. 2016 Aug;159(1):201.\n",
      "\n",
      "737 -- Fam Cancer. 2006; 5(4) \n",
      "\tAcceptance of preventive surgeries by Israeli women who had undergone BRCA testing.\n",
      "\tErratum in Fam Cancer. 2007;6(1):159.\n",
      "\n",
      "772 -- J Clin Oncol. 2008; 26(33) \n",
      "\tClinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.\n",
      "\tErratum in J Clin Oncol. 2009 May 10;27(14):2415.\n",
      "\n",
      "840 -- Cancer Res. 2010; 70(13) \n",
      "\tPoly(ADP-ribose) polymerase is hyperactivated in homologous recombination-defective cells.\n",
      "\tErratum in Cancer Res. 2011 Apr 1;71(7):2803.\n",
      "\n",
      "922 -- PLoS One. 2014; 9(5) \n",
      "\tThe validation and clinical implementation of BRCAplus: a comprehensive high-risk breast cancer diagnostic assay.\n",
      "\tErratum in PLoS One. 2014;9(9):e110156.\n",
      "\n",
      "954 -- J Natl Compr Canc Netw. 2009; 7(10) \n",
      "\tThe role of MRI in breast cancer screening.\n",
      "\tErratum in J Natl Compr Canc Netw. 2010 Jan;8(1):xxi.\n",
      "\n",
      "1008 -- Clin Genet. 2014; 85(1) \n",
      "\tBRCA1 and BRCA2 - update and implications on the genetics of breast cancer: a clinical perspective.\n",
      "\tErratum in Clin Genet. 2014 Mar;85(3):302.\n",
      "\n",
      "1046 -- J Mol Diagn. 2013; 15(6) \n",
      "\tA clinically validated diagnostic second-generation sequencing assay for detection of hereditary BRCA1 and BRCA2 mutations.\n",
      "\tErratum in J Mol Diagn. 2014 May;16(3):378.\n",
      "\n",
      "1062 -- PLoS One. 2013; 8(3) \n",
      "\tPrevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases.\n",
      "\tErratum in PLoS One. 2013;8(4). doi:10.1371/annotation/159f0ba3-5a24-4de9-99be-1cd6d5037760.\n",
      "\n",
      "1095 -- J Gynecol Oncol. 2018; 29(4) \n",
      "\tPrevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube.\n",
      "\tErratum in J Gynecol Oncol. 2018 Sep;29(5):e80.\n",
      "\n",
      "1117 -- Cancer. 2012; 118(6) \n",
      "\tPredictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ.\n",
      "\tErratum in Cancer. 2014 Mar 15;120(6):927.\n",
      "\n",
      "1134 -- Breast Cancer Res Treat. 2021; 189(2) \n",
      "\tGermline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer.\n",
      "\tErratum in Breast Cancer Res Treat. 2022 Jan;191(1):227.\n",
      "\n",
      "1163 -- Ann Surg Oncol. 2015; 22(2) \n",
      "\tNipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.\n",
      "\tErratum in Ann Surg Oncol. 2014 Dec;21 Suppl 4:S788. Weissman, Scott [added].\n",
      "\n",
      "1229 -- J Genet Couns. 2011; 20(3) \n",
      "\tDevelopment and evaluation of a decision aid for BRCA carriers with breast cancer.\n",
      "\tErratum in J Genet Couns. 2013 Jun;22(3):406.\n",
      "\n",
      "1267 -- JAMA. 2018; 319(23) \n",
      "\tDirect-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.\n",
      "\tErratum in JAMA. 2018 Jul 24;320(4):408. JAMA. 2018 Jul 24;320(4):408.\n",
      "\n",
      "1273 -- Cancer Epidemiol Biomarkers Prev. 2009; 18(8) \n",
      "\tMissense polymorphisms in BRCA1 and BRCA2 and risk of breast and ovarian cancer.\n",
      "\tErratum in Cancer Epidemiol Biomarkers Prev. 2010 Jun;19(6):1661.\n",
      "\n",
      "1304 -- Ann Oncol. 2016; 27(suppl 5) \n",
      "\tPrevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.\n",
      "\tErratum in Ann Oncol. 2017 Jul 1;28(suppl_4):iv167-iv168.\n",
      "\n",
      "1353 -- Nature. 2019; 571(7766) \n",
      "\tTumour lineage shapes BRCA-mediated phenotypes.\n",
      "\tErratum in Nature. 2019 Dec 11;:\n",
      "\n",
      "1412 -- Cancer. 2012; 118(2) \n",
      "\tEarlier age of onset of BRCA mutation-related cancers in subsequent generations.\n",
      "\tErratum in Cancer. 2012 Jun 1;118(11):2997.\n",
      "\n",
      "1428 -- Cancer. 2012; 118(8) \n",
      "\tAnnual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.\n",
      "\tErratum in Cancer. 2012 Nov 1;118(21):5448.\n",
      "\n",
      "1685 -- Breast. 2006; 15 Suppl 2 \n",
      "\tMoving genetics into clinical cancer care: examples from BRCA gene testing and telemedicine.\n",
      "\tErratum in Breast. 2008 Apr;17(2):213.\n",
      "\n",
      "1710 -- JAMA Oncol. 2015; 1(9) \n",
      "\tUtilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.\n",
      "\tErratum in JAMA Oncol. 2016 Mar;2(3):404.\n",
      "\n",
      "1814 -- J Health Care Poor Underserved. 2015; 26(3) \n",
      "\tService Delivery Model and Experiences in a Cancer Genetics Clinic for an Underserved Population.\n",
      "\tErratum in J Health Care Poor Underserved. 2015 Nov;26(4):vii. Park, Minjeong [added].\n",
      "\n",
      "1937 -- Br J Cancer. 2008; 98(8) \n",
      "\tThe BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.\n",
      "\tErratum in Br J Cancer. 2008 Jun 17;98(12):2015. Passini, B [corrected to Pasini, B].\n",
      "\n",
      "1950 -- Genet Med. 2017; 19(7) \n",
      "\tPopulation screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.\n",
      "\tErratum in Genet Med. 2020 Mar;22(3):672.\n",
      "\n",
      "2006 -- J Clin Oncol. 2009; 27(8) \n",
      "\tPrediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States.\n",
      "\tErratum in J Clin Oncol. 2009 Jul 1;27(19):3262.\n",
      "\n",
      "2052 -- J Genet Couns. 2014; 23(2) \n",
      "\tChanges in specialists' perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination: then and now.\n",
      "\tErratum in J Genet Couns. 2015 Apr;24(2):371.\n",
      "\n",
      "2072 -- Cancer Epidemiol Biomarkers Prev. 2012; 21(8) \n",
      "\tA nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.\n",
      "\tErratum in Cancer Epidemiol Biomarkers Prev. 2012 Dec;21(12):2278.\n",
      "\n",
      "2109 -- BJU Int. 2007; 99(6) \n",
      "\tA review of targeted screening for prostate cancer: introducing the IMPACT study.\n",
      "\tErratum in BJU Int. 2007 Sep;100(3):718-9.\n",
      "\n",
      "2184 -- Hum Reprod. 2009; 24(4) \n",
      "\tOpinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.\n",
      "\tErratum in Hum Reprod. 2009 Jul;24(7):1772.\n",
      "\n",
      "2299 -- BMJ. 2021; 372 \n",
      "\tUse of SNP chips to detect rare pathogenic variants: retrospective, population based diagnostic evaluation.\n",
      "\tErratum in BMJ. 2021 Mar 22;372:n792.\n",
      "\n",
      "2352 -- Breast Cancer Res Treat. 2014; 144(3) \n",
      "\tRecurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.\n",
      "\tErratum in Breast Cancer Res Treat. 2015 Apr;150(3):699-700.\n",
      "\n",
      "2363 -- Oncology. 2021; 99(8) \n",
      "\tClinicopathological Features of BRCA1/2 Mutation-Positive Breast Cancer.\n",
      "\tErratum in Oncology. 2023 May 16;101(6):406.\n",
      "\n",
      "2371 -- Cancer Res. 2010; 70(15) \n",
      "\t6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.\n",
      "\tErratum in Cancer Res. 2010 Oct 1;70(19):7734. Djurenovic, Tatjana [corrected to Djureinovic, Tatjana].\n",
      "\n",
      "2395 -- Genet Med. 2022; 24(1) \n",
      "\tRisks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.\n",
      "\tErratum in Genet Med. 2022 Oct;24(10):2208.\n",
      "\n",
      "2432 -- JAMA. 2015; 313(13) \n",
      "\tAssociation of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.\n",
      "\tErratum in JAMA. 2015 Aug 11;314(6):628.\n",
      "\n",
      "2435 -- Cancer. 2017; 123(10) \n",
      "\tRisk-reducing salpingectomy: Let us be opportunistic.\n",
      "\tErratum in Cancer. 2022 Apr 15;128(8):1709.\n",
      "\n",
      "2447 -- Breast Cancer Res Treat. 2010; 120(3) \n",
      "\tContralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab).\n",
      "\tErratum in Breast Cancer Res Treat. 2010 Apr;120(3):725-6.\n",
      "\n",
      "2495 -- Genet Med. 2018; 20(5) \n",
      "\tEarly cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants.\n",
      "\tErratum in Genet Med. 2021 Dec;23(12):2470.\n",
      "\n",
      "2502 -- Nurs Womens Health. 2021; 25(3) \n",
      "\tUse of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.\n",
      "\tErratum in Nurs Womens Health. 2021 Oct;25(5):322.\n",
      "\n",
      "2527 -- Breast Cancer Res. 2015; 17 \n",
      "\tQuantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.\n",
      "\tErratum in Breast Cancer Res. 2015;17:144.\n",
      "\n",
      "2538 -- Ann Plast Surg. 2010; 64(5) \n",
      "\tSurgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.\n",
      "\tErratum in Ann Plast Surg. 2010 Jul;65(1):116. Adkinson, Joshua M [added].\n",
      "\n",
      "2550 -- Gynecol Oncol. 2015; 137(3) \n",
      "\tThe sooner the better: Genetic testing following ovarian cancer diagnosis.\n",
      "\tErratum in Gynecol Oncol. 2017 May;145(2):409.\n",
      "\n",
      "2566 -- Eur J Hum Genet. 2021; 29(2) \n",
      "\tIntrafamilial communication of hereditary breast and ovarian cancer genetic information in Italian women: towards a personalised approach.\n",
      "\tErratum in Eur J Hum Genet. 2020 Sep 23;:\n",
      "\n",
      "2606 -- J Clin Oncol. 2010; 28(22) \n",
      "\tGene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.\n",
      "\tErratum in J Clin Oncol. 2010 Nov 10;28(32):4868.\n",
      "\n",
      "2613 -- Gynecol Oncol. 2020; 156(2) \n",
      "\tPrecision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations.\n",
      "\tErratum in Gynecol Oncol. 2021 May;161(2):636.\n",
      "\n",
      "2616 -- Nature. 2016; 535(7612) \n",
      "\tReplication fork stability confers chemoresistance in BRCA-deficient cells.\n",
      "\tErratum in Nature. 2016 Nov 17;539(7629):456.\n",
      "\n",
      "2645 -- Nature. 2016; 534(7605) \n",
      "\tLandscape of somatic mutations in 560 breast cancer whole-genome sequences.\n",
      "\tErratum in Nature. 2019 Feb;566(7742):E1.\n",
      "\n",
      "2693 -- Br J Cancer. 2016; 114(8) \n",
      "\tGene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.\n",
      "\tErratum in Br J Cancer. 2018 Feb 13;:\n",
      "\n",
      "2735 -- J Clin Oncol. 2018; 36(31) \n",
      "\tMulticenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.\n",
      "\tErratum in J Clin Oncol. 2018 Nov 20;36(33):3348. J Clin Oncol. 2019 Feb 1;37(4):362.\n",
      "\n",
      "2802 -- J Pathol. 2011; 225(2) \n",
      "\tFrequent promoter hypermethylation of BRCA2, CDH13, MSH6, PAX5, PAX6 and WT1 in ductal carcinoma in situ and invasive breast cancer.\n",
      "\tErratum in J Pathol. 2012 Jan;226(1):143.\n",
      "\n",
      "2806 -- Lancet Oncol. 2017; 18(9) \n",
      "\tOlaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.\n",
      "\tErratum in Lancet Oncol. 2017 Sep;18(9):e510.\n",
      "\n",
      "2865 -- J Hum Genet. 2018; 63(4) \n",
      "\tGenetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.\n",
      "\tErratum in J Hum Genet. 2018 Jan 31;:\n",
      "\n",
      "2872 -- JAMA. 2019; 322(7) \n",
      "\tRisk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.\n",
      "\tErratum in JAMA. 2019 Nov 12;322(18):1830.\n",
      "\n",
      "2877 -- J Clin Oncol. 2013; 31(2) \n",
      "\tPrevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.\n",
      "\tErratum in J Clin Oncol. 2013 May 1;31(13):1702.\n",
      "\n",
      "2970 -- Psychosomatics. 2012; 53(6) \n",
      "\tBiopsychological stress factors in BRCA mutation carriers.\n",
      "\tErratum in Psychosomatics. 2015 Jan-Feb;56(1):106.\n",
      "\n",
      "2980 -- J Pathol. 2007; 211(1) \n",
      "\tA candidate precursor to serous carcinoma that originates in the distal fallopian tube.\n",
      "\tErratum in J Pathol. 2007 Sep;213(1):116.\n",
      "\n",
      "3001 -- Breast Cancer Res Treat. 2009; 117(1) \n",
      "\tExpression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors.\n",
      "\tErratum in Breast Cancer Res Treat. 2011 Feb;126(1):269. Reedijk, Michael [added]; Egan, Sean E [added].\n",
      "\n",
      "3040 -- Clin Cancer Res. 2018; 24(20) \n",
      "\tPaclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.\n",
      "\tErratum in Clin Cancer Res. 2020 Sep 15;26(18):5050.\n",
      "\n",
      "3061 -- Lancet Oncol. 2014; 15(8) \n",
      "\tOlaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.\n",
      "\tErratum in Lancet Oncol. 2015 Apr;16(4):e158.\n",
      "\n",
      "3095 -- Neoplasia. 2014; 16(1) \n",
      "\tDoubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness.\n",
      "\tErratum in Neoplasia. 2014 Apr;16(4):375. Neoplasia. 2014 Apr;16(4):375.\n",
      "\n",
      "3128 -- J Clin Oncol. 2012; 30(21) \n",
      "\tBRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.\n",
      "\tErratum in J Clin Oncol. 2012 Nov 20;30(33):4180.\n",
      "\n",
      "3129 -- Springerplus. 2012; 1(1) \n",
      "\tSeventeen years after BRCA1: what is the BRCA mutation status of the breast cancer patients in Africa? - a systematic review.\n",
      "\tErratum in Springerplus. 2015;4:340.\n",
      "\n",
      "3161 -- Nature. 2015; 521(7553) \n",
      "\tWhole-genome characterization of chemoresistant ovarian cancer.\n",
      "\tErratum in Nature. 2015 Nov 19;527(7578):398.\n",
      "\n",
      "3277 -- Pathol Oncol Res. 2020; 26(2) \n",
      "\tBRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.\n",
      "\tErratum in Pathol Oncol Res. 2019 Mar 5;:\n",
      "\n",
      "3306 -- Oncogene. 2017; 36(6) \n",
      "\tLoss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions.\n",
      "\tErratum in Oncogene. 2017 Jun 26;:\n",
      "\n",
      "3373 -- Sci Rep. 2020; 10(1) \n",
      "\tClinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.\n",
      "\tErratum in Sci Rep. 2020 Nov 2;10(1):19248.\n",
      "\n",
      "3454 -- Cancer Genet. 2018; 221 \n",
      "\tSurvey of gynecological carcinosarcomas in families with breast and ovarian cancer predisposition.\n",
      "\tErratum in Cancer Genet. 2018 Dec;228-229:128.\n",
      "\n",
      "3545 -- DNA Repair (Amst). 2007; 6(6) \n",
      "\tAnalysis of DNA repair and recombination responses in mouse cells depleted for Brca2 by SiRNA.\n",
      "\tErratum in DNA Repair (Amst). 2007 Oct 1;6(10):1556.\n",
      "\n",
      "3617 -- Clin Transl Oncol. 2018; 20(3) \n",
      "\tRecommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology.\n",
      "\tErratum in Clin Transl Oncol. 2017 Sep 20;:\n",
      "\n",
      "3653 -- Breast Cancer Res Treat. 2017; 164(2) \n",
      "\tBreast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.\n",
      "\tErratum in Breast Cancer Res Treat. 2017 Aug;164(3):745.\n",
      "\n",
      "3686 -- Breast Cancer Res Treat. 2015; 149(1) \n",
      "\tIncidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.\n",
      "\tErratum in Breast Cancer Res Treat. 2015 May;151(1):233.\n",
      "\n",
      "3818 -- Anticancer Res. 2015; 35(5) \n",
      "\tA Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer.\n",
      "\tErratum in Anticancer Res. 2015 Jun;35(6):3741. Anticancer Res. 2015 Dec;35(12):6993.\n",
      "\n",
      "3889 -- Int J Cancer. 2013; 133(2) \n",
      "\tRAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.\n",
      "\tErratum in Int J Cancer. 2015 Sep 15;137(6):E12.\n",
      "\n",
      "3904 -- Genet Med. 2019; 21(3) \n",
      "\tDNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes.\n",
      "\tErratum in Genet Med. 2018 Aug 20;:\n",
      "\n",
      "3958 -- Breast Cancer Res Treat. 2016; 156(3) \n",
      "\tFrequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.\n",
      "\tErratum in Breast Cancer Res Treat. 2017 Sep;165(2):471.\n",
      "\n",
      "3962 -- Cancer. 2018; 124(15) \n",
      "\tGenetic testing for hereditary prostate cancer: Current status and limitations.\n",
      "\tErratum in Cancer. 2019 Jul 1;125(13):2325.\n",
      "\n",
      "4015 -- Genet Med. 2020; 22(8) \n",
      "\tAlternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2.\n",
      "\tErratum in Genet Med. 2020 Jun 24;:\n",
      "\n",
      "4134 -- Blood Adv. 2021; 5(17) \n",
      "\tGermline variants in DNA repair genes, including BRCA1/2, may cause familial myeloproliferative neoplasms.\n",
      "\tErratum in Blood Adv. 2022 Dec 27;6(24):6208.\n",
      "\n",
      "4164 -- Clin Cancer Res. 2017; 23(20) \n",
      "\tGene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.\n",
      "\tErratum in Clin Cancer Res. 2018 May 1;24(9):2234. Chinnaiyan, Arul [corrected to Chinnaiyan, Arul M].\n",
      "\n",
      "4233 -- Front Oncol. 2021; 11 \n",
      "\tExome sequencing in BRCA1-2 candidate familias: the contribution of other cancer susceptibility genes.\n",
      "\tErratum in Front Oncol. 2021 Aug 17;11:740860.\n",
      "\n",
      "4252 -- Breast Cancer Res. 2020; 22(1) \n",
      "\tClinical implications of prospective genomic profiling of metastatic breast cancer patients.\n",
      "\tErratum in Breast Cancer Res. 2022 Jul 15;24(1):50.\n",
      "\n",
      "4289 -- J Med Genet. 2007; 44(2) \n",
      "\tEvaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.\n",
      "\tErratum in J Med Genet. 2007 Jul;44(7):471.\n",
      "\n",
      "4304 -- Br J Cancer. 2018; 119(1) \n",
      "\tRare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.\n",
      "\tErratum in Br J Cancer. 2019 Apr;120(8):867.\n",
      "\n",
      "4340 -- Biochem Biophys Res Commun. 2007; 364(4) \n",
      "\tChanges in protein expression due to deleterious mutations in the FA/BRCA pathway.\n",
      "\tErratum in Biochem Biophys Res Commun. 2008 Aug 15;373(1):175. Pizzatti, Luciana [added]; Bisch, Paulo M [added].\n",
      "\n",
      "4366 -- Precis Clin Med. 2018; 1(2) \n",
      "\tHeterogeneity of germline variants in high risk breast and ovarian cancer susceptibility genes in India.\n",
      "\tErratum in Precis Clin Med. 2018 Dec;1(3):134.\n",
      "\n",
      "4374 -- PLoS Genet. 2016; 12(11) \n",
      "\tComplex Breakpoints and Template Switching Associated with Non-canonical Termination of Homologous Recombination in Mammalian Cells.\n",
      "\tErratum in PLoS Genet. 2016 Dec 13;12 (12 ):e1006509.\n",
      "\n",
      "4421 -- Front Oncol. 2021; 11 \n",
      "\tCorrigendum: Exome Sequencing in BRCA1-2 Candidate Familias: The Contribution of Other Cancer Susceptibility Genes.\n",
      "\tErratum for Front Oncol. 2021 May 07;11:649435. [This corrects the article DOI: 10.3389/fonc.2021.649435.].\n",
      "\n",
      "[4421]\n",
      "4426 -- Proc Natl Acad Sci U S A. 2019; 116(2) \n",
      "\tMutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors.\n",
      "\tErratum in Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5829.\n",
      "\n",
      "4445 -- Nucleic Acids Res. 2018; 46(15) \n",
      "\tNovel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.\n",
      "\tErratum in Nucleic Acids Res. 2018 Nov 30;46(21):11656-11657. Nucleic Acids Res. 2020 Feb 20;48(3):1600-1601.\n",
      "\n",
      "4460 -- Int J Oncol. 2016; 48(1) \n",
      "\tTranscriptome sequencing of human breast cancer reveals aberrant intronic transcription in amplicons and dysregulation of alternative splicing with major therapeutic implications.\n",
      "\tErratum in Int J Oncol. 2017 Sep;51(3):997-0.\n",
      "\n",
      "4475 -- Genet Mol Biol. 2016; 39(2) \n",
      "\tScreening for germline BRCA1, BRCA2, TP53 and CHEK2 mutations in families at-risk for hereditary breast cancer identified in a population-based study from Southern Brazil.\n",
      "\tErratum in Genet Mol Biol. 2017 Mar 16;:0.\n",
      "\n",
      "4568 -- Gynecol Oncol. 2015; 136(1) \n",
      "\tSociety of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions.\n",
      "\tErratum in Gynecol Oncol. 2015 Sep;138(3):765.\n",
      "\n",
      "4597 -- Br J Cancer. 2022; 126(1) \n",
      "\tBasal expression of RAD51 foci predicts olaparib response in patient-derived ovarian cancer xenografts.\n",
      "\tErratum in Br J Cancer. 2023 Mar;128(7):1405.\n",
      "\n",
      "4604 -- Breast Cancer Res. 2007; 9(4) \n",
      "\tBCoR-L1 variation and breast cancer.\n",
      "\tErratum in Breast Cancer Res. 2008;10(5):406.\n",
      "\n",
      "4607 -- J Natl Cancer Inst. 2021; 113(7) \n",
      "\tMolecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer.\n",
      "\tErratum in J Natl Cancer Inst. 2021 Aug 17;:\n",
      "\n",
      "4616 -- Breast Cancer Res Treat. 2020; 183(2) \n",
      "\tCorrection to: Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.\n",
      "\tErratum for Breast Cancer Res Treat. 2020 Jul;182(2):465-476. In the original publication of the article, the first sentence in the abstract was published incorrectly.\n",
      "\n",
      "[4421, 4616]\n",
      "4625 -- Cell. 2016; 165(1) \n",
      "\tGenomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma.\n",
      "\tErratum in Cell. 2017 Jan 26;168(3):542.\n",
      "\n",
      "4659 -- Turk Gogus Kalp Damar Cerrahisi Derg. 2020; 28(1) \n",
      "\tEvaluation of gene expression levels in the diagnosis of lung adenocarcinoma and malignant pleural mesothelioma.\n",
      "\tErratum in Turk Gogus Kalp Damar Cerrahisi Derg. 2022 Jul 29;30(3):488.\n",
      "\n",
      "4660 -- Sci Transl Med. 2021; 13(578) \n",
      "\tWhole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.\n",
      "\tErratum in Sci Transl Med. 2021 Oct 13;13(615):eabm6064.\n",
      "\n",
      "4723 -- BMC Cancer. 2019; 19(1) \n",
      "\tGenetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).\n",
      "\tErratum in BMC Cancer. 2019 Dec 17;19(1):1227.\n",
      "\n",
      "4762 -- Cancer Biol Med. 2019; 16(3) \n",
      "\tPrevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.\n",
      "\tErratum in Cancer Biol Med. 2020 May 15;17(2):513.\n",
      "\n",
      "4769 -- J Clin Oncol. 2010; 28(2) \n",
      "\tAssociation of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks.\n",
      "\tErratum in J Clin Oncol. 2010 Oct 20;28(30):4664.\n",
      "\n",
      "4836 -- Breast Cancer. 2022; 29(1) \n",
      "\tPrevalence of mutations in BRCA and homologous recombination repair genes and real-world standard of care of Asian patients with HER2-negative metastatic breast cancer starting first-line systemic cytotoxic chemotherapy: subgroup analysis of the global BREAKOUT study.\n",
      "\tErratum in Breast Cancer. 2021 Sep 25;:\n",
      "\n",
      "4912 -- JAMA Oncol. 2015; 1(1) \n",
      "\tHereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.\n",
      "\tErratum in JAMA Oncol. 2015 Apr;1(1):110.\n",
      "\n",
      "4916 -- Breast Cancer Res Treat. 2020; 182(2) \n",
      "\tFrequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.\n",
      "\tErratum in Breast Cancer Res Treat. 2020 Sep;183(2):491.\n",
      "\n",
      "4917 -- Br J Cancer. 2009; 101(7) \n",
      "\tBRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression.\n",
      "\tErratum in Br J Cancer. 2009 Nov 17;101(10):1806. Thorne, H [removed].\n",
      "\n",
      "4982 -- Eur J Cancer. 2021; 149 \n",
      "\tPoly (ADP-ribose) polymerase inhibitors in solid tumours: Systematic review and meta-analysis.\n",
      "\tErratum in Eur J Cancer. 2021 Aug;153:274.\n",
      "\n",
      "5038 -- Cell Mol Biol Lett. 2013; 18(4) \n",
      "\tDetection of a novel mutation in exon 20 of the BRCA1 gene.\n",
      "\tErratum in Cell Mol Biol Lett. 2014 Mar 15;19(1):180.\n",
      "\n",
      "5147 -- Nat Genet. 2018; 50(9) \n",
      "\tCancer genetics, precision prevention and a call to action.\n",
      "\tErratum in Nat Genet. 2019 Jan;51(1):196.\n",
      "\n",
      "5176 -- Obstet Gynecol. 2020; 135(6) \n",
      "\tOvarian Cancer After Prophylactic Salpingectomy in a Patient With Germline BRCA1 Mutation.\n",
      "\tErratum in Obstet Gynecol. 2020 Sep;136(3):638.\n",
      "\n",
      "5280 -- Front Oncol. 2015; 5 \n",
      "\tClinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.\n",
      "\tErratum in Front Oncol. 2015;5:271.\n",
      "\n",
      "5352 -- Nature. 2011; 474(7353) \n",
      "\tIntegrated genomic analyses of ovarian carcinoma.\n",
      "\tErratum in Nature. 2012 Oct 11;490(7419):298.\n",
      "\n",
      "5446 -- Oncol Res. 2018; 26(2) \n",
      "\tERRATUM.\n",
      "\tErratum for Oncol Res. 2017 Nov 2;25(9):1441-1451.\n",
      "\n",
      "[4421, 4616, 5446]\n",
      "5479 -- Cancer Res. 2010; 70(7) \n",
      "\tA small interfering RNA screen of genes involved in DNA repair identifies tumor-specific radiosensitization by POLQ knockdown.\n",
      "\tErratum in Cancer Res. 2010 May 1;70(9):3853.\n",
      "\n",
      "5520 -- Cancer Discov. 2012; 2(4) \n",
      "\tTelomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.\n",
      "\tErratum in Cancer Discov. 2013 Aug;3(8):952.\n",
      "\n",
      "5567 -- Biomolecules. 2015; 5(4) \n",
      "\tHsp90: A New Player in DNA Repair?\n",
      "\tErratum in Biomolecules. 2016 Oct 18;6(4):\n",
      "\n",
      "5603 -- PLoS One. 2015; 10(6) \n",
      "\tIntegrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.\n",
      "\tErratum in PLoS One. 2015;10(7):e0132751.\n",
      "\n",
      "5634 -- Fam Cancer. 2013; 12(3) \n",
      "\tFrequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India.\n",
      "\tErratum in Fam Cancer. 2014 Sep;13(3):513.\n",
      "\n",
      "5714 -- Oncol Res. 2017; 25(9) \n",
      "\tThe Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways.\n",
      "\tErratum in Oncol Res. 2018 Mar 5;26(2):333-334.\n",
      "\n",
      "5719 -- J Immunother Cancer. 2021; 9(9) \n",
      "\tAdditive effects of variants of unknown significance in replication repair-associated DNA polymerase genes on mutational burden and prognosis across diverse cancers.\n",
      "\tErratum in J Immunother Cancer. 2021 Oct;9(10):\n",
      "\n",
      "5738 -- J Transl Med. 2021; 19(1) \n",
      "\tThe germline/somatic DNA damage repair gene mutations modulate the therapeutic response in Chinese patients with advanced pancreatic ductal adenocarcinoma.\n",
      "\tErratum in J Transl Med. 2021 Aug 12;19(1):345.\n",
      "\n",
      "5757 -- J Cancer Res Clin Oncol. 2021; 147(3) \n",
      "\tMultigene panel testing for hereditary breast and ovarian cancer in the province of Ontario.\n",
      "\tErratum in J Cancer Res Clin Oncol. 2020 Sep 25;:\n",
      "\n",
      "5829 -- PLoS Genet. 2014; 10(7) \n",
      "\tThe genomic landscape of the Ewing Sarcoma family of tumors reveals recurrent STAG2 mutation.\n",
      "\tErratum in PLoS Genet. 2014 Aug;10(8):e1004629.\n",
      "\n",
      "5851 -- Ann Intern Med. 2018; 168(2) \n",
      "\tWhole-Exome Sequencing in Adults With Chronic Kidney Disease: A Pilot Study.\n",
      "\tErratum in Ann Intern Med. 2018 Feb 20;168(4):308.\n",
      "\n",
      "5856 -- Nat Med. 2016; 22(2) \n",
      "\tBlocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors.\n",
      "\tErratum in Nat Med. 2016 Oct 6;22(10 ):1192.\n",
      "\n",
      "5861 -- J Natl Cancer Inst. 2020; 112(12) \n",
      "\tContribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.\n",
      "\tErratum in J Natl Cancer Inst. 2020 Oct 1;112(10):1071.\n",
      "\n",
      "5930 -- EMBO Rep. 2009; 10(9) \n",
      "\tStructural basis for recruitment of BRCA2 by PALB2.\n",
      "\tErratum in EMBO Rep. 2017 Jul;18(7):1264.\n",
      "\n",
      "6038 -- Nat Struct Mol Biol. 2007; 14(6) \n",
      "\tInteraction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats.\n",
      "\tErratum in Nat Struct Mol Biol. 2007 Jul;14(7):680.\n",
      "\n",
      "6084 -- Proc Natl Acad Sci U S A. 2017; 114(27) \n",
      "\tTargeting reactive nitrogen species suppresses hereditary pancreatic cancer.\n",
      "\tErratum in Proc Natl Acad Sci U S A. 2017 Jul 17;:\n",
      "\n",
      "6088 -- Nat Commun. 2019; 10(1) \n",
      "\tA meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination.\n",
      "\tErratum in Nat Commun. 2019 Feb 25;10(1):986.\n",
      "\n",
      "6112 -- Nat Commun. 2017; 8 \n",
      "\tMUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells.\n",
      "\tErratum in Nat Commun. 2017 Oct 26;8:16171.\n",
      "\n",
      "6150 -- Nat Biotechnol. 2014; 32(3) \n",
      "\tMyriad diversifies, fights rearguard action on patents.\n",
      "\tErratum in Nat Biotechnol. 2014 Jun;32(6):507.\n",
      "\n",
      "6156 -- Int J Oncol. 2007; 30(1) \n",
      "\tConstitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.\n",
      "\tErratum in Int J Oncol. 2016 Jun;48(6):2722.\n",
      "\n",
      "6214 -- Breast Cancer Res Treat. 2012; 131(1) \n",
      "\tThe BRCA2 c.9004G>A (E2002K) [corrected] variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent.\n",
      "\tErratum in Breast Cancer Res Treat. 2012 Jan;131(1):341.\n",
      "\n",
      "6215 -- Cancer Sci. 2008; 99(3) \n",
      "\tLoss of BRCA2 promotes prostate cancer cell invasion through up-regulation of matrix metalloproteinase-9.\n",
      "\tErratum in Cancer Sci. 2014 Jul;105(7):932.\n",
      "\n",
      "6233 -- Nat Cell Biol. 2014; 16(10) \n",
      "\tRASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.\n",
      "\tErratum in Nat Cell Biol. 2015 Apr;17(4):531.\n",
      "\n",
      "6237 -- Cell. 2011; 145(4) \n",
      "\tDouble-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11.\n",
      "\tErratum in Cell. 2011 Jun 10;145(6):993.\n",
      "\n",
      "6271 -- Nat Commun. 2021; 12(1) \n",
      "\tA case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.\n",
      "\tErratum in Nat Commun. 2021 May 14;12(1):2986.\n",
      "\n",
      "6280 -- J Cell Biol. 2014; 207(5) \n",
      "\tBRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells.\n",
      "\tErratum in J Cell Biol. 2015 Mar 16;208(6):857.\n",
      "\n",
      "6392 -- Genet Med. 2019; 21(10) \n",
      "\tVariant classification changes over time in BRCA1 and BRCA2.\n",
      "\tErratum in Genet Med. 2019 May 2;:\n",
      "\n",
      "6556 -- Nat Cell Biol. 2021; 23(10) \n",
      "\tPOLθ-mediated end joining is restricted by RAD52 and BRCA2 until the onset of mitosis.\n",
      "\tErratum in Nat Cell Biol. 2021 Oct 27;:\n",
      "\n",
      "6596 -- PLoS One. 2011; 6(5) \n",
      "\tFANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ.\n",
      "\tErratum in PLoS One. 2011;6(6). doi:10.1371/annotation/c6be24d1-bc23-43b4-ae01-b86dad174069.\n",
      "\n",
      "6615 -- Lancet Oncol. 2006; 7(5) \n",
      "\tScreening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.\n",
      "\tErratum in Lancet Oncol. 2006 Jun;7(6):453. Domcheck, Susan [corrected to Domchek, Susan].\n",
      "\n",
      "6648 -- Trends Biochem Sci. 2016; 41(6) \n",
      "\tRecA: Regulation and Mechanism of a Molecular Search Engine.\n",
      "\tErratum in Trends Biochem Sci. 2016 Jul;41(7):646.\n",
      "\n",
      "6921 -- Nat Commun. 2017; 8(1) \n",
      "\tFAN1 interaction with ubiquitylated PCNA alleviates replication stress and preserves genomic integrity independently of BRCA2.\n",
      "\tErratum in Nat Commun. 2017 Dec 21;8(1):2285.\n",
      "\n",
      "6946 -- Nature. 2017; 543(7643) \n",
      "\tWhole-genome landscape of pancreatic neuroendocrine tumours.\n",
      "\tErratum in Nature. 2017 Sep 27;:\n",
      "\n",
      "6955 -- Eur J Hum Genet. 2017; 25(4) \n",
      "\tEvaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers.\n",
      "\tErratum in Eur J Hum Genet. 2019 Jan;27(1):167-168.\n",
      "\n",
      "6968 -- Sci Rep. 2021; 11(1) \n",
      "\tAnalysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.\n",
      "\tErratum in Sci Rep. 2023 Mar 8;13(1):3874.\n",
      "\n",
      "6990 -- Pediatr Blood Cancer. 2017; 64(5). doi \n",
      "\tSynchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan.\n",
      "\tErratum in Pediatr Blood Cancer. 2020 May;67(5):e28226.\n",
      "\n",
      "7010 -- J Natl Cancer Inst. 2014; 106(6) \n",
      "\tModifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.\n",
      "\tErratum in J Natl Cancer Inst. 2014 Aug;106(8):dju235 doi:10.1093/jnci/dju235.\n",
      "\n",
      "7027 -- Nucleic Acids Res. 2018; 46(18) \n",
      "\tSPOP promotes transcriptional expression of DNA repair and replication factors to prevent replication stress and genomic instability.\n",
      "\tErratum in Nucleic Acids Res. 2018 Oct 12;46(18):9891.\n",
      "\n",
      "7064 -- Ann Oncol. 2013; 24 Suppl 6 \n",
      "\tNewly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.\n",
      "\tErratum in Ann Oncol. 2018 Oct 1;29(Suppl 4):iv259.\n",
      "\n",
      "7098 -- Sci Rep. 2017; 7(1) \n",
      "\tCRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.\n",
      "\tErratum in Sci Rep. 2018 Apr 13;8(1):6231.\n",
      "\n",
      "7191 -- BMC Cancer. 2015; 15 \n",
      "\tSpectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.\n",
      "\tErratum in BMC Cancer. 2017 Mar 16;17 (1):195.\n",
      "\n",
      "7251 -- Cancer. 2015; 121(2) \n",
      "\tCancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.\n",
      "\tErratum in Cancer. 2015 Jul 15;121(14):2474-5.\n",
      "\n",
      "7302 -- Biochem J. 2014; 460(3) \n",
      "\tExploring the roles of PALB2 at the crossroads of DNA repair and cancer.\n",
      "\tErratum in Biochem J. 2014 Aug 1;461(3):539.\n",
      "\n",
      "7341 -- Br J Cancer. 2021; 124(9) \n",
      "\tSurvival from breast cancer in women with a BRCA2 mutation by treatment.\n",
      "\tErratum in Br J Cancer. 2023 Feb;128(4):703.\n",
      "\n",
      "7448 -- Nat Commun. 2020; 11(1) \n",
      "\tMolecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.\n",
      "\tErratum in Nat Commun. 2022 Apr 4;13(1):1916.\n",
      "\n",
      "7452 -- N Engl J Med. 2019; 381(7) \n",
      "\tBRCA2 in Ovarian Development and Function. [No authors listed]\n",
      "\tErratum for N Engl J Med. 2019 Mar 14;380(11):1086-1087.\n",
      "\n",
      "[4421, 4616, 5446, 7452]\n",
      "7454 -- Lancet Oncol. 2021; 22(9) \n",
      "\tTalazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial.\n",
      "\tErratum in Lancet Oncol. 2022 May;23(5):e207. Lancet Oncol. 2022 Jun;23(6):e249.\n",
      "\n",
      "7460 -- PLoS Genet. 2016; 12(1) \n",
      "\tExonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools.\n",
      "\tErratum in PLoS Genet. 2016 Apr;12(4):e1005971.\n",
      "\n",
      "7485 -- Front Oncol. 2021; 11 \n",
      "\tPrevalence and Spectrum of Germline BRCA1 and BRCA2 Variants of Uncertain Significance in Breast/Ovarian Cancer: Mysterious Signals From the Genome.\n",
      "\tErratum in Front Oncol. 2022 May 04;12:920342.\n",
      "\n",
      "7505 -- J Clin Oncol. 2020; 38(30) \n",
      "\tEfficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial.\n",
      "\tErratum in J Clin Oncol. 2021 Apr 20;39(12):1414.\n",
      "\n",
      "7507 -- Int J Cancer. 2015; 137(6) \n",
      "\tErratum: RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of aurora-a and BRCA2. [No authors listed]\n",
      "\tErratum for Int J Cancer. 2013 Jul 15;133(2):275-85.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507]\n",
      "7544 -- Proc Natl Acad Sci U S A. 2018; 115(31) \n",
      "\tStem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing.\n",
      "\tErratum in Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):337.\n",
      "\n",
      "7555 -- Eur J Hum Genet. 2014; 22(2) \n",
      "\tBRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.\n",
      "\tErratum in Eur J Hum Genet. 2014 Feb;22(2):295.\n",
      "\n",
      "7575 -- Breast Cancer Res. 2020; 22(1) \n",
      "\tRisk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.\n",
      "\tErratum in Breast Cancer Res. 2020 Feb 26;22(1):25.\n",
      "\n",
      "7611 -- PLoS One. 2017; 12(11) \n",
      "\tBRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?\n",
      "\tErratum in PLoS One. 2018 May 11;13(5):e0197529.\n",
      "\n",
      "7622 -- PLoS Genet. 2010; 6(10) \n",
      "\tCommon genetic variants and modification of penetrance of BRCA2-associated breast cancer.\n",
      "\tErratum in PLoS Genet. 2010;6(11). doi: 10.1371/annotation/59ea8540-4e63-4f4a-a79e-f68765fdeac7. Greene, Mark I [corrected to Greene, Mark H]. PLoS Genet. 2010;6(11). doi: 10.1371/annotation/b28cf02d-7196-4a16-8b36-6562a0b84f75. EMBRACE [added].\n",
      "\n",
      "7674 -- Ann Surg Oncol. 2018; 25(12) \n",
      "\tBRCA Mutation Status to Personalize Management of Recurrent Ovarian Cancer: A Multicenter Study.\n",
      "\tErratum in Ann Surg Oncol. 2018 Aug 28;:\n",
      "\n",
      "7759 -- Int J Gynecol Cancer. 2021; 31(2) \n",
      "\tBritish Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for germline and tumor testing for BRCA1/2 variants in ovarian cancer in the United Kingdom.\n",
      "\tErratum in Int J Gynecol Cancer. 2021 Dec;31(12):1619.\n",
      "\n",
      "7761 -- Hered Cancer Clin Pract. 2021; 19(1) \n",
      "\tSignificant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.\n",
      "\tErratum in Hered Cancer Clin Pract. 2021 Sep 8;19(1):37.\n",
      "\n",
      "7762 -- Mol Oncol. 2021; 15(1) \n",
      "\tTumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.\n",
      "\tErratum in Mol Oncol. 2021 Jul;15(7):1970.\n",
      "\n",
      "7771 -- Cancer. 2015; 121(14) \n",
      "\tMersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK and Litton JK. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015;121:269-275. [No authors listed]\n",
      "\tErratum for Cancer. 2015 Jan 15;121(2):269-75.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771]\n",
      "7882 -- EMBO Rep. 2017; 18(7) \n",
      "\tStructural basis for recruitment of BRCA2 by PALB2.\n",
      "\tErratum for EMBO Rep. 2009 Sep;10(9):990-6.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882]\n",
      "7885 -- Maturitas. 2010; 65(4) \n",
      "\tMale breast cancer: an update in diagnosis, treatment and molecular profiling.\n",
      "\tErratum in Maturitas. 2010 Jun;66(2):220.\n",
      "\n",
      "7903 -- Mol Diagn Ther. 2020; 24(6) \n",
      "\tDiscrepancies in Genetic Testing Procedures of BRCA1/2 Mutations: A National Survey Across China.\n",
      "\tErratum in Mol Diagn Ther. 2021 Jan 21;:\n",
      "\n",
      "7916 -- Nat Commun. 2017; 8 \n",
      "\tCorrigendum: MUS81 nuclease activity is essential for replication stress tolerance and chromosome segregation in BRCA2-deficient cells.\n",
      "\tErratum for Nat Commun. 2017 Jul 17;8:15983. This corrects the article DOI: 10.1038/ncomms15983.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916]\n",
      "7941 -- J Clin Oncol. 2013; 31(26) \n",
      "\tTen-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer.\n",
      "\tErratum in J Clin Oncol. 2013 Oct 10;31(29):3725.\n",
      "\n",
      "7971 -- Bone Marrow Transplant. 2016; 51(8) \n",
      "\tHighly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation.\n",
      "\tErratum in Bone Marrow Transplant. 2017 Mar;52(3):498.\n",
      "\n",
      "7992 -- JNCI Cancer Spectr. 2018; 2(3) \n",
      "\tErratum to \"Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study\" by Lieske H Schrijver et al. [No authors listed]\n",
      "\tErratum for JNCI Cancer Spectr. 2018 Jun 28;2(2):pky023. [This corrects the article DOI: 10.1093/jncics/pky023.][This corrects the article DOI: 10.1093/jncics/pky023.].\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992]\n",
      "7993 -- Oncogene. 2017; 36(35) \n",
      "\tLoss of BRCA1 or BRCA2 markedly increases the rate of base substitution mutagenesis and has distinct effects on genomic deletions.\n",
      "\tErratum for Oncogene. 2017 Feb 9;36(6):746-755. This corrects the article DOI: 10.1038/onc.2016.243.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993]\n",
      "8009 -- Gynecol Oncol. 2019; 152(2) \n",
      "\tChemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients.\n",
      "\tErratum in Gynecol Oncol. 2020 Jan;156(1):262.\n",
      "\n",
      "8014 -- Nat Commun. 2019; 10(1) \n",
      "\tA practical guide for mutational signature analysis in hematological malignancies.\n",
      "\tErratum in Nat Commun. 2019 Jul 25;10(1):3431.\n",
      "\n",
      "8029 -- Nat Cell Biol. 2015; 17(4) \n",
      "\tRASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2.\n",
      "\tErratum for Nat Cell Biol. 2014 Oct;16(10):962-71, 1-8.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029]\n",
      "8036 -- Breast Cancer Res Treat. 2014; 145(3) \n",
      "\tMRI breast screening in high-risk women: cancer detection and survival analysis.\n",
      "\tErratum in Breast Cancer Res Treat. 2014 Oct;147(3):689. Gareth, Evans D [corrected to Evans, D Gareth]; Nisha, Kesavan [corrected to Kesavan, Nisha]; Yit, Lim [corrected to Lim, Yit]; Soujanye, Gadde [corrected to Gadde, Soujanye]; Emma, Hurley [corrected to Hurley, Emma]; Sarah, Ingham [corrected to Ingham, Sa.\n",
      "\n",
      "8121 -- Breast Cancer Res Treat. 2015; 151(1) \n",
      "\tErratum to: Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.\n",
      "\tErratum for Breast Cancer Res Treat. 2015 Jan;149(1):223-7.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121]\n",
      "8122 -- J Cell Biol. 2015; 208(6) \n",
      "\tBRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells.\n",
      "\tErratum for J Cell Biol. 2014 Dec 8;207(5):599-613.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122]\n",
      "8138 -- Sci Rep. 2018; 8(1) \n",
      "\tChemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.\n",
      "\tErratum in Sci Rep. 2018 Aug 21;8(1):12771.\n",
      "\n",
      "8173 -- Am J Clin Oncol. 2019; 42(5) \n",
      "\tAnalysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI).\n",
      "\tErratum in Am J Clin Oncol. 2019 Jun;42(6):545-542.\n",
      "\n",
      "8177 -- Fam Cancer. 2018; 17(1) \n",
      "\tUse of the BOADICEA Web Application in clinical practice: appraisals by clinicians from various countries.\n",
      "\tErratum in Fam Cancer. 2018 Jul;17(3):469.\n",
      "\n",
      "8182 -- Genet Med. 2019; 21(8) \n",
      "\tBOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors.\n",
      "\tErratum in Genet Med. 2019 Feb 21;:\n",
      "\n",
      "8202 -- Clin Cancer Res. 2017; 23(21) \n",
      "\tDifferential Toxicity in Patients with and without DNA Repair Mutations: Phase I Study of Carboplatin and Talazoparib in Advanced Solid Tumors.\n",
      "\tErratum in Clin Cancer Res. 2018 Feb 15;24(4):985.\n",
      "\n",
      "8203 -- J Cell Biol. 2017; 216(2) \n",
      "\tPhosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells.\n",
      "\tErratum in J Cell Biol. 2017 Jul 24;:\n",
      "\n",
      "8205 -- PLoS One. 2018; 13(5) \n",
      "\tCorrection: BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?\n",
      "\tErratum for PLoS One. 2017 Nov 21;12 (11):e0187630. [This corrects the article DOI: 10.1371/journal.pone.0187630.].\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205]\n",
      "8211 -- Clin Transl Oncol. 2021; 23(10) \n",
      "\tCorrection to: Comprehensive study for BRCA1 and BRCA2 entire coding regions in breast cancer.\n",
      "\tErratum for Clin Transl Oncol. 2021 Jan;23(1):74-81.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211]\n",
      "8227 -- JAMA Oncol. 2020; 6(8) \n",
      "\tCharacterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).\n",
      "\tErratum in JAMA Oncol. 2020 Nov 1;6(11):1815.\n",
      "\n",
      "8266 -- Oncol Lett. 2018; 15(3) \n",
      "\tBRCA1 homozygous unclassified variant in a patient with non-Fanconi anemia: A case report.\n",
      "\tErratum in Oncol Lett. 2018 Sep;16(3):3408.\n",
      "\n",
      "8267 -- JNCI Cancer Spectr. 2018; 2(2) \n",
      "\tOral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study.\n",
      "\tErratum in JNCI Cancer Spectr. 2018 Aug 17;2(3):pky041.\n",
      "\n",
      "8339 -- J Exp Clin Cancer Res. 2016; 35(1) \n",
      "\tDetection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer.\n",
      "\tErratum in J Exp Clin Cancer Res. 2016 Nov 28;35(1):185.\n",
      "\n",
      "8340 -- Breast Cancer Res Treat. 2015; 150(3) \n",
      "\tErratum to: recurrent mutation testing of BRCA1 and BRCA2 in Asian breast cancer patients identify carriers in those with presumed low risk by family history.\n",
      "\tErratum for Breast Cancer Res Treat. 2014 Apr;144(3):635-42.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340]\n",
      "8342 -- Eur Urol. 2015; 67(6) \n",
      "\tCorrigendum to \"Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study\" [Eur Urol 2014;66:489-99].\n",
      "\tErratum for Eur Urol. 2014 Sep;66(3):489-99.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342]\n",
      "8396 -- Cell. 2018; 174(3) \n",
      "\tGenomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.\n",
      "\tErratum in Cell. 2018 Oct 18;175(3):889.\n",
      "\n",
      "8407 -- Breast Cancer Res Treat. 2012; 134(2) \n",
      "\tInhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option.\n",
      "\tErratum in Breast Cancer Res Treat. 2016 Feb;155(3):613.\n",
      "\n",
      "8416 -- Br J Cancer. 2016; 114(7) \n",
      "\tPhase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer.\n",
      "\tErratum in Br J Cancer. 2016 Jun 14;114(12):e21.\n",
      "\n",
      "8430 -- ESMO Open. 2020; 5(3) \n",
      "\tMolecular profile of BRCA-mutated biliary tract cancers.\n",
      "\tErratum in ESMO Open. 2020 Sep;5(5):\n",
      "\n",
      "8437 -- Genet Med. 2020; 22(8) \n",
      "\tCorrection: Alternative mRNA splicing can attenuate the pathogenicity of presumed loss-of-function variants in BRCA2.\n",
      "\tErratum for Genet Med. 2020 Aug;22(8):1355-1365. An amendment to this paper has been published and can be accessed via a link at the top of the paper.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437]\n",
      "8438 -- Nat Commun. 2019; 10(1) \n",
      "\tPublisher Correction: A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination.\n",
      "\tErratum for Nat Commun. 2019 Feb 13;10(1):722.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438]\n",
      "8499 -- NPJ Breast Cancer. 2019; 5 \n",
      "\tHomologous recombination DNA repair defects in PALB2-associated breast cancers.\n",
      "\tErratum in NPJ Breast Cancer. 2019 Nov 19;5:44.\n",
      "\n",
      "8510 -- Gynecol Oncol. 2021; 161(2) \n",
      "\tCorrigendum to \"Precision prophylaxis: Identifying the optimal timing for risk-reducing salpingo-oophorectomy based on type of BRCA1 and BRCA2 cluster region mutations\" [Gynecologic Oncology 156 (2020) 363-376].\n",
      "\tErratum for Gynecol Oncol. 2020 Feb;156(2):363-376.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510]\n",
      "8511 -- Int J Oncol. 2016; 48(6) \n",
      "\t[Corrigendum] Constitutive activation of MAPK/ERK inhibits prostate cancer cell proliferation through upregulation of BRCA2.\n",
      "\tErratum for Int J Oncol. 2007 Jan;30(1):217-24.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511]\n",
      "8536 -- Oncologist. 2019; 24(12) \n",
      "\tChemotherapy Toxicity in BRCA Mutation Carriers Undergoing First-Line Platinum-Based Chemotherapy.\n",
      "\tErratum in Oncologist. 2022 Dec 9;27(12):e981.\n",
      "\n",
      "8559 -- Pathol Oncol Res. 2020; 26(3) \n",
      "\tCorrection to: BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.\n",
      "\tErratum for Pathol Oncol Res. 2020 Apr;26(2):715-726. The original version of this article unfortunately contained an error in the abstract section and Figure 2h image.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559]\n",
      "8602 -- Genet Med. 2020; 22(3) \n",
      "\tCorrection: Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral.\n",
      "\tErratum for Genet Med. 2017 Jul;19(7):754-762. An amendment to this paper has been published and can be accessed via a link at the top of the paper.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602]\n",
      "8609 -- Br J Cancer. 2018; 118(2) \n",
      "\tProstate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition.\n",
      "\tErratum in Br J Cancer. 2018 Mar 06;:\n",
      "\n",
      "8653 -- Sci Rep. 2020; 10(1) \n",
      "\tPublisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes.\n",
      "\tErratum for Sci Rep. 2020 Apr 27;10(1):7073. An amendment to this paper has been published and can be accessed via a link at the top of the paper.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653]\n",
      "8660 -- Lancet Oncol. 2015; 16(1) \n",
      "\tOlaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial.\n",
      "\tErratum in Lancet Oncol. 2015 Feb;16(2):e55. Lancet Oncol. 2015 Jan;16(1):e6.\n",
      "\n",
      "8670 -- Cancer Cell. 2018; 33(6) \n",
      "\tSelective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.\n",
      "\tErratum in Cancer Cell. 2019 Jun 10;35(6):950-952.\n",
      "\n",
      "8674 -- Lancet Oncol. 2019; 20(5) \n",
      "\tNiraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial.\n",
      "\tErratum in Lancet Oncol. 2019 May;20(5):e242.\n",
      "\n",
      "8700 -- Genet Med. 2019; 21(10) \n",
      "\tCorrection: Variant classification changes over time in BRCA1 and BRCA2.\n",
      "\tErratum for Genet Med. 2019 Oct;21(10):2248-2254.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653, 8700]\n",
      "8706 -- Mol Cell. 2021; 81(15) \n",
      "\tReplication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency.\n",
      "\tErratum in Mol Cell. 2021 Aug 5;81(15):3227.\n",
      "\n",
      "8742 -- Lancet. 2006; 367(9510) \n",
      "\tMale breast cancer.\n",
      "\tErratum in Lancet. 2006 Jun 3;367(9525):1818.\n",
      "\n",
      "8758 -- AJR Am J Roentgenol. 2015; 204(4) \n",
      "\tBreast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.\n",
      "\tErratum in AJR Am J Roentgenol. 2015 May;204(5):1137.\n",
      "\n",
      "8795 -- Pediatr Dev Pathol. 2014; 17(4) \n",
      "\tClear cell sarcoma of the kidney in a child with Fanconi anemia.\n",
      "\tErratum in Pediatr Dev Pathol. 2015 Jan-Feb;18(1):79.\n",
      "\n",
      "8815 -- Lancet Oncol. 2019; 20(8) \n",
      "\tAssociation between the cervicovaginal microbiome, BRCA1 mutation status, and risk of ovarian cancer: a case-control study.\n",
      "\tErratum in Lancet Oncol. 2019 Sep;20(9):e468. Lancet Oncol. 2019 Oct;20(10):e559.\n",
      "\n",
      "8826 -- Nat Genet. 2017; 49(4) \n",
      "\tCorrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.\n",
      "\tErratum for Nat Genet. 2014 Jul;46(7):736-41.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653, 8700, 8826]\n",
      "8833 -- Arch Gynecol Obstet. 2020; 301(4) \n",
      "\tUse of oral contraceptives in BRCA mutation carriers and risk for ovarian and breast cancer: a systematic review.\n",
      "\tErratum in Arch Gynecol Obstet. 2022 Jun;305(6):1627.\n",
      "\n",
      "8840 -- Biochim Biophys Acta. 2014; 1843(5) \n",
      "\tAurora-A controls cancer cell radio- and chemoresistance via ATM/Chk2-mediated DNA repair networks.\n",
      "\tErratum in Biochim Biophys Acta. 2014 Jul;1843(7):1308.\n",
      "\n",
      "8858 -- Nat Genet. 2014; 46(7) \n",
      "\tRare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.\n",
      "\tErratum in Nat Genet. 2017 Mar 30;49(4):651.\n",
      "\n",
      "8869 -- BMC Cancer. 2016; 16(1) \n",
      "\t53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.\n",
      "\tErratum in BMC Cancer. 2016 Nov 30;16(1):925.\n",
      "\n",
      "8911 -- Lancet Oncol. 2021; 22(12) \n",
      "\tMaintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial.\n",
      "\tErratum in Lancet Oncol. 2021 Dec;22(12):e539.\n",
      "\n",
      "8921 -- Nat Commun. 2017; 8(1) \n",
      "\tAuthor Correction: FAN1 interaction with ubiquitylated PCNA alleviates replication stress and preserves genomic integrity independently of BRCA2.\n",
      "\tErratum for Nat Commun. 2017 Oct 20;8(1):1073.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653, 8700, 8826, 8921]\n",
      "8929 -- Cell. 2015; 161(5) \n",
      "\tIntegrative clinical genomics of advanced prostate cancer.\n",
      "\tErratum in Cell. 2015 Jul 16;162(2):454.\n",
      "\n",
      "8952 -- Mol Cell. 2017; 66(5) \n",
      "\tRFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.\n",
      "\tErratum in Mol Cell. 2020 Apr 2;78(1):192.\n",
      "\n",
      "8960 -- Curr Pharmacol Rep. 2018; 4(3) \n",
      "\tThe Chemoprevention of Ovarian Cancer: the Need and the Options.\n",
      "\tErratum in Curr Pharmacol Rep. 2018;4(5):414.\n",
      "\n",
      "9172 -- Lancet. 2021; 397(10286) \n",
      "\tBreast cancer.\n",
      "\tErratum in Lancet. 2021 May 8;397(10286):1710.\n",
      "\n",
      "9181 -- Oral Oncol. 2016; 61 \n",
      "\tThe effect of human papillomavirus on DNA repair in head and neck squamous cell carcinoma.\n",
      "\tErratum in Oral Oncol. 2016 Nov;62:e5.\n",
      "\n",
      "9193 -- Front Oncol. 2021; 11 \n",
      "\tIdentification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients.\n",
      "\tErratum in Front Oncol. 2022 Jan 14;11:840551.\n",
      "\n",
      "9227 -- Nucleic Acids Res. 2015; 43(14) \n",
      "\tThe de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80.\n",
      "\tErratum in Nucleic Acids Res. 2016 Apr 7;44(6):2976. van de Broek, Bram [Corrected to van den Broek, Bram].\n",
      "\n",
      "9235 -- Cell Rep. 2020; 32(4) \n",
      "\tL ARP7 Is a BRCA1 Ubiquitinase Substrate and Regulates Genome Stability and Tumorigenesis.\n",
      "\tErratum in Cell Rep. 2020 Aug 18;32(7):108058.\n",
      "\n",
      "9251 -- Bioorg Med Chem Lett. 2021; 31 \n",
      "\tIdentification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors.\n",
      "\tErratum in Bioorg Med Chem Lett. 2022 Jan 15;56:128501.\n",
      "\n",
      "9291 -- Hered Cancer Clin Pract. 2020; 18(1) \n",
      "\tPrevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients.\n",
      "\tErratum in Hered Cancer Clin Pract. 2021 Jan 7;19(1):4.\n",
      "\n",
      "9294 -- Nat Commun. 2019; 10(1) \n",
      "\tRad52 prevents excessive replication fork reversal and protects from nascent strand degradation.\n",
      "\tErratum in Nat Commun. 2019 May 1;10(1):2023.\n",
      "\n",
      "9299 -- Oncogene. 2016; 35(1) \n",
      "\tA novel role for non-ubiquitinated FANCD2 in response to hydroxyurea-induced DNA damage.\n",
      "\tErratum in Oncogene. 2017 Jul 03;:\n",
      "\n",
      "9387 -- Gut. 2013; 62(3) \n",
      "\tInternational Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer.\n",
      "\tErratum in Gut. 2014 Dec;63(12):1978. Hammell, Pascal [corrected to Hammel, Pascal]. Gut. 2014 Jan;63(1):178. Hamell, Pascal [corrected to Hammell, Pascal].\n",
      "\n",
      "9414 -- J Natl Cancer Inst. 2006; 98(19) \n",
      "\tCommonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.\n",
      "\tErratum in J Natl Cancer Inst. 2007 May 7;99(5):411.\n",
      "\n",
      "9423 -- JAMA Oncol. 2015; 1(1) \n",
      "\tComprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies.\n",
      "\tErratum in JAMA Oncol. 2019 Aug 1;5(8):1232.\n",
      "\n",
      "9529 -- JAMA Surg. 2014; 149(12) \n",
      "\tBreast cancer following ovarian cancer in BRCA mutation carriers.\n",
      "\tErratum in JAMA Surg. 2015 Feb;150(2):183.\n",
      "\n",
      "9555 -- Breast Cancer Res. 2020; 22(1) \n",
      "\tCorrection to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.\n",
      "\tErratum for Breast Cancer Res. 2020 Jan 16;22(1):8. After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653, 8700, 8826, 8921, 9555]\n",
      "9557 -- Oncogene. 2020; 39(45) \n",
      "\tRole of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors.\n",
      "\tErratum in Oncogene. 2021 Mar;40(11):2148. Oncogene. 2021 Jun;40(22):3914-3916.\n",
      "\n",
      "9582 -- Nat Commun. 2021; 12(1) \n",
      "\tAuthor Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.\n",
      "\tErratum for Nat Commun. 2021 Feb 17;12(1):1078. A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23162-4.\n",
      "\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653, 8700, 8826, 8921, 9555, 9582]\n",
      "[4421, 4616, 5446, 7452, 7507, 7771, 7882, 7916, 7992, 7993, 8029, 8121, 8122, 8205, 8211, 8340, 8342, 8437, 8438, 8510, 8511, 8559, 8602, 8653, 8700, 8826, 8921, 9555, 9582]\n"
     ]
    }
   ],
   "source": [
    "to_remove = []\n",
    "for i, article in enumerate( articles ):\n",
    "    if article and article['erratum']:\n",
    "        print( f\"{i} -- {article['journal']}. {article['year']}; {article['volume']} \" \n",
    "               f\"\\n\\t{article['title']}\\n\\t{article['erratum']}\\n\")\n",
    "        if article['erratum'][:12] == 'Erratum for ':\n",
    "            to_remove.append(i)\n",
    "            print(to_remove)\n",
    "            \n",
    "print(to_remove)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 233,
   "id": "1ef30ed6",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:29:09.460242Z",
     "start_time": "2024-01-10T16:29:09.437442Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9555\n"
     ]
    }
   ],
   "source": [
    "for i in reversed(to_remove):\n",
    "    articles.pop(i)\n",
    "\n",
    "print(len(articles))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "61c71fee",
   "metadata": {},
   "source": [
    "## Dealing with *Comments* is complicated\n",
    "\n",
    "Some *Comments* are perspectives aiming to publicize the target paper (like News & Views in Nature). These are published in the same issue by different authors.\n",
    "\n",
    "We remove the actual *Comment* (if available) from the set of publications to analyze. We adjust `comment` key of target paper to convey this positive information. \n",
    "\n",
    "Some *Comments* appear to be summaries of the target papers. They are published in a different journal by a subset of the original authors.\n",
    "\n",
    "We remove the actual *Comment* (if available) from the set of publications to analyze. We adjust `comment` key of target paper to convey this information. \n",
    "\n",
    "Some *Comments* appear to be actual criticisms of the target papers. They are published in the same journal as the target bu later than the target and are authored by different researchers.\n",
    "\n",
    "We remove the actual *Comment* (if available) from the set of publications to analyze. We adjust `comment` key of target paper to convey this negative information.  "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 228,
   "id": "fac578e9",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:28:01.370820Z",
     "start_time": "2024-01-10T16:28:01.312046Z"
    },
    "code_folding": [],
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      " 5 Focus:  N Engl J Med 2021  Feb 4 384(5) 471-473 10.1056/NEJMe2035083\n",
      "-- Comment on N Engl J Med. 2021 Feb 4;384(5):440-451. N Engl J Med. 2021 Feb 4;384(5):428-439.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2021 2021\n",
      "===>> 384(5) 384(5)\n",
      "--->  Feb 4  Feb 4\n",
      "--->  Feb 4\n",
      "---> 471 440\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 10 Focus:  J Clin Oncol 2020  Nov 10 38(32) 3735-3739 10.1200/JCO.20.02246\n",
      "-- Comment on J Clin Oncol. 2020 Nov 10;38(32):3763-3772.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2020\n",
      "===>> 38(32) 38(32)\n",
      "--->  Nov 10  Nov 10\n",
      "--->  Nov 10\n",
      "---> 3735 3763\n",
      "---> Article 10 is a commentary and is to be removed\n",
      "\n",
      " 13 Focus:  Clin Cancer Res 2020  Apr 15 26(8) 2047-2064 10.1158/1078-0432.CCR-19-1570\n",
      "-- Comment in Clin Cancer Res. 2020 Apr 15;26(8):1784-1786. Comment on Clin Cancer Res. 2020 Apr 15;26(8):1784-1786.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 26(8) 26(8)\n",
      "--->  Apr 15  Apr 15\n",
      "--->  Apr 15\n",
      "---> 2047 1784\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 15 Focus:  Eur Urol 2016  Jun 69(6) 996-7 10.1016/j.eururo.2015.12.009\n",
      "-- Comment on Eur Urol. 2016 Jun;69(6):992-5.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2016 2016\n",
      "===>> 69(6) 69(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 996 992\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 25 Focus:  Clin Cancer Res 2020  Apr 15 26(8) 1784-1786 10.1158/1078-0432.CCR-19-4033\n",
      "-- Comment in Clin Cancer Res. 2020 Apr 15;26(8):2047-2064. Comment on Clin Cancer Res. 2019 Dec 3;:\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 26(8) 26(8)\n",
      "--->  Apr 15  Apr 15\n",
      "--->  Apr 15\n",
      "---> 1784 2047\n",
      "---> Article 25 is a commentary and is to be removed\n",
      "\n",
      " 26 Focus:  JAMA 2011  Oct 12 306(14) 1597-8 10.1001/jama.2011.1476\n",
      "-- Comment on JAMA. 2011 Oct 12;306(14):1557-65.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2011 2011\n",
      "===>> 306(14) 306(14)\n",
      "--->  Oct 12  Oct 12\n",
      "--->  Oct 12\n",
      "---> 1597 1557\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 32 Focus:  JAMA 2012  Jan 25 307(4) 359-60 None\n",
      "-- Comment on JAMA. 2011 Oct 12;306(14):1557-65.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2012 2011\n",
      "---> Article 32 is a comment and is to be removed\n",
      "\n",
      " 37 Focus:  Ann Surg Oncol 2021  Nov 28(12) 7366-7367 10.1245/s10434-021-10135-6\n",
      "-- Comment on Ann Surg Oncol. 2021 Nov;28(12):7356-7365.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2021 2021\n",
      "===>> 28(12) 28(12)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 7366 7356\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 38 Focus:  J Natl Cancer Inst 2019  May 1 111(5) 522-523 10.1093/jnci/djz012\n",
      "-- Comment in J Natl Cancer Inst. 2019 May 1;111(5):524-525. Comment on J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2019 2019\n",
      "===>> 111(5) 111(5)\n",
      "--->  May 1  May 1\n",
      "--->  May 1\n",
      "---> 522 524\n",
      "---> Article 38 is a commentary and is to be removed\n",
      "\n",
      " 40 Focus:  J Natl Cancer Inst 2020  Apr 1 112(4) 426-427 10.1093/jnci/djz162\n",
      "-- Comment in J Natl Cancer Inst. 2020 Apr 1;112(4):428. Comment on J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2020 2020\n",
      "===>> 112(4) 112(4)\n",
      "--->  Apr 1  Apr 1\n",
      "--->  Apr 1\n",
      "---> 426 428\n",
      "---> Article 40 is a commentary and is to be removed\n",
      "\n",
      " 44 Focus:  Br J Haematol 2006  May 133(4) 446-8 None\n",
      "-- Comment on Br J Haematol. 2005 Sep;130(5):796-7.\n",
      "Br J Haematol\n",
      "Br J Haematol\n",
      "===>> Br J Haematol\n",
      "===>> 2006 2005\n",
      "---> Article 44 is a comment and is to be removed\n",
      "\n",
      " 46 Focus:  JAMA 2012  Jan 25 307(4) 408-10 10.1001/jama.2012.24\n",
      "-- Comment on JAMA. 2012 Jan 25;307(4):382-90.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2012 2012\n",
      "===>> 307(4) 307(4)\n",
      "--->  Jan 25  Jan 25\n",
      "--->  Jan 25\n",
      "---> 408 382\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 48 Focus:  Med J Aust 2021  Nov 15 215(10) 458-459 10.5694/mja2.51285\n",
      "-- Comment on Med J Aust. 2021 Nov 15;215(10):460-464.\n",
      "Med J Aust\n",
      "Med J Aust\n",
      "===>> Med J Aust\n",
      "===>> 2021 2021\n",
      "===>> 215(10) 215(10)\n",
      "--->  Nov 15  Nov 15\n",
      "--->  Nov 15\n",
      "---> 458 460\n",
      "---> Article 48 is a commentary and is to be removed\n",
      "\n",
      " 52 Focus:  Clin Genet 2007  Feb 71(2) 165-70 10.1111/j.1399-0004.2007.00747.x\n",
      "-- Comment in Clin Genet. 2009 Jun;75(6):576-8.\n",
      "Clin Genet\n",
      "Clin Genet\n",
      "===>> Clin Genet\n",
      "===>> 2007 2009\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 58 Focus:  Br J Dermatol 2015  Jun 172(6) 1473 10.1111/bjd.13767\n",
      "-- Comment on Br J Dermatol. 2015 Jun;172(6):1498-506.\n",
      "Br J Dermatol\n",
      "Br J Dermatol\n",
      "===>> Br J Dermatol\n",
      "===>> 2015 2015\n",
      "===>> 172(6) 172(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1473 1498\n",
      "---> Article 58 is a commentary and is to be removed\n",
      "\n",
      " 59 Focus:  Nat Cancer 2021  Dec 2(12) 1296-1297 10.1038/s43018-021-00293-7\n",
      "-- Comment on Nat Cancer. 2021 Dec;2(12):1357-1371.\n",
      "Nat Cancer\n",
      "Nat Cancer\n",
      "===>> Nat Cancer\n",
      "===>> 2021 2021\n",
      "===>> 2(12) 2(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1296 1357\n",
      "---> Article 59 is a commentary and is to be removed\n",
      "\n",
      " 63 Focus:  Cancer 2010  Nov 15 116(22) 5119-21 10.1002/cncr.25450\n",
      "-- Comment on Cancer. 2010 Nov 15;116(22):5261-71.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2010 2010\n",
      "===>> 116(22) 116(22)\n",
      "--->  Nov 15  Nov 15\n",
      "--->  Nov 15\n",
      "---> 5119 5261\n",
      "---> Article 63 is a commentary and is to be removed\n",
      "\n",
      " 67 Focus:  JAMA 2014  Sep 17 312(11) 1091-2 10.1001/jama.2014.12483\n",
      "-- Comment in JAMA. 2015 Feb 3;313(5):525. JAMA. 2015 Feb 3;313(5):525-6.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2014 2015\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 68 Focus:  ANZ J Surg 2007  May 77(5) 309 10.1111/j.1445-2197.2007.04109.x\n",
      "-- Comment on ANZ J Surg. 2007 May;77(5):314-9.\n",
      "ANZ J Surg\n",
      "ANZ J Surg\n",
      "===>> ANZ J Surg\n",
      "===>> 2007 2007\n",
      "===>> 77(5) 77(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 309 314\n",
      "---> Article 68 is a commentary and is to be removed\n",
      "\n",
      " 80 Focus:  N Engl J Med 2007  Jul 12 357(2) 175-6 10.1056/NEJMe078093\n",
      "-- Comment on N Engl J Med. 2007 Jul 12;357(2):115-23.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2007 2007\n",
      "===>> 357(2) 357(2)\n",
      "--->  Jul 12  Jul 12\n",
      "--->  Jul 12\n",
      "---> 175 115\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 82 Focus:  J Clin Oncol 2010  Jan 10 28(2) 189-91 10.1200/JCO.2009.25.6875\n",
      "-- Comment on J Clin Oncol. 2010 Jan 10;28(2):222-31.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(2) 28(2)\n",
      "--->  Jan 10  Jan 10\n",
      "--->  Jan 10\n",
      "---> 189 222\n",
      "---> Article 82 is a commentary and is to be removed\n",
      "\n",
      " 86 Focus:  Br J Cancer 2019  Jul 121(1) 1-2 10.1038/s41416-019-0484-8\n",
      "-- Comment on Br J Cancer. 2019 Jul;121(1):15-21.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2019 2019\n",
      "===>> 121(1) 121(1)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 1 15\n",
      "---> Article 86 is a commentary and is to be removed\n",
      "\n",
      " 100 Focus:  Clin Genet 2014  Jan 85(1) 18-20 10.1111/cge.12306\n",
      "-- Comment on Clin Cancer Res. 2013 Jul 1;19(13):3396-403.\n",
      "Clin Genet\n",
      "Clin Cancer Res\n",
      "---> Article 100 is a commentary and is to be removed\n",
      "\n",
      " 101 Focus:  N Engl J Med 2009  Jul 9 361(2) 189-91 10.1056/NEJMe0903044\n",
      "-- Comment on N Engl J Med. 2009 Jul 9;361(2):123-34.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2009 2009\n",
      "===>> 361(2) 361(2)\n",
      "--->  Jul 9  Jul 9\n",
      "--->  Jul 9\n",
      "---> 189 123\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 102 Focus:  Br J Dermatol 2015  Jun 172(6) 1498-1506 10.1111/bjd.13626\n",
      "-- Comment in Br J Dermatol. 2015 Jun;172(6):1473.\n",
      "Br J Dermatol\n",
      "Br J Dermatol\n",
      "===>> Br J Dermatol\n",
      "===>> 2015 2015\n",
      "===>> 172(6) 172(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1498 1473\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 104 Focus:  Ann Oncol 2019  Mar 1 30(3) 348-350 10.1093/annonc/mdz014\n",
      "-- Comment on Ann Oncol. 2019 Mar 1;30(3):412-417.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2019 2019\n",
      "===>> 30(3) 30(3)\n",
      "--->  Mar 1  Mar 1\n",
      "--->  Mar 1\n",
      "---> 348 412\n",
      "---> Article 104 is a commentary and is to be removed\n",
      "\n",
      " 111 Focus:  Radiology 2015  Nov 277(2) 615-6 None\n",
      "-- Comment on Radiology. 2015 Jun;275(3):675-82. Radiology. 2015 Nov;277(2):614-5.\n",
      "Radiology\n",
      "Radiology\n",
      "===>> Radiology\n",
      "===>> 2015 2015\n",
      "===>> 277(2) 275(3)\n",
      "---> Article 111 is a comment and is to be removed\n",
      "\n",
      " 113 Focus:  J Clin Oncol 2017  Jul 10 35(20) 2221-2223 10.1200/JCO.2017.72.8816\n",
      "-- Comment on J Clin Oncol. 2017 Jul 10;35(20):2232-2239.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(20) 35(20)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 2221 2232\n",
      "---> Article 113 is a commentary and is to be removed\n",
      "\n",
      " 121 Focus:  Breast Cancer Res Treat 2009  Sep 117(1) 215-7 10.1007/s10549-008-0214-z\n",
      "-- Comment on 10.1007/s10549-008-0124-0.\n",
      "\n",
      " 122 Focus:  Ann Surg Oncol 2015  Feb 22(2) 353-4 10.1245/s10434-014-4007-9\n",
      "-- Comment on Ann Surg Oncol. 2015 Feb;22(2):370-6.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2015 2015\n",
      "===>> 22(2) 22(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 353 370\n",
      "---> Article 122 is a commentary and is to be removed\n",
      "\n",
      " 133 Focus:  Obstet Gynecol 2010  May 115(5) 945-952 10.1097/AOG.0b013e3181da08d7\n",
      "-- Comment in Obstet Gynecol. 2010 Aug;116(2 Pt 1):440-1; author reply 441.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2010 2010\n",
      "===>> 115(5) 116(2 Pt 1)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 136 Focus:  J Natl Cancer Inst 2006  Dec 6 98(23) 1675-7 10.1093/jnci/djj500\n",
      "-- Comment on J Natl Cancer Inst. 2006 Dec 6;98(23):1694-706.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2006 2006\n",
      "===>> 98(23) 98(23)\n",
      "--->  Dec 6  Dec 6\n",
      "--->  Dec 6\n",
      "---> 1675 1694\n",
      "---> Article 136 is a commentary and is to be removed\n",
      "\n",
      " 137 Focus:  J Clin Oncol 2008  Sep 10 26(26) 4239-43 10.1200/JCO.2008.17.4201\n",
      "-- Comment on J Clin Oncol. 2008 Sep 10;26(26):4282-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(26) 26(26)\n",
      "--->  Sep 10  Sep 10\n",
      "--->  Sep 10\n",
      "---> 4239 4282\n",
      "---> Article 137 is a commentary and is to be removed\n",
      "\n",
      " 140 Focus:  JAMA 2012  Jan 25 307(4) 359 None\n",
      "-- Comment on JAMA. 2011 Oct 12;306(14):1557-65.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2012 2011\n",
      "---> Article 140 is a comment and is to be removed\n",
      "\n",
      " 142 Focus:  Eur J Surg Oncol 2014  Jun 40(6) 670-2 10.1016/j.ejso.2014.02.218\n",
      "-- Comment in Front Psychol. 2017 Jan 31;8:121.\n",
      "Eur J Surg Oncol\n",
      "Front Psychol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 146 Focus:  Breast Cancer Res Treat 2017  Feb 162(1) 199-200 10.1007/s10549-017-4108-9\n",
      "-- Comment on Breast Cancer Res Treat. 2017 Jan;161(1):135-142.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2017 2017\n",
      "===>> 162(1) 161(1)\n",
      "---> Article 146 is a comment and is to be removed\n",
      "\n",
      " 150 Focus:  J Clin Oncol 2010  Jan 20 28(3) 387-91 10.1200/JCO.2009.25.0712\n",
      "-- Comment in J Clin Oncol. 2010 Jun 20;28(18):e308; author reply e309.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(3) 28(18)\n",
      "---> Article 150 is a comment and is to be removed\n",
      "\n",
      " 152 Focus:  Radiology 2015  Jun 275(3) 675-82 10.1148/radiol.15140967\n",
      "-- Comment in Radiology. 2015 Nov;277(2):615-6. Radiology. 2015 Nov;277(2):614-5. Radiology. 2015 Nov;277(2):615-6.\n",
      "Radiology\n",
      "Radiology\n",
      "===>> Radiology\n",
      "===>> 2015 2015\n",
      "===>> 275(3) 277(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 153 Focus:  Nature 2019  Sep 573(7774) 346 10.1038/d41586-019-02775-2\n",
      "-- Comment on Nature. 2019 Jul;571(7763):27-29.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2019 2019\n",
      "===>> 573(7774) 571(7763)\n",
      "---> Article 153 is a comment and is to be removed\n",
      "\n",
      " 155 Focus:  N Engl J Med 2007  Oct 11 357(15) 1555 None\n",
      "-- Comment on N Engl J Med. 2007 Jul 12;357(2):115-23.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2007 2007\n",
      "===>> 357(15) 357(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 161 Focus:  Br J Cancer 2016  Aug 23 115(5) e2 10.1038/bjc.2016.192\n",
      "-- Comment in Br J Cancer. 2016 Aug 23;115(5):e4. Comment on Br J Cancer. 2016 May 10;114(10 ):1160-4.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2016 2016\n",
      "===>> 115(5) 115(5)\n",
      "--->  Aug 23  Aug 23\n",
      "--->  Aug 23\n",
      "---> e2 e4\n",
      "---> Article 161 is a commentary and is to be removed\n",
      "\n",
      " 165 Focus:  J Natl Compr Canc Netw 2016  Mar 14(3) lxviii None\n",
      "-- Comment on J Natl Compr Canc Netw. 2016 Mar;14(3):lxvi-lxviii.\n",
      "J Natl Compr Canc Netw\n",
      "J Natl Compr Canc Netw\n",
      "===>> J Natl Compr Canc Netw\n",
      "===>> 2016 2016\n",
      "===>> 14(3) 14(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> lxviii lxvi\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 168 Focus:  Nurse Pract 2014  Jun 15 39(6) 8-10 10.1097/01.NPR.0000446876.99650.eb\n",
      "-- Comment in Nurse Pract. 2014 Nov 16;39(11):9.\n",
      "Nurse Pract\n",
      "Nurse Pract\n",
      "===>> Nurse Pract\n",
      "===>> 2014 2014\n",
      "===>> 39(6) 39(11)\n",
      "---> Article 168 is a comment and is to be removed\n",
      "\n",
      " 174 Focus:  Br J Cancer 2016  Aug 23 115(5) e3 10.1038/bjc.2016.224\n",
      "-- Comment in Br J Cancer. 2016 Aug 23;115(5):e4. Comment on Br J Cancer. 2016 May 10;114(10 ):1160-4.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2016 2016\n",
      "===>> 115(5) 115(5)\n",
      "--->  Aug 23  Aug 23\n",
      "--->  Aug 23\n",
      "---> e3 e4\n",
      "---> Article 174 is a commentary and is to be removed\n",
      "\n",
      " 187 Focus:  Br J Cancer 2016  Aug 23 115(5) e4 10.1038/bjc.2016.225\n",
      "-- Comment on Br J Cancer. 2016 May 10;114(10 ):1160-4. Br J Cancer. 2016 Aug 23;115(5):e2. Br J Cancer. 2016 Aug 23;115(5):e3.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2016 2016\n",
      "===>> 115(5) 114(10 )\n",
      "---> Article 187 is a comment and is to be removed\n",
      "\n",
      " 189 Focus:  Eur J Hum Genet 2009  Jun 17(6) 722-31 10.1038/ejhg.2008.212\n",
      "-- Comment in Eur J Hum Genet. 2009 Jul;17(7):855-6.\n",
      "Eur J Hum Genet\n",
      "Eur J Hum Genet\n",
      "===>> Eur J Hum Genet\n",
      "===>> 2009 2009\n",
      "===>> 17(6) 17(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 191 Focus:  Clin Cancer Res 2012  Sep 15 18(18) 4865-7 10.1158/1078-0432.CCR-12-2090\n",
      "-- Comment on Clin Cancer Res. 2012 Sep 15;18(18):4903-9.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2012 2012\n",
      "===>> 18(18) 18(18)\n",
      "--->  Sep 15  Sep 15\n",
      "--->  Sep 15\n",
      "---> 4865 4903\n",
      "---> Article 191 is a commentary and is to be removed\n",
      "\n",
      " 192 Focus:  Cancer Prev Res (Phila) 2010  Jan 3(1) 12-5 10.1158/1940-6207.CAPR-09-0249\n",
      "-- Comment on Cancer Prev Res (Phila). 2010 Jan;3(1):48-61.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2010 2010\n",
      "===>> 3(1) 3(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 12 48\n",
      "---> Article 192 is a commentary and is to be removed\n",
      "\n",
      " 193 Focus:  N Engl J Med 2011  Sep 15 365(11) 1056 None\n",
      "-- Comment on N Engl J Med. 2011 Jun 23;364(25):2381-91.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2011 2011\n",
      "===>> 365(11) 364(25)\n",
      "---> Article 193 is a comment and is to be removed\n",
      "\n",
      " 196 Focus:  J Natl Cancer Inst 2019  May 1 111(5) 524-525 10.1093/jnci/djz013\n",
      "-- Comment on J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. J Natl Cancer Inst. 2019 May 1;111(5):522-523.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2019 2018\n",
      "---> Article 196 is a comment and is to be removed\n",
      "\n",
      " 197 Focus:  Ann Oncol 2009  Apr 20(4) 609-14 10.1093/annonc/mdn669\n",
      "-- Comment in Ann Oncol. 2009 May;20(5):962.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2009 2009\n",
      "===>> 20(4) 20(5)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 200 Focus:  J Clin Oncol 2009  Feb 1 27(4) 642-3 None\n",
      "-- Comment on J Clin Oncol. 2008 Oct 10;26(29):4752-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2009 2008\n",
      "---> Article 200 is a comment and is to be removed\n",
      "\n",
      " 208 Focus:  J Clin Oncol 2006  Jun 20 24(18) 2969-70 None\n",
      "-- Comment on J Clin Oncol. 2006 Feb 1;24(4):700-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(18) 24(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 209 Focus:  Breast Cancer Res Treat 2020  Jan 179(1) 251-252 10.1007/s10549-019-05440-4\n",
      "-- Comment in Breast Cancer Res Treat. 2020 Jan;179(1):253-254. Comment on Breast Cancer Res Treat. 2019 Oct;177(3):723-733.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2020 2020\n",
      "===>> 179(1) 179(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 251 253\n",
      "---> Article 209 is a commentary and is to be removed\n",
      "\n",
      " 210 Focus:  Radiology 2015  Nov 277(2) 614-5 10.1148/radiol.2015151153\n",
      "-- Comment in Radiology. 2015 Nov;277(2):615-6. Comment on Radiology. 2015 Jun;275(3):675-82.\n",
      "Radiology\n",
      "Radiology\n",
      "===>> Radiology\n",
      "===>> 2015 2015\n",
      "===>> 277(2) 277(2)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 614 615\n",
      "---> Article 210 is a commentary and is to be removed\n",
      "\n",
      " 217 Focus:  N Engl J Med 2017  May 25 376(21) 2090-2091 10.1056/NEJMc1701592\n",
      "-- Comment in N Engl J Med. 2017 Aug 24;377(8):795. N Engl J Med. ;377(8):793-5.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2017 2017\n",
      "===>> 376(21) 377(8)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 219 Focus:  Obstet Gynecol 2012  Aug 120(2 Pt 1) 221-2 10.1097/AOG.0b013e3182602599\n",
      "-- Comment on Obstet Gynecol. 2012 Aug;120(2 Pt 1):235-40.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2012 2012\n",
      "===>> 120(2 Pt 1) 120(2 Pt 1)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 221 235\n",
      "---> Article 219 is a commentary and is to be removed\n",
      "\n",
      " 220 Focus:  J Natl Cancer Inst 2007  Jun 20 99(12) 908-9 10.1093/jnci/djm013\n",
      "-- Comment on J Natl Cancer Inst. 2007 Jun 20;99(12):929-35.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2007 2007\n",
      "===>> 99(12) 99(12)\n",
      "--->  Jun 20  Jun 20\n",
      "--->  Jun 20\n",
      "---> 908 929\n",
      "---> Article 220 is a commentary and is to be removed\n",
      "\n",
      " 222 Focus:  Gynecol Oncol 2014  Feb 132(2) 261-3 10.1016/j.ygyno.2014.01.018\n",
      "-- Comment on Gynecol Oncol. 2014 Feb;132(2):280-6.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2014 2014\n",
      "===>> 132(2) 132(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 261 280\n",
      "---> Article 222 is a commentary and is to be removed\n",
      "\n",
      " 223 Focus:  J Med Genet 2006  Mar 43(3) 201-2 10.1136/jmg.2004.028977\n",
      "-- Comment on J Med Genet. 2003 Sep;40(9):719-20. J Med Genet. 2005 Feb;42(2):e6.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2006 2003\n",
      "---> Article 223 is a comment and is to be removed\n",
      "\n",
      " 227 Focus:  J Clin Oncol 2011  Dec 1 29(34) 4477-8 10.1200/JCO.2011.37.6483\n",
      "-- Comment on J Clin Oncol. 2011 Dec 1;29(34):4505-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2011\n",
      "===>> 29(34) 29(34)\n",
      "--->  Dec 1  Dec 1\n",
      "--->  Dec 1\n",
      "---> 4477 4505\n",
      "---> Article 227 is a commentary and is to be removed\n",
      "\n",
      " 231 Focus:  JAMA 2015  Feb 3 313(5) 525-6 10.1001/jama.2014.17442\n",
      "-- Comment on JAMA. 2014 Sep 17;312(11):1091-2. JAMA. 2015 Feb 3;313(5):525.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2015 2014\n",
      "---> Article 231 is a comment and is to be removed\n",
      "\n",
      " 233 Focus:  N Engl J Med 2007  Oct 11 357(15) 1555-6 None\n",
      "-- Comment on N Engl J Med. 2007 Jul 12;357(2):115-23.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2007 2007\n",
      "===>> 357(15) 357(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 234 Focus:  JAMA Oncol 2019  Jan 1 5(1) 58-59 10.1001/jamaoncol.2018.3034\n",
      "-- Comment on JAMA Oncol. 2019 Jan 1;5(1):51-57.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2019 2019\n",
      "===>> 5(1) 5(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 58 51\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 236 Focus:  Am J Obstet Gynecol 2016  Jul 215(1) 133-4 10.1016/j.ajog.2016.03.049\n",
      "-- Comment in Am J Obstet Gynecol. 2016 Jul;215(1):134-5. Comment on Am J Obstet Gynecol. 2016 Jun;214(6):761-3.\n",
      "Am J Obstet Gynecol\n",
      "Am J Obstet Gynecol\n",
      "===>> Am J Obstet Gynecol\n",
      "===>> 2016 2016\n",
      "===>> 215(1) 215(1)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 133 134\n",
      "---> Article 236 is a commentary and is to be removed\n",
      "\n",
      " 237 Focus:  Clin Genet 2014  Jan 85(1) 16-7 10.1111/cge.12302\n",
      "-- Comment on Clin Cancer Res. 2013 Jul 1;19(13):3474-84.\n",
      "Clin Genet\n",
      "Clin Cancer Res\n",
      "---> Article 237 is a commentary and is to be removed\n",
      "\n",
      " 238 Focus:  Nurse Pract 2014  Nov 16 39(11) 9 10.1097/01.NPR.0000456025.48460.c5\n",
      "-- Comment on Nurse Pract. 2014 Jun 15;39(6):8-10.\n",
      "Nurse Pract\n",
      "Nurse Pract\n",
      "===>> Nurse Pract\n",
      "===>> 2014 2014\n",
      "===>> 39(11) 39(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 239 Focus:  Int J Cancer 2006  Apr 1 118(7) 1852 10.1002/ijc.21549\n",
      "-- Comment on Int J Cancer. 2006 Jan 1;118(1):103-7.\n",
      "Int J Cancer\n",
      "Int J Cancer\n",
      "===>> Int J Cancer\n",
      "===>> 2006 2006\n",
      "===>> 118(7) 118(1)\n",
      "---> Article 239 is a comment and is to be removed\n",
      "\n",
      " 241 Focus:  Int J Gynecol Cancer 2021  Jul 31(7) 1096 10.1136/ijgc-2021-002682\n",
      "-- Comment in Int J Gynecol Cancer. 2021 Jul;31(7):1097. Comment on Int J Gynecol Cancer. 2021 Mar;31(3):332-338.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2021 2021\n",
      "===>> 31(7) 31(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 1096 1097\n",
      "---> Article 241 is a commentary and is to be removed\n",
      "\n",
      " 242 Focus:  J Natl Cancer Inst 2018  Jul 1 110(7) 687-689 10.1093/jnci/djx282\n",
      "-- Comment on J Natl Cancer Inst. 2018 Jul 1;110(7):714-725.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2018 2018\n",
      "===>> 110(7) 110(7)\n",
      "--->  Jul 1  Jul 1\n",
      "--->  Jul 1\n",
      "---> 687 714\n",
      "---> Article 242 is a commentary and is to be removed\n",
      "\n",
      " 249 Focus:  Cancer Genet 2016  Jun 209(6) 283-4 10.1016/j.cancergen.2016.04.057\n",
      "-- Comment on Cancer Genet. 2016 Jun;209(6):282-3.\n",
      "Cancer Genet\n",
      "Cancer Genet\n",
      "===>> Cancer Genet\n",
      "===>> 2016 2016\n",
      "===>> 209(6) 209(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 283 282\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 251 Focus:  J Genet Couns 2016  Dec 25(6) 1342-1344 10.1007/s10897-016-0009-z\n",
      "-- Comment on J Genet Couns. 2016 Dec;25(6):1338-1341.\n",
      "J Genet Couns\n",
      "J Genet Couns\n",
      "===>> J Genet Couns\n",
      "===>> 2016 2016\n",
      "===>> 25(6) 25(6)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1342 1338\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 255 Focus:  Clin Genet 2009  Jun 75(6) 576-8 10.1111/j.1399-0004.2008.01137.x\n",
      "-- Comment on Clin Genet. 2007 Feb;71(2):165-70.\n",
      "Clin Genet\n",
      "Clin Genet\n",
      "===>> Clin Genet\n",
      "===>> 2009 2007\n",
      "---> Article 255 is a comment and is to be removed\n",
      "\n",
      " 256 Focus:  J Natl Cancer Inst 2020  Apr 1 112(4) 428 10.1093/jnci/djz163\n",
      "-- Comment on J Natl Cancer Inst. 2018 Nov 1;110(11):1178-1189. J Natl Cancer Inst. 2020 Apr 1;112(4):426-427.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2020 2018\n",
      "---> Article 256 is a comment and is to be removed\n",
      "\n",
      " 259 Focus:  Br J Radiol 2020  Apr 93(1108) 20200038 10.1259/bjr.20200038\n",
      "-- Comment on Br J Radiol. 2019 May;92(1097):20170657.\n",
      "Br J Radiol\n",
      "Br J Radiol\n",
      "===>> Br J Radiol\n",
      "===>> 2020 2019\n",
      "---> Article 259 is a comment and is to be removed\n",
      "\n",
      " 260 Focus:  N Engl J Med 2014  Oct 23 371(17) 1650-1 10.1056/NEJMc1410673\n",
      "-- Comment in N Engl J Med. 2014 Oct 23;371(17):1651-2. Comment on N Engl J Med. 2014 Aug 7;371(6):497-506.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2014 2014\n",
      "===>> 371(17) 371(17)\n",
      "--->  Oct 23  Oct 23\n",
      "--->  Oct 23\n",
      "---> 1650 1651\n",
      "---> Article 260 is a commentary and is to be removed\n",
      "\n",
      " 261 Focus:  Obstet Gynecol 2013  Jan 121(1) 4-6 10.1097/aog.0b013e31827bfc93\n",
      "-- Comment on Obstet Gynecol. 2013 Jan;121(1):14-24.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2013 2013\n",
      "===>> 121(1) 121(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 4 14\n",
      "---> Article 261 is a commentary and is to be removed\n",
      "\n",
      " 271 Focus:  Clin Oncol (R Coll Radiol) 2009  Aug 21(6) 444-7 10.1016/j.clon.2009.04.004\n",
      "-- Comment in Clin Oncol (R Coll Radiol). 2009 Aug;21(6):441-3.\n",
      "Clin Oncol (R Coll Radiol)\n",
      "Clin Oncol (R Coll Radiol)\n",
      "===>> Clin Oncol (R Coll Radiol)\n",
      "===>> 2009 2009\n",
      "===>> 21(6) 21(6)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 444 441\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 275 Focus:  N Engl J Med 2014  Oct 23 371(17) 1651-2 10.1056/NEJMc1410673\n",
      "-- Comment in Nat Rev Clin Oncol. 2014 Oct;11(10):560. Comment on N Engl J Med. 2014 Aug 7;371(6):497-506. N Engl J Med. 2014 Oct 23;371(17):1650. N Engl J Med. 2014 Oct 23;371(17):1650-1.\n",
      "N Engl J Med\n",
      "Nat Rev Clin Oncol\n",
      "---> Article 275 is a commentary and is to be removed\n",
      "\n",
      " 277 Focus:  Breast Cancer Res Treat 2020  Jan 179(1) 253-254 10.1007/s10549-019-05487-3\n",
      "-- Comment on Breast Cancer Res Treat. 2020 Jan;179(1):251-252.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2020 2020\n",
      "===>> 179(1) 179(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 253 251\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 280 Focus:  J Clin Oncol 2011  May 1 29(13) 1652-4 10.1200/JCO.2010.32.5274\n",
      "-- Comment on J Clin Oncol. 2011 May 1;29(13):1664-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2011\n",
      "===>> 29(13) 29(13)\n",
      "--->  May 1  May 1\n",
      "--->  May 1\n",
      "---> 1652 1664\n",
      "---> Article 280 is a commentary and is to be removed\n",
      "\n",
      " 282 Focus:  J Clin Oncol 2010  Nov 20 28(33) e698-9 None\n",
      "-- Comment on J Clin Oncol. 2010 Sep 20;28(27):4120-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(33) 28(27)\n",
      "---> Article 282 is a comment and is to be removed\n",
      "\n",
      " 283 Focus:  J Clin Oncol 2008  Aug 20 26(24) 3918-9 10.1200/JCO.2008.17.4227\n",
      "-- Comment on J Clin Oncol. 2008 Aug 20;26(24):3943-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(24) 26(24)\n",
      "--->  Aug 20  Aug 20\n",
      "--->  Aug 20\n",
      "---> 3918 3943\n",
      "---> Article 283 is a commentary and is to be removed\n",
      "\n",
      " 284 Focus:  Nat Rev Clin Oncol 2014  Oct 11(10) 560 10.1038/nrclinonc.2014.142\n",
      "-- Comment on N Engl J Med. 2014 Oct 23;371(17):1651-2.\n",
      "Nat Rev Clin Oncol\n",
      "N Engl J Med\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 288 Focus:  Cancer 2007  Dec 15 110(12) 2819 None\n",
      "-- Comment on Cancer. 2007 May 1;109(9):1784-90.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2007 2007\n",
      "===>> 110(12) 109(9)\n",
      "---> Article 288 is a comment and is to be removed\n",
      "\n",
      " 291 Focus:  JAMA 2007  Nov 7 298(17) 2007 None\n",
      "-- Comment on JAMA. 2007 Jun 20;297(23):2587-95.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2007 2007\n",
      "===>> 298(17) 297(23)\n",
      "---> Article 291 is a comment and is to be removed\n",
      "\n",
      " 292 Focus:  Clin Genet 2016  Mar 89(3) 400 10.1111/cge.12686\n",
      "-- Comment on Clin Genet. 2015 May;87(5):411-8. Clin Genet. 2016 Mar;89(3):399.\n",
      "Clin Genet\n",
      "Clin Genet\n",
      "===>> Clin Genet\n",
      "===>> 2016 2015\n",
      "---> Article 292 is a comment and is to be removed\n",
      "\n",
      " 293 Focus:  Int J Gynecol Cancer 2021  Jul 31(7) 1097 10.1136/ijgc-2021-002738\n",
      "-- Comment on Int J Gynecol Cancer. 2021 Mar;31(3):332-338. Int J Gynecol Cancer. 2021 Jul;31(7):1096.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2021 2021\n",
      "===>> 31(7) 31(3)\n",
      "---> Article 293 is a comment and is to be removed\n",
      "\n",
      " 294 Focus:  JAMA 2017  Feb 7 317(5) 531-534 10.1001/jama.2016.16918\n",
      "-- Comment on JAMA Oncol. 2015 Jun;1(3):277-8.\n",
      "JAMA\n",
      "JAMA Oncol\n",
      "---> Article 294 is a commentary and is to be removed\n",
      "\n",
      " 296 Focus:  Cancer 2020  Dec 1 126(23) 5007 10.1002/cncr.33302\n",
      "-- Comment on Cancers (Basel). 2020 Jul 17;12(7):\n",
      "Cancer\n",
      "Cancers (Basel)\n",
      "---> Article 296 is a commentary and is to be removed\n",
      "\n",
      " 297 Focus:  Am J Surg 2020  Mar 219(3) 434-435 10.1016/j.amjsurg.2019.11.006\n",
      "-- Comment on Am J Surg. 2020 Mar;219(3):430-433.\n",
      "Am J Surg\n",
      "Am J Surg\n",
      "===>> Am J Surg\n",
      "===>> 2020 2020\n",
      "===>> 219(3) 219(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 434 430\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 298 Focus:  J Med Genet 2008  Jul 45(7) 409-10 10.1136/jmg.2008.058057\n",
      "-- Comment on J Med Genet. 2008 Jul;45(7):425-31.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2008 2008\n",
      "===>> 45(7) 45(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 409 425\n",
      "---> Article 298 is a commentary and is to be removed\n",
      "\n",
      " 299 Focus:  J Clin Oncol 2012  Jan 1 30(1) 2-3 10.1200/JCO.2011.37.6509\n",
      "-- Comment on J Clin Oncol. 2012 Jan 1;30(1):19-26.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2012\n",
      "===>> 30(1) 30(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 2 19\n",
      "---> Article 299 is a commentary and is to be removed\n",
      "\n",
      " 301 Focus:  Oncology (Williston Park) 2011  Oct 25(11) 1033-4 None\n",
      "-- Comment on Oncology (Williston Park). 2011 Oct;25(11):1014-25.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2011 2011\n",
      "===>> 25(11) 25(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1033 1014\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 302 Focus:  EBioMedicine 2015  Sep 24 2(10) 1270-1 10.1016/j.ebiom.2015.09.035\n",
      "-- Comment on EBioMedicine. 2015 Oct;2(10):1331-9.\n",
      "EBioMedicine\n",
      "EBioMedicine\n",
      "===>> EBioMedicine\n",
      "===>> 2015 2015\n",
      "===>> 2(10) 2(10)\n",
      "--->  Sep 24  Oct\n",
      "---> Article 302 is a comment and is to be removed\n",
      "\n",
      " 307 Focus:  J Urol 2011  Apr 185(4) 1277 10.1016/S0022-5347(11)60294-2\n",
      "-- Comment on Br J Cancer. 2010 Sep 28;103(7):1103-8.\n",
      "J Urol\n",
      "Br J Cancer\n",
      "---> Article 307 is a commentary and is to be removed\n",
      "\n",
      " 316 Focus:  Cancer Epidemiol Biomarkers Prev 2007  Nov 16(11) 2517 10.1158/1055-9965.EPI-07-0669\n",
      "-- Comment on Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1416-21.\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "===>> Cancer Epidemiol Biomarkers Prev\n",
      "===>> 2007 2007\n",
      "===>> 16(11) 16(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 317 Focus:  N Engl J Med 2007  Oct 18 357(16) 1663 None\n",
      "-- Comment on N Engl J Med. 2007 Jul 12;357(2):154-62.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2007 2007\n",
      "===>> 357(16) 357(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 325 Focus:  Science 2014  Mar 28 343(6178) 1451 10.1126/science.343.6178.1451\n",
      "-- Comment in Science. 2014 May 9;344(6184):577.\n",
      "Science\n",
      "Science\n",
      "===>> Science\n",
      "===>> 2014 2014\n",
      "===>> 343(6178) 344(6184)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 346 Focus:  J Clin Oncol 2012  Apr 1 30(10) 1142-3 None\n",
      "-- Comment on J Clin Oncol. 2011 Dec 1;29(34):4505-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2011\n",
      "---> Article 346 is a comment and is to be removed\n",
      "\n",
      " 355 Focus:  JAMA 2007  Jun 20 297(23) 2637-9 10.1001/jama.297.23.2637\n",
      "-- Comment on JAMA. 2007 Jun 20;297(23):2587-95.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2007 2007\n",
      "===>> 297(23) 297(23)\n",
      "--->  Jun 20  Jun 20\n",
      "--->  Jun 20\n",
      "---> 2637 2587\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 356 Focus:  J Clin Oncol 2008  Sep 10 26(26) 4282-8 10.1200/JCO.2008.16.6231\n",
      "-- Comment in J Clin Oncol. 2008 Sep 10;26(26):4239-43.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(26) 26(26)\n",
      "--->  Sep 10  Sep 10\n",
      "--->  Sep 10\n",
      "---> 4282 4239\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 358 Focus:  Acad Radiol 2007  May 14(5) 511-2 10.1016/j.acra.2007.03.003\n",
      "-- Comment on Acad Radiol. 2007 May;14(5):513-21.\n",
      "Acad Radiol\n",
      "Acad Radiol\n",
      "===>> Acad Radiol\n",
      "===>> 2007 2007\n",
      "===>> 14(5) 14(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 511 513\n",
      "---> Article 358 is a commentary and is to be removed\n",
      "\n",
      " 359 Focus:  J Natl Cancer Inst 2007  Jul 18 99(14) 1130-1 None\n",
      "-- Comment on J Natl Cancer Inst. 2006 Apr 19;98(8):535-44.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2007 2006\n",
      "---> Article 359 is a comment and is to be removed\n",
      "\n",
      " 360 Focus:  Obstet Gynecol 2010  Aug 116(2 Pt 1) 440-441 10.1097/AOG.0b013e3181eaa0c0\n",
      "-- Comment on Obstet Gynecol. 2010 May;115(5):945-52.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2010 2010\n",
      "===>> 116(2 Pt 1) 115(5)\n",
      "---> Article 360 is a comment and is to be removed\n",
      "\n",
      " 366 Focus:  Evid Based Med 2013  Aug 18(4) e40 10.1136/eb-2012-101075\n",
      "-- Comment on BMJ. 2012;345:e5660.\n",
      "Evid Based Med\n",
      "BMJ\n",
      "---> Article 366 is a commentary and is to be removed\n",
      "\n",
      " 367 Focus:  Am J Prev Med 2017  Nov 53(5) e195-e196 10.1016/j.amepre.2017.05.016\n",
      "-- Comment in Am J Prev Med. 2017 Nov;53(5):e197-e199. Comment on Am J Prev Med. 2017 Jun;52(6):702-709.\n",
      "Am J Prev Med\n",
      "Am J Prev Med\n",
      "===>> Am J Prev Med\n",
      "===>> 2017 2017\n",
      "===>> 53(5) 53(5)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> e195 e197\n",
      "---> Article 367 is a commentary and is to be removed\n",
      "\n",
      " 371 Focus:  J Med Genet 2008  Nov 45(11) 765-6 10.1136/jmg.2008.061903\n",
      "-- Comment on J Med Genet. 2008 Jul;45(7):425-31.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2008 2008\n",
      "===>> 45(11) 45(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 372 Focus:  JAMA 2015  Feb 3 313(5) 525 10.1001/jama.2014.17436\n",
      "-- Comment in JAMA. 2015 Feb 3;313(5):525-6. Comment on JAMA. 2014 Sep 17;312(11):1091-2.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2015 2015\n",
      "===>> 313(5) 313(5)\n",
      "--->  Feb 3  Feb 3\n",
      "--->  Feb 3\n",
      "---> 525 525\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 373 Focus:  Int J Gynecol Cancer 2012  Jan 22(1) 2 10.1097/IGC.0b013e31822d0e91\n",
      "-- Comment on Int J Gynecol Cancer. 2011 Jul;21(5):846-51.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2012 2011\n",
      "---> Article 373 is a comment and is to be removed\n",
      "\n",
      " 377 Focus:  N Engl J Med 2008  Feb 28 358(9) 970 None\n",
      "-- Comment on N Engl J Med. 2007 Oct 18;357(16):1640-8.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2008 2007\n",
      "---> Article 377 is a comment and is to be removed\n",
      "\n",
      " 378 Focus:  J Med Genet 2007  Aug 44(8) e86 None\n",
      "-- Comment on J Med Genet. 2007 Jan;44(1):10-15.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2007 2007\n",
      "===>> 44(8) 44(1)\n",
      "---> Article 378 is a comment and is to be removed\n",
      "\n",
      " 380 Focus:  Oncology (Williston Park) 2011  Oct 25(11) 1028, 1030 None\n",
      "-- Comment on Oncology (Williston Park). 2011 Oct;25(11):1014-25.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2011 2011\n",
      "===>> 25(11) 25(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1028, 1030 1014\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 385 Focus:  J Clin Oncol 2007  Nov 20 25(33) 5327 None\n",
      "-- Comment on J Clin Oncol. 2007 Sep 1;25(25):3831-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(33) 25(25)\n",
      "---> Article 385 is a comment and is to be removed\n",
      "\n",
      " 386 Focus:  Cancer Res 2007  May 15 67(10) 5057 None\n",
      "-- Comment on Cancer Res. 2006 Aug 15;66(16):8297-308.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2007 2006\n",
      "---> Article 386 is a comment and is to be removed\n",
      "\n",
      " 387 Focus:  Proc Biol Sci 2012  Aug 7 279(1740) 2926-9 10.1098/rspb.2012.0542\n",
      "-- Comment on Proc Biol Sci. 2012 Apr 7;279(1732):1389-95.\n",
      "Proc Biol Sci\n",
      "Proc Biol Sci\n",
      "===>> Proc Biol Sci\n",
      "===>> 2012 2012\n",
      "===>> 279(1740) 279(1732)\n",
      "---> Article 387 is a comment and is to be removed\n",
      "\n",
      " 393 Focus:  N Engl J Med 2014  Oct 23 371(17) 1650 10.1056/NEJMc1410673#SA1\n",
      "-- Comment in N Engl J Med. 2014 Oct 23;371(17):1651-2. Comment on N Engl J Med. 2014 Aug 7;371(6):497-506.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2014 2014\n",
      "===>> 371(17) 371(17)\n",
      "--->  Oct 23  Oct 23\n",
      "--->  Oct 23\n",
      "---> 1650 1651\n",
      "---> Article 393 is a commentary and is to be removed\n",
      "\n",
      " 395 Focus:  Cancer Prev Res (Phila) 2011  Jan 4(1) 6-8 10.1158/1940-6207.CAPR-10-0348\n",
      "-- Comment on Cancer Prev Res (Phila). 2011 Jan;4(1):23-33.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2011 2011\n",
      "===>> 4(1) 4(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 6 23\n",
      "---> Article 395 is a commentary and is to be removed\n",
      "\n",
      " 401 Focus:  Cancer Epidemiol Biomarkers Prev 2009  Feb 18(2) 686 10.1158/1055-9965.EPI-08-1087\n",
      "-- Comment on Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):2980-6.\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "===>> Cancer Epidemiol Biomarkers Prev\n",
      "===>> 2009 2008\n",
      "---> Article 401 is a comment and is to be removed\n",
      "\n",
      " 406 Focus:  JAMA Oncol 2015  Dec 1(9) 1225-6 10.1001/jamaoncol.2015.3269\n",
      "-- Comment on JAMA Oncol. 2015 Dec;1(9):1251-60.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(9) 1(9)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1225 1251\n",
      "---> Article 406 is a commentary and is to be removed\n",
      "\n",
      " 407 Focus:  J Clin Oncol 2007  Mar 1 25(7) 911-2 None\n",
      "-- Comment on J Clin Oncol. 2006 Oct 10;24(29):4775-82.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2006\n",
      "---> Article 407 is a comment and is to be removed\n",
      "\n",
      " 414 Focus:  Ann Intern Med 2006  Mar 7 144(5) 376 None\n",
      "-- Comment on Ann Intern Med. 2005 Sep 6;143(5):362-79.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2006 2005\n",
      "---> Article 414 is a comment and is to be removed\n",
      "\n",
      " 415 Focus:  Breast Cancer Res Treat 2011  Sep 129(2) 649-51 None\n",
      "-- Comment on Breast Cancer Res Treat. 2010 Dec;124(3):765-9. Breast Cancer Res Treat. 2011 Jan;125(1):157-61. Breast Cancer Res Treat. 2011 Apr;126(2):365-71. Breast Cancer Res Treat. 2011 Jan;125(2):529-35. Breast Cancer Res Treat. 2011 Feb;125(3):827-35.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2010\n",
      "---> Article 415 is a comment and is to be removed\n",
      "\n",
      " 416 Focus:  Am J Prev Med 2017  Nov 53(5) e197-e199 10.1016/j.amepre.2017.05.015\n",
      "-- Comment on Am J Prev Med. 2017 Jun;52(6):702-709. Am J Prev Med. 2017 Nov;53(5):e195-e196.\n",
      "Am J Prev Med\n",
      "Am J Prev Med\n",
      "===>> Am J Prev Med\n",
      "===>> 2017 2017\n",
      "===>> 53(5) 52(6)\n",
      "---> Article 416 is a comment and is to be removed\n",
      "\n",
      " 419 Focus:  Nat Rev Genet 2011  Mar 12(3) 224 10.1038/nrg2867-c1\n",
      "-- Comment on Nat Rev Genet. 2010 Nov;11(11):773-85.\n",
      "Nat Rev Genet\n",
      "Nat Rev Genet\n",
      "===>> Nat Rev Genet\n",
      "===>> 2011 2010\n",
      "---> Article 419 is a comment and is to be removed\n",
      "\n",
      " 421 Focus:  J Clin Oncol 2010  Jun 20 28(18) e308 None\n",
      "-- Comment on J Clin Oncol. 2010 Jan 20;28(3):387-91.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(18) 28(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 425 Focus:  Fam Cancer 2010  Sep 9(3) 289-90 10.1007/s10689-009-9318-9\n",
      "-- Comment on Fam Cancer. 2009;8(4):339-46.\n",
      "Fam Cancer\n",
      "Fam Cancer\n",
      "===>> Fam Cancer\n",
      "===>> 2010 2009\n",
      "---> Article 425 is a comment and is to be removed\n",
      "\n",
      " 427 Focus:  Clin Genet 2016  Mar 89(3) 399 10.1111/cge.12687\n",
      "-- Comment in Clin Genet. 2016 Mar;89(3):400. Comment on Clin Genet. 2015 May;87(5):411-8.\n",
      "Clin Genet\n",
      "Clin Genet\n",
      "===>> Clin Genet\n",
      "===>> 2016 2016\n",
      "===>> 89(3) 89(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 399 400\n",
      "---> Article 427 is a commentary and is to be removed\n",
      "\n",
      " 431 Focus:  Oncology (Williston Park) 2008  Apr 30 22(5) 548-51 None\n",
      "-- Comment on Oncology (Williston Park). 2008 Apr 30;22(5):545-8.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2008 2008\n",
      "===>> 22(5) 22(5)\n",
      "--->  Apr 30  Apr 30\n",
      "--->  Apr 30\n",
      "---> 548 545\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 432 Focus:  JAMA 2006  Dec 13 296(22) 2681-2 None\n",
      "-- Comment on JAMA. 2006 May 24;295(20):2374-84.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2006 2006\n",
      "===>> 296(22) 295(20)\n",
      "---> Article 432 is a comment and is to be removed\n",
      "\n",
      " 433 Focus:  Ann Surg Oncol 2008  Jun 15(6) 1788-90 None\n",
      "-- Comment on Ann Surg Oncol. 2007 Dec;14(12):3335-44.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2008 2007\n",
      "---> Article 433 is a comment and is to be removed\n",
      "\n",
      " 435 Focus:  J Hum Genet 2013  Feb 58(2) 58 10.1038/jhg.2012.142\n",
      "-- Comment on J Hum Genet. 2013 Feb;58(2):59-66.\n",
      "J Hum Genet\n",
      "J Hum Genet\n",
      "===>> J Hum Genet\n",
      "===>> 2013 2013\n",
      "===>> 58(2) 58(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 58 59\n",
      "---> Article 435 is a commentary and is to be removed\n",
      "\n",
      " 436 Focus:  Breast Cancer Res Treat 2008  Feb 107(3) 455-7 10.1007/s10549-007-9555-2\n",
      "-- Comment on Breast Cancer Res Treat. 2007 May;103(1):111-3.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2008 2007\n",
      "---> Article 436 is a comment and is to be removed\n",
      "\n",
      " 437 Focus:  JAMA Intern Med 2013  Jan 28 173(2) 103-4 10.1001/jamainternmed.2013.2729\n",
      "-- Comment on JAMA Intern Med. 2013 Jan 28;173(2):96-103.\n",
      "JAMA Intern Med\n",
      "JAMA Intern Med\n",
      "===>> JAMA Intern Med\n",
      "===>> 2013 2013\n",
      "===>> 173(2) 173(2)\n",
      "--->  Jan 28  Jan 28\n",
      "--->  Jan 28\n",
      "---> 103 96\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 440 Focus:  Ann Surg 2009  Jun 249(6) 1067-8 10.1097/SLA.0b013e3181a88b69\n",
      "-- Comment on Ann Surg. 2008 Aug;248(2):280-5.\n",
      "Ann Surg\n",
      "Ann Surg\n",
      "===>> Ann Surg\n",
      "===>> 2009 2008\n",
      "---> Article 440 is a comment and is to be removed\n",
      "\n",
      " 441 Focus:  Nat Rev Cancer 2014  Feb 14(2) 74-5 10.1038/nrc3674\n",
      "-- Comment on Cancer Cell. 2013 Dec 9;24(6):751-65.\n",
      "Nat Rev Cancer\n",
      "Cancer Cell\n",
      "---> Article 441 is a commentary and is to be removed\n",
      "\n",
      " 446 Focus:  J Clin Oncol 2014  Nov 10 32(32) 3683 10.1200/JCO.2014.57.6124\n",
      "-- Comment on J Clin Oncol. 2014 Apr 20;32(12):1249-55. J Clin Oncol. 2014 Nov 10;32(32):3682-3.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(32) 32(12)\n",
      "---> Article 446 is a comment and is to be removed\n",
      "\n",
      " 448 Focus:  J Clin Oncol 2014  Nov 10 32(32) 3682-3 10.1200/JCO.2014.57.4848\n",
      "-- Comment in J Clin Oncol. 2014 Nov 10;32(32):3683. Comment on J Clin Oncol. 2014 Apr 20;32(12):1249-55.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(32) 32(32)\n",
      "--->  Nov 10  Nov 10\n",
      "--->  Nov 10\n",
      "---> 3682 3683\n",
      "---> Article 448 is a commentary and is to be removed\n",
      "\n",
      " 450 Focus:  J Natl Compr Canc Netw 2016  Mar 14(3) lxvi-lxviii 10.6004/jnccn.2016.0040\n",
      "-- Comment in J Natl Compr Canc Netw. 2016 Mar;14(3):lxviii. Comment on J Natl Compr Canc Netw. 2015 Jul;13(7):835-45.\n",
      "J Natl Compr Canc Netw\n",
      "J Natl Compr Canc Netw\n",
      "===>> J Natl Compr Canc Netw\n",
      "===>> 2016 2016\n",
      "===>> 14(3) 14(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> lxvi lxviii\n",
      "---> Article 450 is a commentary and is to be removed\n",
      "\n",
      " 453 Focus:  J Clin Oncol 2016  Dec 34(34) 4183 10.1200/JCO.2016.67.7724\n",
      "-- Comment in J Clin Oncol. 2016 Dec;34(34):4187-4188. Comment on J Clin Oncol. 2016 May 1;34(13):1460-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2016 2016\n",
      "===>> 34(34) 34(34)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 4183 4187\n",
      "---> Article 453 is a commentary and is to be removed\n",
      "\n",
      " 471 Focus:  J Genet Couns 2012  Feb 21(1) 7-12 10.1007/s10897-011-9467-5\n",
      "-- Comment on J Genet Couns. 2009 Dec;18(6):524-6. J Genet Couns. 2009 Dec;18(6):521-3.\n",
      "J Genet Couns\n",
      "J Genet Couns\n",
      "===>> J Genet Couns\n",
      "===>> 2012 2009\n",
      "---> Article 471 is a comment and is to be removed\n",
      "\n",
      " 481 Focus:  Int J Gynecol Cancer 2008  Jul-Aug 18(4) 876-7 10.1111/j.1525-1438.2007.01084.x\n",
      "-- Comment in Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1386. Comment on Int J Gynecol Cancer. 2007 Jul-Aug;17(4):789-93.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2008 2008\n",
      "===>> 18(4) 18(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 486 Focus:  N Engl J Med 2008  Apr 10 358(15) 1636 None\n",
      "-- Comment on N Engl J Med. 2007 Dec 20;357(25):2543-51.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2008 2007\n",
      "---> Article 486 is a comment and is to be removed\n",
      "\n",
      " 488 Focus:  J Clin Pathol 2007  Apr 60(4) 478 10.1136/jcp.2006.040501\n",
      "-- Comment on J Clin Pathol. 2005 May;58(5):493-9.\n",
      "J Clin Pathol\n",
      "J Clin Pathol\n",
      "===>> J Clin Pathol\n",
      "===>> 2007 2005\n",
      "---> Article 488 is a comment and is to be removed\n",
      "\n",
      " 492 Focus:  Cancer Res 2007  Mar 15 67(6) 2902 None\n",
      "-- Comment on Cancer Res. 2006 Sep 15;66(18):9017-25.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2007 2006\n",
      "---> Article 492 is a comment and is to be removed\n",
      "\n",
      " 505 Focus:  N Engl J Med 2014  Aug 7 371(6) 566-8 10.1056/NEJMe1405784\n",
      "-- Comment on N Engl J Med. 2014 Aug 7;371(6):497-506.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2014 2014\n",
      "===>> 371(6) 371(6)\n",
      "--->  Aug 7  Aug 7\n",
      "--->  Aug 7\n",
      "---> 566 497\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 509 Focus:  J Clin Oncol 2014  Apr 1 32(10) 1093-4 10.1200/JCO.2013.53.5369\n",
      "-- Comment on J Clin Oncol. 2013 Nov 1;31(31):3914-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2013\n",
      "---> Article 509 is a comment and is to be removed\n",
      "\n",
      " 510 Focus:  Am J Bioeth 2008  Jun 8(6) 18-20 10.1080/15265160802248302\n",
      "-- Comment on Am J Bioeth. 2008 Jun;8(6):5-8.\n",
      "Am J Bioeth\n",
      "Am J Bioeth\n",
      "===>> Am J Bioeth\n",
      "===>> 2008 2008\n",
      "===>> 8(6) 8(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 18 5\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 518 Focus:  J Med Genet 2007  Aug 44(8) e89 None\n",
      "-- Comment on J Med Genet. 2007 Jan;44(1):10-15.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2007 2007\n",
      "===>> 44(8) 44(1)\n",
      "---> Article 518 is a comment and is to be removed\n",
      "\n",
      " 528 Focus:  J Natl Cancer Inst 2011  Jan 19 103(2) 82-3 10.1093/jnci/djq510\n",
      "-- Comment on J Natl Cancer Inst. 2011 Jan 19;103(2):105-16.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2011 2011\n",
      "===>> 103(2) 103(2)\n",
      "--->  Jan 19  Jan 19\n",
      "--->  Jan 19\n",
      "---> 82 105\n",
      "---> Article 528 is a commentary and is to be removed\n",
      "\n",
      " 531 Focus:  Ann Oncol 2009  Jun 20(6) 1143-4 10.1093/annonc/mdp241\n",
      "-- Comment on Ann Oncol. 2009 May;20(5):874-8.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2009 2009\n",
      "===>> 20(6) 20(5)\n",
      "---> Article 531 is a comment and is to be removed\n",
      "\n",
      " 542 Focus:  Cancer Genet 2016  Jun 209(6) 282-3 10.1016/j.cancergen.2016.04.002\n",
      "-- Comment in Cancer Genet. 2016 Jun;209(6):283-4. Comment on Cancer Genet. 2016 Jan-Feb;209(1-2):50-2.\n",
      "Cancer Genet\n",
      "Cancer Genet\n",
      "===>> Cancer Genet\n",
      "===>> 2016 2016\n",
      "===>> 209(6) 209(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 282 283\n",
      "---> Article 542 is a commentary and is to be removed\n",
      "\n",
      " 551 Focus:  Ann Surg Oncol 2021  Nov 28(12) 7356-7365 10.1245/s10434-021-10063-5\n",
      "-- Comment in Ann Surg Oncol. 2021 Nov;28(12):7366-7367.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2021 2021\n",
      "===>> 28(12) 28(12)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 7356 7366\n",
      "---> Article 551 is a commentary and is to be removed\n",
      "\n",
      " 552 Focus:  Cancer Biol Ther 2006  Sep 5(9) 1098-102 10.4161/cbt.5.9.3167\n",
      "-- Comment in Cancer Biol Ther. 2006 Sep;5(9):1103-4.\n",
      "Cancer Biol Ther\n",
      "Cancer Biol Ther\n",
      "===>> Cancer Biol Ther\n",
      "===>> 2006 2006\n",
      "===>> 5(9) 5(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 1098 1103\n",
      "---> Article 552 is a commentary and is to be removed\n",
      "\n",
      " 572 Focus:  N Engl J Med 2009  Mar 26 360(13) 1362 None\n",
      "-- Comment on N Engl J Med. 2009 Jan 1;360(1):63-70.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2009 2009\n",
      "===>> 360(13) 360(1)\n",
      "---> Article 572 is a comment and is to be removed\n",
      "\n",
      " 585 Focus:  J Natl Cancer Inst 2016  Aug 31 108(12) djw172 10.1093/jnci/djw172\n",
      "-- Comment in J Natl Cancer Inst. 2016 Aug 31;108(12): Comment on J Natl Cancer Inst. 2015 Nov 19;108(2):\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2016 2016\n",
      "===>> 108(12) 108(12)\n",
      "--->  Aug 31  Aug 31\n",
      "--->  Aug 31\n",
      "---> djw172  Comment on J Natl Cancer Inst\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 587 Focus:  Cancer Biol Ther 2006  Sep 5(9) 1103-4 10.4161/cbt.5.9.3370\n",
      "-- Comment on Cancer Biol Ther. 2006 Sep;5(9):1098-102.\n",
      "Cancer Biol Ther\n",
      "Cancer Biol Ther\n",
      "===>> Cancer Biol Ther\n",
      "===>> 2006 2006\n",
      "===>> 5(9) 5(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 1103 1098\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 602 Focus:  Breast J 2006  May-Jun 12(3) 280-1 None\n",
      "-- Comment on Breast J. 2004 Nov-Dec;10(6):475-80.\n",
      "Breast J\n",
      "Breast J\n",
      "===>> Breast J\n",
      "===>> 2006 2004\n",
      "---> Article 602 is a comment and is to be removed\n",
      "\n",
      " 610 Focus:  Breast Cancer Res 2009  11(6) 111 10.1186/bcr2451\n",
      "-- Comment on Breast Cancer Res. 2009;11(6):R78.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2009 2009\n",
      "===>> 11(6) 11(6)\n",
      "--->  \n",
      "---> \n",
      "---> 111 R78\n",
      "---> Article 610 is a commentary and is to be removed\n",
      "\n",
      " 611 Focus:  J Clin Oncol 2012  Feb 1 30(4) 347-50 10.1200/JCO.2011.40.1489\n",
      "-- Comment on J Clin Oncol. 2012 Feb 1;30(4):372-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2012\n",
      "===>> 30(4) 30(4)\n",
      "--->  Feb 1  Feb 1\n",
      "--->  Feb 1\n",
      "---> 347 372\n",
      "---> Article 611 is a commentary and is to be removed\n",
      "\n",
      " 621 Focus:  JAMA 2020  Mar 10 323(10) 995-997 10.1001/jama.2020.0229\n",
      "-- Comment in JAMA. 2020 Jul 28;324(4):397.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2020 2020\n",
      "===>> 323(10) 324(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 641 Focus:  N Engl J Med 2007  Jul 12 357(2) 154-62 10.1056/NEJMcp071286\n",
      "-- Comment in N Engl J Med. 2007 Oct 18;357(16):1663; author reply 1663.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2007 2007\n",
      "===>> 357(2) 357(16)\n",
      "---> Article 641 is a comment and is to be removed\n",
      "\n",
      " 673 Focus:  Ann Intern Med 2006  Feb 21 144(4) 303-4 None\n",
      "-- Comment on Ann Intern Med. 2005 Sep 6;143(5):I47. Ann Intern Med. 2005 Sep 6;143(5):355-61.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2006 2005\n",
      "---> Article 673 is a comment and is to be removed\n",
      "\n",
      " 680 Focus:  J Clin Oncol 2006  Jul 10 24(20) 3311 None\n",
      "-- Comment on J Clin Oncol. 2006 Feb 1;24(4):707-15.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(20) 24(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 697 Focus:  J Clin Oncol 2006  Jul 10 24(20) 3312-3 None\n",
      "-- Comment on J Clin Oncol. 2006 Feb 20;24(6):863-71.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(20) 24(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 698 Focus:  J Natl Cancer Inst 2017  Oct 1 109(10). doi  10 None\n",
      "-- Comment in J Natl Cancer Inst. 2017 Oct 1;109(10): Comment on J Natl Cancer Inst. 2016 Sep 06;109(1):\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2017 2017\n",
      "===>> 109(10). doi 109(10)\n",
      "---> Article 698 is a comment and is to be removed\n",
      "\n",
      " 713 Focus:  J Clin Oncol 2007  Nov 1 25(31) 5035-6 None\n",
      "-- Comment on J Clin Oncol. 2007 May 20;25(15):2027-34.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(31) 25(15)\n",
      "---> Article 713 is a comment and is to be removed\n",
      "\n",
      " 717 Focus:  Clin Oncol (R Coll Radiol) 2015  Sep 27(9) 527-35 10.1016/j.clon.2015.06.001\n",
      "-- Comment in Clin Oncol (R Coll Radiol). 2016 Mar;28(3):223-4.\n",
      "Clin Oncol (R Coll Radiol)\n",
      "Clin Oncol (R Coll Radiol)\n",
      "===>> Clin Oncol (R Coll Radiol)\n",
      "===>> 2015 2016\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 718 Focus:  J Genet Couns 2009  Dec 18(6) 527-9 10.1007/s10897-009-9254-8\n",
      "-- Comment on J Genet Couns. 2009 Dec;18(6):521-3.\n",
      "J Genet Couns\n",
      "J Genet Couns\n",
      "===>> J Genet Couns\n",
      "===>> 2009 2009\n",
      "===>> 18(6) 18(6)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 527 521\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 724 Focus:  Ann Surg Oncol 2007  Sep 14(9) 2428-9 10.1245/s10434-007-9379-7\n",
      "-- Comment on Ann Surg Oncol. 2007 Sep;14(9):2510-8.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2007 2007\n",
      "===>> 14(9) 14(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 2428 2510\n",
      "---> Article 724 is a commentary and is to be removed\n",
      "\n",
      " 734 Focus:  Breast Cancer Res Treat 2017  Jan 161(1) 135-142 10.1007/s10549-016-4038-y\n",
      "-- Comment in Breast Cancer Res Treat. 2017 Feb;162(1):199-200.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2017 2017\n",
      "===>> 161(1) 162(1)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 735 Focus:  Breast Cancer Res Treat 2011  Jan 125(2) 325-49 10.1007/s10549-010-0817-z\n",
      "-- Comment in Breast Cancer Res Treat. 2010 Nov;124(1):295-6.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2010\n",
      "---> Article 735 is a comment and is to be removed\n",
      "\n",
      " 737 Focus:  Med Health Care Philos 2018  Jun 21(2) 239-242 10.1007/s11019-017-9803-0\n",
      "-- Comment in Med Health Care Philos. 2019 Dec;22(4):631-637.\n",
      "Med Health Care Philos\n",
      "Med Health Care Philos\n",
      "===>> Med Health Care Philos\n",
      "===>> 2018 2019\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 740 Focus:  World J Surg 2011  Feb 35(2) 458-9 None\n",
      "-- Comment on World J Surg. 2010 Jul;34(7):1416-26.\n",
      "World J Surg\n",
      "World J Surg\n",
      "===>> World J Surg\n",
      "===>> 2011 2010\n",
      "---> Article 740 is a comment and is to be removed\n",
      "\n",
      " 753 Focus:  Expert Rev Mol Diagn 2016  Jul 16(7) 715-7 10.1080/14737159.2016.1184573\n",
      "-- Comment on Expert Rev Mol Diagn. 2015;15(9):1101-5.\n",
      "Expert Rev Mol Diagn\n",
      "Expert Rev Mol Diagn\n",
      "===>> Expert Rev Mol Diagn\n",
      "===>> 2016 2015\n",
      "---> Article 753 is a comment and is to be removed\n",
      "\n",
      " 763 Focus:  J Med Genet 2008  Jan 45(1) 62-3 10.1136/jmg.2007.054494\n",
      "-- Comment on J Med Genet. 2001 Apr;38(4):253-7.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2008 2001\n",
      "---> Article 763 is a comment and is to be removed\n",
      "\n",
      " 764 Focus:  Cancer Prev Res (Phila) 2010  Jan 3(1) 48-61 10.1158/1940-6207.CAPR-09-0078\n",
      "-- Comment in Cancer Prev Res (Phila). 2010 Jan;3(1):12-5.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2010 2010\n",
      "===>> 3(1) 3(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 48 12\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 765 Focus:  Cancer 2016  Jan 1 122(1) 14-6 10.1002/cncr.29708\n",
      "-- Comment on Cancer. 2016 Jan 1;122(1):84-90.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2016 2016\n",
      "===>> 122(1) 122(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 14 84\n",
      "---> Article 765 is a commentary and is to be removed\n",
      "\n",
      " 766 Focus:  Breast Cancer Res Treat 2009  Mar 114(1) 31-8 10.1007/s10549-008-9978-4\n",
      "-- Comment in Breast Cancer Res Treat. 2009 Aug;116(3):617-8.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2009 2009\n",
      "===>> 114(1) 116(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 783 Focus:  Cancer Cell 2012  Jul 10 22(1) 106-16 10.1016/j.ccr.2012.05.015\n",
      "-- Comment in Cancer Cell. 2012 Jul 10;22(1):5-6.\n",
      "Cancer Cell\n",
      "Cancer Cell\n",
      "===>> Cancer Cell\n",
      "===>> 2012 2012\n",
      "===>> 22(1) 22(1)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 106 5\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 796 Focus:  J Clin Oncol 2011  Dec 1 29(34) 4505-9 10.1200/JCO.2010.34.4440\n",
      "-- Comment in J Clin Oncol. 2011 Dec 1;29(34):4477-8. J Clin Oncol. 2012 Apr 1;30(10):1142-3; author reply 1143-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2011\n",
      "===>> 29(34) 29(34)\n",
      "--->  Dec 1  Dec 1\n",
      "--->  Dec 1\n",
      "---> 4505 4477\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 797 Focus:  Ann Oncol 2017  May 1 28(5) 1158-1159 10.1093/annonc/mdx067\n",
      "-- Comment in Ann Oncol. 2017 May 1;28(5):916-917.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2017 2017\n",
      "===>> 28(5) 28(5)\n",
      "--->  May 1  May 1\n",
      "--->  May 1\n",
      "---> 1158 916\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 811 Focus:  Int J Cancer 2007  Sep 1 121(5) 1017-20 10.1002/ijc.22789\n",
      "-- Comment in Int J Cancer. 2008 Apr 15;122(8):1918-9.\n",
      "Int J Cancer\n",
      "Int J Cancer\n",
      "===>> Int J Cancer\n",
      "===>> 2007 2008\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 817 Focus:  Int J Cancer 2008  Apr 15 122(8) 1918-9 10.1002/ijc.23294\n",
      "-- Comment on Int J Cancer. 2007 Sep 1;121(5):1017-20.\n",
      "Int J Cancer\n",
      "Int J Cancer\n",
      "===>> Int J Cancer\n",
      "===>> 2008 2007\n",
      "---> Article 817 is a comment and is to be removed\n",
      "\n",
      " 845 Focus:  Eur Urol 2022  Jun 81(6) 559-567 10.1016/j.eururo.2021.09.029\n",
      "-- Comment in Eur Urol. 2022 Jun;81(6):568-569. Eur Urol. 2022 Dec;82(6):e169. Eur Urol. 2022 Dec;82(6):e170-e171.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2022 2022\n",
      "===>> 81(6) 81(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 559 568\n",
      "---> Article 845 is a commentary and is to be removed\n",
      "\n",
      " 860 Focus:  Nat Rev Cancer 2010  Nov 10(11) 803-8 10.1038/nrc2946\n",
      "-- Comment in Nat Rev Cancer. 2011 Mar;11(3):227; author reply 227.\n",
      "Nat Rev Cancer\n",
      "Nat Rev Cancer\n",
      "===>> Nat Rev Cancer\n",
      "===>> 2010 2011\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 868 Focus:  JAMA 2018  Aug 14 320(6) 597-598 10.1001/jama.2018.8258\n",
      "-- Comment in doi: 10.1001/jama.2016.16918.\n",
      "\n",
      " 872 Focus:  Am J Public Health 2009  Dec 99(12) 2203-9 10.2105/AJPH.2008.154096\n",
      "-- Comment in Am J Public Health. 2009 Dec;99(12):2120-2.\n",
      "Am J Public Health\n",
      "Am J Public Health\n",
      "===>> Am J Public Health\n",
      "===>> 2009 2009\n",
      "===>> 99(12) 99(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 2203 2120\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 904 Focus:  Am J Bioeth 2008  Jun 8(6) 14-6 10.1080/15265160802248252\n",
      "-- Comment on Am J Bioeth. 2008 Jun;8(6):5-8.\n",
      "Am J Bioeth\n",
      "Am J Bioeth\n",
      "===>> Am J Bioeth\n",
      "===>> 2008 2008\n",
      "===>> 8(6) 8(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 14 5\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 908 Focus:  J Clin Oncol 2010  Aug 1 28(22) 3545-8 10.1200/JCO.2010.28.5791\n",
      "-- Comment on J Clin Oncol. 2010 Aug 1;28(22):3555-61.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(22) 28(22)\n",
      "--->  Aug 1  Aug 1\n",
      "--->  Aug 1\n",
      "---> 3545 3555\n",
      "---> Article 908 is a commentary and is to be removed\n",
      "\n",
      " 956 Focus:  J Clin Oncol 2012  Dec 10 30(35) 4330-6 10.1200/JCO.2012.41.7469\n",
      "-- Comment in J Clin Oncol. 2012 Dec 10;30(35):4288-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2012\n",
      "===>> 30(35) 30(35)\n",
      "--->  Dec 10  Dec 10\n",
      "--->  Dec 10\n",
      "---> 4330 4288\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 981 Focus:  J Genet Couns 2009  Dec 18(6) 521-3 10.1007/s10897-009-9251-y\n",
      "-- Comment in J Genet Couns. 2009 Dec;18(6):527-9. J Genet Couns. 2009 Dec;18(6):524-6. J Genet Couns. 2012 Feb;21(1):7-12.\n",
      "J Genet Couns\n",
      "J Genet Couns\n",
      "===>> J Genet Couns\n",
      "===>> 2009 2009\n",
      "===>> 18(6) 18(6)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 521 527\n",
      "---> Article 981 is a commentary and is to be removed\n",
      "\n",
      " 1005 Focus:  J Med Genet 2009  Jun 46(6) 423-4 10.1136/jmg.2009.067462\n",
      "-- Comment on J Med Genet. 2009 Sep;46(9):593-7.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2009 2009\n",
      "===>> 46(6) 46(9)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1020 Focus:  Br J Cancer 2010  Sep 28 103(7) 1103-8 10.1038/sj.bjc.6605876\n",
      "-- Comment in J Urol. 2011 Apr;185(4):1277.\n",
      "Br J Cancer\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 1026 Focus:  J Clin Oncol 2006  Feb 1 24(4) 707-15 10.1200/JCO.2005.01.9737\n",
      "-- Comment in J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. J Clin Oncol. 2007 Jun 20;25(18):2632-4; author reply 2634-5.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(4) 24(20)\n",
      "---> Article 1026 is a comment and is to be removed\n",
      "\n",
      " 1032 Focus:  Breast Cancer Res Treat 2011  Jul 128(1) 297-9 None\n",
      "-- Comment on Breast Cancer Res Treat. 2010 Aug;123(1):219-25. Breast Cancer Res Treat. 2010 Dec;124(3):765-9. Breast Cancer Res Treat. 2011 Jan;125(1):157-61. Breast Cancer Res Treat. 2011 Jan;125(2):529-35. Breast Cancer Res Treat. 2011 Feb;125(3):827-35. Breast Cancer Res Treat. 2011 Feb;126(1):265-6.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2010\n",
      "---> Article 1032 is a comment and is to be removed\n",
      "\n",
      " 1044 Focus:  J Clin Oncol 2007  Aug 1 25(22) 3383-4 None\n",
      "-- Comment on J Clin Oncol. 2007 Apr 10;25(11):1329-33.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(22) 25(11)\n",
      "---> Article 1044 is a comment and is to be removed\n",
      "\n",
      " 1053 Focus:  Cancer Res 2021  Mar 1 81(5) 1388-1397 10.1158/0008-5472.CAN-20-1602\n",
      "-- Comment in Cancer Res. 2021 Mar 1;81(5):1214-1215. Comment on Cancer Res. 2021 Mar 1;81(5):1214-1215.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 81(5) 81(5)\n",
      "--->  Mar 1  Mar 1\n",
      "--->  Mar 1\n",
      "---> 1388 1214\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1062 Focus:  Gynecol Oncol 2019  Nov 155(2) 262-269 10.1016/j.ygyno.2019.09.008\n",
      "-- Comment in Transl Cancer Res. 2020 Feb;9(2):418-420.\n",
      "Gynecol Oncol\n",
      "Transl Cancer Res\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 1070 Focus:  Int J Cancer 2006  Jan 1 118(1) 103-7 10.1002/ijc.21296\n",
      "-- Comment in Int J Cancer. 2006 Apr 1;118(7):1852.\n",
      "Int J Cancer\n",
      "Int J Cancer\n",
      "===>> Int J Cancer\n",
      "===>> 2006 2006\n",
      "===>> 118(1) 118(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1082 Focus:  Fam Cancer 2009  8(4) 339-46 10.1007/s10689-009-9240-1\n",
      "-- Comment in Fam Cancer. 2010 Sep;9(3):289-90.\n",
      "Fam Cancer\n",
      "Fam Cancer\n",
      "===>> Fam Cancer\n",
      "===>> 2009 2010\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1118 Focus:  Surgery 2012  Jan 151(1) 70-5 10.1016/j.surg.2011.06.036\n",
      "-- Comment in Surgery. 2012 Jul;152(1):141-2. Surgery. 2012 Jul;152(1):143-4.\n",
      "Surgery\n",
      "Surgery\n",
      "===>> Surgery\n",
      "===>> 2012 2012\n",
      "===>> 151(1) 152(1)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1124 Focus:  ANZ J Surg 2007  May 77(5) 314-9 10.1111/j.1445-2197.2007.04050.x\n",
      "-- Comment in ANZ J Surg. 2007 May;77(5):309.\n",
      "ANZ J Surg\n",
      "ANZ J Surg\n",
      "===>> ANZ J Surg\n",
      "===>> 2007 2007\n",
      "===>> 77(5) 77(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 314 309\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1128 Focus:  J Obstet Gynaecol Can 2007  Jun 29(6) 510-1 10.1016/s1701-2163(16)32475-6\n",
      "-- Comment on J Obstet Gynaecol Can. 2007 Jan;29(1):45-60.\n",
      "J Obstet Gynaecol Can\n",
      "J Obstet Gynaecol Can\n",
      "===>> J Obstet Gynaecol Can\n",
      "===>> 2007 2007\n",
      "===>> 29(6) 29(1)\n",
      "---> Article 1128 is a comment and is to be removed\n",
      "\n",
      " 1131 Focus:  Am J Bioeth 2008  Jun 8(6) 12-4 10.1080/15265160802248393\n",
      "-- Comment on Am J Bioeth. 2008 Jun;8(6):5-8.\n",
      "Am J Bioeth\n",
      "Am J Bioeth\n",
      "===>> Am J Bioeth\n",
      "===>> 2008 2008\n",
      "===>> 8(6) 8(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 12 5\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1139 Focus:  Eur Urol 2020  Jan 77(1) 24-35 10.1016/j.eururo.2019.08.025\n",
      "-- Comment in Eur Urol. 2020 Jan;77(1):36-37. J Urol. 2020 Mar;203(3):463-464.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2020 2020\n",
      "===>> 77(1) 77(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 24 36\n",
      "---> Article 1139 is a commentary and is to be removed\n",
      "\n",
      " 1141 Focus:  Ann Surg Oncol 2007  Sep 14(9) 2510-8 10.1245/s10434-007-9372-1\n",
      "-- Comment in Ann Surg Oncol. 2007 Sep;14(9):2428-9.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2007 2007\n",
      "===>> 14(9) 14(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 2510 2428\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1167 Focus:  JAMA 2019  Aug 20 322(7) 702 10.1001/jama.2019.11251\n",
      "-- Original report in JAMA. 2019 Aug 20;322(7):652-665. \n",
      "JAMA\n",
      "Original report in JAMA\n",
      "FUCK!!!\n",
      "\n",
      " 1184 Focus:  J Clin Oncol 2007  Jun 20 25(18) 2632-4 None\n",
      "-- Comment on J Clin Oncol. 2002 Mar 15;20(6):1480-90. J Clin Oncol. 2002 Jun 1;20(11):2701-12. J Clin Oncol. 2006 Feb 1;24(4):707-15.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2002\n",
      "---> Article 1184 is a comment and is to be removed\n",
      "\n",
      " 1215 Focus:  J Natl Cancer Inst 2007  Jun 20 99(12) 929-35 10.1093/jnci/djm005\n",
      "-- Comment in J Natl Cancer Inst. 2007 Jun 20;99(12):908-9. Eur Urol. 2007 Nov;52(5):1529.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2007 2007\n",
      "===>> 99(12) 99(12)\n",
      "--->  Jun 20  Jun 20\n",
      "--->  Jun 20\n",
      "---> 929 908\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1222 Focus:  J Clin Oncol 2008  Oct 10 26(29) 4752-8 10.1200/JCO.2008.16.8310\n",
      "-- Comment in J Clin Oncol. 2009 Feb 1;27(4):642-3; author reply 643-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2009\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1259 Focus:  Nat Rev Urol 2014  Mar 11(3) 124 10.1038/nrurol.2014.19\n",
      "-- Comment on Eur Urol. 2014 Sep;66(3):489-99.\n",
      "Nat Rev Urol\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 1282 Focus:  J Clin Oncol 2007  Sep 1 25(25) 3831-6 10.1200/JCO.2007.11.1179\n",
      "-- Comment in J Clin Oncol. 2007 Nov 20;25(33):5327; author reply 5327-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(25) 25(33)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1289 Focus:  N Engl J Med 2009  Oct 22 361(17) 1707 None\n",
      "-- Comment on N Engl J Med. 2009 Jul 9;361(2):123-34.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2009 2009\n",
      "===>> 361(17) 361(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1298 Focus:  Ann Surg Oncol 2015  Feb 22(2) 370-6 10.1245/s10434-014-3883-3\n",
      "-- Comment in Ann Surg Oncol. 2015 Feb;22(2):353-4.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2015 2015\n",
      "===>> 22(2) 22(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 370 353\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1308 Focus:  Ann Surg Oncol 2021  Sep 28(9) 4967-4973 10.1245/s10434-021-09855-6\n",
      "-- Comment in Ann Surg Oncol. 2021 Sep;28(9):4764-4766.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2021 2021\n",
      "===>> 28(9) 28(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 4967 4764\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1315 Focus:  Lancet 2010  Jul 24 376(9737) 211-3 10.1016/S0140-6736(10)61119-1\n",
      "-- Comment on Lancet. 2010 Jul 24;376(9737):235-44. Lancet. 2010 Jul 24;376(9737):245-51.\n",
      "Lancet\n",
      "Lancet\n",
      "===>> Lancet\n",
      "===>> 2010 2010\n",
      "===>> 376(9737) 376(9737)\n",
      "--->  Jul 24  Jul 24\n",
      "--->  Jul 24\n",
      "---> 211 235\n",
      "---> Article 1315 is a commentary and is to be removed\n",
      "\n",
      " 1332 Focus:  J Hum Genet 2013  Feb 58(2) 59-66 10.1038/jhg.2012.127\n",
      "-- Comment in J Hum Genet. 2013 Feb;58(2):58.\n",
      "J Hum Genet\n",
      "J Hum Genet\n",
      "===>> J Hum Genet\n",
      "===>> 2013 2013\n",
      "===>> 58(2) 58(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 59 58\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1348 Focus:  Ned Tijdschr Geneeskd 2008  Oct 25 152(43) 2317-8 None\n",
      "-- Comment on Ned Tijdschr Geneeskd. 2008 Oct 25;152(43):2341-5.\n",
      "Ned Tijdschr Geneeskd\n",
      "Ned Tijdschr Geneeskd\n",
      "===>> Ned Tijdschr Geneeskd\n",
      "===>> 2008 2008\n",
      "===>> 152(43) 152(43)\n",
      "--->  Oct 25  Oct 25\n",
      "--->  Oct 25\n",
      "---> 2317 2341\n",
      "---> Article 1348 is a commentary and is to be removed\n",
      "\n",
      " 1375 Focus:  Maturitas 2010  Nov 67(3) 290 10.1016/j.maturitas.2010.08.009\n",
      "-- Comment on Maturitas. 2010 Jul;66(3):310-4.\n",
      "Maturitas\n",
      "Maturitas\n",
      "===>> Maturitas\n",
      "===>> 2010 2010\n",
      "===>> 67(3) 66(3)\n",
      "---> Article 1375 is a comment and is to be removed\n",
      "\n",
      " 1391 Focus:  J Clin Oncol 2006  Feb 1 24(4) 700-6 10.1200/JCO.2005.01.7541\n",
      "-- Comment in J Clin Oncol. 2006 Jun 20;24(18):2969-70; author reply 2970-1.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(4) 24(18)\n",
      "---> Article 1391 is a comment and is to be removed\n",
      "\n",
      " 1392 Focus:  Breast Cancer Res Treat 2011  Apr 126(2) 365-71 10.1007/s10549-010-0937-5\n",
      "-- Comment in Breast Cancer Res Treat. 2011 Sep;129(2):649-51; author reply 652-3.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2011\n",
      "===>> 126(2) 129(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1400 Focus:  Clin Genet 2015  May 87(5) 411-8 10.1111/cge.12497\n",
      "-- Comment in Clin Genet. 2016 Mar;89(3):400. Clin Genet. 2016 Mar;89(3):399.\n",
      "Clin Genet\n",
      "Clin Genet\n",
      "===>> Clin Genet\n",
      "===>> 2015 2016\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1423 Focus:  Cancer Res 2020  Oct 1 80(19) 4044-4045 10.1158/0008-5472.CAN-20-2731\n",
      "-- Comment in Cancer Res. 2020 Oct 1;80(19):4172-4184. Comment on Cancer Res. 2020 Jul 30;:\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 80(19) 80(19)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 4044 4172\n",
      "---> Article 1423 is a commentary and is to be removed\n",
      "\n",
      " 1424 Focus:  Breast Cancer Res Treat 2006  Sep 99(1) 85-90 10.1007/s10549-006-9184-1\n",
      "-- Comment in Breast Cancer Res Treat. 2006 Dec;100(3):329-30.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2006 2006\n",
      "===>> 99(1) 100(3)\n",
      "---> Article 1424 is a comment and is to be removed\n",
      "\n",
      " 1438 Focus:  Nat Biotechnol 2011  May 29(5) 373-4 10.1038/nbt0511-373\n",
      "-- Comment in Nat Biotechnol. 2011 Dec;29(12):1078-9.\n",
      "Nat Biotechnol\n",
      "Nat Biotechnol\n",
      "===>> Nat Biotechnol\n",
      "===>> 2011 2011\n",
      "===>> 29(5) 29(12)\n",
      "---> Article 1438 is a comment and is to be removed\n",
      "\n",
      " 1445 Focus:  Br J Cancer 2019  Jul 121(1) 15-21 10.1038/s41416-019-0446-1\n",
      "-- Comment in Br J Cancer. 2019 Jul;121(1):1-2.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2019 2019\n",
      "===>> 121(1) 121(1)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 15 1\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1456 Focus:  J Med Genet 2007  Jan 44(1) 10-15 10.1136/jmg.2006.043091\n",
      "-- Comment in J Med Genet. 2007 May;44(5):e79. J Med Genet. 2007 Jun;44(6):e82. J Med Genet. 2007 Aug;44(8):e86; author reply e88. J Med Genet. 2007 Aug;44(8):e87; author reply e88. J Med Genet. 2007 Aug;44(8):e89; author reply e88.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2007 2007\n",
      "===>> 44(1) 44(5)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1458 Focus:  Nature 2012  May 30 485(7400) S64-5 10.1038/485S64a\n",
      "-- Comment in Nature. 2012 Jun 28;486(7404):473.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2012 2012\n",
      "===>> 485(7400) 486(7404)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1467 Focus:  Eur Urol 2014  Sep 66(3) 500-1 10.1016/j.eururo.2014.03.021\n",
      "-- Comment on Eur Urol. 2014 Sep;66(3):489-99.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2014 2014\n",
      "===>> 66(3) 66(3)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 500 489\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1489 Focus:  Oncology (Williston Park) 2011  Oct 25(11) 1014-25 None\n",
      "-- Comment in Oncology (Williston Park). 2011 Oct;25(11):1028, 1030. Oncology (Williston Park). 2011 Oct;25(11):1033-4.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2011 2011\n",
      "===>> 25(11) 25(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1014 1028, 1030\n",
      "---> Article 1489 is a commentary and is to be removed\n",
      "\n",
      " 1495 Focus:  Clin Cancer Res 2012  Sep 15 18(18) 4903-9 10.1158/1078-0432.CCR-12-1100\n",
      "-- Comment in Clin Cancer Res. 2012 Sep 15;18(18):4865-7.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2012 2012\n",
      "===>> 18(18) 18(18)\n",
      "--->  Sep 15  Sep 15\n",
      "--->  Sep 15\n",
      "---> 4903 4865\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1496 Focus:  Nature 2019  Jul 571(7766) 576-579 10.1038/s41586-019-1382-1\n",
      "-- Comment in Nat Rev Clin Oncol. 2019 Dec;16(12):725-726. Pigment Cell Melanoma Res. 2020 Jan;33(1):6-7. N Engl J Med. 2020 Jul 16;383(3):286-288. Klin Padiatr. 2021 May;233(3):141-144.\n",
      "Nature\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 1502 Focus:  Lancet 2010  Jul 24 376(9737) 235-44 10.1016/S0140-6736(10)60892-6\n",
      "-- Comment in Lancet. 2010 Jul 24;376(9737):211-3. Nat Rev Clin Oncol. 2010 Oct;7(10):549. Biomark Med. 2010 Dec;4(6):792-3.\n",
      "Lancet\n",
      "Lancet\n",
      "===>> Lancet\n",
      "===>> 2010 2010\n",
      "===>> 376(9737) 376(9737)\n",
      "--->  Jul 24  Jul 24\n",
      "--->  Jul 24\n",
      "---> 235 211\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1504 Focus:  BJOG 2022  Feb 129(3) 433-442 10.1111/1471-0528.16975\n",
      "-- Comment in BJOG. 2022 Feb;129(3):443.\n",
      "BJOG\n",
      "BJOG\n",
      "===>> BJOG\n",
      "===>> 2022 2022\n",
      "===>> 129(3) 129(3)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 433 443\n",
      "---> Article 1504 is a commentary and is to be removed\n",
      "\n",
      " 1511 Focus:  J Natl Cancer Inst 2010  May 19 102(10) 665-8 10.1093/jnci/djq141\n",
      "-- Comment on J Natl Cancer Inst. 2010 May 19;102(10):680-91.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2010 2010\n",
      "===>> 102(10) 102(10)\n",
      "--->  May 19  May 19\n",
      "--->  May 19\n",
      "---> 665 680\n",
      "---> Article 1511 is a commentary and is to be removed\n",
      "\n",
      " 1513 Focus:  Eur Urol 2021  Mar 79(3) 353-361 10.1016/j.eururo.2020.07.038\n",
      "-- Comment in Eur Urol. 2021 Mar;79(3):362-363.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2021 2021\n",
      "===>> 79(3) 79(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 353 362\n",
      "---> Article 1513 is a commentary and is to be removed\n",
      "\n",
      " 1531 Focus:  J Med Genet 2008  Jul 45(7) 425-31 10.1136/jmg.2007.056556\n",
      "-- Comment in J Med Genet. 2008 Jul;45(7):409-10. J Med Genet. 2008 Nov;45(11):765-6.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2008 2008\n",
      "===>> 45(7) 45(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 425 409\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1535 Focus:  Breast J 2009  Jan-Feb 15(1) 4-16 10.1111/j.1524-4741.2008.00665.x\n",
      "-- Comment in Breast J. 2009 Jan-Feb;15(1):1-3.\n",
      "Breast J\n",
      "Breast J\n",
      "===>> Breast J\n",
      "===>> 2009 2009\n",
      "===>> 15(1) 15(1)\n",
      "--->  Jan-Feb  Jan-Feb\n",
      "--->  Jan-Feb\n",
      "---> 4 1\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1557 Focus:  Gynecol Oncol 2016  Nov 143(2) 231-235 10.1016/j.ygyno.2016.08.336\n",
      "-- Comment in Gynecol Oncol. 2016 Nov;143(2):227-228.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2016 2016\n",
      "===>> 143(2) 143(2)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 231 227\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1575 Focus:  N Engl J Med 2009  Jul 9 361(2) 123-34 10.1056/NEJMoa0900212\n",
      "-- Comment in N Engl J Med. 2009 Jul 9;361(2):189-91. Curr Oncol Rep. 2009 Nov;11(6):414-6. N Engl J Med. 2009 Oct 22;361(17):1707; author reply 1707-8.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2009 2009\n",
      "===>> 361(2) 361(2)\n",
      "--->  Jul 9  Jul 9\n",
      "--->  Jul 9\n",
      "---> 123 189\n",
      "---> Article 1575 is a commentary and is to be removed\n",
      "\n",
      " 1580 Focus:  JAMA 2010  Sep 1 304(9) 1011-2 10.1001/jama.2010.1263\n",
      "-- Comment on JAMA. 2010 Sep 1;304(9):967-75.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2010 2010\n",
      "===>> 304(9) 304(9)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 1011 967\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1582 Focus:  Ann Oncol 2018  Jan 1 29(1) 237-243 10.1093/annonc/mdx639\n",
      "-- Comment in Ann Oncol. 2018 Jan 1;29(1):26-28.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2018 2018\n",
      "===>> 29(1) 29(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 237 26\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1590 Focus:  Cancer Epidemiol Biomarkers Prev 2008  Nov 17(11) 2980-6 10.1158/1055-9965.EPI-07-2879\n",
      "-- Comment in Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):686.\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "===>> Cancer Epidemiol Biomarkers Prev\n",
      "===>> 2008 2009\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1599 Focus:  N Engl J Med 2016  Feb 4 374(5) 454-68 10.1056/NEJMra1503523\n",
      "-- Comment in N Engl J Med. 2016 Jun 16;374(24):2404. N Engl J Med. 2016 Jun 16;374(24):2403. N Engl J Med. 2016 Jun 16;374(24):2403-4.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2016 2016\n",
      "===>> 374(5) 374(24)\n",
      "---> Article 1599 is a comment and is to be removed\n",
      "\n",
      " 1606 Focus:  JAMA 2012  Jan 25 307(4) 382-90 10.1001/jama.2012.20\n",
      "-- Comment in JAMA. 2012 Jan 25;307(4):408-10. Strahlenther Onkol. 2012 Nov;188(11):1057-8.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2012 2012\n",
      "===>> 307(4) 307(4)\n",
      "--->  Jan 25  Jan 25\n",
      "--->  Jan 25\n",
      "---> 382 408\n",
      "---> Article 1606 is a commentary and is to be removed\n",
      "\n",
      " 1613 Focus:  JAAPA 2008  May 21(5) 18, 21 10.1097/01720610-200805000-00008\n",
      "-- Comment in JAAPA. 2008 May;21(5):14.\n",
      "JAAPA\n",
      "JAAPA\n",
      "===>> JAAPA\n",
      "===>> 2008 2008\n",
      "===>> 21(5) 21(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 18, 21 14\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1628 Focus:  Cancer Epidemiol Biomarkers Prev 2007  Jul 16(7) 1416-21 10.1158/1055-9965.EPI-07-0129\n",
      "-- Comment in Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2517.\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "===>> Cancer Epidemiol Biomarkers Prev\n",
      "===>> 2007 2007\n",
      "===>> 16(7) 16(11)\n",
      "---> Article 1628 is a comment and is to be removed\n",
      "\n",
      " 1630 Focus:  Breast Cancer Res Treat 2011  Oct 129(3) 971-82 10.1007/s10549-011-1599-7\n",
      "-- Comment in Breast Cancer Res Treat. 2012 Jan;131(2):723-5.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1631 Focus:  Lancet Oncol 2011  May 12(5) 415-6 10.1016/S1470-2045(11)70084-5\n",
      "-- Comment on Lancet Oncol. 2011 May;12(5):477-88.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2011 2011\n",
      "===>> 12(5) 12(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 415 477\n",
      "---> Article 1631 is a commentary and is to be removed\n",
      "\n",
      " 1636 Focus:  J Natl Cancer Inst 2018  Nov 1 110(11) 1178-1189 10.1093/jnci/djy148\n",
      "-- Comment in J Natl Cancer Inst. 2019 May 1;111(5):524-525. J Natl Cancer Inst. 2019 May 1;111(5):522-523. J Natl Cancer Inst. 2020 Apr 1;112(4):426-427. J Natl Cancer Inst. 2020 Apr 1;112(4):428.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2018 2019\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1643 Focus:  J Natl Cancer Inst 2016  Sep 6 109(1) djw177 10.1093/jnci/djw177\n",
      "-- Comment in J Natl Cancer Inst. 2017 Oct 1;109(10): J Natl Cancer Inst. 2017 Oct 1;109(10):\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2016 2017\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1657 Focus:  Histopathology 2009  Mar 54(4) 494-5 10.1111/j.1365-2559.2009.03237.x\n",
      "-- Comment in Histopathology. 2009 Nov;55(5):619. Comment on Histopathology. 2008 Aug;53(2):127-38.\n",
      "Histopathology\n",
      "Histopathology\n",
      "===>> Histopathology\n",
      "===>> 2009 2009\n",
      "===>> 54(4) 55(5)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1663 Focus:  Histopathology 2009  Nov 55(5) 619 10.1111/j.1365-2559.2009.03408.x\n",
      "-- Comment on Histopathology. 2009 Mar;54(4):494-5.\n",
      "Histopathology\n",
      "Histopathology\n",
      "===>> Histopathology\n",
      "===>> 2009 2009\n",
      "===>> 55(5) 54(4)\n",
      "---> Article 1663 is a comment and is to be removed\n",
      "\n",
      " 1666 Focus:  Lancet Oncol 2006  Mar 7(3) 191-3 10.1016/S1470-2045(06)70589-7\n",
      "-- Comment on Lancet Oncol. 2006 Mar;7(3):223-9.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2006 2006\n",
      "===>> 7(3) 7(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 191 223\n",
      "---> Article 1666 is a commentary and is to be removed\n",
      "\n",
      " 1670 Focus:  JAMA Surg 2015  Jun 150(6) 512-8 10.1001/jamasurg.2014.3852\n",
      "-- Comment in JAMA Surg. 2015 Jun;150(6):518-9.\n",
      "JAMA Surg\n",
      "JAMA Surg\n",
      "===>> JAMA Surg\n",
      "===>> 2015 2015\n",
      "===>> 150(6) 150(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 512 518\n",
      "---> Article 1670 is a commentary and is to be removed\n",
      "\n",
      " 1675 Focus:  J Clin Oncol 2013  Nov 1 31(31) 3914-9 10.1200/JCO.2012.47.7893\n",
      "-- Comment in J Clin Oncol. 2014 Apr 1;32(10):1093-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2013 2014\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1685 Focus:  Nature 2008  Feb 28 451(7182) 1066-7 10.1038/4511066a\n",
      "-- Comment on Nature. 2008 Feb 28;451(7182):1116-20. Nature. 2008 Feb 28;451(7182):1111-5.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2008 2008\n",
      "===>> 451(7182) 451(7182)\n",
      "--->  Feb 28  Feb 28\n",
      "--->  Feb 28\n",
      "---> 1066 1116\n",
      "---> Article 1685 is a commentary and is to be removed\n",
      "\n",
      " 1687 Focus:  Cancer Biol Ther 2006  Dec 5(12) 1632-6 10.4161/cbt.5.12.3351\n",
      "-- Comment in Cancer Biol Ther. 2006 Dec;5(12):1637-9.\n",
      "Cancer Biol Ther\n",
      "Cancer Biol Ther\n",
      "===>> Cancer Biol Ther\n",
      "===>> 2006 2006\n",
      "===>> 5(12) 5(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1632 1637\n",
      "---> Article 1687 is a commentary and is to be removed\n",
      "\n",
      " 1700 Focus:  Cancer 2018  Feb 1 124(3) 466-474 10.1002/cncr.31069\n",
      "-- Comment in Cancer. 2018 Feb 15;124(4):865. Cancer. 2018 Feb 15;124(4):866.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2018 2018\n",
      "===>> 124(3) 124(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1703 Focus:  JAMA Surg 2018  Feb 1 153(2) 123-129 10.1001/jamasurg.2017.3422\n",
      "-- Comment in JAMA Surg. 2018 Feb 1;153(2):129.\n",
      "JAMA Surg\n",
      "JAMA Surg\n",
      "===>> JAMA Surg\n",
      "===>> 2018 2018\n",
      "===>> 153(2) 153(2)\n",
      "--->  Feb 1  Feb 1\n",
      "--->  Feb 1\n",
      "---> 123 129\n",
      "---> Article 1703 is a commentary and is to be removed\n",
      "\n",
      " 1732 Focus:  Psychooncology 2011  Dec 20(12) 1301-8 10.1002/pon.1846\n",
      "-- OBJECTIVE: To evaluate patient' satisfaction and cancer risk management decision making, following attendance at a novel multidisciplinary one-stop follow-up clinic (MDOSC) for BRCA1/2 carriers. PATIENTS AND METHODS: 172 patients attended the MDOSC over a 2-year period between 2006 and 2008. A total of 96 and 76 patients were seen in the first and second year, respectively. All patients who attended the MDOSC were sent a 17-item Satisfaction Questionnaire (SQ) designed to examine their views about the MDOSC, using rating scales and open questions after the first year. Patients were asked to comment on the most helpful aspects of the MDOSC and on how the service might be improved. Changes were made based on this feedback. During the second year, all patients were given the SQ with three questions about cancer risk management decision making on the day of the MDOSC. RESULTS: In total, 132 (77%) patients responded and overall satisfaction was high with a mean of 8.94 (range 1-10). BRCA1/2 carriers were pleased to see a range of health care professionals on the same day, who they viewed gave consistent information, considered every aspect of care and addressed psychosocial needs. Following improvements, based on patients' feedback, satisfaction significantly increased in year 2. Furthermore, the MDOSC also helped patients to move forward with their cancer risk management decisions. CONCLUSIONS: BRCA1/2 carriers were highly satisfied with the MDOSC, which met their needs and helped them to make informed decisions regarding their cancer risk management.\n",
      "\n",
      " 1741 Focus:  Ann Intern Med 2013  Sep 17 159(6) 373-81 10.7326/0003-4819-159-6-201309170-00003\n",
      "-- Comment in Ann Intern Med. 2013 Sep 17;159(6):428-9. Ann Surg Oncol. 2015 Nov;22(12):3767-8.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2013 2013\n",
      "===>> 159(6) 159(6)\n",
      "--->  Sep 17  Sep 17\n",
      "--->  Sep 17\n",
      "---> 373 428\n",
      "---> Article 1741 is a commentary and is to be removed\n",
      "\n",
      " 1750 Focus:  Breast Cancer Res Treat 2011  Jan 125(2) 529-35 10.1007/s10549-010-1031-8\n",
      "-- Comment in Breast Cancer Res Treat. 2011 Feb;126(1):265-6. Breast Cancer Res Treat. 2011 Jul;128(1):297-9; author reply 300. Breast Cancer Res Treat. 2011 Sep;129(2):649-51; author reply 652-3.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2011\n",
      "===>> 125(2) 126(1)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1759 Focus:  J Clin Oncol 2012  Jan 1 30(1) 19-26 10.1200/JCO.2010.33.0068\n",
      "-- Comment in J Clin Oncol. 2012 Jan 1;30(1):2-3.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2012\n",
      "===>> 30(1) 30(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 19 2\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1768 Focus:  J Natl Cancer Inst 2006  Dec 6 98(23) 1694-706 10.1093/jnci/djj465\n",
      "-- Comment in J Natl Cancer Inst. 2006 Dec 6;98(23):1675-7.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2006 2006\n",
      "===>> 98(23) 98(23)\n",
      "--->  Dec 6  Dec 6\n",
      "--->  Dec 6\n",
      "---> 1694 1675\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1777 Focus:  Clin Breast Cancer 2010  Apr 10(2) 113-8 10.3816/CBC.2010.n.022\n",
      "-- Comment in Clin Breast Cancer. 2010 Apr;10(2):111-2. Clin Breast Cancer. 2011 Oct;11(5):346-7.\n",
      "Clin Breast Cancer\n",
      "Clin Breast Cancer\n",
      "===>> Clin Breast Cancer\n",
      "===>> 2010 2010\n",
      "===>> 10(2) 10(2)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 113 111\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1790 Focus:  Ann Intern Med 2007  Oct 2 147(7) 441-50 10.7326/0003-4819-147-7-200710020-00002\n",
      "-- Comment in Ann Intern Med. 2007 Oct 2;147(7):515-7.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2007 2007\n",
      "===>> 147(7) 147(7)\n",
      "--->  Oct 2  Oct 2\n",
      "--->  Oct 2\n",
      "---> 441 515\n",
      "---> Article 1790 is a commentary and is to be removed\n",
      "\n",
      " 1799 Focus:  Eur Urol 2019  May 75(5) 743-749 10.1016/j.eururo.2018.09.021\n",
      "-- Comment in Eur Urol. 2019 May;75(5):750-751. J Urol. 2019 May;201(5):860.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2019 2019\n",
      "===>> 75(5) 75(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 743 750\n",
      "---> Article 1799 is a commentary and is to be removed\n",
      "\n",
      " 1809 Focus:  J Clin Oncol 2007  Apr 10 25(11) 1329-33 10.1200/JCO.2006.09.1066\n",
      "-- Comment in J Clin Oncol. 2007 Aug 1;25(22):3383-4; author reply 3384.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(11) 25(22)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1820 Focus:  J Genet Couns 2017  Oct 26(5) 1144-1152 10.1007/s10897-017-0093-8\n",
      "-- Comment in J Genet Couns. 2018 Sep;27(5):1312-1313. J Genet Couns. 2018 Sep;27(5):1314-1315.\n",
      "J Genet Couns\n",
      "J Genet Couns\n",
      "===>> J Genet Couns\n",
      "===>> 2017 2018\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1830 Focus:  J Clin Oncol 2012  Feb 10 30(5) 471-3 10.1200/JCO.2011.40.1562\n",
      "-- Comment on J Clin Oncol. 2005 Oct 1;23(28):6890-8. J Clin Oncol. 2005 Nov 20;23(33):8469-76. J Clin Oncol. 2011 May 1;29(13):1664-9. J Clin Oncol. 2012 Feb 10;30(5):497-506.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2005\n",
      "---> Article 1830 is a comment and is to be removed\n",
      "\n",
      " 1844 Focus:  Obstet Gynecol 2012  Aug 120(2 Pt 1) 235-40 10.1097/AOG.0b013e31825f3576\n",
      "-- Comment in Obstet Gynecol. 2012 Aug;120(2 Pt 1):221-2.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2012 2012\n",
      "===>> 120(2 Pt 1) 120(2 Pt 1)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 235 221\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1872 Focus:  JAMA Oncol 2015  Dec 1(9) 1251-60 10.1001/jamaoncol.2015.3048\n",
      "-- Comment in JAMA Oncol. 2015 Dec;1(9):1225-6.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(9) 1(9)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1251 1225\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1913 Focus:  N Engl J Med 2018  Jun 14 378(24) 2311-2320 10.1056/NEJMra1707939\n",
      "-- Comment in N Engl J Med. 2018 Oct 04;379(14):1385.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2018 2018\n",
      "===>> 378(24) 379(14)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1918 Focus:  J Natl Cancer Inst 2009  Jan 21 101(2) 70-1 10.1093/jnci/djn476\n",
      "-- Comment on J Natl Cancer Inst. 2009 Jan 21;101(2):80-7.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2009 2009\n",
      "===>> 101(2) 101(2)\n",
      "--->  Jan 21  Jan 21\n",
      "--->  Jan 21\n",
      "---> 70 80\n",
      "---> Article 1918 is a commentary and is to be removed\n",
      "\n",
      " 1922 Focus:  Cancer Genet 2016  Jan-Feb 209(1-2) 50-2 10.1016/j.cancergen.2015.11.003\n",
      "-- Comment in Cancer Genet. 2016 Jun;209(6):282-3.\n",
      "Cancer Genet\n",
      "Cancer Genet\n",
      "===>> Cancer Genet\n",
      "===>> 2016 2016\n",
      "===>> 209(1-2) 209(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1927 Focus:  JAMA 2006  Mar 22 295(12) 1379-88 10.1001/jama.295.12.1379\n",
      "-- Comment in JAMA. 2006 Nov 1;296(17):2091; author reply 2091-2.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2006 2006\n",
      "===>> 295(12) 296(17)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1934 Focus:  J Natl Cancer Inst 2018  Sep 1 110(9) 967-974 10.1093/jnci/djy002\n",
      "-- Comment in J Natl Cancer Inst. 2018 Sep 1;110(9):925-926.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2018 2018\n",
      "===>> 110(9) 110(9)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 967 925\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1937 Focus:  J Clin Oncol 2006  Jul 20 24(21) 3328-30 10.1200/JCO.2006.05.8586\n",
      "-- Comment in J Clin Oncol. 2007 Feb 10;25(5):604; author reply 605. Comment on J Clin Oncol. 2006 Jul 20;24(21):3361-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 1947 Focus:  Ann Intern Med 2007  Apr 3 146(7) 511-5 10.7326/0003-4819-146-7-200704030-00007\n",
      "-- Comment in Ann Intern Med. 2007 Apr 3;146(7):529-31. Ann Intern Med. 2007 Nov 20;147(10):740-1; author reply 741. Ann Intern Med. 2007 Dec 18;147(12):882.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2007 2007\n",
      "===>> 146(7) 146(7)\n",
      "--->  Apr 3  Apr 3\n",
      "--->  Apr 3\n",
      "---> 511 529\n",
      "---> Article 1947 is a commentary and is to be removed\n",
      "\n",
      " 1952 Focus:  Cancer 2010  Nov 15 116(22) 5261-71 10.1002/cncr.25439\n",
      "-- Comment in Cancer. 2010 Nov 15;116(22):5119-21.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2010 2010\n",
      "===>> 116(22) 116(22)\n",
      "--->  Nov 15  Nov 15\n",
      "--->  Nov 15\n",
      "---> 5261 5119\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1965 Focus:  Med J Aust 2021  Nov 15 215(10) 460-464 10.5694/mja2.51226\n",
      "-- Comment in Med J Aust. 2021 Nov 15;215(10):458-459.\n",
      "Med J Aust\n",
      "Med J Aust\n",
      "===>> Med J Aust\n",
      "===>> 2021 2021\n",
      "===>> 215(10) 215(10)\n",
      "--->  Nov 15  Nov 15\n",
      "--->  Nov 15\n",
      "---> 460 458\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 1986 Focus:  J Clin Oncol 2017  Jul 10 35(20) 2329-2337 10.1200/JCO.2016.70.3439\n",
      "-- Comment in J Clin Oncol. 2017 Jul 10;35(20):2226-2228.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(20) 35(20)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 2329 2226\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2007 Focus:  Clin Cancer Res 2013  Jul 1 19(13) 3396-403 10.1158/1078-0432.CCR-12-3020\n",
      "-- Comment in Clin Genet. 2014 Jan;85(1):18-20.\n",
      "Clin Cancer Res\n",
      "Clin Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2011 Focus:  Br J Radiol 2019  May 92(1097) 20170657 10.1259/bjr.20170657\n",
      "-- Comment in Br J Radiol. 2020 Apr;93(1108):20200038.\n",
      "Br J Radiol\n",
      "Br J Radiol\n",
      "===>> Br J Radiol\n",
      "===>> 2019 2020\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2014 Focus:  Nat Biotechnol 2010  Aug 28(8) 784-91 10.1038/nbt0810-784\n",
      "-- Comment in Nat Biotechnol. 2010 Dec;28(12):1242-3; author reply 1243.\n",
      "Nat Biotechnol\n",
      "Nat Biotechnol\n",
      "===>> Nat Biotechnol\n",
      "===>> 2010 2010\n",
      "===>> 28(8) 28(12)\n",
      "---> Article 2014 is a comment and is to be removed\n",
      "\n",
      " 2044 Focus:  J Oncol Pract 2017  Apr 13(4) e303-e309 10.1200/JOP.2016.015503\n",
      "-- Comment in J Oncol Pract. 2017 Apr;13(4):219-220.\n",
      "J Oncol Pract\n",
      "J Oncol Pract\n",
      "===>> J Oncol Pract\n",
      "===>> 2017 2017\n",
      "===>> 13(4) 13(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> e303 219\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2054 Focus:  Obstet Gynecol 2010  Sep 116(3) 733-743 10.1097/AOG.0b013e3181ec5fc1\n",
      "-- Comment in Obstet Gynecol. 2011 Feb;117(2 Pt 1):404; author reply 404.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2010 2011\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2059 Focus:  N Engl J Med 2018  Sep 13 379(11) 1042-1049 10.1056/NEJMoa1800024\n",
      "-- Comment in N Engl J Med. 2019 Mar 14;380(11):1086. N Engl J Med. 2019 Mar 14;380(11):1086-1087.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2018 2019\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2087 Focus:  Br J Cancer 2006  Mar 27 94(6) 814-9 10.1038/sj.bjc.6603015\n",
      "-- Comment in Br J Cancer. 2006 Oct 23;95(8):1124; author reply 1126-7. Br J Cancer. 2006 Oct 23;95(8):1125; author reply 1126-7.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2006 2006\n",
      "===>> 94(6) 95(8)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2097 Focus:  Menopause 2019  Feb 26(2) 132-139 10.1097/GME.0000000000001176\n",
      "-- Comment in Menopause. 2019 Feb;26(2):118-120.\n",
      "Menopause\n",
      "Menopause\n",
      "===>> Menopause\n",
      "===>> 2019 2019\n",
      "===>> 26(2) 26(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 132 118\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2127 Focus:  Cell 2007  Mar 9 128(5) 991-1002 10.1016/j.cell.2007.02.025\n",
      "-- Comment on Cell. 2007 Mar 9;128(5):977-89.\n",
      "Cell\n",
      "Cell\n",
      "===>> Cell\n",
      "===>> 2007 2007\n",
      "===>> 128(5) 128(5)\n",
      "--->  Mar 9  Mar 9\n",
      "--->  Mar 9\n",
      "---> 991 977\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2132 Focus:  J Am Acad Dermatol 2007  Oct 57(4) 731-2 10.1016/j.jaad.2007.03.023\n",
      "-- Comment on J Am Acad Dermatol. 2006 Dec;55(6):1101-2.\n",
      "J Am Acad Dermatol\n",
      "J Am Acad Dermatol\n",
      "===>> J Am Acad Dermatol\n",
      "===>> 2007 2006\n",
      "---> Article 2132 is a comment and is to be removed\n",
      "\n",
      " 2138 Focus:  J Obstet Gynaecol Can 2007  Jan 29(1) 45-60 10.1016/s1701-2163(16)32349-0\n",
      "-- Comment in J Obstet Gynaecol Can. 2007 Jun;29(6):510-1.\n",
      "J Obstet Gynaecol Can\n",
      "J Obstet Gynaecol Can\n",
      "===>> J Obstet Gynaecol Can\n",
      "===>> 2007 2007\n",
      "===>> 29(1) 29(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2149 Focus:  N Engl J Med 2015  Jun 4 372(23) 2243-57 10.1056/NEJMsr1501341\n",
      "-- Comment in N Engl J Med. 2015 Oct;373(14):1378. N Engl J Med. 2015 Oct;373(14):1376-7. N Engl J Med. 2015 Oct;373(14):1377. N Engl J Med. 2015 Oct;373(14):1377. N Engl J Med. 2015 Oct;373(14):1377-8.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2015 2015\n",
      "===>> 372(23) 373(14)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2151 Focus:  JAMA 2006  May 24 295(20) 2374-84 10.1001/jama.295.20.2374\n",
      "-- Comment in JAMA. 2006 Dec 13;296(22):2681-2; author reply 2682.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2006 2006\n",
      "===>> 295(20) 296(22)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2171 Focus:  J Natl Cancer Inst 2006  Apr 19 98(8) 535-44 10.1093/jnci/djj132\n",
      "-- Comment in J Natl Cancer Inst. 2007 Jul 18;99(14):1130-1; author reply 1131.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2191 Focus:  Ann Oncol 2014  Jun 25(6) 1152-8 10.1093/annonc/mdu134\n",
      "-- Comment in Ann Oncol. 2014 Oct;25(10):2095. Ann Oncol. 2014 Oct;25(10):2094-5.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2014 2014\n",
      "===>> 25(6) 25(10)\n",
      "---> Article 2191 is a comment and is to be removed\n",
      "\n",
      " 2193 Focus:  Acad Radiol 2007  May 14(5) 513-21 10.1016/j.acra.2007.02.003\n",
      "-- Comment in Acad Radiol. 2007 May;14(5):511-2.\n",
      "Acad Radiol\n",
      "Acad Radiol\n",
      "===>> Acad Radiol\n",
      "===>> 2007 2007\n",
      "===>> 14(5) 14(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 513 511\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2195 Focus:  J Clin Oncol 2006  Jul 20 24(21) 3361-6 10.1200/JCO.2005.03.3126\n",
      "-- Comment in J Clin Oncol. 2006 Jul 20;24(21):3328-30.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(21) 24(21)\n",
      "--->  Jul 20  Jul 20\n",
      "--->  Jul 20\n",
      "---> 3361 3328\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2206 Focus:  J Clin Oncol 2010  Jan 10 28(2) 222-31 10.1200/JCO.2009.22.7991\n",
      "-- Comment in J Clin Oncol. 2010 Jan 10;28(2):189-91. J Am Coll Surg. 2011 Sep;213(3):447-50.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(2) 28(2)\n",
      "--->  Jan 10  Jan 10\n",
      "--->  Jan 10\n",
      "---> 222 189\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2242 Focus:  EBioMedicine 2015  Nov 4 2(12) 1980-6 10.1016/j.ebiom.2015.11.005\n",
      "-- Comment in EBioMedicine. 2015 Dec;2(12):1858-9.\n",
      "EBioMedicine\n",
      "EBioMedicine\n",
      "===>> EBioMedicine\n",
      "===>> 2015 2015\n",
      "===>> 2(12) 2(12)\n",
      "--->  Nov 4  Dec\n",
      "---> Article 2242 is a comment and is to be removed\n",
      "\n",
      " 2244 Focus:  JAMA 2010  Dec 22 304(24) 2695 None\n",
      "-- Comment on JAMA. 2010 Sep 1;304(9):967-75.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2010 2010\n",
      "===>> 304(24) 304(9)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2252 Focus:  Health (London) 2012  Nov 16(6) 636-54 10.1177/1363459312442420\n",
      "-- Increasingly, 18-24-year-old women from hereditary breast/ovarian cancer (HBOC) families are pursuing genetic testing, despite their low absolute risks of breast and ovarian cancer and the fact that evidence-based management options used with older high-risk women are not generally available. Difficult clinical decisions in older carriers take on substantially more complexity and value-laden import in very young carriers. As a result, many of the latter receive highly personal and emotionally charged cancer risk information in a life context where management strategies are not well defined. We analyzed 32 in-depth interviews with BRCA1/2 mutation-positive women aged 18-24 using techniques of grounded theory and interpretive description. Participants described feeling vulnerable to a cancer diagnosis but in a quandary regarding their care because evidence-based approaches to management have not been developed and clinical trials have not been undertaken. Our participants demonstrated a wide range of genetic and health literacy. Inconsistent recommendations, surveillance fatigue, and the unpredictability of their having health insurance coverage for surgical risk-reducing procedures led several to contemplate risk-reducing mastectomy before age 25. Parents remained a primary source of emotional and financial support, slowing age-appropriate independence and complicating patient privacy. Our findings suggest that, for 18-24-year-olds, readiness to autonomously elect genetic testing, to fully understand and act on genetic information, and to confidently make decisions with life-long implications are all evolving processes. We comment on the tensions between informed consent, privacy, and the unique developmental needs of BRCA1/2 mutation-positive women just emerging into their adult years.\n",
      "\n",
      " 2278 Focus:  BJU Int 2007  Jun 99(6) 1350-5 10.1111/j.1464-410X.2007.06759.x\n",
      "-- Comment in BJU Int. 2008 Feb;101(3):392.\n",
      "BJU Int\n",
      "BJU Int\n",
      "===>> BJU Int\n",
      "===>> 2007 2008\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2280 Focus:  N Engl J Med 2007  Jul 12 357(2) 115-23 10.1056/NEJMoa070608\n",
      "-- Comment in N Engl J Med. 2007 Jul 12;357(2):175-6. N Engl J Med. 2007 Oct 11;357(15):1555; author reply 1556. N Engl J Med. 2007 Oct 11;357(15):1555-6; author reply 1556.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2007 2007\n",
      "===>> 357(2) 357(2)\n",
      "--->  Jul 12  Jul 12\n",
      "--->  Jul 12\n",
      "---> 115 175\n",
      "---> Article 2280 is a commentary and is to be removed\n",
      "\n",
      " 2288 Focus:  Cancer 2016  Jan 1 122(1) 84-90 10.1002/cncr.29707\n",
      "-- Comment in Cancer. 2016 Jan 1;122(1):14-6.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2016 2016\n",
      "===>> 122(1) 122(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 84 14\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2289 Focus:  J Clin Oncol 2006  Dec 20 24(36) 5652-7 10.1200/JCO.2006.06.5664\n",
      "-- Comment in J Clin Oncol. 2007 Apr 1;25(10):1294-5; author reply 1295-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2292 Focus:  JAMA 2011  Oct 12 306(14) 1557-65 10.1001/jama.2011.1456\n",
      "-- Comment in JAMA. 2011 Oct 12;306(14):1597-8. Nat Rev Clin Oncol. 2011 Dec;8(12):692. Nat Rev Cancer. 2011 Dec;11(12):831. JAMA. 2012 Jan 25;307(4):359; author reply 360-1. JAMA. 2012 Jan 25;307(4):359-60; author reply 360-1.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2011 2011\n",
      "===>> 306(14) 306(14)\n",
      "--->  Oct 12  Oct 12\n",
      "--->  Oct 12\n",
      "---> 1557 1597\n",
      "---> Article 2292 is a commentary and is to be removed\n",
      "\n",
      " 2300 Focus:  J Natl Cancer Inst 2011  Jan 19 103(2) 105-16 10.1093/jnci/djq494\n",
      "-- Comment in J Natl Cancer Inst. 2011 Jan 19;103(2):82-3.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2011 2011\n",
      "===>> 103(2) 103(2)\n",
      "--->  Jan 19  Jan 19\n",
      "--->  Jan 19\n",
      "---> 105 82\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2323 Focus:  Eur Urol 2016  Jun 69(6) 992-5 10.1016/j.eururo.2015.11.022\n",
      "-- Comment in Eur Urol. 2016 Jun;69(6):996-7. Urol Oncol. 2017 Aug;35(8):536.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2016 2016\n",
      "===>> 69(6) 69(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 992 996\n",
      "---> Article 2323 is a commentary and is to be removed\n",
      "\n",
      " 2334 Focus:  PLoS Genet 2018  Dec 26 14(12) e1007752 10.1371/journal.pgen.1007752\n",
      "-- Comment in Cancer Discov. 2019 Mar;9(3):311-312.\n",
      "PLoS Genet\n",
      "Cancer Discov\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2338 Focus:  J Clin Oncol 2014  Apr 20 32(12) 1249-55 10.1200/JCO.2013.50.6055\n",
      "-- Comment in J Clin Oncol. 2014 Nov 10;32(32):3682-3. J Clin Oncol. 2014 Nov 10;32(32):3683.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(12) 32(32)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2339 Focus:  JAMA 2007  Jun 20 297(23) 2587-95 10.1001/jama.297.23.2587\n",
      "-- Comment in JAMA. 2007 Jun 20;297(23):2637-9. JAMA. 2007 Nov 7;298(17):2007; author reply 2007-8.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2007 2007\n",
      "===>> 297(23) 297(23)\n",
      "--->  Jun 20  Jun 20\n",
      "--->  Jun 20\n",
      "---> 2587 2637\n",
      "---> Article 2339 is a commentary and is to be removed\n",
      "\n",
      " 2346 Focus:  Clin Cancer Res 2013  Jul 1 19(13) 3474-84 10.1158/1078-0432.CCR-13-0066\n",
      "-- Comment in Clin Genet. 2014 Jan;85(1):16-7.\n",
      "Clin Cancer Res\n",
      "Clin Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2363 Focus:  JAMA Oncol 2016  Nov 1 2(11) 1434-1440 10.1001/jamaoncol.2016.1820\n",
      "-- Comment in JAMA Oncol. 2017 Mar 1;3(3):417. JAMA Oncol. 2017 Mar 1;3(3):417-418.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2016 2017\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2368 Focus:  J Clin Oncol 2016  Aug 20 34(24) 2914-24 10.1200/JCO.2015.65.9557\n",
      "-- Comment in J Clin Oncol. 2017 Apr 10;35(11):1255. J Clin Oncol. 2017 Apr 10;35(11):1255-1256.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2016 2017\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2384 Focus:  J Natl Cancer Inst 2010  May 19 102(10) 680-91 10.1093/jnci/djq088\n",
      "-- Comment in J Natl Cancer Inst. 2010 May 19;102(10):665-8.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2010 2010\n",
      "===>> 102(10) 102(10)\n",
      "--->  May 19  May 19\n",
      "--->  May 19\n",
      "---> 680 665\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2390 Focus:  Lancet Oncol 2006  Mar 7(3) 223-9 10.1016/S1470-2045(06)70585-X\n",
      "-- Comment in Lancet Oncol. 2006 Mar;7(3):191-3.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2006 2006\n",
      "===>> 7(3) 7(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 223 191\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2394 Focus:  Eur Urol 2019  Oct 76(4) 452-458 10.1016/j.eururo.2019.02.002\n",
      "-- Comment in Eur Urol. 2019 Oct;76(4):459-460. Eur Urol. 2019 Oct;76(4):e109-e110.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2019 2019\n",
      "===>> 76(4) 76(4)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 452 459\n",
      "---> Article 2394 is a commentary and is to be removed\n",
      "\n",
      " 2399 Focus:  Lancet 2010  Jul 24 376(9737) 245-51 10.1016/S0140-6736(10)60893-8\n",
      "-- Comment in Lancet. 2010 Jul 24;376(9737):211-3. Nat Rev Clin Oncol. 2010 Oct;7(10):549. Biomark Med. 2010 Dec;4(6):792-3.\n",
      "Lancet\n",
      "Lancet\n",
      "===>> Lancet\n",
      "===>> 2010 2010\n",
      "===>> 376(9737) 376(9737)\n",
      "--->  Jul 24  Jul 24\n",
      "--->  Jul 24\n",
      "---> 245 211\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2416 Focus:  Tumori 2020  Dec 106(6) NP67-NP72 10.1177/0300891620936752\n",
      "-- Comment in Tumori. 2021 Dec;107(6):578-579.\n",
      "Tumori\n",
      "Tumori\n",
      "===>> Tumori\n",
      "===>> 2020 2021\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2438 Focus:  Clin Cancer Res 2017  Dec 1 23(23) 7165-7170 10.1158/1078-0432.CCR-17-1337\n",
      "-- Comment in Clin Cancer Res. 2017 Dec 1;23(23):7155-7157.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2017 2017\n",
      "===>> 23(23) 23(23)\n",
      "--->  Dec 1  Dec 1\n",
      "--->  Dec 1\n",
      "---> 7165 7155\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2439 Focus:  Lancet 2014  Oct 11 384(9951) 1376-88 10.1016/S0140-6736(13)62146-7\n",
      "-- Comment in Hum Genomics. 2016 Dec 28;10(1):40.\n",
      "Lancet\n",
      "Hum Genomics\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2441 Focus:  Breast Cancer Res 2007  9(2) R26 10.1186/bcr1668\n",
      "-- Comment in Breast Cancer Res. 2007;9(3):106.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2007 2007\n",
      "===>> 9(2) 9(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2442 Focus:  J Med Genet 2013  Jun 50(6) 368-72 10.1136/jmedgenet-2013-101607\n",
      "-- Comment in Clin Genet. 2014 Jan;85(1):17-8.\n",
      "J Med Genet\n",
      "Clin Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2444 Focus:  J Natl Cancer Inst 2009  Jan 21 101(2) 80-7 10.1093/jnci/djn442\n",
      "-- Comment in J Natl Cancer Inst. 2009 Jan 21;101(2):70-1.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2009 2009\n",
      "===>> 101(2) 101(2)\n",
      "--->  Jan 21  Jan 21\n",
      "--->  Jan 21\n",
      "---> 80 70\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2472 Focus:  J Am Coll Surg 2018  Apr 226(4) 630-637 10.1016/j.jamcollsurg.2017.12.021\n",
      "-- Comment in J Am Coll Surg. 2018 Apr;226(4):637-640.\n",
      "J Am Coll Surg\n",
      "J Am Coll Surg\n",
      "===>> J Am Coll Surg\n",
      "===>> 2018 2018\n",
      "===>> 226(4) 226(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 630 637\n",
      "---> Article 2472 is a commentary and is to be removed\n",
      "\n",
      " 2477 Focus:  Am J Bioeth 2008  Jun 8(6) 5-8 10.1080/15265160802248179\n",
      "-- Comment in Am J Bioeth. 2008 Jun;8(6):9-10. Am J Bioeth. 2008 Jun;8(6):10-2. Am J Bioeth. 2008 Jun;8(6):12-4. Am J Bioeth. 2008 Jun;8(6):14-6. Am J Bioeth. 2008 Jun;8(6):16-8. Am J Bioeth. 2008 Jun;8(6):18-20.\n",
      "Am J Bioeth\n",
      "Am J Bioeth\n",
      "===>> Am J Bioeth\n",
      "===>> 2008 2008\n",
      "===>> 8(6) 8(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 5 9\n",
      "---> Article 2477 is a commentary and is to be removed\n",
      "\n",
      " 2479 Focus:  J Clin Oncol 2008  Aug 20 26(24) 3943-9 10.1200/JCO.2007.13.9568\n",
      "-- Comment in J Clin Oncol. 2008 Aug 20;26(24):3918-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(24) 26(24)\n",
      "--->  Aug 20  Aug 20\n",
      "--->  Aug 20\n",
      "---> 3943 3918\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2498 Focus:  Cancer 2016  Jan 15 122(2) 304-11 10.1002/cncr.29615\n",
      "-- Comment in Cancer. 2016 Jan 15;122(2):178-80.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2016 2016\n",
      "===>> 122(2) 122(2)\n",
      "--->  Jan 15  Jan 15\n",
      "--->  Jan 15\n",
      "---> 304 178\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2525 Focus:  Asian Pac J Cancer Prev 2014  15(8) 3353-8 10.7314/apjcp.2014.15.8.3353\n",
      "-- Comment in Asian Pac J Cancer Prev. 2015;16(5):2103.\n",
      "Asian Pac J Cancer Prev\n",
      "Asian Pac J Cancer Prev\n",
      "===>> Asian Pac J Cancer Prev\n",
      "===>> 2014 2015\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2552 Focus:  Am J Prev Med 2017  Jun 52(6) 702-709 10.1016/j.amepre.2017.01.027\n",
      "-- Comment in Am J Prev Med. 2017 Nov;53(5):e195-e196. Am J Prev Med. 2017 Nov;53(5):e197-e199.\n",
      "Am J Prev Med\n",
      "Am J Prev Med\n",
      "===>> Am J Prev Med\n",
      "===>> 2017 2017\n",
      "===>> 52(6) 53(5)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2576 Focus:  J Nurs Scholarsh 2010  Dec 42(4) 367-78 10.1111/j.1547-5069.2010.01366.x\n",
      "-- Comment in Evid Based Nurs. 2011 Oct;14(4):126-7.\n",
      "J Nurs Scholarsh\n",
      "Evid Based Nurs\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2592 Focus:  J Clin Oncol 2011  May 1 29(13) 1664-9 10.1200/JCO.2009.27.0835\n",
      "-- Comment in J Clin Oncol. 2011 May 1;29(13):1652-4. J Clin Oncol. 2012 Feb 10;30(5):471-3.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2011\n",
      "===>> 29(13) 29(13)\n",
      "--->  May 1  May 1\n",
      "--->  May 1\n",
      "---> 1664 1652\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2593 Focus:  Maturitas 2010  Jul 66(3) 310-4 10.1016/j.maturitas.2010.03.018\n",
      "-- Comment in Maturitas. 2010 Nov;67(3):290.\n",
      "Maturitas\n",
      "Maturitas\n",
      "===>> Maturitas\n",
      "===>> 2010 2010\n",
      "===>> 66(3) 67(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2606 Focus:  JAMA Intern Med 2014  Jan 174(1) 114-21 10.1001/jamainternmed.2013.11958\n",
      "-- Comment in JAMA Intern Med. 2014 Jan;174(1):122-4.\n",
      "JAMA Intern Med\n",
      "JAMA Intern Med\n",
      "===>> JAMA Intern Med\n",
      "===>> 2014 2014\n",
      "===>> 174(1) 174(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 114 122\n",
      "---> Article 2606 is a commentary and is to be removed\n",
      "\n",
      " 2612 Focus:  Cancer 2017  May 15 123(10) 1714-1720 10.1002/cncr.30528\n",
      "-- Comment in Cancer. 2017 May 15;123(10):1699-1702.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2017 2017\n",
      "===>> 123(10) 123(10)\n",
      "--->  May 15  May 15\n",
      "--->  May 15\n",
      "---> 1714 1699\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2640 Focus:  J Natl Compr Canc Netw 2015  Jul 13(7) 835-45 10.6004/jnccn.2015.0101\n",
      "-- Comment in J Natl Compr Canc Netw. 2016 Mar;14(3):lxviii. J Natl Compr Canc Netw. 2016 Mar;14(3):lxvi-lxviii.\n",
      "J Natl Compr Canc Netw\n",
      "J Natl Compr Canc Netw\n",
      "===>> J Natl Compr Canc Netw\n",
      "===>> 2015 2016\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2643 Focus:  Lancet Oncol 2018  Feb 19(2) 169-180 10.1016/S1470-2045(17)30891-4\n",
      "-- Comment in Lancet Oncol. 2018 Feb;19(2):150-151. Lancet Oncol. 2018 Apr;19(4):e182. Lancet Oncol. 2018 Apr;19(4):e183.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2018 2018\n",
      "===>> 19(2) 19(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 169 150\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2645 Focus:  Gynecol Oncol 2006  Jan 100(1) 1-2 10.1016/j.ygyno.2005.11.026\n",
      "-- Comment on Gynecol Oncol. 2006 Jan;100(1):58-64.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2006 2006\n",
      "===>> 100(1) 100(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 1 58\n",
      "---> Article 2645 is a commentary and is to be removed\n",
      "\n",
      " 2687 Focus:  Gynecol Oncol 2014  Feb 132(2) 280-6 10.1016/j.ygyno.2013.12.009\n",
      "-- Comment in Gynecol Oncol. 2014 Feb;132(2):261-3.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2014 2014\n",
      "===>> 132(2) 132(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 280 261\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2692 Focus:  Menopause 2011  Feb 18(2) 123-4 10.1097/gme.0b013e31820246da\n",
      "-- Comment on Menopause. 2011 Feb;18(2):133-7.\n",
      "Menopause\n",
      "Menopause\n",
      "===>> Menopause\n",
      "===>> 2011 2011\n",
      "===>> 18(2) 18(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 123 133\n",
      "---> Article 2692 is a commentary and is to be removed\n",
      "\n",
      " 2697 Focus:  BMJ 2012  Sep 6 345 e5660 10.1136/bmj.e5660\n",
      "-- Comment in Nat Rev Clin Oncol. 2012 Nov;9(11):611. Evid Based Med. 2013 Aug;18(4):e40.\n",
      "BMJ\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2698 Focus:  Lancet Oncol 2020  Oct 21(10) 1269-1282 10.1016/S1470-2045(20)30447-2\n",
      "-- Comment in Nat Rev Clin Oncol. 2021 Feb;18(2):69-70.\n",
      "Lancet Oncol\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2700 Focus:  JAMA Oncol 2021  Apr 1 7(4) 585-592 10.1001/jamaoncol.2020.7995\n",
      "-- Comment in JAMA Oncol. 2021 Sep 1;7(9):1402. JAMA Oncol. 2021 Sep 1;7(9):1401.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2021 2021\n",
      "===>> 7(4) 7(9)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2714 Focus:  JAMA 2019  Sep 3 322(9) 857-867 10.1001/jama.2019.11885\n",
      "-- Comment in JAMA. 2019 Sep 3;322(9):821-823. Ann Intern Med. 2019 Dec 17;171(12):JC62.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2019 2019\n",
      "===>> 322(9) 322(9)\n",
      "--->  Sep 3  Sep 3\n",
      "--->  Sep 3\n",
      "---> 857 821\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2732 Focus:  Genet Med 2011  Feb 13(2) 148-54 10.1097/GIM.0b013e318207f564\n",
      "-- Comment in Genet Med. 2011 Feb;13(2):173.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2011 2011\n",
      "===>> 13(2) 13(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 148 173\n",
      "---> Article 2732 is a commentary and is to be removed\n",
      "\n",
      " 2749 Focus:  J Med Genet 2022  Feb 59(2) 133-140 10.1136/jmedgenet-2020-107356\n",
      "-- Comment in BMJ. 2022 Feb 15;376:o258.\n",
      "J Med Genet\n",
      "BMJ\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2759 Focus:  Gynecol Oncol 2006  Jan 100(1) 58-64 10.1016/j.ygyno.2005.06.065\n",
      "-- Comment in Gynecol Oncol. 2006 Jan;100(1):1-2.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2006 2006\n",
      "===>> 100(1) 100(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 58 1\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2763 Focus:  Cancer 2007  May 1 109(9) 1784-90 10.1002/cncr.22603\n",
      "-- Comment in Cancer. 2007 Dec 15;110(12):2819; author reply 2819-20.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2007 2007\n",
      "===>> 109(9) 110(12)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2773 Focus:  Oncology (Williston Park) 2010  Jul 24(8) 738, 740 None\n",
      "-- Comment on Oncology (Williston Park). 2010 Jul;24(8):721-8.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2010 2010\n",
      "===>> 24(8) 24(8)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 738, 740 721\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2785 Focus:  J Clin Oncol 2008  Jan 1 26(1) 20-5 10.1200/JCO.2007.11.6905\n",
      "-- Comment in J Clin Oncol. 2008 Jan 1;26(1):9-10.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(1) 26(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 20 9\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2786 Focus:  J Clin Oncol 2010  Aug 1 28(22) 3555-61 10.1200/JCO.2009.27.5719\n",
      "-- Comment in J Clin Oncol. 2010 Aug 1;28(22):3545-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(22) 28(22)\n",
      "--->  Aug 1  Aug 1\n",
      "--->  Aug 1\n",
      "---> 3555 3545\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2787 Focus:  J Clin Oncol 2006  Feb 20 24(6) 863-71 10.1200/JCO.2005.03.6772\n",
      "-- Comment in J Clin Oncol. 2006 Jul 10;24(20):3312-3; author reply 3313-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2006 2006\n",
      "===>> 24(6) 24(20)\n",
      "---> Article 2787 is a comment and is to be removed\n",
      "\n",
      " 2792 Focus:  J Clin Oncol 2012  Feb 10 30(5) 497-506 10.1200/JCO.2011.38.6060\n",
      "-- Comment in J Clin Oncol. 2012 Feb 10;30(5):471-3.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2012\n",
      "===>> 30(5) 30(5)\n",
      "--->  Feb 10  Feb 10\n",
      "--->  Feb 10\n",
      "---> 497 471\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2821 Focus:  Eur Urol 2021  Sep 80(3) 295-303 10.1016/j.eururo.2021.03.031\n",
      "-- Comment in Eur Urol. 2021 Sep;80(3):304-305.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2021 2021\n",
      "===>> 80(3) 80(3)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 295 304\n",
      "---> Article 2821 is a commentary and is to be removed\n",
      "\n",
      " 2827 Focus:  Nature 2016  Jun 2 534(7605) 47-54 10.1038/nature17676\n",
      "-- Comment in Nat Rev Genet. 2016 Jul;17(7):378. Nat Rev Clin Oncol. 2016 May 20;13(6):327. Cell Death Differ. 2016 Oct;23(10):1577-8. Chin Clin Oncol. 2017 Feb;6(1):4.\n",
      "Nature\n",
      "Nat Rev Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2828 Focus:  Nature 2008  Feb 28 451(7182) 1116-20 10.1038/nature06633\n",
      "-- Comment in Nature. 2008 Feb 28;451(7182):1066-7.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2008 2008\n",
      "===>> 451(7182) 451(7182)\n",
      "--->  Feb 28  Feb 28\n",
      "--->  Feb 28\n",
      "---> 1116 1066\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2835 Focus:  Obstet Gynecol 2013  Jan 121(1) 14-24 10.1097/aog.0b013e3182783c2f\n",
      "-- Comment in Obstet Gynecol. 2013 Jan;121(1):4-6.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2013 2013\n",
      "===>> 121(1) 121(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 14 4\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2853 Focus:  Plast Reconstr Surg 2006  May 117(6) 1675-82 None\n",
      "-- Comment in Plast Reconstr Surg. 2006 Nov;118(6):1496-7.\n",
      "Plast Reconstr Surg\n",
      "Plast Reconstr Surg\n",
      "===>> Plast Reconstr Surg\n",
      "===>> 2006 2006\n",
      "===>> 117(6) 118(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2861 Focus:  J Natl Compr Canc Netw 2021  Jan 6 19(1) 77-102 10.6004/jnccn.2021.0001\n",
      "-- Comment in J Natl Compr Canc Netw. 2022 Feb;20(2):xxvi. J Natl Compr Canc Netw. 2022 Feb;20(2):xxv.\n",
      "J Natl Compr Canc Netw\n",
      "J Natl Compr Canc Netw\n",
      "===>> J Natl Compr Canc Netw\n",
      "===>> 2021 2022\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2865 Focus:  Ann Surg Oncol 2010  Mar 17(3) 939 None\n",
      "-- Comment on Ann Surg Oncol. 2009 Oct;16(10):2697-704.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2010 2009\n",
      "---> Article 2865 is a comment and is to be removed\n",
      "\n",
      " 2870 Focus:  Proc Biol Sci 2012  Apr 7 279(1732) 1389-95 10.1098/rspb.2011.1697\n",
      "-- Comment in Proc Biol Sci. 2012 Aug 7;279(1740):2926-9.\n",
      "Proc Biol Sci\n",
      "Proc Biol Sci\n",
      "===>> Proc Biol Sci\n",
      "===>> 2012 2012\n",
      "===>> 279(1732) 279(1740)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2873 Focus:  Nature 2008  Feb 28 451(7182) 1111-5 10.1038/nature06548\n",
      "-- Comment in Nature. 2008 Feb 28;451(7182):1066-7.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2008 2008\n",
      "===>> 451(7182) 451(7182)\n",
      "--->  Feb 28  Feb 28\n",
      "--->  Feb 28\n",
      "---> 1111 1066\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2899 Focus:  N Engl J Med 2018  Aug 23 379(8) 753-763 10.1056/NEJMoa1802905\n",
      "-- Comment in Nat Rev Clin Oncol. 2018 Nov;15(11):655.\n",
      "N Engl J Med\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2907 Focus:  J Clin Invest 2017  Jun 1 127(6) 2392-2406 10.1172/JCI90825\n",
      "-- Comment in Sci Transl Med. 2017 May 24;9(391):\n",
      "J Clin Invest\n",
      "Sci Transl Med\n",
      "---> Article 2907 is a commentary and is to be removed\n",
      "\n",
      " 2909 Focus:  J Clin Oncol 2006  Jun 1 24(16) 2437-43 10.1200/JCO.2005.02.7888\n",
      "-- Comment in Nat Clin Pract Oncol. 2007 Jan;4(1):10-1.\n",
      "J Clin Oncol\n",
      "Nat Clin Pract Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2910 Focus:  J Clin Oncol 2017  Apr 10 35(11) 1240-1249 10.1200/JCO.2016.71.3677\n",
      "-- Comment in J Clin Oncol. 2017 Apr 10;35(11):1151-1153.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(11) 35(11)\n",
      "--->  Apr 10  Apr 10\n",
      "--->  Apr 10\n",
      "---> 1240 1151\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2916 Focus:  J Clin Oncol 2017  Jul 10 35(20) 2232-2239 10.1200/JCO.2016.71.6480\n",
      "-- Comment in J Clin Oncol. 2017 Jul 10;35(20):2221-2223.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(20) 35(20)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 2232 2221\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2923 Focus:  Nature 2020  Oct 586(7831) 749-756 10.1038/s41586-020-2853-0\n",
      "-- Comment in Kidney Int. 2021 Jun;99(6):1255-1259. Nature. 2021 Feb;590(7845):218-219.\n",
      "Nature\n",
      "Kidney Int\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 2932 Focus:  Cancer 2017  Sep 15 123(18) 3532-3539 10.1002/cncr.30808\n",
      "-- Comment in Cancer. 2017 Sep 15;123(18):3441-3444.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2017 2017\n",
      "===>> 123(18) 123(18)\n",
      "--->  Sep 15  Sep 15\n",
      "--->  Sep 15\n",
      "---> 3532 3441\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2948 Focus:  J Med Genet 2009  Sep 46(9) 593-7 10.1136/jmg.2008.058248\n",
      "-- Comment in J Med Genet. 2009 Jun;46(6):423-4.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2009 2009\n",
      "===>> 46(9) 46(6)\n",
      "---> Article 2948 is a comment and is to be removed\n",
      "\n",
      " 2949 Focus:  Nat Struct Mol Biol 2010  Jun 17(6) 688-95 10.1038/nsmb.1831\n",
      "-- Comment on Cancer Cell. 2010 May 18;17(5):423-5.\n",
      "Nat Struct Mol Biol\n",
      "Cancer Cell\n",
      "---> Article 2949 is a commentary and is to be removed\n",
      "\n",
      " 2952 Focus:  JAMA 2006  Jul 12 296(2) 185-92 10.1001/jama.296.2.185\n",
      "-- Comment in JAMA. 2006 Dec 6;296(21):2558; author reply 2558.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2006 2006\n",
      "===>> 296(2) 296(21)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2958 Focus:  Hum Reprod Update 2010  Nov-Dec 16(6) 631-50 10.1093/humupd/dmq022\n",
      "-- Comment in Hum Reprod Update. 2011 Nov-Dec;17(6):861; discussion 861-2.\n",
      "Hum Reprod Update\n",
      "Hum Reprod Update\n",
      "===>> Hum Reprod Update\n",
      "===>> 2010 2011\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2969 Focus:  Am J Obstet Gynecol 2013  Nov 209(5) 409-14 10.1016/j.ajog.2013.04.019\n",
      "-- Comment in Am J Obstet Gynecol. 2013 Oct;209(4):395-6. Am J Obstet Gynecol. 2013 Oct;209(4):396.\n",
      "Am J Obstet Gynecol\n",
      "Am J Obstet Gynecol\n",
      "===>> Am J Obstet Gynecol\n",
      "===>> 2013 2013\n",
      "===>> 209(5) 209(4)\n",
      "---> Article 2969 is a comment and is to be removed\n",
      "\n",
      " 2976 Focus:  J Clin Oncol 2016  May 1 34(13) 1460-8 10.1200/JCO.2015.65.0747\n",
      "-- Comment in J Clin Oncol. 2016 Dec;34(34):4183. J Clin Oncol. 2016 Dec;34(34):4187-4188. Chin Clin Oncol. 2017 Apr;6(2):15.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2016 2016\n",
      "===>> 34(13) 34(34)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2985 Focus:  World J Surg 2010  Jul 34(7) 1416-26 10.1007/s00268-010-0477-5\n",
      "-- Comment in World J Surg. 2011 Feb;35(2):458-9; author reply 460-1.\n",
      "World J Surg\n",
      "World J Surg\n",
      "===>> World J Surg\n",
      "===>> 2010 2011\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 2993 Focus:  Lancet Oncol 2017  Sep 18(9) 1274-1284 10.1016/S1470-2045(17)30469-2\n",
      "-- Comment in Lancet Oncol. 2017 Sep;18(9):1151-1152. Nat Rev Clin Oncol. 2017 Oct;14(10):586-587.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2017 2017\n",
      "===>> 18(9) 18(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 1274 1151\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 2998 Focus:  Int J Gynecol Cancer 2011  Jul 21(5) 846-51 10.1097/IGC.0b013e31821bc7e3\n",
      "-- Comment in Int J Gynecol Cancer. 2012 Jan;22(1):2.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3014 Focus:  JAMA 2010  Sep 1 304(9) 967-75 10.1001/jama.2010.1237\n",
      "-- Comment in JAMA. 2010 Sep 1;304(9):1011-2. Nat Rev Clin Oncol. 2010 Nov;7(11):609. JAMA. 2010 Dec 22;304(24):2695; author reply 2695-6. Arch Surg. 2011 Apr;146(4):479-80.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2010 2010\n",
      "===>> 304(9) 304(9)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 967 1011\n",
      "---> Article 3014 is a commentary and is to be removed\n",
      "\n",
      " 3017 Focus:  Eur Urol 2019  Dec 76(6) 831-842 10.1016/j.eururo.2019.08.019\n",
      "-- Comment in Nat Rev Urol. 2019 Nov;16(11):639.\n",
      "Eur Urol\n",
      "Nat Rev Urol\n",
      "---> Article 3017 is a commentary and is to be removed\n",
      "\n",
      " 3025 Focus:  Nature 2017  Oct 19 550(7676) 360-365 10.1038/nature24060\n",
      "-- Comment in Nature. 2017 Oct 19;550(7676):342-343.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2017 2017\n",
      "===>> 550(7676) 550(7676)\n",
      "--->  Oct 19  Oct 19\n",
      "--->  Oct 19\n",
      "---> 360 342\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3032 Focus:  JAMA 2019  Aug 20 322(7) 666-685 10.1001/jama.2019.8430\n",
      "-- Comment in JAMA. 2019 Aug 20;322(7):619-621.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2019 2019\n",
      "===>> 322(7) 322(7)\n",
      "--->  Aug 20  Aug 20\n",
      "--->  Aug 20\n",
      "---> 666 619\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3049 Focus:  JAMA Intern Med 2013  Jan 28 173(2) 96-103 10.1001/2013.jamainternmed.962\n",
      "-- Comment in JAMA Intern Med. 2013 Jan 28;173(2):103-4.\n",
      "JAMA Intern Med\n",
      "JAMA Intern Med\n",
      "===>> JAMA Intern Med\n",
      "===>> 2013 2013\n",
      "===>> 173(2) 173(2)\n",
      "--->  Jan 28  Jan 28\n",
      "--->  Jan 28\n",
      "---> 96 103\n",
      "---> Article 3049 is a commentary and is to be removed\n",
      "\n",
      " 3051 Focus:  N Engl J Med 2012  Apr 12 366(15) 1382-92 10.1056/NEJMoa1105535\n",
      "-- Comment in N Engl J Med. 2012 Jul 12;367(2):179; author reply 179-80.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2012 2012\n",
      "===>> 366(15) 367(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3054 Focus:  Gynecol Oncol 2008  May 109(2) 168-73 10.1016/j.ygyno.2008.01.012\n",
      "-- Comment in Gynecol Oncol. 2008 May;109(2):161-3.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2008 2008\n",
      "===>> 109(2) 109(2)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 168 161\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3062 Focus:  JAMA 2019  Aug 20 322(7) 652-665 10.1001/jama.2019.10987\n",
      "-- Comment in JAMA. 2019 Aug 20;322(7):619-621. JAMA. 2020 Jan 14;323(2):188. JAMA. 2020 Jan 14;323(2):187-188.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2019 2019\n",
      "===>> 322(7) 322(7)\n",
      "--->  Aug 20  Aug 20\n",
      "--->  Aug 20\n",
      "---> 652 619\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3068 Focus:  Menopause 2011  Feb 18(2) 133-7 10.1097/gme.0b013e3181ecfb51\n",
      "-- Comment in Menopause. 2011 Feb;18(2):123-4.\n",
      "Menopause\n",
      "Menopause\n",
      "===>> Menopause\n",
      "===>> 2011 2011\n",
      "===>> 18(2) 18(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 133 123\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3076 Focus:  J Clin Oncol 2020  Apr 10 38(11) 1164-1174 10.1200/JCO.19.02745\n",
      "-- Comment in J Clin Oncol. 2020 Aug 10;38(23):2698. J Clin Oncol. 2020 Aug 10;38(23):2697-2698.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2020\n",
      "===>> 38(11) 38(23)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3079 Focus:  Cancer Cell 2013  Dec 9 24(6) 751-65 10.1016/j.ccr.2013.10.013\n",
      "-- Comment in Nat Rev Cancer. 2014 Feb;14(2):74-5.\n",
      "Cancer Cell\n",
      "Nat Rev Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 3081 Focus:  J Clin Oncol 2017  Jul 10 35(20) 2240-2250 10.1200/JCO.2016.69.4935\n",
      "-- Comment in J Clin Oncol. 2017 Jul 10;35(20):2224-2225.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(20) 35(20)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 2240 2224\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3089 Focus:  Cancer 2022  Jan 1 128(1) 94-102 10.1002/cncr.33866\n",
      "-- Comment in Cancer. 2022 Jan 1;128(1):30-33.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2022 2022\n",
      "===>> 128(1) 128(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 94 30\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3102 Focus:  Nature 2019  Jul 571(7763) 27-29 10.1038/d41586-019-02015-7\n",
      "-- Comment in Nature. 2019 Sep;573(7774):346.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2019 2019\n",
      "===>> 571(7763) 573(7774)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3117 Focus:  Eur Urol 2014  Sep 66(3) 489-99 10.1016/j.eururo.2014.01.003\n",
      "-- Comment in Nat Rev Urol. 2014 Mar;11(3):124. Eur Urol. 2014 Sep;66(3):500-1.\n",
      "Eur Urol\n",
      "Nat Rev Urol\n",
      "---> Article 3117 is a commentary and is to be removed\n",
      "\n",
      " 3133 Focus:  J Clin Oncol 2014  Mar 1 32(7) 618-26 10.1200/JCO.2013.51.3226\n",
      "-- Comment in J Clin Oncol. 2014 Mar 1;32(7):611-2.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(7) 32(7)\n",
      "--->  Mar 1  Mar 1\n",
      "--->  Mar 1\n",
      "---> 618 611\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3138 Focus:  Ann Pathol 2011  Feb 31(1) 3-10 10.1016/j.annpat.2010.10.008\n",
      "-- Comment in Ann Pathol. 2011 Feb;31(1):2.\n",
      "Ann Pathol\n",
      "Ann Pathol\n",
      "===>> Ann Pathol\n",
      "===>> 2011 2011\n",
      "===>> 31(1) 31(1)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 3 2\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3139 Focus:  J Minim Invasive Gynecol 2017  Jul-Aug 24(5) 772-776 10.1016/j.jmig.2017.03.001\n",
      "-- Comment in J Minim Invasive Gynecol. 2017 Jul - Aug;24(5):691. J Minim Invasive Gynecol. 2017 Nov - Dec;24(7):1243-1244. J Minim Invasive Gynecol. 2017 Nov - Dec;24(7):1244.\n",
      "J Minim Invasive Gynecol\n",
      "J Minim Invasive Gynecol\n",
      "===>> J Minim Invasive Gynecol\n",
      "===>> 2017 2017\n",
      "===>> 24(5) 24(5)\n",
      "--->  Jul-Aug  Jul-Aug\n",
      "--->  Jul-Aug\n",
      "---> 772 691\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3143 Focus:  N Engl J Med 2017  Aug 10 377(6) 523-533 10.1056/NEJMoa1706450\n",
      "-- Comment in N Engl J Med. ;377(18):1792.\n",
      "\n",
      " 3155 Focus:  J Clin Oncol 2012  Feb 1 30(4) 372-9 10.1200/JCO.2011.36.9215\n",
      "-- Comment in J Clin Oncol. 2012 Feb 1;30(4):347-50.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2012 2012\n",
      "===>> 30(4) 30(4)\n",
      "--->  Feb 1  Feb 1\n",
      "--->  Feb 1\n",
      "---> 372 347\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3167 Focus:  N Engl J Med 2015  Oct 29 373(18) 1697-708 10.1056/NEJMoa1506859\n",
      "-- Comment in BMJ. 2015;351:h5783. Nat Rev Clin Oncol. 2015 Dec;12(12):683. Urology. 2016 Mar;89:10-1. Asian J Androl. 2016 Jul-Aug;18(4):592-3. BJU Int. 2017 Jan;119(1):8-9. Eur Urol. 2016 Jul;70(1):204-5. J Urol. 2016 Apr;195(4 Pt 1):925-8.\n",
      "N Engl J Med\n",
      "BMJ\n",
      "---> Article 3167 is a commentary and is to be removed\n",
      "\n",
      " 3170 Focus:  N Engl J Med 2014  Aug 7 371(6) 497-506 10.1056/NEJMoa1400382\n",
      "-- Comment in N Engl J Med. 2014 Aug 7;371(6):566-8. N Engl J Med. 2014 Oct 23;371(17):1651-2. N Engl J Med. 2014 Oct 23;371(17):1650. N Engl J Med. 2014 Oct 23;371(17):1650-1.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2014 2014\n",
      "===>> 371(6) 371(6)\n",
      "--->  Aug 7  Aug 7\n",
      "--->  Aug 7\n",
      "---> 497 566\n",
      "---> Article 3170 is a commentary and is to be removed\n",
      "\n",
      " 3171 Focus:  J Gynecol Oncol 2017  Jul 28(4) e39 10.3802/jgo.2017.28.e39\n",
      "-- Comment in J Gynecol Oncol. 2017 Jul;28(4):e51.\n",
      "J Gynecol Oncol\n",
      "J Gynecol Oncol\n",
      "===>> J Gynecol Oncol\n",
      "===>> 2017 2017\n",
      "===>> 28(4) 28(4)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> e39 e51\n",
      "---> Article 3171 is a commentary and is to be removed\n",
      "\n",
      " 3172 Focus:  N Engl J Med 2019  Jul 25 381(4) 317-327 10.1056/NEJMoa1903387\n",
      "-- Comment in Cancer Discov. 2019 Aug;9(8):OF6. Nat Rev Clin Oncol. 2019 Oct;16(10):595-596. N Engl J Med. 2019 Oct 10;381(15):1491. N Engl J Med. 2019 Oct 10;381(15):1491-1492. Transl Cancer Res. 2020 Apr;9(4):2154-2156. Transl Cancer Res. 2020 Apr;9(4):2157-2160.\n",
      "N Engl J Med\n",
      "Cancer Discov\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 3182 Focus:  JAMA 2019  Sep 3 322(9) 868-886 10.1001/jama.2019.5780\n",
      "-- Comment in JAMA. 2019 Sep 3;322(9):821-823.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2019 2019\n",
      "===>> 322(9) 322(9)\n",
      "--->  Sep 3  Sep 3\n",
      "--->  Sep 3\n",
      "---> 868 821\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3184 Focus:  Nature 2015  Feb 12 518(7538) 254-7 10.1038/nature14157\n",
      "-- Comment in Nature. 2015 Feb 12;518(7538):174-6. Nat Rev Clin Oncol. 2015 Mar;12(3):125.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2015 2015\n",
      "===>> 518(7538) 518(7538)\n",
      "--->  Feb 12  Feb 12\n",
      "--->  Feb 12\n",
      "---> 254 174\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3202 Focus:  J Clin Oncol 2020  Apr 10 38(11) 1222-1245 10.1200/JCO.19.02960\n",
      "-- Comment in Int J Gynecol Cancer. 2020 Sep;30(9):1465-1466.\n",
      "J Clin Oncol\n",
      "Int J Gynecol Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 3213 Focus:  EBioMedicine 2015  Oct 21 2(11) 1827-33 10.1016/j.ebiom.2015.10.022\n",
      "-- Comment in EBioMedicine. 2015 Nov;2(11):1598-9.\n",
      "EBioMedicine\n",
      "EBioMedicine\n",
      "===>> EBioMedicine\n",
      "===>> 2015 2015\n",
      "===>> 2(11) 2(11)\n",
      "--->  Oct 21  Nov\n",
      "---> Article 3213 is a comment and is to be removed\n",
      "\n",
      " 3217 Focus:  J Clin Oncol 2007  Apr 10 25(11) 1383-9 10.1200/JCO.2006.06.7884\n",
      "-- Comment in J Clin Oncol. 2007 Apr 10;25(11):1303-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(11) 25(11)\n",
      "--->  Apr 10  Apr 10\n",
      "--->  Apr 10\n",
      "---> 1383 1303\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3242 Focus:  BJOG 2020  Feb 127(3) 364-375 10.1111/1471-0528.15905\n",
      "-- Comment in BJOG. 2020 Feb;127(3):376.\n",
      "BJOG\n",
      "BJOG\n",
      "===>> BJOG\n",
      "===>> 2020 2020\n",
      "===>> 127(3) 127(3)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 364 376\n",
      "---> Article 3242 is a commentary and is to be removed\n",
      "\n",
      " 3252 Focus:  EBioMedicine 2015  Sep 9 2(10) 1331-9 10.1016/j.ebiom.2015.08.037\n",
      "-- Comment in EBioMedicine. 2015 Oct;2(10):1270-1.\n",
      "EBioMedicine\n",
      "EBioMedicine\n",
      "===>> EBioMedicine\n",
      "===>> 2015 2015\n",
      "===>> 2(10) 2(10)\n",
      "--->  Sep 9  Oct\n",
      "---> Article 3252 is a comment and is to be removed\n",
      "\n",
      " 3259 Focus:  Lancet Oncol 2014  Jul 15(8) 852-61 10.1016/S1470-2045(14)70228-1\n",
      "-- Comment in Lancet Oncol. 2014 Jul;15(8):783-5.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2014 2014\n",
      "===>> 15(8) 15(8)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 852 783\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3274 Focus:  J Clin Oncol 2010  May 20 28(15) 2512-9 10.1200/JCO.2009.26.9589\n",
      "-- Comment in J Clin Oncol. 2010 Oct 10;28(29):e563-4; author reply e565-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(15) 28(29)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3277 Focus:  N Engl J Med 2021  Jun 24 384(25) 2394-2405 10.1056/NEJMoa2105215\n",
      "-- Comment in Nat Rev Clin Oncol. 2021 Oct;18(10):607-608. N Engl J Med. 2021 Oct 7;385(15):1439. N Engl J Med. 2021 Oct 7;385(15):1439-1440.\n",
      "N Engl J Med\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 3287 Focus:  J Clin Oncol 2014  Oct 10 32(29) 3275-83 10.1200/JCO.2013.54.1987\n",
      "-- Comment in J Clin Oncol. 2015 May 1;33(13):1515. J Clin Oncol. 2015 May 1;33(13):1514.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2015\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3302 Focus:  N Engl J Med 2018  Dec 27 379(26) 2495-2505 10.1056/NEJMoa1810858\n",
      "-- Comment in Nat Rev Clin Oncol. 2018 Dec;15(12):725. N Engl J Med. 2018 Dec 27;379(26):2567-2568.\n",
      "N Engl J Med\n",
      "Nat Rev Clin Oncol\n",
      "---> Article 3302 is a commentary and is to be removed\n",
      "\n",
      " 3303 Focus:  Breast Cancer Res Treat 2010  Nov 124(1) 295-6 10.1007/s10549-010-1111-9\n",
      "-- Comment on Breast Cancer Res Treat. 2011 Jan;125(2):325-49.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2010 2011\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3305 Focus:  N Engl J Med 2020  May 28 382(22) 2091-2102 10.1056/NEJMoa1911440\n",
      "-- Comment in Nat Rev Clin Oncol. 2020 Aug;17(8):455-456. Eur Urol. 2020 Nov;78(5):767-768. Nat Rev Urol. 2020 Aug;17(8):432. J Urol. 2020 Oct;204(4):877-878. N Engl J Med. 2020 Aug 27;383(9):890. N Engl J Med. 2020 Aug 27;383(9):890-891. Eur Urol. 2021 Feb;79(2):319-320.\n",
      "N Engl J Med\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 3311 Focus:  Ann Oncol 2018  Jan 1 29(1) 154-161 10.1093/annonc/mdx505\n",
      "-- Comment in Ann Oncol. 2018 Jan 1;29(1):18-21.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2018 2018\n",
      "===>> 29(1) 29(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 154 18\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3350 Focus:  Eur J Surg Oncol 2019  Nov 45(11) 2009-2015 10.1016/j.ejso.2019.06.007\n",
      "-- Comment in Eur J Surg Oncol. 2020 Jul;46(7):1391-1392.\n",
      "Eur J Surg Oncol\n",
      "Eur J Surg Oncol\n",
      "===>> Eur J Surg Oncol\n",
      "===>> 2019 2020\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3402 Focus:  Lancet Oncol 2018  Apr 19(4) 497-509 10.1016/S1470-2045(18)30111-6\n",
      "-- Comment in Lancet Oncol. 2018 Apr;19(4):434-436.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2018 2018\n",
      "===>> 19(4) 19(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 497 434\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3407 Focus:  N Engl J Med 2019  Dec 19 381(25) 2403-2415 10.1056/NEJMoa1909707\n",
      "-- Comment in N Engl J Med. 2019 Dec 19;381(25):2471-2474.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2019 2019\n",
      "===>> 381(25) 381(25)\n",
      "--->  Dec 19  Dec 19\n",
      "--->  Dec 19\n",
      "---> 2403 2471\n",
      "---> Article 3407 is a commentary and is to be removed\n",
      "\n",
      " 3412 Focus:  Oncology (Williston Park) 2016  Oct 15 30(10) 896-904 None\n",
      "-- Comment in Oncology (Williston Park). 2016 Oct 15;30(10 ):906-7.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2016 2016\n",
      "===>> 30(10) 30(10 )\n",
      "---> Article 3412 is a comment and is to be removed\n",
      "\n",
      " 3501 Focus:  Lancet Oncol 2007  Jan 8(1) 26-34 10.1016/S1470-2045(06)70983-4\n",
      "-- Comment in Lancet Oncol. 2007 Jan;8(1):5-6.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2007 2007\n",
      "===>> 8(1) 8(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 26 5\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3516 Focus:  J Clin Oncol 2017  Apr 1 35(10) 1086-1095 10.1200/JCO.2016.71.0012\n",
      "-- Comment in J Clin Oncol. 2017 Aug 1;35(22):2588. J Clin Oncol. 2017 Aug 1;35(22):2588-2589.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(10) 35(22)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3568 Focus:  Cancer 2018  Mar 1 124(5) 952-959 10.1002/cncr.31211\n",
      "-- Comment in Cancer. 2018 Mar 1;124(5):884-887.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2018 2018\n",
      "===>> 124(5) 124(5)\n",
      "--->  Mar 1  Mar 1\n",
      "--->  Mar 1\n",
      "---> 952 884\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3595 Focus:  Genet Med 2010  Apr 12(4 Suppl) S15-38 10.1097/GIM.0b013e3181d5a67b\n",
      "-- Comment in Genet Med. 2010 Jul;12(7):471; author reply 471-2.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2010 2010\n",
      "===>> 12(4 Suppl) 12(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3607 Focus:  Clin Breast Cancer 2020  Apr 20(2) 125-130 10.1016/j.clbc.2019.07.004\n",
      "-- Comment in Clin Breast Cancer. 2020 Apr;20(2):e196-e197. Clin Breast Cancer. 2020 Apr;20(2):e198-e199.\n",
      "Clin Breast Cancer\n",
      "Clin Breast Cancer\n",
      "===>> Clin Breast Cancer\n",
      "===>> 2020 2020\n",
      "===>> 20(2) 20(2)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 125 e196\n",
      "---> Article 3607 is a commentary and is to be removed\n",
      "\n",
      " 3616 Focus:  Cancer Res 2006  Aug 15 66(16) 8297-308 10.1158/0008-5472.CAN-06-0503\n",
      "-- Comment in Cancer Res. 2007 May 15;67(10):5057; author reply 5057-8.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3624 Focus:  Gynecol Oncol 2022  Feb 164(2) 245-253 10.1016/j.ygyno.2021.12.003\n",
      "-- Comment in Gynecol Oncol. 2022 Feb;164(2):243-244.\n",
      "Gynecol Oncol\n",
      "Gynecol Oncol\n",
      "===>> Gynecol Oncol\n",
      "===>> 2022 2022\n",
      "===>> 164(2) 164(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 245 243\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3679 Focus:  JAMA Oncol 2018  Jul 1 4(7) 1012 10.1001/jamaoncol.2018.0595\n",
      "-- Comment in JAMA Oncol. 2018 Jul 1;4(7):1012-1013. Comment on JAMA Oncol. 2017 Dec 1;3(12):1647-1653.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2018 2018\n",
      "===>> 4(7) 4(7)\n",
      "--->  Jul 1  Jul 1\n",
      "--->  Jul 1\n",
      "---> 1012 1012\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3682 Focus:  JAMA Oncol 2018  Jul 1 4(7) 1012-1013 10.1001/jamaoncol.2018.0616\n",
      "-- Comment on JAMA Oncol. 2017 Dec 1;3(12):1647-1653. JAMA Oncol. 2018 Jul 1;4(7):1012.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2018 2017\n",
      "---> Article 3682 is a comment and is to be removed\n",
      "\n",
      " 3695 Focus:  Hastings Cent Rep 2018  May 48(3) 10-17 10.1002/hast.849\n",
      "-- Comment in Hastings Cent Rep. 2018 May;48(3):2. Hastings Cent Rep. 2018 May;48(3):18-19.\n",
      "Hastings Cent Rep\n",
      "Hastings Cent Rep\n",
      "===>> Hastings Cent Rep\n",
      "===>> 2018 2018\n",
      "===>> 48(3) 48(3)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 10 2\n",
      "---> Article 3695 is a commentary and is to be removed\n",
      "\n",
      " 3698 Focus:  Cell 2017  Jun 1 169(6) 979-981 10.1016/j.cell.2017.05.021\n",
      "-- Comment on Cell. 2017 Jun 1;169(6):1105-1118.e15.\n",
      "Cell\n",
      "Cell\n",
      "===>> Cell\n",
      "===>> 2017 2017\n",
      "===>> 169(6) 169(6)\n",
      "--->  Jun 1  Jun 1\n",
      "--->  Jun 1\n",
      "---> 979 1105\n",
      "---> Article 3698 is a commentary and is to be removed\n",
      "\n",
      " 3719 Focus:  J Gynecol Oncol 2019  Jul 30(4) e80 10.3802/jgo.2019.30.e80\n",
      "-- Comment on J Gynecol Oncol. 2019 Jul;30(4):e60.\n",
      "J Gynecol Oncol\n",
      "J Gynecol Oncol\n",
      "===>> J Gynecol Oncol\n",
      "===>> 2019 2019\n",
      "===>> 30(4) 30(4)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> e80 e60\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 3797 Focus:  Nat Rev Cancer 2011  Dec 23 12(1) 68-78 10.1038/nrc3181\n",
      "-- Comment in Nat Rev Cancer. 2012 May;12(5):372-3; author reply 372. Nat Rev Cancer. 2012 May;12(5):372; author reply 372.\n",
      "Nat Rev Cancer\n",
      "Nat Rev Cancer\n",
      "===>> Nat Rev Cancer\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3824 Focus:  Breast Cancer Res 2011  13(6) R119 10.1186/bcr3062\n",
      "-- Comment in Breast Cancer Res. 2012;14(2):401.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3830 Focus:  PLoS Genet 2011  Jul 7(7) e1002148 10.1371/journal.pgen.1002148\n",
      "-- Comment in PLoS Genet. 2011 Jul;7(7):e1002183.\n",
      "PLoS Genet\n",
      "PLoS Genet\n",
      "===>> PLoS Genet\n",
      "===>> 2011 2011\n",
      "===>> 7(7) 7(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> e1002148 e1002183\n",
      "---> Article 3830 is a commentary and is to be removed\n",
      "\n",
      " 3881 Focus:  JAMA Oncol 2017  Dec 1 3(12) 1647-1653 10.1001/jamaoncol.2017.1996\n",
      "-- Comment in JAMA Oncol. 2018 Jul 1;4(7):1012-1013. JAMA Oncol. 2018 Jul 1;4(7):1012.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2017 2018\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 3962 Focus:  Oncogene 2014  Oct 2 33(40) 4803-12 10.1038/onc.2013.421\n",
      "-- Comment in Breast Cancer Res. 2016 Nov 9;18(1):111.\n",
      "Oncogene\n",
      "Breast Cancer Res\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 3967 Focus:  Urol Oncol 2017  Sep 35(9) 575-576 10.1016/j.urolonc.2017.07.006\n",
      "-- Comment on N Engl J Med. 2016 Aug 4;375(5):443-53.\n",
      "Urol Oncol\n",
      "N Engl J Med\n",
      "---> Article 3967 is a commentary and is to be removed\n",
      "\n",
      " 3999 Focus:  Int J Gynecol Cancer 2007  Jul-Aug 17(4) 789-93 10.1111/j.1525-1438.2007.00875.x\n",
      "-- Comment in Int J Gynecol Cancer. 2008 Jul-Aug;18(4):876-7.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2007 2008\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4005 Focus:  J Clin Oncol 2019  Feb 20 37(6) 490-503 10.1200/JCO.18.00358\n",
      "-- Comment in Eur Urol. 2020 Jan;77(1):130-131.\n",
      "J Clin Oncol\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4029 Focus:  Cell Res 2016  Jul 26(7) 761-74 10.1038/cr.2016.69\n",
      "-- Comment in Cell Res. 2016 Jul;26(7):751-2.\n",
      "Cell Res\n",
      "Cell Res\n",
      "===>> Cell Res\n",
      "===>> 2016 2016\n",
      "===>> 26(7) 26(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 761 751\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4041 Focus:  J Clin Oncol 2021  Aug 10 39(23) 2528-2534 10.1200/JCO.21.00999\n",
      "-- Comment in 2564.\n",
      "\n",
      " 4051 Focus:  Ginekol Pol 2019  90(12) 707-710 10.5603/GP.2019.0121\n",
      "-- Comment in J Orthod. 2020 Jun;47(2):190-192.\n",
      "Ginekol Pol\n",
      "J Orthod\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4076 Focus:  Nat Commun 2017  Jan 9 8 13671 10.1038/ncomms13671\n",
      "-- Comment in Nat Rev Urol. 2017 Mar;14(3):134.\n",
      "Nat Commun\n",
      "Nat Rev Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4106 Focus:  Sci Transl Med 2013  Feb 13 5(172) 172ra21 10.1126/scitranslmed.3004925\n",
      "-- Comment in Sci Transl Med. 2013 Feb 13;5(172):172fs5.\n",
      "Sci Transl Med\n",
      "Sci Transl Med\n",
      "===>> Sci Transl Med\n",
      "===>> 2013 2013\n",
      "===>> 5(172) 5(172)\n",
      "--->  Feb 13  Feb 13\n",
      "--->  Feb 13\n",
      "---> 172ra21 172fs5\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4119 Focus:  J Clin Invest 2009  Oct 119(10) 3160-71 10.1172/JCI39836\n",
      "-- Comment in J Clin Invest. 2009 Oct;119(10):2895-7.\n",
      "J Clin Invest\n",
      "J Clin Invest\n",
      "===>> J Clin Invest\n",
      "===>> 2009 2009\n",
      "===>> 119(10) 119(10)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 3160 2895\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4150 Focus:  Endocr Relat Cancer 2012  Feb 13 19(1) 69-81 10.1530/ERC-11-0338\n",
      "-- Comment in Endocr Relat Cancer. 2012 Apr;19(2):C23-7.\n",
      "Endocr Relat Cancer\n",
      "Endocr Relat Cancer\n",
      "===>> Endocr Relat Cancer\n",
      "===>> 2012 2012\n",
      "===>> 19(1) 19(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4170 Focus:  Cancer Discov 2012  Nov 2(11) 982-4 10.1158/2159-8290.CD-12-0433\n",
      "-- Comment on Cancer Discov. 2012 Nov;2(11):1048-63. Cancer Discov. 2012 Nov;2(11):1036-47.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2012 2012\n",
      "===>> 2(11) 2(11)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 982 1048\n",
      "---> Article 4170 is a commentary and is to be removed\n",
      "\n",
      " 4201 Focus:  Strahlenther Onkol 2011  Oct 187(10) 656-64 10.1007/s00066-011-2251-5\n",
      "-- Comment in Strahlenther Onkol. 2012 Jan;188(1):91-2; author reply 92-3.\n",
      "Strahlenther Onkol\n",
      "Strahlenther Onkol\n",
      "===>> Strahlenther Onkol\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4211 Focus:  Sci Rep 2016  Jul 13 6 29506 10.1038/srep29506\n",
      "-- Comment in BMJ. 2016 Jul 13;354:i3900.\n",
      "Sci Rep\n",
      "BMJ\n",
      "FUCK!!!\n",
      "\n",
      " 4219 Focus:  PLoS Genet 2011  Jul 7(7) e1002182 10.1371/journal.pgen.1002182\n",
      "-- Comment in Nat Rev Genet. 2011 Sep;12(9):588.\n",
      "PLoS Genet\n",
      "Nat Rev Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4307 Focus:  J Med Genet 2021  Dec 58(12) 850-852 10.1136/jmedgenet-2020-107320\n",
      "-- Comment in CRISPR J. 2020 Dec;3(6):425-427.\n",
      "J Med Genet\n",
      "CRISPR J\n",
      "---> Article 4307 is a commentary and is to be removed\n",
      "\n",
      " 4315 Focus:  Am J Surg 2018  May 215(5) 899-903 10.1016/j.amjsurg.2018.02.010\n",
      "-- Comment in Am J Surg. 2018 May;215(5):904.\n",
      "Am J Surg\n",
      "Am J Surg\n",
      "===>> Am J Surg\n",
      "===>> 2018 2018\n",
      "===>> 215(5) 215(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 899 904\n",
      "---> Article 4315 is a commentary and is to be removed\n",
      "\n",
      " 4318 Focus:  Cancer Discov 2017  Sep 7(9) 999-1005 10.1158/2159-8290.CD-17-0146\n",
      "-- Comment in Cancer Discov. 2017 Sep;7(9):937-939.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2017 2017\n",
      "===>> 7(9) 7(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 999 937\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4340 Focus:  JAMA Oncol 2017  Oct 1 3(10) 1378-1385 10.1001/jamaoncol.2017.1007\n",
      "-- Comment in JAMA Oncol. 2017 Oct 1;3(10):1312-1314.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2017 2017\n",
      "===>> 3(10) 3(10)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 1378 1312\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4368 Focus:  Isr Med Assoc J 2008  Oct 10(10) 722-7 None\n",
      "-- Comment in Isr Med Assoc J. 2009 Jan;11(1):66.\n",
      "Isr Med Assoc J\n",
      "Isr Med Assoc J\n",
      "===>> Isr Med Assoc J\n",
      "===>> 2008 2009\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4404 Focus:  J Gynecol Oncol 2021  Mar 32(2) e23 10.3802/jgo.2021.32.e23\n",
      "-- Comment in J Gynecol Oncol. 2021 Mar;32(2):e33.\n",
      "J Gynecol Oncol\n",
      "J Gynecol Oncol\n",
      "===>> J Gynecol Oncol\n",
      "===>> 2021 2021\n",
      "===>> 32(2) 32(2)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> e23 e33\n",
      "---> Article 4404 is a commentary and is to be removed\n",
      "\n",
      " 4421 Focus:  EMBO Mol Med 2009  Sep 1(6-7) 315-22 10.1002/emmm.200900041\n",
      "-- Comment in EMBO Mol Med. 2009 Sep;1(6-7):297-9.\n",
      "EMBO Mol Med\n",
      "EMBO Mol Med\n",
      "===>> EMBO Mol Med\n",
      "===>> 2009 2009\n",
      "===>> 1(6-7) 1(6-7)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 315 297\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4426 Focus:  Radiology 2019  Jun 291(3) 554-569 10.1148/radiol.2019181814\n",
      "-- Comment in Radiology. 2019 Nov;293(2):480-481.\n",
      "Radiology\n",
      "Radiology\n",
      "===>> Radiology\n",
      "===>> 2019 2019\n",
      "===>> 291(3) 293(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4462 Focus:  JCO Precis Oncol 2018  2 PO 10.1200/PO.17.00176\n",
      "-- Comment in JCO Precis Oncol. 2018 Feb 14;2:\n",
      "JCO Precis Oncol\n",
      "JCO Precis Oncol\n",
      "===>> JCO Precis Oncol\n",
      "===>> 2018 2018\n",
      "===>> 2 2\n",
      "--->   Feb 14\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4467 Focus:  Nat Commun 2017  Nov 24 8(1) 1751 10.1038/s41467-017-01883-9\n",
      "-- Comment in Br J Cancer. 2018 Apr;118(7):933-935.\n",
      "Nat Commun\n",
      "Br J Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4474 Focus:  Nat Aging 2021  Sep 1(9) 838-849 10.1038/s43587-021-00104-9\n",
      "-- Comment in Nat Aging. 2021 Sep;1(9):757-759.\n",
      "Nat Aging\n",
      "Nat Aging\n",
      "===>> Nat Aging\n",
      "===>> 2021 2021\n",
      "===>> 1(9) 1(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 838 757\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4500 Focus:  Ann Oncol 2019  Jul 1 30(7) 1071-1079 10.1093/annonc/mdz132\n",
      "-- Comment in Ann Oncol. 2019 Jul 1;30(7):1023-1025.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2019 2019\n",
      "===>> 30(7) 30(7)\n",
      "--->  Jul 1  Jul 1\n",
      "--->  Jul 1\n",
      "---> 1071 1023\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4520 Focus:  Cell Cycle 2012  Oct 15 11(20) 3837-50 10.4161/cc.22026\n",
      "-- Comment in Cell Cycle. 2012 Nov 1;11(21):3916. Cell Cycle. 2012 Nov 15;11(22):4110.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2012 2012\n",
      "===>> 11(20) 11(21)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4528 Focus:  Cell 2012  May 25 149(5) 979-93 10.1016/j.cell.2012.04.024\n",
      "-- Comment in Cell. 2012 May 25;149(5):959-61.\n",
      "Cell\n",
      "Cell\n",
      "===>> Cell\n",
      "===>> 2012 2012\n",
      "===>> 149(5) 149(5)\n",
      "--->  May 25  May 25\n",
      "--->  May 25\n",
      "---> 979 959\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4567 Focus:  JAMA Oncol 2015  Oct 1(7) 943-51 10.1001/jamaoncol.2015.2690\n",
      "-- Comment in JAMA Oncol. 2015 Oct;1(7):951-2.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(7) 1(7)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 943 951\n",
      "---> Article 4567 is a commentary and is to be removed\n",
      "\n",
      " 4576 Focus:  J Clin Oncol 2014  Jul 1 32(19) 2001-9 10.1200/JCO.2013.53.6607\n",
      "-- Comment in J Clin Oncol. 2014 Jul 1;32(19):1987-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(19) 32(19)\n",
      "--->  Jul 1  Jul 1\n",
      "--->  Jul 1\n",
      "---> 2001 1987\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4584 Focus:  Cell 2021  Feb 18 184(4) 1064-1080 10.1016/j.cell.2021.01.012\n",
      "-- Comment in Mol Cell. 2021 Feb 18;81(4):647-648. Nat Rev Genet. 2021 Apr;22(4):200-201. Signal Transduct Target Ther. 2021 Jun 4;6(1):221.\n",
      "Cell\n",
      "Mol Cell\n",
      "FUCK!!!\n",
      "\n",
      " 4623 Focus:  Cell 2010  Jul 9 142(1) 65-76 10.1016/j.cell.2010.06.021\n",
      "-- Comment in Mol Cell. 2010 Jul 30;39(2):167-9. Nat Rev Mol Cell Biol. 2010 Sep;11(9):603.\n",
      "Cell\n",
      "Mol Cell\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4635 Focus:  Cancer 2019  Aug 15 125(16) 2829-2836 10.1002/cncr.32083\n",
      "-- Comment in Cancer. 2019 Aug 15;125(16):2728-2729.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2019 2019\n",
      "===>> 125(16) 125(16)\n",
      "--->  Aug 15  Aug 15\n",
      "--->  Aug 15\n",
      "---> 2829 2728\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4646 Focus:  J Clin Oncol 2015  Feb 1 33(4) 304-11 10.1200/JCO.2014.57.1414\n",
      "-- Comment in J Clin Oncol. 2015 Feb 1;33(4):295-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(4) 33(4)\n",
      "--->  Feb 1  Feb 1\n",
      "--->  Feb 1\n",
      "---> 304 295\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4659 Focus:  Cell Stem Cell 2013  Jul 3 13(1) 117-30 10.1016/j.stem.2013.05.004\n",
      "-- Comment in Breast Cancer Res. 2013;15(5):312.\n",
      "Cell Stem Cell\n",
      "Breast Cancer Res\n",
      "---> Article 4659 is a commentary and is to be removed\n",
      "\n",
      " 4665 Focus:  Urology 2021  Oct 156 96-103 10.1016/j.urology.2021.05.078\n",
      "-- Comment in Urology. 2021 Oct;156:102-103.\n",
      "Urology\n",
      "Urology\n",
      "===>> Urology\n",
      "===>> 2021 2021\n",
      "===>> 156 156\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 96 102\n",
      "---> Article 4665 is a commentary and is to be removed\n",
      "\n",
      " 4681 Focus:  J Natl Cancer Inst 2017  Dec 1 109(12) djx118 10.1093/jnci/djx118\n",
      "-- Comment in Nat Rev Urol. 2017 Sep;14(9):518. J Urol. 2018 Jun;199(6):1396-1398. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):1-4.\n",
      "J Natl Cancer Inst\n",
      "Nat Rev Urol\n",
      "---> Article 4681 is a commentary and is to be removed\n",
      "\n",
      " 4707 Focus:  Proc Natl Acad Sci U S A 2020  Aug 11 117(32) 19415-19424 10.1073/pnas.2009237117\n",
      "-- Comment in Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):21849-21850.\n",
      "Proc Natl Acad Sci U S A\n",
      "Proc Natl Acad Sci U S A\n",
      "===>> Proc Natl Acad Sci U S A\n",
      "===>> 2020 2020\n",
      "===>> 117(32) 117(36)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4735 Focus:  Breast Cancer Res 2012  Nov 13 14(6) 115 10.1186/bcr3332\n",
      "-- Comment on Breast Cancer Res. 2012;14(4):R110.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2012 2012\n",
      "===>> 14(6) 14(4)\n",
      "---> Article 4735 is a comment and is to be removed\n",
      "\n",
      " 4742 Focus:  J Clin Oncol 2011  Nov 20 29(33) 4373-80 10.1200/JCO.2010.33.6446\n",
      "-- Comment in J Clin Oncol. 2012 Dec 10;30(35):4447-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4749 Focus:  Nat Commun 2015  Apr 9 6 6744 10.1038/ncomms7744\n",
      "-- Comment in Nat Rev Clin Oncol. 2015 Aug;12(8):442-4.\n",
      "Nat Commun\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4752 Focus:  J Pathol 2011  Jul 224(3) 301-5 10.1002/path.2903\n",
      "-- Comment on J Pathol. 2011 May;224(1):10-21.\n",
      "J Pathol\n",
      "J Pathol\n",
      "===>> J Pathol\n",
      "===>> 2011 2011\n",
      "===>> 224(3) 224(1)\n",
      "---> Article 4752 is a comment and is to be removed\n",
      "\n",
      " 4760 Focus:  Breast J 2020  Sep 26(9) 1639-1644 10.1111/tbj.13877\n",
      "-- Comment in Breast J. 2020 Sep;26(9):1637-1638.\n",
      "Breast J\n",
      "Breast J\n",
      "===>> Breast J\n",
      "===>> 2020 2020\n",
      "===>> 26(9) 26(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 1639 1637\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4788 Focus:  Gastroenterology 2015  Mar 148(3) 556-64 10.1053/j.gastro.2014.11.042\n",
      "-- Comment in Gastroenterology. 2015 Mar;148(3):496-8. Comment on Gastroenterology. 2015 Mar;148(3):459-61.\n",
      "Gastroenterology\n",
      "Gastroenterology\n",
      "===>> Gastroenterology\n",
      "===>> 2015 2015\n",
      "===>> 148(3) 148(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 556 496\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4830 Focus:  PLoS Genet 2013  9(3) e1003173 10.1371/journal.pgen.1003173\n",
      "-- Comment in Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors.\n",
      "\n",
      " 4836 Focus:  Nat Cancer 2021  Dec 2(12) 1357-1371 10.1038/s43018-021-00266-w\n",
      "-- Comment in Nat Cancer. 2021 Dec;2(12):1296-1297.\n",
      "Nat Cancer\n",
      "Nat Cancer\n",
      "===>> Nat Cancer\n",
      "===>> 2021 2021\n",
      "===>> 2(12) 2(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1357 1296\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4844 Focus:  Cell 2016  Mar 24 165(1) 35-44 10.1016/j.cell.2016.02.065\n",
      "-- Comment in Nat Rev Clin Oncol. 2016 May;13(5):263. Comment on Cancer Discov. 2016 May;6(5):472.\n",
      "Cell\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4851 Focus:  Eur Urol 2010  Mar 57(3) 398-406 10.1016/j.eururo.2009.10.029\n",
      "-- Comment in Eur Urol. 2010 Mar;57(3):407-8; discussion 408-9.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2010 2010\n",
      "===>> 57(3) 57(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 398 407\n",
      "---> Article 4851 is a commentary and is to be removed\n",
      "\n",
      " 4853 Focus:  J Clin Oncol 2011  Oct 1 29(28) 3739-46 10.1200/JCO.2011.35.2682\n",
      "-- Comment in J Clin Oncol. 2011 Oct 1;29(28):3724-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2011\n",
      "===>> 29(28) 29(28)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 3739 3724\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4854 Focus:  JAMA Oncol 2017  Sep 1 3(9) 1190-1196 10.1001/jamaoncol.2017.0424\n",
      "-- Comment in JAMA Oncol. 2017 Sep 1;3(9):1176-1177. JAMA Oncol. 2018 Apr 1;4(4):587.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2017 2017\n",
      "===>> 3(9) 3(9)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 1190 1176\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4865 Focus:  J Natl Cancer Inst 2009  Jan 7 101(1) 24-36 10.1093/jnci/djn437\n",
      "-- Comment in J Natl Cancer Inst. 2009 Jan 7;101(1):4-5.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2009 2009\n",
      "===>> 101(1) 101(1)\n",
      "--->  Jan 7  Jan 7\n",
      "--->  Jan 7\n",
      "---> 24 4\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4900 Focus:  J Clin Oncol 2018  Oct 1 36(28) 2820-2825 10.1200/JCO.2018.78.3977\n",
      "-- Comment in J Clin Oncol. 2018 Oct 1;36(28):2817-2819.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2018 2018\n",
      "===>> 36(28) 36(28)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 2820 2817\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4908 Focus:  Eur Urol 2017  May 71(5) 740-747 10.1016/j.eururo.2016.11.033\n",
      "-- Comment in Eur Urol. 2017 May;71(5):748-749. J Urol. 2017 Oct;198(4):742-743.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2017 2017\n",
      "===>> 71(5) 71(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 740 748\n",
      "---> Article 4908 is a commentary and is to be removed\n",
      "\n",
      " 4938 Focus:  J Pathol 2011  May 224(1) 10-21 10.1002/path.2861\n",
      "-- Comment in J Pathol. 2011 Jul;224(3):301-5.\n",
      "J Pathol\n",
      "J Pathol\n",
      "===>> J Pathol\n",
      "===>> 2011 2011\n",
      "===>> 224(1) 224(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 4939 Focus:  Urol Oncol 2017  Aug 35(8) 536-537 10.1016/j.urolonc.2017.05.012\n",
      "-- Comment on N Engl J Med. 2016 Aug 4;375(5):443-53.\n",
      "Urol Oncol\n",
      "N Engl J Med\n",
      "---> Article 4939 is a commentary and is to be removed\n",
      "\n",
      " 4940 Focus:  Genet Med 2019  Sep 21(9) 1958-1968 10.1038/s41436-019-0457-6\n",
      "-- Comment in Genet Med. 2019 Dec;21(12):2840-2841. Genet Med. 2019 Dec;21(12):2842-2843.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2019 2019\n",
      "===>> 21(9) 21(12)\n",
      "---> Article 4940 is a comment and is to be removed\n",
      "\n",
      " 4954 Focus:  JAMA Oncol 2018  Aug 1 4(8) 1066-1072 10.1001/jamaoncol.2018.0644\n",
      "-- Comment in JAMA Oncol. 2018 Dec 1;4(12):1787-1788.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2018 2018\n",
      "===>> 4(8) 4(12)\n",
      "---> Article 4954 is a comment and is to be removed\n",
      "\n",
      " 4976 Focus:  Nat Biotechnol 2015  Aug 33(8) 877-81 10.1038/nbt.3295\n",
      "-- Comment in Nat Methods. 2015 Sep;12(9):806-7.\n",
      "Nat Biotechnol\n",
      "Nat Methods\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 4983 Focus:  Lancet Gastroenterol Hepatol 2018  Jul 3(7) 489-498 10.1016/S2468-1253(18)30079-7\n",
      "-- Comment in Lancet Gastroenterol Hepatol. 2018 Jul;3(7):451-452.\n",
      "Lancet Gastroenterol Hepatol\n",
      "Lancet Gastroenterol Hepatol\n",
      "===>> Lancet Gastroenterol Hepatol\n",
      "===>> 2018 2018\n",
      "===>> 3(7) 3(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 489 451\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 4986 Focus:  Eur Urol 2017  Jul 72(1) 34-42 10.1016/j.eururo.2017.02.023\n",
      "-- Comment in Eur Urol. 2017 Jul;72 (1):43-44. J Urol. 2018 May;199(5):1113.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2017 2017\n",
      "===>> 72(1) 72 (1)\n",
      "---> Article 4986 is a comment and is to be removed\n",
      "\n",
      " 5006 Focus:  Hered Cancer Clin Pract 2015  Jun 16 13(1) 15 10.1186/s13053-015-0036-z\n",
      "-- Comment in Maturitas. 2016 May;87:3-4.\n",
      "Hered Cancer Clin Pract\n",
      "Maturitas\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5028 Focus:  J Clin Oncol 2021  Nov 1 39(31) 3430-3440 10.1200/JCO.21.00531\n",
      "-- Comment in J Clin Oncol. 2021 Nov 1;39(31):3415-3418.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2021 2021\n",
      "===>> 39(31) 39(31)\n",
      "--->  Nov 1  Nov 1\n",
      "--->  Nov 1\n",
      "---> 3430 3415\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5029 Focus:  Cancer Discov 2013  Apr 3(4) 399-405 10.1158/2159-8290.CD-12-0421\n",
      "-- Comment in Cancer Discov. 2013 Apr;3(4):376-8.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2013 2013\n",
      "===>> 3(4) 3(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 399 376\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5042 Focus:  Cancer Discov 2017  Sep 7(9) 937-939 10.1158/2159-8290.CD-17-0734\n",
      "-- Comment on Cancer Discov. 2017 Sep;7(9):1006-1017. Cancer Discov. 2017 Sep;7(9):999-1005. Cancer Discov. 2017 Sep;7(9):984-998.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2017 2017\n",
      "===>> 7(9) 7(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 937 1006\n",
      "---> Article 5042 is a commentary and is to be removed\n",
      "\n",
      " 5061 Focus:  Ann Lab Med 2020  Mar 40(2) 148-154 10.3343/alm.2020.40.2.148\n",
      "-- Comment in Ann Lab Med. 2020 Mar;40(2):99-100.\n",
      "Ann Lab Med\n",
      "Ann Lab Med\n",
      "===>> Ann Lab Med\n",
      "===>> 2020 2020\n",
      "===>> 40(2) 40(2)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 148 99\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5064 Focus:  J Urol 2021  Aug 206(2) 279-288 10.1097/JU.0000000000001731\n",
      "-- Comment in J Urol. 2021 Aug;206(2):288.\n",
      "J Urol\n",
      "J Urol\n",
      "===>> J Urol\n",
      "===>> 2021 2021\n",
      "===>> 206(2) 206(2)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 279 288\n",
      "---> Article 5064 is a commentary and is to be removed\n",
      "\n",
      " 5076 Focus:  JAMA Oncol 2015  Jul 1(4) 486-94 10.1001/jamaoncol.2015.1432\n",
      "-- Comment in Nat Rev Clin Oncol. 2015 Sep;12(9):504.\n",
      "JAMA Oncol\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5132 Focus:  JAMA Oncol 2020  Sep 1 6(9) 1390-1396 10.1001/jamaoncol.2020.2965\n",
      "-- Comment in JAMA Oncol. 2021 Mar 1;7(3):461. JAMA Oncol. 2021 Mar 1;7(3):460-461.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2020 2021\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5139 Focus:  JAMA Oncol 2015  Apr 1(1) 23-32 10.1001/jamaoncol.2014.168\n",
      "-- Comment in JAMA Oncol. 2015 Apr;1(1):16-8.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(1) 1(1)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 23 16\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5166 Focus:  JAMA Oncol 2016  Apr 2(4) 482-90 10.1001/jamaoncol.2015.5495\n",
      "-- Comment in JAMA Oncol. 2016 Apr;2(4):491-2.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2016 2016\n",
      "===>> 2(4) 2(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 482 491\n",
      "---> Article 5166 is a commentary and is to be removed\n",
      "\n",
      " 5174 Focus:  Proc Natl Acad Sci U S A 2019  Nov 5 116(45) 22609-22618 10.1073/pnas.1903765116\n",
      "-- Comment in Proc Natl Acad Sci U S A. 2019 Nov 5;116(45):22429-22431.\n",
      "Proc Natl Acad Sci U S A\n",
      "Proc Natl Acad Sci U S A\n",
      "===>> Proc Natl Acad Sci U S A\n",
      "===>> 2019 2019\n",
      "===>> 116(45) 116(45)\n",
      "--->  Nov 5  Nov 5\n",
      "--->  Nov 5\n",
      "---> 22609 22429\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5202 Focus:  Cancer Res 2006  Sep 15 66(18) 9017-25 10.1158/0008-5472.CAN-06-0222\n",
      "-- Comment in Cancer Res. 2007 Mar 15;67(6):2902; author reply 2902-3.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5207 Focus:  Clin Cancer Res 2014  Feb 1 20(3) 764-75 10.1158/1078-0432.CCR-13-2287\n",
      "-- Comment in Clin Cancer Res. 2015 Feb 1;21(3):658. Clin Cancer Res. 2015 Feb 1;21(3):659.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2014 2015\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5211 Focus:  Clin Cancer Res 2014  Dec 15 20(24) 6605-17 10.1158/1078-0432.CCR-14-0257\n",
      "-- Comment in J Urol. 2016 Aug;196(2):351-2.\n",
      "Clin Cancer Res\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5237 Focus:  J Clin Oncol 2016  May 1 34(13) 1455-9 10.1200/JCO.2015.63.7454\n",
      "-- Comment in J Clin Oncol. 2016 May 1;34(13):1433-5.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2016 2016\n",
      "===>> 34(13) 34(13)\n",
      "--->  May 1  May 1\n",
      "--->  May 1\n",
      "---> 1455 1433\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5242 Focus:  Gastroenterology 2015  Sep 149(3) 604-13 10.1053/j.gastro.2015.05.006\n",
      "-- Comment in Gastroenterology. 2015 Sep;149(3):526-8.\n",
      "Gastroenterology\n",
      "Gastroenterology\n",
      "===>> Gastroenterology\n",
      "===>> 2015 2015\n",
      "===>> 149(3) 149(3)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 604 526\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5277 Focus:  Cancer Discov 2021  Nov 11(11) 2812-2827 10.1158/2159-8290.CD-21-0007\n",
      "-- Comment in Cancer Discov. 11:2659.\n",
      "\n",
      " 5289 Focus:  Breast Cancer Res 2007  9(3) 106 10.1186/bcr1733\n",
      "-- Comment on Breast Cancer Res. 2007;9(2):R26.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2007 2007\n",
      "===>> 9(3) 9(2)\n",
      "---> Article 5289 is a comment and is to be removed\n",
      "\n",
      " 5325 Focus:  Value Health 2017  Apr 20(4) 547-555 10.1016/j.jval.2017.01.006\n",
      "-- Comment in Value Health. 2018 Jul;21(7):891-893.\n",
      "Value Health\n",
      "Value Health\n",
      "===>> Value Health\n",
      "===>> 2017 2018\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5353 Focus:  Elife 2018  Jan 15 7 e31723 10.7554/eLife.31723\n",
      "-- Comment in Elife. 2018 Mar 01;7:\n",
      "Elife\n",
      "Elife\n",
      "===>> Elife\n",
      "===>> 2018 2018\n",
      "===>> 7 7\n",
      "--->  Jan 15  Mar 01\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5368 Focus:  Eur Urol 2018  Aug 74(2) 218-225 10.1016/j.eururo.2018.01.035\n",
      "-- Comment in J Urol. 2018 Nov;200(5):945.\n",
      "Eur Urol\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5375 Focus:  AJR Am J Roentgenol 2022  May 218(5) 810-820 10.2214/AJR.21.27022\n",
      "-- Comment in AJR Am J Roentgenol. 2022 Jan 5;:\n",
      "AJR Am J Roentgenol\n",
      "AJR Am J Roentgenol\n",
      "===>> AJR Am J Roentgenol\n",
      "===>> 2022 2022\n",
      "===>> 218(5) \n",
      "---> Article 5375 is a comment and is to be removed\n",
      "\n",
      " 5382 Focus:  J Am Coll Radiol 2017  Apr 14(4) 561-568 10.1016/j.jacr.2016.10.003\n",
      "-- Comment in J Am Coll Radiol. 2017 May;14 (5):582. J Am Coll Radiol. 2017 May;14 (5):582-584.\n",
      "J Am Coll Radiol\n",
      "J Am Coll Radiol\n",
      "===>> J Am Coll Radiol\n",
      "===>> 2017 2017\n",
      "===>> 14(4) 14 (5)\n",
      "---> Article 5382 is a comment and is to be removed\n",
      "\n",
      " 5408 Focus:  Obstet Gynecol 2020  Jun 135(6) 1270-1274 10.1097/AOG.0000000000003864\n",
      "-- Comment in Obstet Gynecol. 2020 Jun;135(6):1267-1269.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2020 2020\n",
      "===>> 135(6) 135(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1270 1267\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5410 Focus:  Urol Oncol 2017  Aug 35(8) 535 10.1016/j.urolonc.2017.05.010\n",
      "-- Comment on Cell. 2015 May 21;161(5):1215-1228.\n",
      "Urol Oncol\n",
      "Cell\n",
      "---> Article 5410 is a commentary and is to be removed\n",
      "\n",
      " 5419 Focus:  Genet Med 2014  Nov 16(11) 830-7 10.1038/gim.2014.40\n",
      "-- Comment in Genet Med. 2014 Nov;16(11):827-9.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2014 2014\n",
      "===>> 16(11) 16(11)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 830 827\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5425 Focus:  Cancer Res 2021  Mar 1 81(5) 1214-1215 10.1158/0008-5472.CAN-20-4340\n",
      "-- Comment in Cancer Res. 2021 Mar 1;81(5):1388-1397. Comment on Cancer Res. 2020 Nov 12;:\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 81(5) 81(5)\n",
      "--->  Mar 1  Mar 1\n",
      "--->  Mar 1\n",
      "---> 1214 1388\n",
      "---> Article 5425 is a commentary and is to be removed\n",
      "\n",
      " 5426 Focus:  Eur J Gastroenterol Hepatol 2008  Aug 20(8) 713-5 10.1097/MEG.0b013e3282f9460e\n",
      "-- Comment on Eur J Gastroenterol Hepatol. 2008 Aug;20(8):732-9.\n",
      "Eur J Gastroenterol Hepatol\n",
      "Eur J Gastroenterol Hepatol\n",
      "===>> Eur J Gastroenterol Hepatol\n",
      "===>> 2008 2008\n",
      "===>> 20(8) 20(8)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 713 732\n",
      "---> Article 5426 is a commentary and is to be removed\n",
      "\n",
      " 5432 Focus:  J Clin Oncol 2020  Aug 20 38(24) 2798-2811 10.1200/JCO.20.00046\n",
      "-- Comment in Urol Clin North Am. 2021 Aug;48(3):xi-xii.\n",
      "J Clin Oncol\n",
      "Urol Clin North Am\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5465 Focus:  Clin Cancer Res 2020  Jun 1 26(11) 2439-2440 10.1158/1078-0432.CCR-20-0707\n",
      "-- Comment in Clin Cancer Res. 2020 Jun 1;26(11):2487-2496. Comment on Clin Cancer Res. 2020 Feb 21;:\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 26(11) 26(11)\n",
      "--->  Jun 1  Jun 1\n",
      "--->  Jun 1\n",
      "---> 2439 2487\n",
      "---> Article 5465 is a commentary and is to be removed\n",
      "\n",
      " 5478 Focus:  Oncology (Williston Park) 2016  May 30(5) 377-85 None\n",
      "-- Comment in Oncology (Williston Park). 2016 May;30(5):393-4, 485.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2016 2016\n",
      "===>> 30(5) 30(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 377 393\n",
      "---> Article 5478 is a commentary and is to be removed\n",
      "\n",
      " 5521 Focus:  Radiographics 2020  Jul-Aug 40(4) 913-936 10.1148/rg.2020190181\n",
      "-- Comment in Radiographics. 2020 May 29;:190218.\n",
      "Radiographics\n",
      "Radiographics\n",
      "===>> Radiographics\n",
      "===>> 2020 2020\n",
      "===>> 40(4) \n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5528 Focus:  J Clin Oncol 2019  Jun 1 37(16) 1359-1364 10.1200/JCO.19.00500\n",
      "-- Comment in J Clin Oncol. 2019 Oct 10;37(29):2708-2709. J Clin Oncol. 2019 Oct 10;37(29):2707-2708. Comment on J Clin Oncol. 2019 Jun 1;37(16):1380-1390.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2019 2019\n",
      "===>> 37(16) 37(29)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5549 Focus:  Eur J Cancer 2020  Dec 141 1-8 10.1016/j.ejca.2020.09.023\n",
      "-- Comment in Eur J Cancer. 2021 Jun;150:281-282. Eur J Cancer. 2021 Jun;150:278-280.\n",
      "Eur J Cancer\n",
      "Eur J Cancer\n",
      "===>> Eur J Cancer\n",
      "===>> 2020 2021\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5558 Focus:  Clin Cancer Res 2021  Sep 1 27(17) 4836-4847 10.1158/1078-0432.CCR-21-0121\n",
      "-- Comment on Clin Cancer Res. 2021 Sep 1;27(17):4665.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 27(17) 27(17)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 4836 4665\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5562 Focus:  Proc Natl Acad Sci U S A 2015  Jan 27 112(4) 1107-12 10.1073/pnas.1422640112\n",
      "-- Comment in J Genet Genomics. 2015 Oct 20;42(10):517-9.\n",
      "Proc Natl Acad Sci U S A\n",
      "J Genet Genomics\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5609 Focus:  N Engl J Med 2016  Aug 4 375(5) 443-53 10.1056/NEJMoa1603144\n",
      "-- Comment in Eur Urol. 2016 Oct;70(4):703-704. Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e92. N Engl J Med. 2016 Nov 3;375(18):1802-1805. N Engl J Med. 2016 Nov 3;375(18):1802-1803. N Engl J Med. 2016 Nov 3;375(18):1803. Eur Urol. 2017 Apr;71(4):692. J Urol. 2017 Feb;197(2):399-400. N Engl J Med. ;375(18):1803-4. Urol Oncol. 2017 Aug;35(8):536-537. Cancer Biol Ther. 2017 Aug 3;18(8):545-546. Urol Oncol. 2017 Sep;35(9):575-576.\n",
      "N Engl J Med\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5649 Focus:  J Urol 2020  Oct 204(4) 707-713 10.1097/JU.0000000000001027\n",
      "-- Comment in J Urol. 2020 Oct;204(4):713. J Urol. 2020 Oct;204(4):712-713.\n",
      "J Urol\n",
      "J Urol\n",
      "===>> J Urol\n",
      "===>> 2020 2020\n",
      "===>> 204(4) 204(4)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 707 713\n",
      "---> Article 5649 is a commentary and is to be removed\n",
      "\n",
      " 5737 Focus:  Hum Mutat 2020  May 41(5) 1033-1041 10.1002/humu.23997\n",
      "-- Comment in Hum Mutat. 2020 Sep;41(9):1697-1699. Hum Mutat. 2020 Sep;41(9):1700-1701.\n",
      "Hum Mutat\n",
      "Hum Mutat\n",
      "===>> Hum Mutat\n",
      "===>> 2020 2020\n",
      "===>> 41(5) 41(9)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5744 Focus:  Epidemiology 2010  May 21(3) 366-72 10.1097/EDE.0b013e3181cc8871\n",
      "-- Comment in Epidemiology. 2010 May;21(3):373-5.\n",
      "Epidemiology\n",
      "Epidemiology\n",
      "===>> Epidemiology\n",
      "===>> 2010 2010\n",
      "===>> 21(3) 21(3)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 366 373\n",
      "---> Article 5744 is a commentary and is to be removed\n",
      "\n",
      " 5748 Focus:  Eur Urol 2011  Jul 60(1) 131-40 10.1016/j.eururo.2011.04.020\n",
      "-- Comment in Nat Rev Urol. 2011 Jul;8(7):355.\n",
      "Eur Urol\n",
      "Nat Rev Urol\n",
      "FUCK!!!\n",
      "\n",
      " 5814 Focus:  J Clin Oncol 2017  Oct 20 35(30) 3382-3390 10.1200/JCO.2017.72.3502\n",
      "-- Comment in J Clin Oncol. 2017 Oct 20;35(30):3375-3377.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(30) 35(30)\n",
      "--->  Oct 20  Oct 20\n",
      "--->  Oct 20\n",
      "---> 3382 3375\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5817 Focus:  Cancer Biol Ther 2011  May 15 11(10) 853-65 10.4161/cbt.11.10.15177\n",
      "-- Comment in Cancer Biol Ther. 2011 Jun 15;11(12):1065-6.\n",
      "Cancer Biol Ther\n",
      "Cancer Biol Ther\n",
      "===>> Cancer Biol Ther\n",
      "===>> 2011 2011\n",
      "===>> 11(10) 11(12)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5848 Focus:  Cell 2016  May 5 165(4) 867-81 10.1016/j.cell.2016.04.006\n",
      "-- Comment in Nat Rev Mol Cell Biol. 2016 Jun;17(6):330-1. Nat Rev Immunol. 2016 Jun;16(6):336-7.\n",
      "Cell\n",
      "Nat Rev Mol Cell Biol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5879 Focus:  Breast Cancer Res Treat 2014  Oct 147(3) 685-7 10.1007/s10549-014-3097-1\n",
      "-- Comment in Breast Cancer Res Treat. 2014 Oct;147(3):689. Comment on Breast Cancer Res Treat. 2014 Jun;145(3):663-72.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2014 2014\n",
      "===>> 147(3) 147(3)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 685 689\n",
      "---> Article 5879 is a commentary and is to be removed\n",
      "\n",
      " 5882 Focus:  Eur Urol Oncol 2021  Feb 4(1) 1-9 10.1016/j.euo.2020.11.011\n",
      "-- Comment in Eur Urol Oncol. 2021 Feb;4(1):10-11. Eur Urol Oncol. 2021 Aug;4(4):674-675.\n",
      "Eur Urol Oncol\n",
      "Eur Urol Oncol\n",
      "===>> Eur Urol Oncol\n",
      "===>> 2021 2021\n",
      "===>> 4(1) 4(1)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 1 10\n",
      "---> Article 5882 is a commentary and is to be removed\n",
      "\n",
      " 5898 Focus:  JAMA Oncol 2019  Jan 1 5(1) 51-57 10.1001/jamaoncol.2018.2956\n",
      "-- Comment in JAMA Oncol. 2019 Jan 1;5(1):58-59. JAMA Oncol. 2019 Jan 1;5(1):119-120. JAMA Oncol. 2019 Jan 1;5(1):120. JAMA Oncol. 2019 Jan 1;5(1):120-121. JAMA Oncol. 2019 Jan 1;5(1):121-122.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2019 2019\n",
      "===>> 5(1) 5(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 51 58\n",
      "---> Article 5898 is a commentary and is to be removed\n",
      "\n",
      " 5903 Focus:  Arch Toxicol 2011  Jun 85(6) 539-54 10.1007/s00204-011-0676-3\n",
      "-- Comment in Arch Toxicol. 2012 Nov;86(11):1637-9.\n",
      "Arch Toxicol\n",
      "Arch Toxicol\n",
      "===>> Arch Toxicol\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5905 Focus:  J Clin Oncol 2018  Feb 1 36(4) 414-424 10.1200/JCO.2017.74.1173\n",
      "-- Comment in Eur Urol. 2018 Sep;74(3):397.\n",
      "J Clin Oncol\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5907 Focus:  J Clin Oncol 2018  Oct 1 36(28) 2863-2871 10.1200/JCO.2018.78.5204\n",
      "-- Comment in Nat Rev Clin Oncol. 2018 Nov;15(11):655.\n",
      "J Clin Oncol\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5908 Focus:  Genome Med 2016  Mar 2 8(1) 24 10.1186/s13073-016-0269-0\n",
      "-- Comment in Nat Rev Genet. 2016 May;17(5):253.\n",
      "Genome Med\n",
      "Nat Rev Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5935 Focus:  JAMA 2011  Apr 20 305(15) 1568-76 10.1001/jama.2011.473\n",
      "-- Comment in JAMA. 2011 Apr 20;305(15):1596-7.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2011 2011\n",
      "===>> 305(15) 305(15)\n",
      "--->  Apr 20  Apr 20\n",
      "--->  Apr 20\n",
      "---> 1568 1596\n",
      "---> Article 5935 is a commentary and is to be removed\n",
      "\n",
      " 5939 Focus:  JAMA Oncol 2021  Jan 1 7(1) 107-110 10.1001/jamaoncol.2020.5161\n",
      "-- Comment in JAMA Oncol. 2021 Jan 1;7(1):111-112. Cancer Discov. 2021 Jan;11(1):6.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2021 2021\n",
      "===>> 7(1) 7(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 107 111\n",
      "---> Article 5939 is a commentary and is to be removed\n",
      "\n",
      " 5944 Focus:  Oncologist 2021  Feb 26(2) e279-e289 10.1002/onco.13573\n",
      "-- Comment in Oncologist. 2022 Jul 5;27(7):e604-e605. Oncologist. 2022 Jul 5;27(7):e606-e607.\n",
      "Oncologist\n",
      "Oncologist\n",
      "===>> Oncologist\n",
      "===>> 2021 2022\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5961 Focus:  Mayo Clin Proc 2021  Jun 96(6) 1407-1417 10.1016/j.mayocp.2020.08.051\n",
      "-- Comment in Mayo Clin Proc. 2021 Jun;96(6):1383-1386.\n",
      "Mayo Clin Proc\n",
      "Mayo Clin Proc\n",
      "===>> Mayo Clin Proc\n",
      "===>> 2021 2021\n",
      "===>> 96(6) 96(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1407 1383\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 5974 Focus:  Oncologist 2020  May 25(5) 414-421 10.1634/theoncologist.2019-0558\n",
      "-- Comment in Oncologist. 2020 Dec;25(12):e2019-e2020. Oncologist. 2020 Dec;25(12):e2021.\n",
      "Oncologist\n",
      "Oncologist\n",
      "===>> Oncologist\n",
      "===>> 2020 2020\n",
      "===>> 25(5) 25(12)\n",
      "---> Article 5974 is a comment and is to be removed\n",
      "\n",
      " 5981 Focus:  Nat Genet 2014  May 46(5) 478-481 10.1038/ng.2947\n",
      "-- Comment in Clin Genet. 2014 Sep;86(3):217-8.\n",
      "Nat Genet\n",
      "Clin Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 5991 Focus:  JAMA 2018  Jun 19 319(23) 2401-2409 10.1001/jama.2018.6228\n",
      "-- Comment in JAMA. 2018 Jun 19;319(23 ):2383-2385. Cancer Discov. 2018 Sep;8(9):1054. Nat Rev Gastroenterol Hepatol. 2018 Aug;15(8):454.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2018 2018\n",
      "===>> 319(23) 319(23 )\n",
      "---> Article 5991 is a comment and is to be removed\n",
      "\n",
      " 5996 Focus:  N Engl J Med 2015  Dec 10 373(24) 2336-2346 10.1056/NEJMoa1508054\n",
      "-- Comment in N Engl J Med. 2015 Dec 10;373(24):2373-5. Lancet Oncol. 2016 Jan;17(1):e8. N Engl J Med. 2016 Apr 7;374(14):1391. N Engl J Med. 2016 Apr 7;374(14):1390-1. Klin Padiatr. 2021 May;233(3):141-144.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2015 2015\n",
      "===>> 373(24) 373(24)\n",
      "--->  Dec 10  Dec 10\n",
      "--->  Dec 10\n",
      "---> 2336 2373\n",
      "---> Article 5996 is a commentary and is to be removed\n",
      "\n",
      " 5997 Focus:  Elife 2021  Aug 18 10 e68699 10.7554/eLife.68699\n",
      "-- Comment in Elife. 2021 Sep 29;10:\n",
      "Elife\n",
      "Elife\n",
      "===>> Elife\n",
      "===>> 2021 2021\n",
      "===>> 10 10\n",
      "--->  Aug 18  Sep 29\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 5999 Focus:  Blood 2021  Jan 21 137(3) 336-348 10.1182/blood.2019003782\n",
      "-- Comment in Blood. 2021 Jan 21;137(3):286-288.\n",
      "Blood\n",
      "Blood\n",
      "===>> Blood\n",
      "===>> 2021 2021\n",
      "===>> 137(3) 137(3)\n",
      "--->  Jan 21  Jan 21\n",
      "--->  Jan 21\n",
      "---> 336 286\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6014 Focus:  Science 2021  Apr 9 372(6538) 156-165 10.1126/science.abb4542\n",
      "-- Comment in Science. 2021 Apr 9;372(6538):127-128.\n",
      "Science\n",
      "Science\n",
      "===>> Science\n",
      "===>> 2021 2021\n",
      "===>> 372(6538) 372(6538)\n",
      "--->  Apr 9  Apr 9\n",
      "--->  Apr 9\n",
      "---> 156 127\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6042 Focus:  Cancer Prev Res (Phila) 2018  Oct 11(10) 655-664 10.1158/1940-6207.CAPR-18-0072\n",
      "-- Comment in Cancer Prev Res (Phila). 2019 Mar;12(3):195-196. Cancer Prev Res (Phila). 2019 Mar;12(3):197-198.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2018 2019\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6051 Focus:  JCO Precis Oncol 2017  Jul 2017 PO 10.1200/PO.17.00029\n",
      "-- Comment in https://doi.org/10.1200/PO.17.00064.\n",
      "\n",
      " 6063 Focus:  Nature 2018  Jul 559(7713) 285-289 10.1038/s41586-018-0291-z\n",
      "-- Comment in Nat Chem Biol. 2018 Sep;14(9):831.\n",
      "Nature\n",
      "Nat Chem Biol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6067 Focus:  Ann Oncol 2016  May 27(5) 795-800 10.1093/annonc/mdw018\n",
      "-- Comment in Ann Oncol. 2016 May;27(5):758-9.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2016 2016\n",
      "===>> 27(5) 27(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 795 758\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6068 Focus:  N Engl J Med 2020  Dec 10 383(24) 2345-2357 10.1056/NEJMoa2022485\n",
      "-- Comment in Eur Urol Oncol. 2020 Dec;3(6):806. N Engl J Med. 2021 Mar 25;384(12):1174. N Engl J Med. 2021 Mar 25;384(12):1174-1175. N Engl J Med. 2021 Mar 25;384(12):1175. J Urol. 2021 Jul;206(1):158-161. Aktuelle Urol. 2022 Apr;53(2):116-118.\n",
      "N Engl J Med\n",
      "Eur Urol Oncol\n",
      "---> Article 6068 is a commentary and is to be removed\n",
      "\n",
      " 6075 Focus:  Ann Oncol 2016  Apr 27(4) 635-41 10.1093/annonc/mdv604\n",
      "-- Comment in Ann Oncol. 2016 Apr;27(4):557-8.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2016 2016\n",
      "===>> 27(4) 27(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 635 557\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6081 Focus:  NPJ Precis Oncol 2021  Jun 18 5(1) 55 10.1038/s41698-021-00199-8\n",
      "-- Comment in Eur J Hum Genet. 2023 Dec;31(12):1355-1356.\n",
      "NPJ Precis Oncol\n",
      "Eur J Hum Genet\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6084 Focus:  Eur J Cancer 2020  Sep 136 16-24 10.1016/j.ejca.2020.05.001\n",
      "-- Comment in Eur J Cancer. 2021 Feb;144:392-394. Eur J Cancer. 2021 Feb;144:395-396.\n",
      "Eur J Cancer\n",
      "Eur J Cancer\n",
      "===>> Eur J Cancer\n",
      "===>> 2020 2021\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6086 Focus:  J Clin Oncol 2021  Aug 10 39(23) 2564-2573 10.1200/JCO.20.01992\n",
      "-- Comment in 2528.\n",
      "\n",
      " 6087 Focus:  Cancer Discov 2017  Sep 7(9) 984-998 10.1158/2159-8290.CD-17-0419\n",
      "-- Comment in Cancer Discov. 2017 Sep;7(9):937-939.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2017 2017\n",
      "===>> 7(9) 7(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 984 937\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6091 Focus:  JCO Precis Oncol 2020  4 355-366 10.1200/po.19.00346\n",
      "-- Comment in Eur Urol. 2020 Nov;78(5):768-770.\n",
      "JCO Precis Oncol\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6101 Focus:  Ann Intern Med 2018  Jan 16 168(2) 100-109 10.7326/M17-1319\n",
      "-- Comment in Am J Kidney Dis. 2018 Nov;72(5):761-763. Ann Intern Med. 2018 Jul 17;169(2):131-132. Ann Intern Med. 2018 Jul 17;169(2):132-133.\n",
      "Ann Intern Med\n",
      "Am J Kidney Dis\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6109 Focus:  JAMA Oncol 2017  Apr 1 3(4) 464-471 10.1001/jamaoncol.2016.5194\n",
      "-- Comment in JAMA Oncol. 2017 Apr 1;3(4):448-449. JAMA Oncol. 2017 Nov 1;3(11):1587. JAMA Oncol. 2017 Nov 1;3(11):1585. JAMA Oncol. 2017 Nov 1;3(11):1586-1587. JAMA Oncol. 2017 Nov 1;3(11):1585. JAMA Oncol. 2017 Nov 1;3(11):1586.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2017 2017\n",
      "===>> 3(4) 3(4)\n",
      "--->  Apr 1  Apr 1\n",
      "--->  Apr 1\n",
      "---> 464 448\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6111 Focus:  J Natl Cancer Inst 2020  Dec 14 112(12) 1213-1221 10.1093/jnci/djaa040\n",
      "-- Comment in J Natl Cancer Inst. 2020 Dec 14;112(12):1179-1180.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2020 2020\n",
      "===>> 112(12) 112(12)\n",
      "--->  Dec 14  Dec 14\n",
      "--->  Dec 14\n",
      "---> 1213 1179\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6122 Focus:  Ann Oncol 2021  Jun 32(6) 726-735 10.1016/j.annonc.2021.03.196\n",
      "-- Comment in Ann Oncol. 2021 Jun;32(6):694-695.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2021 2021\n",
      "===>> 32(6) 32(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 726 694\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6124 Focus:  Gastroenterology 2020  Jul 159(1) 358-362 10.1053/j.gastro.2020.03.088\n",
      "-- Comment in Hepatobiliary Surg Nutr. 2021 Apr;10(2):264-266.\n",
      "Gastroenterology\n",
      "Hepatobiliary Surg Nutr\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6125 Focus:  Gastroenterology 2015  Apr 148(4) 806-18 10.1053/j.gastro.2014.12.028\n",
      "-- Comment in Gastroenterology. 2015 Apr;148(4):707-10.\n",
      "Gastroenterology\n",
      "Gastroenterology\n",
      "===>> Gastroenterology\n",
      "===>> 2015 2015\n",
      "===>> 148(4) 148(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 806 707\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6129 Focus:  Lancet Oncol 2018  Jun 19(6) 785-798 10.1016/S1470-2045(18)30242-0\n",
      "-- Comment in Lancet Oncol. 2018 Jun;19(6):722-723. Cancer Discov. 2018 Aug;8(8):OF7.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2018 2018\n",
      "===>> 19(6) 19(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 785 722\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6130 Focus:  Lancet Oncol 2016  Sep 17(9) 1261-71 10.1016/S1470-2045(16)30147-4\n",
      "-- Comment in Lancet Oncol. 2016 Sep;17(9):1179-81. Lancet Oncol. 2016 Nov;17 (11):e470. Lancet Oncol. 2016 Nov;17 (11):e471.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2016 2016\n",
      "===>> 17(9) 17(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 1261 1179\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6159 Focus:  Nature 2010  Oct 7 467(7316) 667-8 10.1038/467667a\n",
      "-- Comment on Nature. 2010 Oct 7;467(7316):678-83.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2010 2010\n",
      "===>> 467(7316) 467(7316)\n",
      "--->  Oct 7  Oct 7\n",
      "--->  Oct 7\n",
      "---> 667 678\n",
      "---> Article 6159 is a commentary and is to be removed\n",
      "\n",
      " 6163 Focus:  Nat Rev Urol 2017  Mar 14(3) 134 10.1038/nrurol.2017.8\n",
      "-- Comment on Nat Commun. 2017 Jan 09;8:13671.\n",
      "Nat Rev Urol\n",
      "Nat Commun\n",
      "---> Article 6163 is a commentary and is to be removed\n",
      "\n",
      " 6164 Focus:  Gastroenterology 2011  Apr 140(4) 1143-6 10.1053/j.gastro.2011.02.026\n",
      "-- Comment on Gastroenterology. 2011 Apr;140(4):1303-1313.e1-3.\n",
      "Gastroenterology\n",
      "Gastroenterology\n",
      "===>> Gastroenterology\n",
      "===>> 2011 2011\n",
      "===>> 140(4) 140(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 1143 1303\n",
      "---> Article 6164 is a commentary and is to be removed\n",
      "\n",
      " 6180 Focus:  J Clin Oncol 2017  Jul 10 35(20) 2226-2228 10.1200/JCO.2017.72.8774\n",
      "-- Comment on J Clin Oncol. 2017 Jul 10;35(20):2329-2337.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(20) 35(20)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 2226 2329\n",
      "---> Article 6180 is a commentary and is to be removed\n",
      "\n",
      " 6181 Focus:  Nat Struct Mol Biol 2007  Jun 14(6) 461-2 10.1038/nsmb0607-461\n",
      "-- Comment on Nat Struct Mol Biol. 2007 Jun;14(6):468-74.\n",
      "Nat Struct Mol Biol\n",
      "Nat Struct Mol Biol\n",
      "===>> Nat Struct Mol Biol\n",
      "===>> 2007 2007\n",
      "===>> 14(6) 14(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 461 468\n",
      "---> Article 6181 is a commentary and is to be removed\n",
      "\n",
      " 6204 Focus:  Am J Surg 2018  May 215(5) 904 10.1016/j.amjsurg.2017.11.067\n",
      "-- Comment on Am J Surg. 2018 May;215(5):899-903.\n",
      "Am J Surg\n",
      "Am J Surg\n",
      "===>> Am J Surg\n",
      "===>> 2018 2018\n",
      "===>> 215(5) 215(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 904 899\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6228 Focus:  Lancet Oncol 2018  Feb 19(2) 150-151 10.1016/S1470-2045(18)30008-1\n",
      "-- Comment on Lancet Oncol. 2018 Feb;19(2):169-180.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2018 2018\n",
      "===>> 19(2) 19(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 150 169\n",
      "---> Article 6228 is a commentary and is to be removed\n",
      "\n",
      " 6231 Focus:  Nat Struct Mol Biol 2007  Jun 14(6) 468-74 10.1038/nsmb1245\n",
      "-- Comment in Nat Struct Mol Biol. 2007 Jun;14(6):461-2.\n",
      "Nat Struct Mol Biol\n",
      "Nat Struct Mol Biol\n",
      "===>> Nat Struct Mol Biol\n",
      "===>> 2007 2007\n",
      "===>> 14(6) 14(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 468 461\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6234 Focus:  Cell 2017  Jun 1 169(6) 1105-1118 10.1016/j.cell.2017.05.010\n",
      "-- Comment in Cell. 2017 Jun 1;169(6):979-981. EMBO Mol Med. 2017 Oct;9(10):1331-1333.\n",
      "Cell\n",
      "Cell\n",
      "===>> Cell\n",
      "===>> 2017 2017\n",
      "===>> 169(6) 169(6)\n",
      "--->  Jun 1  Jun 1\n",
      "--->  Jun 1\n",
      "---> 1105 979\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6238 Focus:  Cancer Res 2020  Oct 15 80(20) 4476-4486 10.1158/0008-5472.CAN-20-0977\n",
      "-- Comment in Eur Urol. 2021 Mar;79(3):428-429. Eur Urol. 2021 Apr;79(4):e119-e120.\n",
      "Cancer Res\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6243 Focus:  Urol Oncol 2017  Aug 35(8) 536 10.1016/j.urolonc.2017.05.011\n",
      "-- Comment on Eur Urol. 2016 Jun;69(6):992-5.\n",
      "Urol Oncol\n",
      "Eur Urol\n",
      "---> Article 6243 is a commentary and is to be removed\n",
      "\n",
      " 6249 Focus:  Proc Natl Acad Sci U S A 2011  Jan 11 108(2) 686-91 10.1073/pnas.1010959107\n",
      "-- Comment in Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):441-2.\n",
      "Proc Natl Acad Sci U S A\n",
      "Proc Natl Acad Sci U S A\n",
      "===>> Proc Natl Acad Sci U S A\n",
      "===>> 2011 2011\n",
      "===>> 108(2) 108(2)\n",
      "--->  Jan 11  Jan 11\n",
      "--->  Jan 11\n",
      "---> 686 441\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6256 Focus:  Nature 2010  Oct 7 467(7316) 678-83 10.1038/nature09399\n",
      "-- Comment in Nature. 2010 Oct 7;467(7316):667-8.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2010 2010\n",
      "===>> 467(7316) 467(7316)\n",
      "--->  Oct 7  Oct 7\n",
      "--->  Oct 7\n",
      "---> 678 667\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6262 Focus:  J Urol 2020  Sep 204(3) 619-620 10.1097/JU.0000000000001176.01\n",
      "-- Comment on Cancer Res. 2020 Feb 1;80(3):624-638.\n",
      "J Urol\n",
      "Cancer Res\n",
      "---> Article 6262 is a commentary and is to be removed\n",
      "\n",
      " 6264 Focus:  Nat Rev Urol 2019  Nov 16(11) 639 10.1038/s41585-019-0249-4\n",
      "-- Comment on Eur Urol. 2019 Dec;76(6):831-842.\n",
      "Nat Rev Urol\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6272 Focus:  Nat Rev Cancer 2012  May 24 12(5) 372 None\n",
      "-- Comment on Nat Rev Cancer. 2012 Jan;12(1):68-78.\n",
      "Nat Rev Cancer\n",
      "Nat Rev Cancer\n",
      "===>> Nat Rev Cancer\n",
      "===>> 2012 2012\n",
      "===>> 12(5) 12(1)\n",
      "---> Article 6272 is a comment and is to be removed\n",
      "\n",
      " 6284 Focus:  Ann Oncol 2009  Jul 20(7) 1285 None\n",
      "-- Comment on Ann Oncol. 2009 May;20(5):874-8.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2009 2009\n",
      "===>> 20(7) 20(5)\n",
      "---> Article 6284 is a comment and is to be removed\n",
      "\n",
      " 6285 Focus:  Nat Rev Cancer 2012  May 24 12(5) 372-3 None\n",
      "-- Comment on Nat Rev Cancer. 2012 Jan;12(1):68-78.\n",
      "Nat Rev Cancer\n",
      "Nat Rev Cancer\n",
      "===>> Nat Rev Cancer\n",
      "===>> 2012 2012\n",
      "===>> 12(5) 12(1)\n",
      "---> Article 6285 is a comment and is to be removed\n",
      "\n",
      " 6287 Focus:  Mol Cell 2009  Nov 25 36(4) 539-40 10.1016/j.molcel.2009.11.003\n",
      "-- Comment on Mol Cell. 2009 Nov 25;36(4):620-30.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2009 2009\n",
      "===>> 36(4) 36(4)\n",
      "--->  Nov 25  Nov 25\n",
      "--->  Nov 25\n",
      "---> 539 620\n",
      "---> Article 6287 is a commentary and is to be removed\n",
      "\n",
      " 6294 Focus:  Oncology (Williston Park) 2010  Jan 24(1) 62, 65-6 None\n",
      "-- Comment on Oncology (Williston Park). 2010 Jan;24(1):55-62.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2010 2010\n",
      "===>> 24(1) 24(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 62, 65 55\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6304 Focus:  J Urol 2020  Mar 203(3) 463-464 10.1097/JU.0000000000000677.02\n",
      "-- Comment on Eur Urol. 2020 Jan;77(1):24-35.\n",
      "J Urol\n",
      "Eur Urol\n",
      "---> Article 6304 is a commentary and is to be removed\n",
      "\n",
      " 6326 Focus:  BJOG 2018  Oct 125(11) 1460 10.1111/1471-0528.15225\n",
      "-- Comment on BJOG. 2018 Oct;125(11):1451-1458.\n",
      "BJOG\n",
      "BJOG\n",
      "===>> BJOG\n",
      "===>> 2018 2018\n",
      "===>> 125(11) 125(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1460 1451\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6327 Focus:  J Clin Oncol 2018  Feb 10 36(5) 517 10.1200/JCO.2017.75.8490\n",
      "-- Comment in J Clin Oncol. 2018 Feb 10;36(5):517-518. Comment on J Clin Oncol. 2017 Dec 1;35(34):3800-3806. J Clin Oncol. 2017 Dec 1;35(34):3789-3791.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2018 2018\n",
      "===>> 36(5) 36(5)\n",
      "--->  Feb 10  Feb 10\n",
      "--->  Feb 10\n",
      "---> 517 517\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6329 Focus:  Fertil Steril 2013  May 99(6) 1560 10.1016/j.fertnstert.2013.01.091\n",
      "-- Comment on Fertil Steril. 2013 May;99(6):1724-8.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2013 2013\n",
      "===>> 99(6) 99(6)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 1560 1724\n",
      "---> Article 6329 is a commentary and is to be removed\n",
      "\n",
      " 6354 Focus:  Int J Cancer 2015  Jan 1 136(1) 11-20 10.1002/ijc.28948\n",
      "-- Comment in J Urol. 2015 Jul;194(1):260.\n",
      "Int J Cancer\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6359 Focus:  JAMA 2019  Aug 20 322(7) 619-621 10.1001/jama.2019.9688\n",
      "-- Comment on JAMA. 2019 Aug 20;322(7):666-685. JAMA. 2019 Aug 20;322(7):652-665.\n",
      "JAMA\n",
      "JAMA\n",
      "===>> JAMA\n",
      "===>> 2019 2019\n",
      "===>> 322(7) 322(7)\n",
      "--->  Aug 20  Aug 20\n",
      "--->  Aug 20\n",
      "---> 619 666\n",
      "---> Article 6359 is a commentary and is to be removed\n",
      "\n",
      " 6380 Focus:  Ann Surg Oncol 2017  Oct 24(11) 3107-3109 10.1245/s10434-017-5999-8\n",
      "-- Comment on Ann Surg Oncol. 2017 Oct;24(11):3116-3123.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2017 2017\n",
      "===>> 24(11) 24(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 3107 3116\n",
      "---> Article 6380 is a commentary and is to be removed\n",
      "\n",
      " 6387 Focus:  J Clin Oncol 2009  Dec 10 27(35) 5862-4 10.1200/JCO.2009.25.1652\n",
      "-- Comment on J Clin Oncol. 2009 Dec 10;27(35):5887-92.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2009 2009\n",
      "===>> 27(35) 27(35)\n",
      "--->  Dec 10  Dec 10\n",
      "--->  Dec 10\n",
      "---> 5862 5887\n",
      "---> Article 6387 is a commentary and is to be removed\n",
      "\n",
      " 6409 Focus:  J Natl Cancer Inst 2018  Sep 1 110(9) 925-926 10.1093/jnci/djy047\n",
      "-- Comment on J Natl Cancer Inst. 2018 Sep 1;110(9):967-974.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2018 2018\n",
      "===>> 110(9) 110(9)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 925 967\n",
      "---> Article 6409 is a commentary and is to be removed\n",
      "\n",
      " 6412 Focus:  JAMA Oncol 2021  Sep 1 7(9) 1402 10.1001/jamaoncol.2021.2040\n",
      "-- Comment on JAMA Oncol. 2021 Apr 1;7(4):585-592. JAMA Oncol. 2021 Sep 1;7(9):1401.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2021 2021\n",
      "===>> 7(9) 7(4)\n",
      "---> Article 6412 is a comment and is to be removed\n",
      "\n",
      " 6413 Focus:  Gastroenterology 2011  Apr 140(4) 1303-1313 10.1053/j.gastro.2010.12.039\n",
      "-- Comment in Gastroenterology. 2011 Apr;140(4):1143-6.\n",
      "Gastroenterology\n",
      "Gastroenterology\n",
      "===>> Gastroenterology\n",
      "===>> 2011 2011\n",
      "===>> 140(4) 140(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 1303 1143\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6415 Focus:  JAMA Oncol 2021  Sep 1 7(9) 1401 10.1001/jamaoncol.2021.2037\n",
      "-- Comment in JAMA Oncol. 2021 Sep 1;7(9):1402. Comment on JAMA Oncol. 2021 Apr 1;7(4):585-592.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2021 2021\n",
      "===>> 7(9) 7(9)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 1401 1402\n",
      "---> Article 6415 is a commentary and is to be removed\n",
      "\n",
      " 6422 Focus:  J Clin Oncol 2015  Oct 1 33(28) 3080-1 10.1200/JCO.2015.61.6961\n",
      "-- Comment on J Clin Oncol. 2015 Oct 1;33(28):3124-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(28) 33(28)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 3080 3124\n",
      "---> Article 6422 is a commentary and is to be removed\n",
      "\n",
      " 6426 Focus:  Genet Med 2009  Sep 11(9) 620-1 10.1097/GIM.0b013e3181b765d3\n",
      "-- Comment on Genet Med. 2009 Sep;11(9):629-39.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2009 2009\n",
      "===>> 11(9) 11(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 620 629\n",
      "---> Article 6426 is a commentary and is to be removed\n",
      "\n",
      " 6449 Focus:  BMJ 2014  Feb 11 348 g1379 10.1136/bmj.g1379\n",
      "-- Comment on BMJ. 2014;348:g226.\n",
      "BMJ\n",
      "BMJ\n",
      "===>> BMJ\n",
      "===>> 2014 2014\n",
      "===>> 348 348\n",
      "--->  Feb 11 \n",
      "---> Article 6449 is a comment and is to be removed\n",
      "\n",
      " 6450 Focus:  Blood 2007  Jun 15 109(12) 5522-3 10.1182/blood-2006-12-061572\n",
      "-- Comment on Blood. 2006 Nov 1;108(9):3161-7.\n",
      "Blood\n",
      "Blood\n",
      "===>> Blood\n",
      "===>> 2007 2006\n",
      "---> Article 6450 is a comment and is to be removed\n",
      "\n",
      " 6465 Focus:  J Clin Oncol 2015  Jan 20 33(3) 229-31 10.1200/JCO.2014.59.2311\n",
      "-- Comment on J Clin Oncol. 2015 Jan 20;33(3):244-50.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(3) 33(3)\n",
      "--->  Jan 20  Jan 20\n",
      "--->  Jan 20\n",
      "---> 229 244\n",
      "---> Article 6465 is a commentary and is to be removed\n",
      "\n",
      " 6466 Focus:  J Clin Oncol 2014  May 20 32(15) 1531-3 10.1200/JCO.2013.54.8925\n",
      "-- Comment on J Clin Oncol. 2014 May 20;32(15):1547-53.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(15) 32(15)\n",
      "--->  May 20  May 20\n",
      "--->  May 20\n",
      "---> 1531 1547\n",
      "---> Article 6466 is a commentary and is to be removed\n",
      "\n",
      " 6476 Focus:  Eur Urol 2015  Aug 68(2) 194-5 10.1016/j.eururo.2014.11.005\n",
      "-- Comment on Eur Urol. 2015 Aug;68(2):186-93.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2015 2015\n",
      "===>> 68(2) 68(2)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 194 186\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6477 Focus:  Breast Cancer Res Treat 2009  Aug 116(3) 617-8 10.1007/s10549-008-0124-0\n",
      "-- Comment on Breast Cancer Res Treat. 2009 Mar;114(1):31-8.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2009 2009\n",
      "===>> 116(3) 114(1)\n",
      "---> Article 6477 is a comment and is to be removed\n",
      "\n",
      " 6481 Focus:  Ann Surg Oncol 2021  Oct 28(10) 5657-5662 10.1245/s10434-021-10445-9\n",
      "-- Comment in Ann Surg Oncol. 2022 Dec;29(Suppl 3):560-561.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2021 2022\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6483 Focus:  Menopause 2020  Jul 27(7) 727-729 10.1097/GME.0000000000001572\n",
      "-- Comment on Menopause. 2020 Jul;27(7):746-755.\n",
      "Menopause\n",
      "Menopause\n",
      "===>> Menopause\n",
      "===>> 2020 2020\n",
      "===>> 27(7) 27(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 727 746\n",
      "---> Article 6483 is a commentary and is to be removed\n",
      "\n",
      " 6497 Focus:  Eur Urol 2020  Jan 77(1) 36-37 10.1016/j.eururo.2019.10.001\n",
      "-- Comment on Eur Urol. 2020 Jan;77(1):24-35.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2020 2020\n",
      "===>> 77(1) 77(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 36 24\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6500 Focus:  Cell Cycle 2015  14(14) 2195-6 10.1080/15384101.2015.1056614\n",
      "-- Comment on Cell Cycle. 2015;14(13):2080-90.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2015 2015\n",
      "===>> 14(14) 14(13)\n",
      "---> Article 6500 is a comment and is to be removed\n",
      "\n",
      " 6508 Focus:  Cancer Biol Ther 2011  Jun 1 11(11) 959-68 10.4161/cbt.11.11.15534\n",
      "-- Comment in Cancer Biol Ther. 2011 Jun 1;11(11):969-73.\n",
      "Cancer Biol Ther\n",
      "Cancer Biol Ther\n",
      "===>> Cancer Biol Ther\n",
      "===>> 2011 2011\n",
      "===>> 11(11) 11(11)\n",
      "--->  Jun 1  Jun 1\n",
      "--->  Jun 1\n",
      "---> 959 969\n",
      "---> Article 6508 is a commentary and is to be removed\n",
      "\n",
      " 6510 Focus:  Lancet Oncol 2013  Nov 14(12) 1151-2 10.1016/S1470-2045(13)70481-9\n",
      "-- Comment on Lancet Oncol. 2013 Nov;14(12):1226-32.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2013 2013\n",
      "===>> 14(12) 14(12)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 1151 1226\n",
      "---> Article 6510 is a commentary and is to be removed\n",
      "\n",
      " 6517 Focus:  Eur Urol 2015  Mar 67(3) 496-503 10.1016/j.eururo.2014.08.007\n",
      "-- Comment in Eur Urol. 2015 Mar;67(3):504-7.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2015 2015\n",
      "===>> 67(3) 67(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 496 504\n",
      "---> Article 6517 is a commentary and is to be removed\n",
      "\n",
      " 6519 Focus:  Cell 2011  May 13 145(4) 529-42 10.1016/j.cell.2011.03.041\n",
      "-- Comment in Nat Rev Mol Cell Biol. 2011 Jul;12(7):400.\n",
      "Cell\n",
      "Nat Rev Mol Cell Biol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6536 Focus:  Cancer Epidemiol Biomarkers Prev 2012  Aug 21(8) 1389 10.1158/1055-9965.EPI-12-0603\n",
      "-- Comment on Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):1089-96.\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "===>> Cancer Epidemiol Biomarkers Prev\n",
      "===>> 2012 2012\n",
      "===>> 21(8) 21(7)\n",
      "---> Article 6536 is a comment and is to be removed\n",
      "\n",
      " 6554 Focus:  Oncologist 2017  Jul 22(7) 797-803 10.1634/theoncologist.2016-0431\n",
      "-- Comment in Oncologist. 2017 Dec;22(12):1540. Oncologist. 2017 Dec;22(12):1562.\n",
      "Oncologist\n",
      "Oncologist\n",
      "===>> Oncologist\n",
      "===>> 2017 2017\n",
      "===>> 22(7) 22(12)\n",
      "---> Article 6554 is a comment and is to be removed\n",
      "\n",
      " 6555 Focus:  Biometrics 2007  Sep 63(3) 964-5 None\n",
      "-- Comment on Biometrics. 2006 Mar;62(1):36-48.\n",
      "Biometrics\n",
      "Biometrics\n",
      "===>> Biometrics\n",
      "===>> 2007 2006\n",
      "---> Article 6555 is a comment and is to be removed\n",
      "\n",
      " 6559 Focus:  Breast Cancer Res Treat 2011  May 127(1) 283-6 10.1007/s10549-011-1375-8\n",
      "-- Comment on Breast Cancer Res Treat. 2011 May;127(1):273-81.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2011 2011\n",
      "===>> 127(1) 127(1)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 283 273\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6569 Focus:  Ann Transl Med 2019  Dec 7(23) 777 10.21037/atm.2019.11.29\n",
      "-- Comment in Ann Transl Med. 2020 Sep;8(17):1043.\n",
      "Ann Transl Med\n",
      "Ann Transl Med\n",
      "===>> Ann Transl Med\n",
      "===>> 2019 2020\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6603 Focus:  JAMA Oncol 2016  Jun 1 2(6) 723-4 10.1001/jamaoncol.2015.5975\n",
      "-- Comment on JAMA Oncol.\n",
      "\n",
      " 6604 Focus:  Eur J Hum Genet 2014  Feb 22(2) 155-6 10.1038/ejhg.2013.213\n",
      "-- Comment on Eur J Hum Genet. 2014 Feb;22(2):280-2.\n",
      "Eur J Hum Genet\n",
      "Eur J Hum Genet\n",
      "===>> Eur J Hum Genet\n",
      "===>> 2014 2014\n",
      "===>> 22(2) 22(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 155 280\n",
      "---> Article 6604 is a commentary and is to be removed\n",
      "\n",
      " 6605 Focus:  Lancet Oncol 2013  Aug 14(9) 798-9 10.1016/S1470-2045(13)70276-6\n",
      "-- Comment on Lancet Oncol. 2013 Aug;14(9):882-92.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2013 2013\n",
      "===>> 14(9) 14(9)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 798 882\n",
      "---> Article 6605 is a commentary and is to be removed\n",
      "\n",
      " 6606 Focus:  PLoS Genet 2011  Jul 7(7) e1002183 10.1371/journal.pgen.1002183\n",
      "-- Comment on PLoS Genet. 2011 Jul;7(7):e1002148.\n",
      "PLoS Genet\n",
      "PLoS Genet\n",
      "===>> PLoS Genet\n",
      "===>> 2011 2011\n",
      "===>> 7(7) 7(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> e1002183 e1002148\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6620 Focus:  Mol Oncol 2020  Jun 14(6) 1121-1123 10.1002/1878-0261.12679\n",
      "-- Comment on Mol Oncol. 2020 Jun;14(6):1124-1133. Adamson et al. report that BRCA2 mutation carriers inheriting RAD52 S346X variant have reduced breast cancer risk. The RAD52 S346X variant lacks the nuclear localization sequence, which mislocalizes the protein to the cytoplasm and renders it nonfunctional. Combined loss of BRCA2-mediated DNA repair by homologous recombination and RAD52-mediated single-strand annealing may result in cell death and reduce breast cancer risk. Comment on: https://doi.org/10.1002/1878-0261.12665.\n",
      "Mol Oncol\n",
      "Mol Oncol\n",
      "===>> Mol Oncol\n",
      "===>> 2020 2020\n",
      "===>> 14(6) 14(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1121 1124\n",
      "---> Article 6620 is a commentary and is to be removed\n",
      "\n",
      " 6628 Focus:  Laeknabladid 2018  Jun 104(6) 281 10.17992/lbl.2018.06.187\n",
      "-- Comment on Laeknabladid. 2018 Jun;104(6):289-296.\n",
      "Laeknabladid\n",
      "Laeknabladid\n",
      "===>> Laeknabladid\n",
      "===>> 2018 2018\n",
      "===>> 104(6) 104(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 281 289\n",
      "---> Article 6628 is a commentary and is to be removed\n",
      "\n",
      " 6629 Focus:  J Clin Oncol 2008  Jan 1 26(1) 9-10 10.1200/JCO.2007.14.0244\n",
      "-- Comment on J Clin Oncol. 2008 Jan 1;26(1):20-5.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(1) 26(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 9 20\n",
      "---> Article 6629 is a commentary and is to be removed\n",
      "\n",
      " 6644 Focus:  Cancer 2014  Apr 1 120(7) 963-7 10.1002/cncr.28504\n",
      "-- Comment in Cancer. 2014 Apr 1;120(7):932-4.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2014 2014\n",
      "===>> 120(7) 120(7)\n",
      "--->  Apr 1  Apr 1\n",
      "--->  Apr 1\n",
      "---> 963 932\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6649 Focus:  Br J Cancer 2016  May 10 114(10) 1160-4 10.1038/bjc.2016.58\n",
      "-- Comment in Br J Cancer. 2016 Aug 23;115(5):e4. Br J Cancer. 2016 Aug 23;115(5):e2. Br J Cancer. 2016 Aug 23;115(5):e3.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2016 2016\n",
      "===>> 114(10) 115(5)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6650 Focus:  Pigment Cell Melanoma Res 2020  Jan 33(1) 6-7 10.1111/pcmr.12833\n",
      "-- Comment on Nature. 2019 Jul;571(7766):576-579.\n",
      "Pigment Cell Melanoma Res\n",
      "Nature\n",
      "---> Article 6650 is a commentary and is to be removed\n",
      "\n",
      " 6659 Focus:  Mol Oncol 2020  Jun 14(6) 1124-1133 10.1002/1878-0261.12665\n",
      "-- Comment in Mol Oncol. 2020 Jun;14(6):1121-1123.\n",
      "Mol Oncol\n",
      "Mol Oncol\n",
      "===>> Mol Oncol\n",
      "===>> 2020 2020\n",
      "===>> 14(6) 14(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1124 1121\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6660 Focus:  Eur J Radiol 2013  Dec 82(12) e908 10.1016/j.ejrad.2013.08.012\n",
      "-- Comment on Eur J Radiol. 2013 Sep;82(9):1416-22. Eur J Radiol. 2013 Dec;82(12):e906-7.\n",
      "Eur J Radiol\n",
      "Eur J Radiol\n",
      "===>> Eur J Radiol\n",
      "===>> 2013 2013\n",
      "===>> 82(12) 82(9)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6670 Focus:  Breast Cancer Res Treat 2015  Jun 151(2) 475-6 10.1007/s10549-015-3394-3\n",
      "-- Comment on Breast Cancer Res Treat. 2015 May;151(1):219-24.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2015 2015\n",
      "===>> 151(2) 151(1)\n",
      "---> Article 6670 is a comment and is to be removed\n",
      "\n",
      " 6671 Focus:  Breast Cancer Res Treat 2014  Dec 148(3) 685 10.1007/s10549-014-3177-2\n",
      "-- Comment in Breast Cancer Res Treat. 2014 Dec;148(3):691-2. Comment on Breast Cancer Res Treat. 2014 Feb;143(3):517-29.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2014 2014\n",
      "===>> 148(3) 148(3)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 685 691\n",
      "---> Article 6671 is a commentary and is to be removed\n",
      "\n",
      " 6672 Focus:  J Med Genet 2007  May 44(5) e79 10.1136/jmg.2006.048785\n",
      "-- Comment on J Med Genet. 2007 Jan;44(1):10-15.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2007 2007\n",
      "===>> 44(5) 44(1)\n",
      "---> Article 6672 is a comment and is to be removed\n",
      "\n",
      " 6675 Focus:  J Clin Oncol 2017  Jul 10 35(20) 2224-2225 10.1200/JCO.2017.72.8071\n",
      "-- Comment on J Clin Oncol. 2017 Jul 10;35(20):2240-2250.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2017 2017\n",
      "===>> 35(20) 35(20)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 2224 2240\n",
      "---> Article 6675 is a commentary and is to be removed\n",
      "\n",
      " 6676 Focus:  Clin Genet 2014  Jan 85(1) 17-8 10.1111/cge.12303\n",
      "-- Comment on J Med Genet. 2013 Jun;50(6):368-72.\n",
      "Clin Genet\n",
      "J Med Genet\n",
      "---> Article 6676 is a commentary and is to be removed\n",
      "\n",
      " 6691 Focus:  J Natl Cancer Inst 2018  Jul 1 110(7) 714-725 10.1093/jnci/djx265\n",
      "-- Comment in J Natl Cancer Inst. 2018 Jul 1;110(7):687-689. Oncotarget. 2018 Sep 4;9(69):33062-33063.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2018 2018\n",
      "===>> 110(7) 110(7)\n",
      "--->  Jul 1  Jul 1\n",
      "--->  Jul 1\n",
      "---> 714 687\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6694 Focus:  Breast Cancer Res Treat 2014  Dec 148(3) 691-2 10.1007/s10549-014-3186-1\n",
      "-- Comment on Breast Cancer Res Treat. 2014 Feb;143(3):517-29. Breast Cancer Res Treat. 2014 Dec;148(3):685.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2014 2014\n",
      "===>> 148(3) 143(3)\n",
      "---> Article 6694 is a comment and is to be removed\n",
      "\n",
      " 6695 Focus:  BMJ 2014  Mar 6 348 g1863 10.1136/bmj.g1863\n",
      "-- Comment on BMJ. 2014;348:g226.\n",
      "BMJ\n",
      "BMJ\n",
      "===>> BMJ\n",
      "===>> 2014 2014\n",
      "===>> 348 348\n",
      "--->  Mar 6 \n",
      "---> Article 6695 is a comment and is to be removed\n",
      "\n",
      " 6696 Focus:  Genet Med 2020  May 22(5) 825-830 10.1038/s41436-019-0740-6\n",
      "-- Comment in Clin Chem. 2020 Oct 1;66(10):1263-1265.\n",
      "Genet Med\n",
      "Clin Chem\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 6705 Focus:  JAMA Oncol 2015  Jun 1(3) 313 10.1001/jamaoncol.2015.0708\n",
      "-- Comment on JAMA Oncol. 2015 Jun;1(3):306-13.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(3) 1(3)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 313 306\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6706 Focus:  Cancer Biol Ther 2011  Jun 1 11(11) 969-73 10.4161/cbt.11.11.16573\n",
      "-- Comment on Cancer Biol Ther. 2011 Jun 1;11(11):959-68.\n",
      "Cancer Biol Ther\n",
      "Cancer Biol Ther\n",
      "===>> Cancer Biol Ther\n",
      "===>> 2011 2011\n",
      "===>> 11(11) 11(11)\n",
      "--->  Jun 1  Jun 1\n",
      "--->  Jun 1\n",
      "---> 969 959\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6732 Focus:  Br J Cancer 2016  Mar 29 114(7) 713-5 10.1038/bjc.2016.67\n",
      "-- Comment on Br J Cancer. 2016 Mar 29;114(7):723-30.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2016 2016\n",
      "===>> 114(7) 114(7)\n",
      "--->  Mar 29  Mar 29\n",
      "--->  Mar 29\n",
      "---> 713 723\n",
      "---> Article 6732 is a commentary and is to be removed\n",
      "\n",
      " 6733 Focus:  Cancer Prev Res (Phila) 2009  Feb 2(2) 100-3 10.1158/1940-6207.CAPR-08-0243\n",
      "-- Comment on Cancer Prev Res (Phila). 2009 Feb;2(2):122-7.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2009 2009\n",
      "===>> 2(2) 2(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 100 122\n",
      "---> Article 6733 is a commentary and is to be removed\n",
      "\n",
      " 6741 Focus:  J Clin Oncol 2007  May 20 25(15) 2027-34 10.1200/JCO.2006.06.9443\n",
      "-- Comment in J Clin Oncol. 2007 Nov 1;25(31):5035-6; author reply 5036-8.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2007 2007\n",
      "===>> 25(15) 25(31)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6747 Focus:  J Clin Oncol 2020  Dec 20 38(36) 4352 10.1200/JCO.20.02253\n",
      "-- Comment in J Clin Oncol. 2020 Dec 20;38(36):4352-4354. Comment on J Clin Oncol. 2020 Sep 10;38(26):3012-3023.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2020\n",
      "===>> 38(36) 38(36)\n",
      "--->  Dec 20  Dec 20\n",
      "--->  Dec 20\n",
      "---> 4352 4352\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6771 Focus:  Nat Genet 2007  Feb 39(2) 159-61 10.1038/ng1942\n",
      "-- Comment in Nat Genet. 2007 Feb;39(2):142-3.\n",
      "Nat Genet\n",
      "Nat Genet\n",
      "===>> Nat Genet\n",
      "===>> 2007 2007\n",
      "===>> 39(2) 39(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 159 142\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6775 Focus:  J Natl Cancer Inst 2015  Aug 11 107(9) djv218 10.1093/jnci/djv218\n",
      "-- Comment on J Natl Cancer Inst. 2015 May;107(5). pii: djv033. doi: 10.1093/jnci/djv033. J Natl Cancer Inst. 2015 Sep;107(9). pii: djv217. doi: 10.1093/jnci/djv217.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2015 2015\n",
      "===>> 107(9) 107(5). pii\n",
      "---> Article 6775 is a comment and is to be removed\n",
      "\n",
      " 6776 Focus:  Surgery 2012  Apr 151(4) 637-8 10.1016/j.surg.2011.12.031\n",
      "-- Comment on Surgery. 2011 Jun;149(6):731-4.\n",
      "Surgery\n",
      "Surgery\n",
      "===>> Surgery\n",
      "===>> 2012 2011\n",
      "---> Article 6776 is a comment and is to be removed\n",
      "\n",
      " 6778 Focus:  J Urol 2013  Dec 190(6) 2093 10.1016/j.juro.2013.08.101\n",
      "-- Comment on J Clin Oncol. 2013 May 10;31(14):1748-57.\n",
      "J Urol\n",
      "J Clin Oncol\n",
      "---> Article 6778 is a commentary and is to be removed\n",
      "\n",
      " 6780 Focus:  Surgery 2012  Apr 151(4) 634-7 10.1016/j.surg.2011.12.030\n",
      "-- Comment on Surgery. 2011 Jun;149(6):731-4.\n",
      "Surgery\n",
      "Surgery\n",
      "===>> Surgery\n",
      "===>> 2012 2011\n",
      "---> Article 6780 is a comment and is to be removed\n",
      "\n",
      " 6785 Focus:  Ann Oncol 2009  May 20(5) 874-8 10.1093/annonc/mdn724\n",
      "-- Comment in Ann Oncol. 2009 Jun;20(6):1143-4. Ann Oncol. 2009 Jul;20(7):1285; author reply 1285-6.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2009 2009\n",
      "===>> 20(5) 20(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6794 Focus:  Breast Cancer Res Treat 2012  Jan 131(2) 723-5 10.1007/s10549-011-1878-3\n",
      "-- Comment on Breast Cancer Res Treat. 2011 Oct;129(3):971-82.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2012 2011\n",
      "---> Article 6794 is a comment and is to be removed\n",
      "\n",
      " 6795 Focus:  Lancet Oncol 2006  May 7(5) 360-2 10.1016/S1470-2045(06)70670-2\n",
      "-- Comment on Lancet Oncol. 2006 May;7(5):402-6.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2006 2006\n",
      "===>> 7(5) 7(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 360 402\n",
      "---> Article 6795 is a commentary and is to be removed\n",
      "\n",
      " 6798 Focus:  J Clin Oncol 2016  Dec 34(34) 4183-4185 10.1200/JCO.2016.67.0554\n",
      "-- Comment in J Clin Oncol. 2016 Dec;34(34):4187.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2016 2016\n",
      "===>> 34(34) 34(34)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 4183 4187\n",
      "---> Article 6798 is a commentary and is to be removed\n",
      "\n",
      " 6805 Focus:  Fam Cancer 2019  Oct 18(4) 377-379 10.1007/s10689-019-00142-8\n",
      "-- Comment on Breast Cancer Res Treat. 2019 Oct;177(3):723-733.\n",
      "Fam Cancer\n",
      "Breast Cancer Res Treat\n",
      "FUCK!!!\n",
      "\n",
      " 6811 Focus:  J Clin Oncol 2009  Dec 10 27(35) 5887-92 10.1200/JCO.2008.19.9430\n",
      "-- Comment in J Clin Oncol. 2009 Dec 10;27(35):5862-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2009 2009\n",
      "===>> 27(35) 27(35)\n",
      "--->  Dec 10  Dec 10\n",
      "--->  Dec 10\n",
      "---> 5887 5862\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6814 Focus:  Fertil Steril 2016  Mar 105(3) 605-606 10.1016/j.fertnstert.2015.12.005\n",
      "-- Comment on Fertil Steril. 2016 Mar;105(3):781-5.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2016 2016\n",
      "===>> 105(3) 105(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 605 781\n",
      "---> Article 6814 is a commentary and is to be removed\n",
      "\n",
      " 6815 Focus:  Clin Cancer Res 2015  Aug 15 21(16) 3806 10.1158/1078-0432.CCR-15-0418\n",
      "-- Comment in Clin Cancer Res. 2015 Aug 15;21(16):3807. Comment on Clin Cancer Res. 2015 Jan 1;21(1):211-20.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2015 2015\n",
      "===>> 21(16) 21(16)\n",
      "--->  Aug 15  Aug 15\n",
      "--->  Aug 15\n",
      "---> 3806 3807\n",
      "---> Article 6815 is a commentary and is to be removed\n",
      "\n",
      " 6816 Focus:  Eur J Radiol 2013  Dec 82(12) e906-7 10.1016/j.ejrad.2013.08.025\n",
      "-- Comment in Eur J Radiol. 2013 Dec;82(12):e908. Comment on Eur J Radiol. 2013 Sep;82(9):1416-22.\n",
      "Eur J Radiol\n",
      "Eur J Radiol\n",
      "===>> Eur J Radiol\n",
      "===>> 2013 2013\n",
      "===>> 82(12) 82(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> e906 e908\n",
      "---> Article 6816 is a commentary and is to be removed\n",
      "\n",
      " 6820 Focus:  Pathol Res Pract 2021  Jun 222 153456 10.1016/j.prp.2021.153456\n",
      "-- Comment on Nature. 2018 Oct;562(7726):217-222.\n",
      "Pathol Res Pract\n",
      "Nature\n",
      "---> Article 6820 is a commentary and is to be removed\n",
      "\n",
      " 6821 Focus:  Lancet Oncol 2007  Jan 8(1) 5-6 10.1016/S1470-2045(06)70987-1\n",
      "-- Comment on Lancet Oncol. 2007 Jan;8(1):26-34.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2007 2007\n",
      "===>> 8(1) 8(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 5 26\n",
      "---> Article 6821 is a commentary and is to be removed\n",
      "\n",
      " 6826 Focus:  Eur Urol 2019  Oct 76(4) e109-e110 10.1016/j.eururo.2019.04.041\n",
      "-- Comment on Eur Urol. 2019 Oct;76(4):452-458.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2019 2019\n",
      "===>> 76(4) 76(4)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> e109 452\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6831 Focus:  Genet Med 2010  Apr 12(4) 240 10.1097/GIM.0b013e3181d4bc3a\n",
      "-- Comment on Genet Med. 2009 Nov;11(11):783-9.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2010 2009\n",
      "---> Article 6831 is a comment and is to be removed\n",
      "\n",
      " 6832 Focus:  Oncology (Williston Park) 2010  Jan 24(1) 66, 68 None\n",
      "-- Comment on Oncology (Williston Park). 2010 Jan;24(1):55-62.\n",
      "Oncology (Williston Park)\n",
      "Oncology (Williston Park)\n",
      "===>> Oncology (Williston Park)\n",
      "===>> 2010 2010\n",
      "===>> 24(1) 24(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 66, 68 55\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6834 Focus:  Proc Natl Acad Sci U S A 2011  Jan 11 108(2) 441-2 10.1073/pnas.1016614108\n",
      "-- Comment on Proc Natl Acad Sci U S A. 2011 Jan 11;108(2):686-91.\n",
      "Proc Natl Acad Sci U S A\n",
      "Proc Natl Acad Sci U S A\n",
      "===>> Proc Natl Acad Sci U S A\n",
      "===>> 2011 2011\n",
      "===>> 108(2) 108(2)\n",
      "--->  Jan 11  Jan 11\n",
      "--->  Jan 11\n",
      "---> 441 686\n",
      "---> Article 6834 is a commentary and is to be removed\n",
      "\n",
      " 6874 Focus:  J Clin Oncol 2015  Aug 10 33(23) 2582 10.1200/JCO.2015.61.0576\n",
      "-- Comment in J Clin Oncol. 2015 Aug 10;33(23):2583-4. Comment on J Clin Oncol. 2015 Jan 20;33(3):244-50.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(23) 33(23)\n",
      "--->  Aug 10  Aug 10\n",
      "--->  Aug 10\n",
      "---> 2582 2583\n",
      "---> Article 6874 is a commentary and is to be removed\n",
      "\n",
      " 6879 Focus:  Fertil Steril 2013  May 99(6) 1724-8 10.1016/j.fertnstert.2013.01.109\n",
      "-- Comment in Fertil Steril. 2013 May;99(6):1560.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2013 2013\n",
      "===>> 99(6) 99(6)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 1724 1560\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6897 Focus:  J Clin Oncol 2021  Nov 1 39(31) 3415-3418 10.1200/JCO.21.01761\n",
      "-- Comment on J Clin Oncol. 2021 Nov 1;39(31):3430-3440.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2021 2021\n",
      "===>> 39(31) 39(31)\n",
      "--->  Nov 1  Nov 1\n",
      "--->  Nov 1\n",
      "---> 3415 3430\n",
      "---> Article 6897 is a commentary and is to be removed\n",
      "\n",
      " 6898 Focus:  J Clin Oncol 2015  Aug 10 33(23) 2581-2 10.1200/JCO.2014.60.0585\n",
      "-- Comment in J Clin Oncol. 2015 Aug 10;33(23):2583-4. Comment on J Clin Oncol. 2015 Jan 20;33(3):244-50.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(23) 33(23)\n",
      "--->  Aug 10  Aug 10\n",
      "--->  Aug 10\n",
      "---> 2581 2583\n",
      "---> Article 6898 is a commentary and is to be removed\n",
      "\n",
      " 6902 Focus:  Clin Cancer Res 2015  Jan 1 21(1) 211-20 10.1158/1078-0432.CCR-14-1816\n",
      "-- Comment in Clin Cancer Res. 2015 Aug 15;21(16):3806. Clin Cancer Res. 2015 Aug 15;21(16):3807.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2015 2015\n",
      "===>> 21(1) 21(16)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6905 Focus:  Br J Cancer 2006  Oct 23 95(8) 1124 None\n",
      "-- Comment on Br J Cancer. 2006 Mar 27;94(6):814-9.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2006 2006\n",
      "===>> 95(8) 94(6)\n",
      "---> Article 6905 is a comment and is to be removed\n",
      "\n",
      " 6924 Focus:  Br J Cancer 2006  Oct 23 95(8) 1125 None\n",
      "-- Comment on Br J Cancer. 2006 Mar 27;94(6):814-9.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2006 2006\n",
      "===>> 95(8) 94(6)\n",
      "---> Article 6924 is a comment and is to be removed\n",
      "\n",
      " 6926 Focus:  Mol Cell 2018  Sep 20 71(6) 877-878 10.1016/j.molcel.2018.08.045\n",
      "-- Comment on Nature. 2018 Jul;559(7713):279-284. Mol Cell. 2018 Jul 19;71(2):319-331.e3.\n",
      "Mol Cell\n",
      "Nature\n",
      "---> Article 6926 is a commentary and is to be removed\n",
      "\n",
      " 6936 Focus:  Lancet Oncol 2006  May 7(5) 402-6 10.1016/S1470-2045(06)70624-6\n",
      "-- Comment in Lancet Oncol. 2006 May;7(5):360-2.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2006 2006\n",
      "===>> 7(5) 7(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 402 360\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 6965 Focus:  Endocr Relat Cancer 2012  Apr 10 19(2) C23-7 10.1530/ERC-12-0003\n",
      "-- Comment on Endocr Relat Cancer. 2012 Feb;19(1):69-81.\n",
      "Endocr Relat Cancer\n",
      "Endocr Relat Cancer\n",
      "===>> Endocr Relat Cancer\n",
      "===>> 2012 2012\n",
      "===>> 19(2) 19(1)\n",
      "---> Article 6965 is a comment and is to be removed\n",
      "\n",
      " 6983 Focus:  Breast Cancer Res Treat 2019  Nov 178(1) 245-246 10.1007/s10549-019-05373-y\n",
      "-- Comment on Breast Cancer Res Treat. 2019 Jun;175(3):749-754.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2019 2019\n",
      "===>> 178(1) 175(3)\n",
      "---> Article 6983 is a comment and is to be removed\n",
      "\n",
      " 6984 Focus:  J Clin Oncol 2015  Aug 10 33(23) 2583-4 10.1200/JCO.2015.61.8298\n",
      "-- Comment on J Clin Oncol. 2015 Jan 20;33(3):244-50. J Clin Oncol. 2015 Aug 10;33(23):2581-2. J Clin Oncol. 2015 Aug 10;33(23):2582.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(23) 33(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 6999 Focus:  Cancer 2017  Sep 15 123(18) 3441-3444 10.1002/cncr.30806\n",
      "-- Comment on Cancer. 2017 Sep 15;123(18):3532-3539.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2017 2017\n",
      "===>> 123(18) 123(18)\n",
      "--->  Sep 15  Sep 15\n",
      "--->  Sep 15\n",
      "---> 3441 3532\n",
      "---> Article 6999 is a commentary and is to be removed\n",
      "\n",
      " 7015 Focus:  BJOG 2020  Feb 127(3) 376 10.1111/1471-0528.15984\n",
      "-- Comment on BJOG. 2020 Feb;127(3):364-375.\n",
      "BJOG\n",
      "BJOG\n",
      "===>> BJOG\n",
      "===>> 2020 2020\n",
      "===>> 127(3) 127(3)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 376 364\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7020 Focus:  Cell Cycle 2015  14(13) 2080-90 10.1080/15384101.2015.1042632\n",
      "-- Comment in Cell Cycle. 2015;14(14):2195-6.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2015 2015\n",
      "===>> 14(13) 14(14)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7041 Focus:  Proc Natl Acad Sci U S A 2011  Jun 14 108(24) 9851-6 10.1073/pnas.1101053108\n",
      "-- Comment in Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9731-2.\n",
      "Proc Natl Acad Sci U S A\n",
      "Proc Natl Acad Sci U S A\n",
      "===>> Proc Natl Acad Sci U S A\n",
      "===>> 2011 2011\n",
      "===>> 108(24) 108(24)\n",
      "--->  Jun 14  Jun 14\n",
      "--->  Jun 14\n",
      "---> 9851 9731\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7042 Focus:  J Clin Oncol 2008  Feb 1 26(4) 542-8 10.1200/JCO.2007.12.5922\n",
      "-- Comment in J Clin Oncol. 2008 Feb 1;26(4):519-20. J Clin Oncol. 2008 May 10;26(14):2419; author reply 2419-20.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2008 2008\n",
      "===>> 26(4) 26(4)\n",
      "--->  Feb 1  Feb 1\n",
      "--->  Feb 1\n",
      "---> 542 519\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7048 Focus:  Proc Natl Acad Sci U S A 2011  Jun 14 108(24) 9731-2 10.1073/pnas.1106456108\n",
      "-- Comment on Proc Natl Acad Sci U S A. 2011 Jun 14;108(24):9851-6.\n",
      "Proc Natl Acad Sci U S A\n",
      "Proc Natl Acad Sci U S A\n",
      "===>> Proc Natl Acad Sci U S A\n",
      "===>> 2011 2011\n",
      "===>> 108(24) 108(24)\n",
      "--->  Jun 14  Jun 14\n",
      "--->  Jun 14\n",
      "---> 9731 9851\n",
      "---> Article 7048 is a commentary and is to be removed\n",
      "\n",
      " 7074 Focus:  J Clin Oncol 2010  Oct 10 28(29) e563-4 None\n",
      "-- Comment on J Clin Oncol. 2010 May 20;28(15):2512-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2010 2010\n",
      "===>> 28(29) 28(15)\n",
      "---> Article 7074 is a comment and is to be removed\n",
      "\n",
      " 7089 Focus:  Nat Genet 2007  Feb 39(2) 165-7 10.1038/ng1959\n",
      "-- Comment in Nat Genet. 2007 Feb;39(2):142-3.\n",
      "Nat Genet\n",
      "Nat Genet\n",
      "===>> Nat Genet\n",
      "===>> 2007 2007\n",
      "===>> 39(2) 39(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 165 142\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7092 Focus:  J Natl Cancer Inst 2015  Apr 2 107(5) djv066 10.1093/jnci/djv066\n",
      "-- Comment on J Natl Cancer Inst. 2015 May;107(5). pii: djv037. doi: 10.1093/jnci/djv037.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2015 2015\n",
      "===>> 107(5) 107(5). pii\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7100 Focus:  EMBO Mol Med 2017  Oct 9(10) 1398-1414 10.15252/emmm.201607446\n",
      "-- Comment in EMBO Mol Med. 2017 Oct;9(10):1331-1333.\n",
      "EMBO Mol Med\n",
      "EMBO Mol Med\n",
      "===>> EMBO Mol Med\n",
      "===>> 2017 2017\n",
      "===>> 9(10) 9(10)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1398 1331\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7101 Focus:  BJOG 2018  Oct 125(11) 1451-1458 10.1111/1471-0528.15171\n",
      "-- Comment in BJOG. 2018 Oct;125(11):1459. BJOG. 2018 Oct;125(11):1460.\n",
      "BJOG\n",
      "BJOG\n",
      "===>> BJOG\n",
      "===>> 2018 2018\n",
      "===>> 125(11) 125(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1451 1459\n",
      "---> Article 7101 is a commentary and is to be removed\n",
      "\n",
      " 7132 Focus:  Mol Cell 2016  Dec 15 64(6) 1117-1126 10.1016/j.molcel.2016.10.037\n",
      "-- Comment in Mol Cell. 2016 Dec 15;64(6):1017-1019.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2016 2016\n",
      "===>> 64(6) 64(6)\n",
      "--->  Dec 15  Dec 15\n",
      "--->  Dec 15\n",
      "---> 1117 1017\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7141 Focus:  Nat Rev Clin Oncol 2019  Dec 16(12) 725-726 10.1038/s41571-019-0285-2\n",
      "-- Comment on Nature. 2019 Jul;571(7766):576-579.\n",
      "Nat Rev Clin Oncol\n",
      "Nature\n",
      "---> Article 7141 is a commentary and is to be removed\n",
      "\n",
      " 7156 Focus:  J Natl Cancer Inst 2015  Apr 2 107(5) djv037 10.1093/jnci/djv037\n",
      "-- Comment in J Natl Cancer Inst. 2015 May;107(5). pii: djv066. doi: 10.1093/jnci/djv066.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2015 2015\n",
      "===>> 107(5) 107(5). pii\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7157 Focus:  Surgery 2011  Jun 149(6) 731-4 10.1016/j.surg.2010.11.009\n",
      "-- Comment in Surgery. 2012 Apr;151(4):637-8. Surgery. 2012 Apr;151(4):634-7.\n",
      "Surgery\n",
      "Surgery\n",
      "===>> Surgery\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7158 Focus:  Nat Genet 2007  Feb 39(2) 142-3 10.1038/ng0207-142\n",
      "-- Comment on Nat Genet. 2007 Feb;39(2):165-7. Nat Genet. 2007 Feb;39(2):162-4. Nat Genet. 2007 Feb;39(2):159-61.\n",
      "Nat Genet\n",
      "Nat Genet\n",
      "===>> Nat Genet\n",
      "===>> 2007 2007\n",
      "===>> 39(2) 39(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 142 165\n",
      "---> Article 7158 is a commentary and is to be removed\n",
      "\n",
      " 7196 Focus:  Mol Cell 2012  Aug 24 47(4) 511-22 10.1016/j.molcel.2012.05.047\n",
      "-- Comment in Mol Cell. 2012 Aug 24;47(4):493-4.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2012 2012\n",
      "===>> 47(4) 47(4)\n",
      "--->  Aug 24  Aug 24\n",
      "--->  Aug 24\n",
      "---> 511 493\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7205 Focus:  Genet Med 2020  Apr 22(4) 681-685 10.1038/s41436-019-0712-x\n",
      "-- Comment in Genet Med. 2020 Apr;22(4):698-700.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2020 2020\n",
      "===>> 22(4) 22(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 681 698\n",
      "---> Article 7205 is a commentary and is to be removed\n",
      "\n",
      " 7215 Focus:  J Clin Oncol 2015  Jun 10 33(17) 1867-9 10.1200/JCO.2014.60.5501\n",
      "-- Comment on J Clin Oncol. 2015 Jun 10;33(17):1895-901. J Clin Oncol. 2015 Jun 10;33(17):1902-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(17) 33(17)\n",
      "--->  Jun 10  Jun 10\n",
      "--->  Jun 10\n",
      "---> 1867 1895\n",
      "---> Article 7215 is a commentary and is to be removed\n",
      "\n",
      " 7231 Focus:  Breast Cancer Res Treat 2019  Oct 177(3) 723-733 10.1007/s10549-019-05345-2\n",
      "-- Comment in Fam Cancer. 2019 Oct;18(4):377-379. Breast Cancer Res Treat. 2020 Jan;179(1):251-252.\n",
      "Breast Cancer Res Treat\n",
      "Fam Cancer\n",
      "FUCK!!!\n",
      "\n",
      " 7232 Focus:  JAMA Oncol 2015  Jun 1(3) 306-13 10.1001/jamaoncol.2015.0658\n",
      "-- Comment in JAMA Oncol. 2015 Jun;1(3):313.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(3) 1(3)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 306 313\n",
      "---> Article 7232 is a commentary and is to be removed\n",
      "\n",
      " 7255 Focus:  BMJ 2014  Feb 11 348 g226 10.1136/bmj.g226\n",
      "-- Comment in BMJ. 2014;348:g1379. BMJ. 2014;348:g1863.\n",
      "BMJ\n",
      "BMJ\n",
      "===>> BMJ\n",
      "===>> 2014 2014\n",
      "===>> 348 348\n",
      "--->  Feb 11 \n",
      "---> Article 7255 is a comment and is to be removed\n",
      "\n",
      " 7261 Focus:  Eur Urol 2019  Oct 76(4) 459-460 10.1016/j.eururo.2019.03.029\n",
      "-- Comment on Eur Urol. 2019 Oct;76(4):452-458.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2019 2019\n",
      "===>> 76(4) 76(4)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 459 452\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7287 Focus:  Nat Aging 2021  Sep 1(9) 757-759 10.1038/s43587-021-00113-8\n",
      "-- Comment on Nat Aging. 2021 Sep;1(9):838-849.\n",
      "Nat Aging\n",
      "Nat Aging\n",
      "===>> Nat Aging\n",
      "===>> 2021 2021\n",
      "===>> 1(9) 1(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 757 838\n",
      "---> Article 7287 is a commentary and is to be removed\n",
      "\n",
      " 7290 Focus:  Climacteric 2016  Oct 19(5) 417-8 10.1080/13697137.2016.1202914\n",
      "-- Comment on Acta Obstet Gynecol Scand. 2015 Jan;94(1):86-94.\n",
      "Climacteric\n",
      "Acta Obstet Gynecol Scand\n",
      "---> Article 7290 is a commentary and is to be removed\n",
      "\n",
      " 7292 Focus:  Eur Urol 2015  Mar 67(3) 504-7 10.1016/j.eururo.2014.08.060\n",
      "-- Comment on Eur Urol. 2015 Mar;67(3):496-503.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2015 2015\n",
      "===>> 67(3) 67(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 504 496\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7298 Focus:  J Natl Cancer Inst 2010  Apr 7 102(7) 444-5 10.1093/jnci/djq058\n",
      "-- Comment on J Natl Cancer Inst. 2010 Apr 7;102(7):475-83.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2010 2010\n",
      "===>> 102(7) 102(7)\n",
      "--->  Apr 7  Apr 7\n",
      "--->  Apr 7\n",
      "---> 444 475\n",
      "---> Article 7298 is a commentary and is to be removed\n",
      "\n",
      " 7304 Focus:  JAMA Netw Open 2021  Apr 1 4(4) e216259 10.1001/jamanetworkopen.2021.6259\n",
      "-- Comment in JAMA Netw Open. 2021 Apr 1;4(4):e216391.\n",
      "JAMA Netw Open\n",
      "JAMA Netw Open\n",
      "===>> JAMA Netw Open\n",
      "===>> 2021 2021\n",
      "===>> 4(4) 4(4)\n",
      "--->  Apr 1  Apr 1\n",
      "--->  Apr 1\n",
      "---> e216259 e216391\n",
      "---> Article 7304 is a commentary and is to be removed\n",
      "\n",
      " 7325 Focus:  Int J Cancer 2019  Apr 1 144(7) 1758-1760 10.1002/ijc.32013\n",
      "-- Comment on Int J Cancer. 2019 Apr 1;144(7):1761-1763.\n",
      "Int J Cancer\n",
      "Int J Cancer\n",
      "===>> Int J Cancer\n",
      "===>> 2019 2019\n",
      "===>> 144(7) 144(7)\n",
      "--->  Apr 1  Apr 1\n",
      "--->  Apr 1\n",
      "---> 1758 1761\n",
      "---> Article 7325 is a commentary and is to be removed\n",
      "\n",
      " 7349 Focus:  Ann Oncol 2021  Dec 32(12) 1582-1589 10.1016/j.annonc.2021.08.2154\n",
      "-- Comment in Ann Oncol. 2021 Dec;32(12):1460-1462.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2021 2021\n",
      "===>> 32(12) 32(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 1582 1460\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7355 Focus:  BJOG 2018  Oct 125(11) 1459 10.1111/1471-0528.15174\n",
      "-- Comment on BJOG. 2018 Oct;125(11):1451-1458.\n",
      "BJOG\n",
      "BJOG\n",
      "===>> BJOG\n",
      "===>> 2018 2018\n",
      "===>> 125(11) 125(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 1459 1451\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7373 Focus:  J Cell Biol 2017  Nov 6 216(11) 3521-3534 10.1083/jcb.201703144\n",
      "-- Comment in Cell Cycle. 2018;17(4):401-402.\n",
      "J Cell Biol\n",
      "Cell Cycle\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 7381 Focus:  Cancer Res 2006  Aug 15 66(16) 8109-15 10.1158/0008-5472.CAN-06-0140\n",
      "-- Comment in Cancer Res. 2023 Apr 14;83(8):1173-1174.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2006 2023\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7382 Focus:  Laeknabladid 2018  Jun 104(6) 289-296 10.17992/lbl.2018.06.189\n",
      "-- Comment in Laeknabladid. 2018 Jun;104(6):281.\n",
      "Laeknabladid\n",
      "Laeknabladid\n",
      "===>> Laeknabladid\n",
      "===>> 2018 2018\n",
      "===>> 104(6) 104(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 289 281\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7398 Focus:  Science 2006  Oct 13 314(5797) 261-2 10.1126/science.1133758\n",
      "-- Comment on Science. 2006 Oct 13;314(5797):294-7.\n",
      "Science\n",
      "Science\n",
      "===>> Science\n",
      "===>> 2006 2006\n",
      "===>> 314(5797) 314(5797)\n",
      "--->  Oct 13  Oct 13\n",
      "--->  Oct 13\n",
      "---> 261 294\n",
      "---> Article 7398 is a commentary and is to be removed\n",
      "\n",
      " 7401 Focus:  Eur J Radiol 2013  Sep 82(9) 1416-22 10.1016/j.ejrad.2013.03.003\n",
      "-- Comment in Eur J Radiol. 2013 Dec;82(12):e906-7. Eur J Radiol. 2013 Dec;82(12):e908.\n",
      "Eur J Radiol\n",
      "Eur J Radiol\n",
      "===>> Eur J Radiol\n",
      "===>> 2013 2013\n",
      "===>> 82(9) 82(12)\n",
      "---> Article 7401 is a comment and is to be removed\n",
      "\n",
      " 7402 Focus:  Cancer Res 2020  Jul 15 80(14) 2977-2978 10.1158/0008-5472.CAN-20-1451\n",
      "-- Comment in Cancer Res. 2020 Jul 15;80(14):3033-3045. Comment on Cancer Res. 2020 Mar 19;:\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 80(14) 80(14)\n",
      "--->  Jul 15  Jul 15\n",
      "--->  Jul 15\n",
      "---> 2977 3033\n",
      "---> Article 7402 is a commentary and is to be removed\n",
      "\n",
      " 7417 Focus:  Ann Oncol 2020  Aug 31(8) 1089-1090 10.1016/j.annonc.2020.04.472\n",
      "-- Comment in Ann Oncol. 2020 Aug;31(8):1090-1091. Comment on Ann Oncol. 2020 Mar 10;:null.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2020 2020\n",
      "===>> 31(8) 31(8)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 1089 1090\n",
      "---> Article 7417 is a commentary and is to be removed\n",
      "\n",
      " 7420 Focus:  Clin Cancer Res 2015  Aug 15 21(16) 3807 10.1158/1078-0432.CCR-15-0931\n",
      "-- Comment on Clin Cancer Res. 2015 Jan 1;21(1):211-20. Clin Cancer Res. 2015 Aug 15;21(16):3806.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2015 2015\n",
      "===>> 21(16) 21(1)\n",
      "---> Article 7420 is a comment and is to be removed\n",
      "\n",
      " 7430 Focus:  Fertil Steril 2016  Mar 105(3) 781-785 10.1016/j.fertnstert.2015.11.034\n",
      "-- Comment in Fertil Steril. 2016 Mar;105(3):605-6.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2016 2016\n",
      "===>> 105(3) 105(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 781 605\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7437 Focus:  Cancer Epidemiol Biomarkers Prev 2012  Jul 21(7) 1089-96 10.1158/1055-9965.EPI-12-0201\n",
      "-- Comment in Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1389.\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "Cancer Epidemiol Biomarkers Prev\n",
      "===>> Cancer Epidemiol Biomarkers Prev\n",
      "===>> 2012 2012\n",
      "===>> 21(7) 21(8)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7442 Focus:  Nature 2015  Dec 17 528(7582) 422-6 10.1038/nature16142\n",
      "-- Comment in Nat Rev Mol Cell Biol. 2016 Feb;17(2):65. Nat Rev Genet. 2016 Feb;17(2):65. Cell Res. 2016 Apr;26(4):397-8.\n",
      "Nature\n",
      "Nat Rev Mol Cell Biol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 7473 Focus:  J Clin Oncol 2015  Oct 1 33(28) 3124-9 10.1200/JCO.2014.59.7401\n",
      "-- Comment in J Clin Oncol. 2015 Oct 1;33(28):3080-1.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(28) 33(28)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 3124 3080\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7482 Focus:  Lancet 2020  Jun 27 395(10242) 2008-2020 10.1016/S0140-6736(20)30974-0\n",
      "-- Comment in Hepatobiliary Surg Nutr. 2021 Jun;10(3):376-378.\n",
      "Lancet\n",
      "Hepatobiliary Surg Nutr\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 7508 Focus:  Nat Rev Dis Primers 2019  Sep 23 5(1) 66 10.1038/s41572-019-0111-2\n",
      "-- Comment in Nat Rev Dis Primers. 2020 Apr 23;6(1):30.\n",
      "Nat Rev Dis Primers\n",
      "Nat Rev Dis Primers\n",
      "===>> Nat Rev Dis Primers\n",
      "===>> 2019 2020\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7523 Focus:  Breast Cancer Res Treat 2015  May 151(1) 219-24 10.1007/s10549-015-3358-7\n",
      "-- Comment in Breast Cancer Res Treat. 2015 Jun;151(2):475-6.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2015 2015\n",
      "===>> 151(1) 151(2)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7536 Focus:  J Natl Cancer Inst 2015  Aug 11 107(9) djv217 10.1093/jnci/djv217\n",
      "-- Comment in J Natl Cancer Inst. 2015 Sep;107(9). pii: djv218. doi: 10.1093/jnci/djv218. Comment on J Natl Cancer Inst. 2015 May;107(5). pii: djv033. doi: 10.1093/jnci/djv033.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2015 2015\n",
      "===>> 107(9) 107(9). pii\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7539 Focus:  Br J Cancer 2020  Feb 122(3) 293-294 10.1038/s41416-019-0645-9\n",
      "-- Comment on Br J Cancer. 2020 Feb;122(3):333-339.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2020 2020\n",
      "===>> 122(3) 122(3)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 293 333\n",
      "---> Article 7539 is a commentary and is to be removed\n",
      "\n",
      " 7559 Focus:  Oncologist 2015  Jun 20(6) 584-5 10.1634/theoncologist.2015-0174\n",
      "-- Comment on Oncologist. 2015 Jun;20(6):593-7. Oncologist. 2015 Jun;20(6):586-92.\n",
      "Oncologist\n",
      "Oncologist\n",
      "===>> Oncologist\n",
      "===>> 2015 2015\n",
      "===>> 20(6) 20(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 584 593\n",
      "---> Article 7559 is a commentary and is to be removed\n",
      "\n",
      " 7567 Focus:  Mol Cell 2019  Jan 17 73(2) 224-237 10.1016/j.molcel.2018.11.003\n",
      "-- Comment in Mol Cell. 2019 Jan 17;73(2):195-196.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2019 2019\n",
      "===>> 73(2) 73(2)\n",
      "--->  Jan 17  Jan 17\n",
      "--->  Jan 17\n",
      "---> 224 195\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7569 Focus:  Mol Cell 2020  Oct 15 80(2) 327-344 10.1016/j.molcel.2020.08.018\n",
      "-- Comment in Mol Cell. 2020 Oct 15;80(2):177-180.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2020 2020\n",
      "===>> 80(2) 80(2)\n",
      "--->  Oct 15  Oct 15\n",
      "--->  Oct 15\n",
      "---> 327 177\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7571 Focus:  Strahlenther Onkol 2012  Nov 188(11) 1057-8 10.1007/s00066-012-0219-8\n",
      "-- Comment on JAMA. 2012 Jan 25;307(4):382-90.\n",
      "Strahlenther Onkol\n",
      "JAMA\n",
      "---> Article 7571 is a commentary and is to be removed\n",
      "\n",
      " 7582 Focus:  J Clin Oncol 2013  May 10 31(14) 1748-57 10.1200/JCO.2012.43.1882\n",
      "-- Comment in J Urol. 2013 Dec;190(6):2093.\n",
      "J Clin Oncol\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 7618 Focus:  Oncotarget 2017  Jun 27 8(26) 41782-41783 10.18632/oncotarget.18448\n",
      "-- Comment in BRCA2, EGFR, and NTRK mutations in mismatch repair-deficient colorectal cancers with MSH2 or MLH1 mutations.\n",
      "\n",
      " 7635 Focus:  Breast Cancer Res 2014  May 15 16(3) R47 10.1186/bcr3655\n",
      "-- Comment in Breast Cancer Res. 2014;16(4):409.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2014 2014\n",
      "===>> 16(3) 16(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7660 Focus:  J Allergy Clin Immunol Pract 2017  May-Jun 5(3) 816-818 10.1016/j.jaip.2016.08.012\n",
      "-- Comment on J Allergy Clin Immunol Pract.\n",
      "\n",
      " 7661 Focus:  Breast Cancer Res 2014  Jul 14 16(4) 409 10.1186/s13058-014-0409-7\n",
      "-- Comment on Breast Cancer Res. 2014;16(3):R47.\n",
      "Breast Cancer Res\n",
      "Breast Cancer Res\n",
      "===>> Breast Cancer Res\n",
      "===>> 2014 2014\n",
      "===>> 16(4) 16(3)\n",
      "---> Article 7661 is a comment and is to be removed\n",
      "\n",
      " 7682 Focus:  Am J Obstet Gynecol 2016  Jun 214(6) 761-3 10.1016/j.ajog.2016.02.011\n",
      "-- Comment in Am J Obstet Gynecol. 2016 Jul;215(1):134-5. Am J Obstet Gynecol. 2016 Jul;215(1):133-4.\n",
      "Am J Obstet Gynecol\n",
      "Am J Obstet Gynecol\n",
      "===>> Am J Obstet Gynecol\n",
      "===>> 2016 2016\n",
      "===>> 214(6) 215(1)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7702 Focus:  J Clin Invest 2013  Jan 123(1) 517-25 10.1172/JCI65833\n",
      "-- Comment in Nat Rev Clin Oncol. 2013 Feb;10(2):68.\n",
      "J Clin Invest\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 7722 Focus:  J Clin Oncol 2014  May 20 32(15) 1547-53 10.1200/JCO.2013.53.2820\n",
      "-- Comment in J Clin Oncol. 2014 May 20;32(15):1531-3.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(15) 32(15)\n",
      "--->  May 20  May 20\n",
      "--->  May 20\n",
      "---> 1547 1531\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7744 Focus:  Breast Cancer Res 2016  Nov 9 18(1) 111 10.1186/s13058-016-0762-9\n",
      "-- Comment on Oncogene. 2014 Oct 2;33(40):4803-12.\n",
      "Breast Cancer Res\n",
      "Oncogene\n",
      "---> Article 7744 is a commentary and is to be removed\n",
      "\n",
      " 7798 Focus:  Nat Commun 2020  Sep 25 11(1) 4858 10.1038/s41467-020-18640-0\n",
      "-- Comment in J Urol. 2021 Aug;206(2):474-476. Nat Commun. 2021 Aug 10;12(1):4834. Nat Commun. 2021 Aug 10;12(1):4833.\n",
      "Nat Commun\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 7801 Focus:  Lancet Oncol 2011  Sep 12(9) 852-61 10.1016/S1470-2045(11)70214-5\n",
      "-- Comment in Lancet Oncol. 2011 Sep;12(9):827-8.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2011 2011\n",
      "===>> 12(9) 12(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 852 827\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7804 Focus:  Lancet Oncol 2021  Sep 22(9) 1250-1264 10.1016/S1470-2045(21)00376-4\n",
      "-- Comment in Lancet Oncol. 2021 Sep;22(9):1203-1204.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2021 2021\n",
      "===>> 22(9) 22(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 1250 1203\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7807 Focus:  FEBS J 2021  May 288(9) 2884-2887 10.1111/febs.15730\n",
      "-- Comment on FEBS J. 2020 Nov 18;:null.\n",
      "FEBS J\n",
      "FEBS J\n",
      "===>> FEBS J\n",
      "===>> 2021 2020\n",
      "---> Article 7807 is a comment and is to be removed\n",
      "\n",
      " 7829 Focus:  Cancer Prev Res (Phila) 2009  Feb 2(2) 122-7 10.1158/1940-6207.CAPR-08-0050\n",
      "-- Comment in Cancer Prev Res (Phila). 2009 Feb;2(2):100-3.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2009 2009\n",
      "===>> 2(2) 2(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 122 100\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7843 Focus:  Ann Surg Oncol 2017  Oct 24(11) 3116-3123 10.1245/s10434-017-5995-z\n",
      "-- Comment in Ann Surg Oncol. 2017 Oct;24(11):3107-3109.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2017 2017\n",
      "===>> 24(11) 24(11)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 3116 3107\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7854 Focus:  Biometrics 2006  Mar 62(1) 36-48 10.1111/j.1541-0420.2005.00442.x\n",
      "-- Comment in Biometrics. 2007 Sep;63(3):964-5; author reply 965-6.\n",
      "Biometrics\n",
      "Biometrics\n",
      "===>> Biometrics\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7856 Focus:  J Clin Oncol 2020  Oct 20 38(30) 3528-3537 10.1200/JCO.20.00799\n",
      "-- Comment in J Clin Oncol. 2021 Jan 20;39(3):256. J Clin Oncol. 2021 Jan 20;39(3):255.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2021\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7866 Focus:  J Clin Oncol 2020  Nov 10 38(32) 3763-3772 10.1200/JCO.20.01035\n",
      "-- Comment in J Clin Oncol. 2020 Nov 10;38(32):3735-3739.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2020\n",
      "===>> 38(32) 38(32)\n",
      "--->  Nov 10  Nov 10\n",
      "--->  Nov 10\n",
      "---> 3763 3735\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7874 Focus:  Recenti Prog Med 2017  Mar 108(3) 136-140 10.1701/2656.27236\n",
      "-- In the last decade the use of assisted reproduction techniques (ART) significantly increased and, due to the improved quality of the procedures and management of patients, it has led to progressively better outcomes. In parallel, the latest literature data show an increased incidence of ovarian cancer, that to date does not have a protocol with high sensitivity and specificity for early diagnosis. Considering the accumulating evidence about the etiology of ovarian cancer, it has been postulated a correlation between the increasing use of necessary and propaedeutic pharmacological treatments for ART and the increased incidence of this tumor. Despite the current data in the literature do not allow to draw definitive conclusions, the aim of this work is to propose a brief comment on the possible correlation between fertility treatments and the occurrence of ovarian cancer, particularly in women with BRCA mutations.\n",
      "\n",
      " 7880 Focus:  Mol Cell 2012  Feb 10 45(3) 371-83 10.1016/j.molcel.2011.12.028\n",
      "-- Comment in Mol Cell. 2012 Feb 10;45(3):273-5.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2012 2012\n",
      "===>> 45(3) 45(3)\n",
      "--->  Feb 10  Feb 10\n",
      "--->  Feb 10\n",
      "---> 371 273\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7890 Focus:  Nat Rev Clin Oncol 2011  Oct 25 8(12) 692 10.1038/nrclinonc.2011.161\n",
      "-- Comment on JAMA. 2011 Oct 12;306(14):1557-65.\n",
      "Nat Rev Clin Oncol\n",
      "JAMA\n",
      "---> Article 7890 is a commentary and is to be removed\n",
      "\n",
      " 7909 Focus:  J Natl Cancer Inst 2014  Jan 106(1) djt323 10.1093/jnci/djt323\n",
      "-- Comment in J Natl Cancer Inst. 2014 Jan;106(1):djt350. J Natl Cancer Inst. 2014 Apr;106(4):dju045. J Natl Cancer Inst. 2014 Apr;106(4):dju046.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2014 2014\n",
      "===>> 106(1) 106(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> djt323 djt350\n",
      "---> Article 7909 is a commentary and is to be removed\n",
      "\n",
      " 7910 Focus:  Eur J Hum Genet 2014  Feb 22(2) 280-2 10.1038/ejhg.2013.193\n",
      "-- Comment in Eur J Hum Genet. 2014 Feb;22(2):155-6.\n",
      "Eur J Hum Genet\n",
      "Eur J Hum Genet\n",
      "===>> Eur J Hum Genet\n",
      "===>> 2014 2014\n",
      "===>> 22(2) 22(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 280 155\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7930 Focus:  Nat Rev Mol Cell Biol 2011  Jun 2 12(7) 400 10.1038/nrm3135\n",
      "-- Comment on Cell. 2011 May 13;145(4):529-42.\n",
      "Nat Rev Mol Cell Biol\n",
      "Cell\n",
      "---> Article 7930 is a commentary and is to be removed\n",
      "\n",
      " 7938 Focus:  Fertil Steril 2021  Aug 116(2) 538-545 10.1016/j.fertnstert.2021.02.030\n",
      "-- Comment in Fertil Steril. 2021 Aug;116(2):359-360.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2021 2021\n",
      "===>> 116(2) 116(2)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 538 359\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7943 Focus:  Cancer Discov 2012  Nov 2(11) 1036-47 10.1158/2159-8290.CD-11-0348\n",
      "-- Comment in Nat Rev Cancer. 2012 Oct;12(10):658. Cancer Discov. 2012 Nov;2(11):982-4.\n",
      "Cancer Discov\n",
      "Nat Rev Cancer\n",
      "---> Article 7943 is a commentary and is to be removed\n",
      "\n",
      " 7975 Focus:  J Natl Cancer Inst 2021  Sep 4 113(9) 1203-1211 10.1093/jnci/djab036\n",
      "-- Comment in J Natl Cancer Inst. 2021 Sep 4;113(9):1127-1128. J Natl Cancer Inst. 2022 Feb 7;114(2):320-321.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2021 2021\n",
      "===>> 113(9) 113(9)\n",
      "--->  Sep 4  Sep 4\n",
      "--->  Sep 4\n",
      "---> 1203 1127\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 7983 Focus:  Int J Gynecol Cancer 2021  Mar 31(3) 332-338 10.1136/ijgc-2020-002071\n",
      "-- Comment in Int J Gynecol Cancer. 2021 Jul;31(7):1097. Int J Gynecol Cancer. 2021 Jul;31(7):1096.\n",
      "Int J Gynecol Cancer\n",
      "Int J Gynecol Cancer\n",
      "===>> Int J Gynecol Cancer\n",
      "===>> 2021 2021\n",
      "===>> 31(3) 31(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 7989 Focus:  Nat Rev Clin Oncol 2010  Oct 7(10) 549 10.1038/nrclinonc.2010.143\n",
      "-- Comment on Lancet. 2010 Jul 24;376(9737):235-44. Lancet. 2010 Jul 24;376(9737):245-51.\n",
      "Nat Rev Clin Oncol\n",
      "Lancet\n",
      "---> Article 7989 is a commentary and is to be removed\n",
      "\n",
      " 7996 Focus:  Oncologist 2015  Jun 20(6) 593-7 10.1634/theoncologist.2014-0425\n",
      "-- Comment in Oncologist. 2015 Jun;20(6):584-5.\n",
      "Oncologist\n",
      "Oncologist\n",
      "===>> Oncologist\n",
      "===>> 2015 2015\n",
      "===>> 20(6) 20(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 593 584\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8002 Focus:  N Engl J Med 2019  Mar 14 380(11) 1086 10.1056/NEJMc1813800\n",
      "-- Comment in N Engl J Med. 2019 Mar 14;380(11):1087. Comment on N Engl J Med. 2018 Sep 13;379(11):1042-1049.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2019 2019\n",
      "===>> 380(11) 380(11)\n",
      "--->  Mar 14  Mar 14\n",
      "--->  Mar 14\n",
      "---> 1086 1087\n",
      "---> Article 8002 is a commentary and is to be removed\n",
      "\n",
      " 8022 Focus:  Br J Cancer 2020  Feb 122(3) 333-339 10.1038/s41416-019-0582-7\n",
      "-- Comment in Br J Cancer. 2020 Feb;122(3):293-294.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2020 2020\n",
      "===>> 122(3) 122(3)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 333 293\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8028 Focus:  Cancer Discov 2018  Apr 8(4) 444-457 10.1158/2159-8290.CD-17-0937\n",
      "-- Comment in Cancer Discov. 2018 Apr;8(4):392-394.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2018 2018\n",
      "===>> 8(4) 8(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 444 392\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8040 Focus:  Lancet Oncol 2013  Nov 14(12) 1226-32 10.1016/S1470-2045(13)70448-0\n",
      "-- Comment in Lancet Oncol. 2013 Nov;14(12):1151-2.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2013 2013\n",
      "===>> 14(12) 14(12)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 1226 1151\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8063 Focus:  J Clin Oncol 2007  Sep 1 25(25) 3985-90 10.1200/JCO.2007.12.2622\n",
      "-- Comment in Nat Clin Pract Oncol. 2008 Mar;5(3):134-5.\n",
      "J Clin Oncol\n",
      "Nat Clin Pract Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8106 Focus:  N Engl J Med 2019  Mar 14 380(11) 1086-1087 10.1056/NEJMc1813800\n",
      "-- Comment in N Engl J Med. 2019 Mar 14;380(11):1087. Comment on N Engl J Med. 2018 Sep 13;379(11):1042-1049.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2019 2019\n",
      "===>> 380(11) 380(11)\n",
      "--->  Mar 14  Mar 14\n",
      "--->  Mar 14\n",
      "---> 1086 1087\n",
      "---> Article 8106 is a commentary and is to be removed\n",
      "\n",
      " 8117 Focus:  N Engl J Med 2019  Mar 14 380(11) 1087 10.1056/NEJMc1813800\n",
      "-- Comment on N Engl J Med. 2019 Mar 14;380(11):1086. N Engl J Med. 2019 Mar 14;380(11):1086-1087.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2019 2019\n",
      "===>> 380(11) 380(11)\n",
      "--->  Mar 14  Mar 14\n",
      "--->  Mar 14\n",
      "---> 1087 1086\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8118 Focus:  Eur Urol 2007  Nov 52(5) 1529 10.1016/j.eururo.2007.08.011\n",
      "-- Comment on J Natl Cancer Inst. 2007 Jun 20;99(12):929-35.\n",
      "Eur Urol\n",
      "J Natl Cancer Inst\n",
      "---> Article 8118 is a commentary and is to be removed\n",
      "\n",
      " 8127 Focus:  Menopause 2020  Jul 27(7) 746-755 10.1097/GME.0000000000001535\n",
      "-- Comment in Menopause. 2020 Jul;27(7):727-729.\n",
      "Menopause\n",
      "Menopause\n",
      "===>> Menopause\n",
      "===>> 2020 2020\n",
      "===>> 27(7) 27(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 746 727\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8132 Focus:  Cancer 2015  Jul 15 121(14) 2474-5 10.1002/cncr.29357\n",
      "-- Comment in Cancer. 2015 Sep 1;121(17):3047. Cancer. 2015 Sep 1;121(17):3046.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2015 2015\n",
      "===>> 121(14) 121(17)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8142 Focus:  Oral Oncol 2020  Jan 100 104469 10.1016/j.oraloncology.2019.104469\n",
      "-- Comment in Oral Oncol. 2020 May;104:104624.\n",
      "Oral Oncol\n",
      "Oral Oncol\n",
      "===>> Oral Oncol\n",
      "===>> 2020 2020\n",
      "===>> 100 104\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8143 Focus:  Plast Reconstr Surg 2019  Jul 144(1) 12-20 10.1097/PRS.0000000000005693\n",
      "-- Comment in Plast Reconstr Surg. 2019 Jul;144(1):21-22.\n",
      "Plast Reconstr Surg\n",
      "Plast Reconstr Surg\n",
      "===>> Plast Reconstr Surg\n",
      "===>> 2019 2019\n",
      "===>> 144(1) 144(1)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 12 21\n",
      "---> Article 8143 is a commentary and is to be removed\n",
      "\n",
      " 8147 Focus:  Breast Cancer Res Treat 2019  Jun 175(3) 749-754 10.1007/s10549-019-05199-8\n",
      "-- Comment in Breast Cancer Res Treat. 2019 Nov;178(1):245-246.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2019 2019\n",
      "===>> 175(3) 178(1)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8171 Focus:  Nat Commun 2016  May 24 7 11620 10.1038/ncomms11620\n",
      "-- Comment in Biol Reprod. 2016 Aug;95(2):35.\n",
      "Nat Commun\n",
      "Biol Reprod\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8180 Focus:  World J Gastroenterol 2021  Oct 21 27(39) 6515-6521 10.3748/wjg.v27.i39.6515\n",
      "-- In this editorial, we comment on pancreatic cancer (PC), one of the most aggressive and lethal cancers. Only minimal improvements in survival rates have been achieved over recent years. Available chemotherapeutic regimens have little impact, and surgical resection remains the only reliable curative approach. We address current treatment options for these patients, focusing on the usefulness of breast cancer (BRCA) gene mutation as a prognostic biomarker and predictor of response to chemotherapy. Superior survival outcomes have been reported in patients with PC and mutant BRCA gene treated with first-line platinum-based chemotherapy. Therefore, it appears appropriate to include BRCA gene status among clinical criteria used to select the chemotherapy regimen. In addition, maintenance treatment with poly(ADP-ribose) polymerase inhibitors has been found to improve progression-free survival in patients with PC and mutated BRCA whose disease does not progress after first-line platinum-based chemotherapy. This combination has therefore been proposed as the optimal treatment regimen for these patients.\n",
      "\n",
      " 8198 Focus:  J Clin Oncol 2010  Sep 20 28(27) 4214-20 10.1200/JCO.2010.28.0719\n",
      "-- Comment in Nat Rev Clin Oncol. 2010 Nov;7(11):611.\n",
      "J Clin Oncol\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8205 Focus:  Arch Gynecol Obstet 2018  Jan 297(1) 147-152 10.1007/s00404-017-4551-1\n",
      "-- Comment in Arch Gynecol Obstet. 2018 Apr;297(4):1067-1068. Arch Gynecol Obstet. 2018 Apr;297(4):1069.\n",
      "Arch Gynecol Obstet\n",
      "Arch Gynecol Obstet\n",
      "===>> Arch Gynecol Obstet\n",
      "===>> 2018 2018\n",
      "===>> 297(1) 297(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8231 Focus:  Cancer 2015  Sep 1 121(17) 3046 10.1002/cncr.29447\n",
      "-- Comment in Cancer. 2015 Sep 1;121(17):3047. Comment on Cancer. 2015 Jul 15;121(14):2474-5.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2015 2015\n",
      "===>> 121(17) 121(17)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 3046 3047\n",
      "---> Article 8231 is a commentary and is to be removed\n",
      "\n",
      " 8235 Focus:  Gastrointest Endosc 2018  Jun 87(6) 1443-1450 10.1016/j.gie.2017.12.019\n",
      "-- Comment in Gastrointest Endosc. 2018 Jun;87(6):1451-1453.\n",
      "Gastrointest Endosc\n",
      "Gastrointest Endosc\n",
      "===>> Gastrointest Endosc\n",
      "===>> 2018 2018\n",
      "===>> 87(6) 87(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1443 1451\n",
      "---> Article 8235 is a commentary and is to be removed\n",
      "\n",
      " 8236 Focus:  J Natl Cancer Inst 2015  Nov 19 108(2) djv315 10.1093/jnci/djv315\n",
      "-- Comment in J Natl Cancer Inst. 2016 Aug 31;108(12): J Natl Cancer Inst. 2016 Aug 31;108(12):\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2015 2016\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8249 Focus:  J Breast Health 2014  Oct 1 10(4) 189 10.5152/tjbh.2014.0079\n",
      "-- Comment in J Breast Health. 371:497.\n",
      "\n",
      " 8253 Focus:  Genet Med 2009  Nov 11(11) 783-9 10.1097/GIM.0b013e3181b9b04a\n",
      "-- Comment in Genet Med. 2010 Apr;12(4):240.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2009 2010\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8262 Focus:  Genet Med 2009  Sep 11(9) 629-39 10.1097/GIM.0b013e3181afd322\n",
      "-- Comment in Genet Med. 2009 Sep;11(9):620-1.\n",
      "Genet Med\n",
      "Genet Med\n",
      "===>> Genet Med\n",
      "===>> 2009 2009\n",
      "===>> 11(9) 11(9)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 629 620\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8276 Focus:  Nat Genet 2007  Feb 39(2) 162-4 10.1038/ng1947\n",
      "-- Comment in Nat Genet. 2007 Feb;39(2):142-3.\n",
      "Nat Genet\n",
      "Nat Genet\n",
      "===>> Nat Genet\n",
      "===>> 2007 2007\n",
      "===>> 39(2) 39(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 162 142\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8280 Focus:  JAMA Oncol 2016  Jun 1 2(6) 730-6 10.1001/jamaoncol.2015.5941\n",
      "-- Comment in CA Cancer J Clin. 2016 Jul;66(4):269-70.\n",
      "JAMA Oncol\n",
      "CA Cancer J Clin\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8288 Focus:  Fertil Steril 2019  Feb 111(2) 363-371 10.1016/j.fertnstert.2018.10.014\n",
      "-- Comment in Fertil Steril. 2019 Feb;111(2):260-261.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2019 2019\n",
      "===>> 111(2) 111(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 363 260\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8291 Focus:  Evid Based Nurs 2011  Oct 14(4) 126-7 10.1136/ebn1168\n",
      "-- Comment on J Nurs Scholarsh. 2010 Dec;42(4):367-78.\n",
      "Evid Based Nurs\n",
      "J Nurs Scholarsh\n",
      "---> Article 8291 is a commentary and is to be removed\n",
      "\n",
      " 8294 Focus:  Eur J Cancer 2020  Mar 127 240-250 10.1016/j.ejca.2019.12.003\n",
      "-- Comment in Eur J Cancer. 2020 Mar;127:236-239.\n",
      "Eur J Cancer\n",
      "Eur J Cancer\n",
      "===>> Eur J Cancer\n",
      "===>> 2020 2020\n",
      "===>> 127 127\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 240 236\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8328 Focus:  Health Expect 2008  Sep 11(3) 220-31 10.1111/j.1369-7625.2008.00494.x\n",
      "-- Comment in Health Expect. 2008 Sep;11(3):205-7.\n",
      "Health Expect\n",
      "Health Expect\n",
      "===>> Health Expect\n",
      "===>> 2008 2008\n",
      "===>> 11(3) 11(3)\n",
      "--->  Sep  Sep\n",
      "--->  Sep\n",
      "---> 220 205\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8362 Focus:  Ann Transl Med 2020  Sep 8(17) 1043 10.21037/atm-2020-113\n",
      "-- Comment on Ann Transl Med. 2019 Dec;7(23):777.\n",
      "Ann Transl Med\n",
      "Ann Transl Med\n",
      "===>> Ann Transl Med\n",
      "===>> 2020 2019\n",
      "---> Article 8362 is a comment and is to be removed\n",
      "\n",
      " 8366 Focus:  Mol Cell 2019  Mar 21 73(6) 1267-1281 10.1016/j.molcel.2018.12.010\n",
      "-- Comment in Mol Cell. 2019 Mar 21;73(6):1089-1091.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2019 2019\n",
      "===>> 73(6) 73(6)\n",
      "--->  Mar 21  Mar 21\n",
      "--->  Mar 21\n",
      "---> 1267 1089\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8390 Focus:  Cancer Res 2021  Dec 15 81(24) 6171-6182 10.1158/0008-5472.CAN-21-1415\n",
      "-- Comment in Cancer Res. 2021 Dec 15;81(24):6080-6082.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 81(24) 81(24)\n",
      "--->  Dec 15  Dec 15\n",
      "--->  Dec 15\n",
      "---> 6171 6080\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8397 Focus:  Oncologist 2017  Dec 22(12) 1540 10.1634/theoncologist.2017-0320\n",
      "-- Comment on Oncologist. 2017 Jul;22(7):797-803. Oncologist. 2017 Dec;22(12):1562.\n",
      "Oncologist\n",
      "Oncologist\n",
      "===>> Oncologist\n",
      "===>> 2017 2017\n",
      "===>> 22(12) 22(7)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8403 Focus:  J Natl Cancer Inst 2014  May 19 106(6) dju089 10.1093/jnci/dju089\n",
      "-- Comment in doi: 10.1093/jnci/dju119.\n",
      "\n",
      " 8405 Focus:  Cancer 2019  Aug 15 125(16) 2728-2729 10.1002/cncr.32334\n",
      "-- Comment on Cancer. 2019 Aug 15;125(16):2829-2836.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2019 2019\n",
      "===>> 125(16) 125(16)\n",
      "--->  Aug 15  Aug 15\n",
      "--->  Aug 15\n",
      "---> 2728 2829\n",
      "---> Article 8405 is a commentary and is to be removed\n",
      "\n",
      " 8407 Focus:  Breast Cancer Res Treat 2014  Jun 145(3) 663-72 10.1007/s10549-014-2931-9\n",
      "-- Comment in Breast Cancer Res Treat. 2014 Oct;147(3):685-7. Breast Cancer Res Treat. 2014 Oct;147(3):689. Breast Cancer Res Treat. 2014 Dec;148(3):687-8. Breast Cancer Res Treat. 2014 Dec;148(3):693.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2014 2014\n",
      "===>> 145(3) 147(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8457 Focus:  N Engl J Med 2021  Feb 4 384(5) 428-439 10.1056/NEJMoa1913948\n",
      "-- Comment in N Engl J Med. 2021 Feb 4;384(5):471-473. Nat Rev Clin Oncol. 2021 May;18(5):259-260.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2021 2021\n",
      "===>> 384(5) 384(5)\n",
      "--->  Feb 4  Feb 4\n",
      "--->  Feb 4\n",
      "---> 428 471\n",
      "---> Article 8457 is a commentary and is to be removed\n",
      "\n",
      " 8490 Focus:  Obstet Gynecol Sci 2015  Jul 58(4) 331-2 10.5468/ogs.2015.58.4.331\n",
      "-- Comment on Obstet Gynecol Sci. 58:175.\n",
      "\n",
      " 8492 Focus:  Cancer 2015  Sep 1 121(17) 3047 10.1002/cncr.29446\n",
      "-- Comment on Cancer. 2015 Sep 1;121(17):3046. Cancer. 2015 Jul 15;121(14):2474-5.\n",
      "Cancer\n",
      "Cancer\n",
      "===>> Cancer\n",
      "===>> 2015 2015\n",
      "===>> 121(17) 121(17)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 3047 3046\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8512 Focus:  J Clin Oncol 2018  Aug 1 36(22) 2281-2287 10.1200/JCO.2017.77.2285\n",
      "-- Comment in Transl Cancer Res. 2019 Mar;8(Suppl 2):S99-S102.\n",
      "J Clin Oncol\n",
      "Transl Cancer Res\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8518 Focus:  Ann Oncol 2019  Mar 1 30(3) 412-417 10.1093/annonc/mdy515\n",
      "-- Comment in Ann Oncol. 2019 Mar 1;30(3):348-350. Ann Transl Med. 2019 Apr;7(8):165.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2019 2019\n",
      "===>> 30(3) 30(3)\n",
      "--->  Mar 1  Mar 1\n",
      "--->  Mar 1\n",
      "---> 412 348\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8527 Focus:  Lancet Oncol 2013  Aug 14(9) 882-92 10.1016/S1470-2045(13)70240-7\n",
      "-- Comment in Lancet Oncol. 2013 Aug;14(9):798-9.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2013 2013\n",
      "===>> 14(9) 14(9)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 882 798\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8528 Focus:  Eur Urol 2015  Aug 68(2) 186-93 10.1016/j.eururo.2014.10.022\n",
      "-- Comment in Eur Urol. 2015 Aug;68(2):194-5.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2015 2015\n",
      "===>> 68(2) 68(2)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 186 194\n",
      "---> Article 8528 is a commentary and is to be removed\n",
      "\n",
      " 8547 Focus:  J Gynecol Oncol 2019  Jul 30(4) e60 10.3802/jgo.2019.30.e60\n",
      "-- Comment in J Gynecol Oncol. 2019 Jul;30(4):e80.\n",
      "J Gynecol Oncol\n",
      "J Gynecol Oncol\n",
      "===>> J Gynecol Oncol\n",
      "===>> 2019 2019\n",
      "===>> 30(4) 30(4)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> e60 e80\n",
      "---> Article 8547 is a commentary and is to be removed\n",
      "\n",
      " 8550 Focus:  J Natl Cancer Inst 2019  Aug 1 111(8) 795-802 10.1093/jnci/djz008\n",
      "-- Comment in J Natl Cancer Inst. 2019 Aug 1;111(8):751-753.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2019 2019\n",
      "===>> 111(8) 111(8)\n",
      "--->  Aug 1  Aug 1\n",
      "--->  Aug 1\n",
      "---> 795 751\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8578 Focus:  J Cell Biol 2017  Feb 216(2) 409-424 10.1083/jcb.201607008\n",
      "-- Comment in J Cell Biol. 2017 Feb;216(2):295-297.\n",
      "J Cell Biol\n",
      "J Cell Biol\n",
      "===>> J Cell Biol\n",
      "===>> 2017 2017\n",
      "===>> 216(2) 216(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 409 295\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8606 Focus:  Cell Cycle 2013  Dec 1 12(23) 3585 10.4161/cc.26820\n",
      "-- Comment on Cell Cycle. 2013 Nov 1;12(21):3442-7.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2013 2013\n",
      "===>> 12(23) 12(21)\n",
      "---> Article 8606 is a comment and is to be removed\n",
      "\n",
      " 8608 Focus:  J Clin Oncol 2011  Dec 1 29(34) 4586-8 None\n",
      "-- Comment on J Clin Oncol. 2011 Jun 1;29(16):2150-7.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2011 2011\n",
      "===>> 29(34) 29(16)\n",
      "---> Article 8608 is a comment and is to be removed\n",
      "\n",
      " 8616 Focus:  Breast Cancer Res Treat 2014  Feb 143(3) 517-29 10.1007/s10549-013-2821-6\n",
      "-- Comment in Breast Cancer Res Treat. 2014 Dec;148(3):685. Breast Cancer Res Treat. 2014 Dec;148(3):691-2.\n",
      "Breast Cancer Res Treat\n",
      "Breast Cancer Res Treat\n",
      "===>> Breast Cancer Res Treat\n",
      "===>> 2014 2014\n",
      "===>> 143(3) 148(3)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8621 Focus:  Fertil Steril 2020  Jun 113(6) 1251-1260 10.1016/j.fertnstert.2020.01.033\n",
      "-- Comment in Fertil Steril. 2020 Jun;113(6):1161-1162.\n",
      "Fertil Steril\n",
      "Fertil Steril\n",
      "===>> Fertil Steril\n",
      "===>> 2020 2020\n",
      "===>> 113(6) 113(6)\n",
      "--->  Jun  Jun\n",
      "--->  Jun\n",
      "---> 1251 1161\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8632 Focus:  Lancet Oncol 2020  Sep 21(9) 1155-1164 10.1016/S1470-2045(20)30324-7\n",
      "-- Comment in Breast Cancer Res Treat. 2021 Feb;186(1):265-266.\n",
      "Lancet Oncol\n",
      "Breast Cancer Res Treat\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8665 Focus:  J Clin Oncol 2015  Jun 10 33(17) 1895-901 10.1200/JCO.2014.57.0085\n",
      "-- Comment in J Clin Oncol. 2015 Jun 10;33(17):1867-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(17) 33(17)\n",
      "--->  Jun 10  Jun 10\n",
      "--->  Jun 10\n",
      "---> 1895 1867\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8666 Focus:  Lancet Oncol 2018  Aug 19(8) 1126-1134 10.1016/S1470-2045(18)30343-7\n",
      "-- Comment in Lancet Oncol. 2018 Oct;19(10):e504.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2018 2018\n",
      "===>> 19(8) 19(10)\n",
      "---> Article 8666 is a comment and is to be removed\n",
      "\n",
      " 8667 Focus:  J Natl Cancer Inst 2014  Nov 30 107(1) 379 10.1093/jnci/dju379\n",
      "-- Comment in doi: 10.1093/jnci/dju380.\n",
      "\n",
      " 8668 Focus:  J Clin Oncol 2015  Jan 20 33(3) 244-50 10.1200/JCO.2014.56.2728\n",
      "-- Comment in J Clin Oncol. 2015 Jan 20;33(3):229-31. J Clin Oncol. 2015 Aug 10;33(23):2581-2. J Clin Oncol. 2015 Aug 10;33(23):2582. J Clin Oncol. 2015 Aug 10;33(23):2583-4. Bull Cancer. 2019 Sep;106(9):717-718.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(3) 33(3)\n",
      "--->  Jan 20  Jan 20\n",
      "--->  Jan 20\n",
      "---> 244 229\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8681 Focus:  Clin Cancer Res 2021  Jun 1 27(11) 3094-3105 10.1158/1078-0432.CCR-20-4805\n",
      "-- Comment in Nat Rev Urol. 2021 May;18(5):255-256. Clin Cancer Res. 2021 Jun 1;27(11):2961-2963.\n",
      "Clin Cancer Res\n",
      "Nat Rev Urol\n",
      "---> Article 8681 is a commentary and is to be removed\n",
      "\n",
      " 8713 Focus:  Clin Cancer Res 2018  Sep 1 24(17) 4066-4071 10.1158/1078-0432.CCR-18-0042\n",
      "-- Comment in Clin Cancer Res. 2018 Sep 1;24(17):4062-4065.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2018 2018\n",
      "===>> 24(17) 24(17)\n",
      "--->  Sep 1  Sep 1\n",
      "--->  Sep 1\n",
      "---> 4066 4062\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8718 Focus:  Int J Gynecol Pathol 2018  Mar 37(2) 101-109 10.1097/PGP.0000000000000394\n",
      "-- Comment in Int J Gynecol Pathol. 2020 Jan;39(1):e1.\n",
      "Int J Gynecol Pathol\n",
      "Int J Gynecol Pathol\n",
      "===>> Int J Gynecol Pathol\n",
      "===>> 2018 2020\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8722 Focus:  Nat Commun 2021  Jun 17 12(1) 3636 10.1038/s41467-021-23463-8\n",
      "-- Comment in Nat Rev Cancer. 2021 Sep;21(9):540. Nat Cancer. 2021 Jun;2(6):581-583.\n",
      "Nat Commun\n",
      "Nat Rev Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8735 Focus:  N Engl J Med 2021  Feb 4 384(5) 440-451 10.1056/NEJMoa2005936\n",
      "-- Comment in N Engl J Med. 2021 Feb 4;384(5):471-473. Nat Rev Clin Oncol. 2021 May;18(5):259-260.\n",
      "N Engl J Med\n",
      "N Engl J Med\n",
      "===>> N Engl J Med\n",
      "===>> 2021 2021\n",
      "===>> 384(5) 384(5)\n",
      "--->  Feb 4  Feb 4\n",
      "--->  Feb 4\n",
      "---> 440 471\n",
      "---> Article 8735 is a commentary and is to be removed\n",
      "\n",
      " 8746 Focus:  Ann Surg Oncol 2007  Dec 14(12) 3335-44 10.1245/s10434-007-9449-x\n",
      "-- Comment in Ann Surg Oncol. 2007 Dec;14(12):3283-4. Ann Surg Oncol. 2008 Jun;15(6):1788-90; author reply 1791-2.\n",
      "Ann Surg Oncol\n",
      "Ann Surg Oncol\n",
      "===>> Ann Surg Oncol\n",
      "===>> 2007 2007\n",
      "===>> 14(12) 14(12)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> 3335 3283\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8760 Focus:  JAMA Oncol 2020  Sep 1 6(9) 1381-1389 10.1001/jamaoncol.2020.2922\n",
      "-- Comment in AJR Am J Roentgenol. 2021 Jul;217(1):258.\n",
      "JAMA Oncol\n",
      "AJR Am J Roentgenol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8762 Focus:  JCO Precis Oncol 2018  Feb 14 2 PO 10.1200/PO.17.00169\n",
      "-- Comment on JCO Precis Oncol. 2018;2:\n",
      "JCO Precis Oncol\n",
      "JCO Precis Oncol\n",
      "===>> JCO Precis Oncol\n",
      "===>> 2018 2018\n",
      "===>> 2 2\n",
      "--->  Feb 14 \n",
      "---> Article 8762 is a comment and is to be removed\n",
      "\n",
      " 8763 Focus:  J Clin Oncol 2020  Sep 10 38(26) 3012-3023 10.1200/JCO.19.02399\n",
      "-- Comment in J Clin Oncol. 2020 Dec 20;38(36):4352. J Clin Oncol. 2020 Dec 20;38(36):4352-4354.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2020\n",
      "===>> 38(26) 38(36)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8779 Focus:  Cell 2018  Jul 26 174(3) 758-769 10.1016/j.cell.2018.06.039\n",
      "-- Comment in Nature. 2018 Aug;560(7720):557-559.\n",
      "Cell\n",
      "Nature\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8799 Focus:  Br J Cancer 2016  Mar 29 114(7) 723-30 10.1038/bjc.2016.41\n",
      "-- Comment in Br J Cancer. 2016 Mar 29;114(7):713-5.\n",
      "Br J Cancer\n",
      "Br J Cancer\n",
      "===>> Br J Cancer\n",
      "===>> 2016 2016\n",
      "===>> 114(7) 114(7)\n",
      "--->  Mar 29  Mar 29\n",
      "--->  Mar 29\n",
      "---> 723 713\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8813 Focus:  ESMO Open 2020  Jun 5(3) e000682 10.1136/esmoopen-2020-000682\n",
      "-- Comment in ESMO Open. 2020 Sep;5(5):e001042.\n",
      "ESMO Open\n",
      "ESMO Open\n",
      "===>> ESMO Open\n",
      "===>> 2020 2020\n",
      "===>> 5(3) 5(5)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8842 Focus:  Mol Cell 2021  Mar 4 81(5) 1058-1073 10.1016/j.molcel.2020.12.020\n",
      "-- Comment in Mol Cell. 2021 Mar 4;81(5):898-900.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2021 2021\n",
      "===>> 81(5) 81(5)\n",
      "--->  Mar 4  Mar 4\n",
      "--->  Mar 4\n",
      "---> 1058 898\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8844 Focus:  Clin Cancer Res 2021  Oct 15 27(20) 5482-5491 10.1158/1078-0432.CCR-21-0310\n",
      "-- Comment on Clin Cancer Res. 2021 Oct 15;27(20):5441.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 27(20) 27(20)\n",
      "--->  Oct 15  Oct 15\n",
      "--->  Oct 15\n",
      "---> 5482 5441\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8850 Focus:  Lancet Oncol 2018  Feb 19(2) 207-215 10.1016/S1470-2045(18)30009-3\n",
      "-- Comment in Lancet Oncol. 2018 Feb;19(2):154-156.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2018 2018\n",
      "===>> 19(2) 19(2)\n",
      "--->  Feb  Feb\n",
      "--->  Feb\n",
      "---> 207 154\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8860 Focus:  J Natl Cancer Inst 2020  Feb 1 112(2) 161-169 10.1093/jnci/djz080\n",
      "-- Comment in J Natl Cancer Inst. 2020 Apr 1;112(4):423-424. J Natl Cancer Inst. 2020 Apr 1;112(4):425.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2020 2020\n",
      "===>> 112(2) 112(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8884 Focus:  Ann Oncol 2019  Apr 1 30(4) 551-557 10.1093/annonc/mdz018\n",
      "-- Comment in Ann Oncol. 2019 Apr 1;30(4):497-498.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2019 2019\n",
      "===>> 30(4) 30(4)\n",
      "--->  Apr 1  Apr 1\n",
      "--->  Apr 1\n",
      "---> 551 497\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8885 Focus:  Ann Oncol 2018  Dec 1 29(12) 2341-2347 10.1093/annonc/mdy460\n",
      "-- Comment in Ann Oncol. 2018 Dec 1;29(12):2278-2280.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2018 2018\n",
      "===>> 29(12) 29(12)\n",
      "--->  Dec 1  Dec 1\n",
      "--->  Dec 1\n",
      "---> 2341 2278\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8886 Focus:  J Natl Cancer Inst 2015  Mar 18 107(5) djv033 10.1093/jnci/djv033\n",
      "-- Comment in J Natl Cancer Inst. 2015 Sep;107(9). pii: djv217. doi: 10.1093/jnci/djv217. J Natl Cancer Inst. 2015 Sep;107(9). pii: djv218. doi: 10.1093/jnci/djv218.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2015 2015\n",
      "===>> 107(5) 107(9). pii\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8891 Focus:  JAMA Oncol 2019  Dec 1 5(12) 1718-1730 10.1001/jamaoncol.2019.3323\n",
      "-- Comment in JAMA Oncol. 2020 May 1;6(5):785. JAMA Oncol. 2020 May 1;6(5):785-786.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2019 2020\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8895 Focus:  Lancet Oncol 2016  Nov 17(11) 1579-1589 10.1016/S1470-2045(16)30376-X\n",
      "-- Comment in Lancet Oncol. 2016 Nov;17 (11):1474-1475.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2016 2016\n",
      "===>> 17(11) 17 (11)\n",
      "---> Article 8895 is a comment and is to be removed\n",
      "\n",
      " 8935 Focus:  Cancer Cell 2012  Jul 10 22(1) 5-6 10.1016/j.ccr.2012.06.006\n",
      "-- Comment on Cancer Cell. 2012 Jul 10;22(1):106-16.\n",
      "Cancer Cell\n",
      "Cancer Cell\n",
      "===>> Cancer Cell\n",
      "===>> 2012 2012\n",
      "===>> 22(1) 22(1)\n",
      "--->  Jul 10  Jul 10\n",
      "--->  Jul 10\n",
      "---> 5 106\n",
      "---> Article 8935 is a commentary and is to be removed\n",
      "\n",
      " 8947 Focus:  Clin Cancer Res 2017  Jan 15 23(2) 514-522 10.1158/1078-0432.CCR-15-1348\n",
      "-- Comment in Chin J Cancer. 2017 Mar 30;36(1):37.\n",
      "Clin Cancer Res\n",
      "Chin J Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 8949 Focus:  Clin Cancer Res 2019  Mar 15 25(6) 1786-1794 10.1158/1078-0432.CCR-18-0200\n",
      "-- Comment in Clin Cancer Res. 2019 Mar 15;25(6):1693-1695.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2019 2019\n",
      "===>> 25(6) 25(6)\n",
      "--->  Mar 15  Mar 15\n",
      "--->  Mar 15\n",
      "---> 1786 1693\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 8950 Focus:  J Natl Cancer Inst 2014  Nov 30 107(1) 380 10.1093/jnci/dju380\n",
      "-- Comment in doi: 10.1093/jnci/dju379. doi: 10.1093/jnci/dju420.\n",
      "\n",
      " 8968 Focus:  Ann Oncol 2017  Mar 1 28(3) 512-518 10.1093/annonc/mdw672\n",
      "-- Comment in Ann Oncol. 2017 Jun 1;28(6):1167-1168.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2017 2017\n",
      "===>> 28(3) 28(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 8992 Focus:  Cancer Discov 2018  Apr 8(4) 392-394 10.1158/2159-8290.CD-18-0124\n",
      "-- Comment on Cancer Discov. 2018 Apr;8(4):444-457.\n",
      "Cancer Discov\n",
      "Cancer Discov\n",
      "===>> Cancer Discov\n",
      "===>> 2018 2018\n",
      "===>> 8(4) 8(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 392 444\n",
      "---> Article 8992 is a commentary and is to be removed\n",
      "\n",
      " 9003 Focus:  Cancer Prev Res (Phila) 2021  Jan 14(1) 131-144 10.1158/1940-6207.CAPR-20-0369\n",
      "-- Comment in Cancer Prev Res (Phila). 2021 Jan;14(1):1-4.\n",
      "Cancer Prev Res (Phila)\n",
      "Cancer Prev Res (Phila)\n",
      "===>> Cancer Prev Res (Phila)\n",
      "===>> 2021 2021\n",
      "===>> 14(1) 14(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 131 1\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9013 Focus:  J Urol 2021  Apr 205(4) 977-986 10.1097/JU.0000000000001570\n",
      "-- Comment in J Urol. 2021 Apr;205(4):986.\n",
      "J Urol\n",
      "J Urol\n",
      "===>> J Urol\n",
      "===>> 2021 2021\n",
      "===>> 205(4) 205(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 977 986\n",
      "---> Article 9013 is a commentary and is to be removed\n",
      "\n",
      " 9032 Focus:  Sci Transl Med 2019  May 15 11(492) eaav4508 10.1126/scitranslmed.aav4508\n",
      "-- Comment in Cancer Discov. 2019 Aug;9(8):990-991.\n",
      "Sci Transl Med\n",
      "Cancer Discov\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9038 Focus:  Cell Res 2016  Jul 26(7) 751-2 10.1038/cr.2016.79\n",
      "-- Comment on Cell Res. 2016 Jul;26(7):761-74.\n",
      "Cell Res\n",
      "Cell Res\n",
      "===>> Cell Res\n",
      "===>> 2016 2016\n",
      "===>> 26(7) 26(7)\n",
      "--->  Jul  Jul\n",
      "--->  Jul\n",
      "---> 751 761\n",
      "---> Article 9038 is a commentary and is to be removed\n",
      "\n",
      " 9048 Focus:  Lancet Oncol 2017  Jan 18(1) 75-87 10.1016/S1470-2045(16)30559-9\n",
      "-- Comment in Lancet Oncol. 2017 Jan;18(1):8-9. Nat Rev Clin Oncol. 2017 Feb;14 (2):71.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2017 2017\n",
      "===>> 18(1) 18(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 75 8\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9049 Focus:  Lancet Oncol 2015  Jan 16(1) 87-97 10.1016/S1470-2045(14)71135-0\n",
      "-- Comment in Lancet Oncol. 2015 Jan;16(1):10-2.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2015 2015\n",
      "===>> 16(1) 16(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 87 10\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9051 Focus:  Cancer Res 2020  Jun 1 80(11) 2085-2086 10.1158/0008-5472.CAN-20-0966\n",
      "-- Comment in Cancer Res. 2020 Jun 1;80(11):2094-2100. Comment on Cancer Res. 2020 Mar 3;:\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 80(11) 80(11)\n",
      "--->  Jun 1  Jun 1\n",
      "--->  Jun 1\n",
      "---> 2085 2094\n",
      "---> Article 9051 is a commentary and is to be removed\n",
      "\n",
      " 9064 Focus:  Lancet Oncol 2019  May 20(5) 636-648 10.1016/S1470-2045(19)30029-4\n",
      "-- Comment in Lancet Oncol. 2019 May;20(5):603-605.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2019 2019\n",
      "===>> 20(5) 20(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 636 603\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9065 Focus:  J Clin Oncol 2015  Jun 10 33(17) 1902-9 10.1200/JCO.2014.57.6660\n",
      "-- Comment in J Clin Oncol. 2015 Jun 10;33(17):1867-9.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2015 2015\n",
      "===>> 33(17) 33(17)\n",
      "--->  Jun 10  Jun 10\n",
      "--->  Jun 10\n",
      "---> 1902 1867\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9069 Focus:  Ann Oncol 2017  Jul 1 28(7) 1597-1604 10.1093/annonc/mdx162\n",
      "-- Comment in Ann Oncol. 2017 Jul 1;28(7):1417-1418.\n",
      "Ann Oncol\n",
      "Ann Oncol\n",
      "===>> Ann Oncol\n",
      "===>> 2017 2017\n",
      "===>> 28(7) 28(7)\n",
      "--->  Jul 1  Jul 1\n",
      "--->  Jul 1\n",
      "---> 1597 1417\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9084 Focus:  Ann Intern Med 2019  May 7 170(9) 643-650 10.7326/M18-2356\n",
      "-- Comment in Ann Intern Med. 2019 May 7;170(9):660-661.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2019 2019\n",
      "===>> 170(9) 170(9)\n",
      "--->  May 7  May 7\n",
      "--->  May 7\n",
      "---> 643 660\n",
      "---> Article 9084 is a commentary and is to be removed\n",
      "\n",
      " 9145 Focus:  Cancer Res 2020  Feb 1 80(3) 624-638 10.1158/0008-5472.CAN-19-1840\n",
      "-- Comment in J Urol. 2020 Sep;204(3):619-620.\n",
      "Cancer Res\n",
      "J Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9146 Focus:  Eur Urol 2019  Oct 76(4) 469-478 10.1016/j.eururo.2019.06.030\n",
      "-- Comment in Eur Urol. 2019 Oct;76(4):479-481. Eur Urol. 2020 Apr;77(4):559-560. Transl Androl Urol. 2020 Jun;9(3):977-980.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2019 2019\n",
      "===>> 76(4) 76(4)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 469 479\n",
      "---> Article 9146 is a commentary and is to be removed\n",
      "\n",
      " 9156 Focus:  Br J Surg 2006  Aug 93(8) 961-8 10.1002/bjs.5344\n",
      "-- Comment in Br J Surg. 2007 Jan;94(1):121; author reply 121-2.\n",
      "Br J Surg\n",
      "Br J Surg\n",
      "===>> Br J Surg\n",
      "===>> 2006 2007\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9175 Focus:  Cancer Res 2020  Jan 1 80(1) 23-24 10.1158/0008-5472.CAN-19-3350\n",
      "-- Comment in Cancer Res. 2020 Jan 1;80(1):116-125. Comment on Cancer Res. 2019 Oct 2;:\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 80(1) 80(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 23 116\n",
      "---> Article 9175 is a commentary and is to be removed\n",
      "\n",
      " 9208 Focus:  Lancet Oncol 2019  Aug 20(8) 1171-1182 10.1016/S1470-2045(19)30340-7\n",
      "-- Comment in Lancet Oncol. 2019 Aug;20(8):1049-1051.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2019 2019\n",
      "===>> 20(8) 20(8)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 1171 1049\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9219 Focus:  EMBO Mol Med 2017  Oct 9(10) 1331-1333 10.15252/emmm.201708194\n",
      "-- Comment on Cell. 2017 Jun 1;169(6):1105-1118.e15. EMBO Mol Med. 2017 Oct;9(10 ):1398-1414.\n",
      "EMBO Mol Med\n",
      "Cell\n",
      "---> Article 9219 is a commentary and is to be removed\n",
      "\n",
      " 9260 Focus:  JAMA Oncol 2018  Aug 1 4(8) 1059-1065 10.1001/jamaoncol.2018.0211\n",
      "-- Comment in JAMA Oncol. 2018 Dec 1;4(12):1786.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2018 2018\n",
      "===>> 4(8) 4(12)\n",
      "---> Article 9260 is a comment and is to be removed\n",
      "\n",
      " 9261 Focus:  Cancer Discov 2017  Sep 7(9) 1006-1017 10.1158/2159-8290.CD-17-0261\n",
      "-- Comment in Nat Rev Urol. 2017 Jul;14(7):390. Cancer Discov. 2017 Sep;7(9):937-939.\n",
      "Cancer Discov\n",
      "Nat Rev Urol\n",
      "---> Article 9261 is a commentary and is to be removed\n",
      "\n",
      " 9266 Focus:  PLoS Genet 2013  9(3) e1003212 10.1371/journal.pgen.1003212\n",
      "-- Comment in Identification of a BRCA2-specific Modifier Locus at 6p24 Related to Breast Cancer Risk. Evidence of Gene-Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors.\n",
      "\n",
      " 9269 Focus:  J Pak Med Assoc 2016  Jan 66(1) 107-10 None\n",
      "-- Comment in J Pak Med Assoc. 2016 Apr;66(4):490.\n",
      "J Pak Med Assoc\n",
      "J Pak Med Assoc\n",
      "===>> J Pak Med Assoc\n",
      "===>> 2016 2016\n",
      "===>> 66(1) 66(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9296 Focus:  Ned Tijdschr Geneeskd 2008  Nov 8 152(45) 2437-41 None\n",
      "-- Comment on Ned Tijdschr Geneeskd. 2008 Nov 8;152(45):2452-5.\n",
      "Ned Tijdschr Geneeskd\n",
      "Ned Tijdschr Geneeskd\n",
      "===>> Ned Tijdschr Geneeskd\n",
      "===>> 2008 2008\n",
      "===>> 152(45) 152(45)\n",
      "--->  Nov 8  Nov 8\n",
      "--->  Nov 8\n",
      "---> 2437 2452\n",
      "---> Article 9296 is a commentary and is to be removed\n",
      "\n",
      " 9298 Focus:  Nat Med 2018  May 24(5) 628-637 10.1038/s41591-018-0009-7\n",
      "-- Comment in Nat Med. 2018 May;24(5):535-537. Stem Cell Investig. 2019 Feb 22;6:4.\n",
      "Nat Med\n",
      "Nat Med\n",
      "===>> Nat Med\n",
      "===>> 2018 2018\n",
      "===>> 24(5) 24(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 628 535\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9309 Focus:  Eur Urol 2017  Oct 72(4) 492-495 10.1016/j.eururo.2017.03.013\n",
      "-- Comment in Eur Urol. 2017 Oct;72(4):496-498. J Urol. 2017 Dec;198(6):1208-1211.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2017 2017\n",
      "===>> 72(4) 72(4)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 492 496\n",
      "---> Article 9309 is a commentary and is to be removed\n",
      "\n",
      " 9312 Focus:  Lancet Oncol 2021  Nov 22(11) 1618-1631 10.1016/S1470-2045(21)00522-2\n",
      "-- Comment in Lancet Oncol. 2021 Nov;22(11):1491-1492. Eur Urol. 2022 Feb;81(2):216-218. J Urol. 2022 Jun;207(6):1348-1351.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2021 2021\n",
      "===>> 22(11) 22(11)\n",
      "--->  Nov  Nov\n",
      "--->  Nov\n",
      "---> 1618 1491\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9316 Focus:  Cancer Res 2021  Dec 15 81(24) 6080-6082 10.1158/0008-5472.CAN-21-3480\n",
      "-- Comment on Cancer Res. 2021 Dec 15;81(24):6171-6182.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 81(24) 81(24)\n",
      "--->  Dec 15  Dec 15\n",
      "--->  Dec 15\n",
      "---> 6080 6171\n",
      "---> Article 9316 is a commentary and is to be removed\n",
      "\n",
      " 9329 Focus:  Cell 2015  May 21 161(5) 1215-1228 10.1016/j.cell.2015.05.001\n",
      "-- Comment in Cancer Biol Ther. 2016;17(3):231-2. Urol Oncol. 2017 Aug;35(8):535.\n",
      "Cell\n",
      "Cancer Biol Ther\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9348 Focus:  J Clin Oncol 2016  Jun 10 34(17) 2010-9 10.1200/JCO.2015.64.0730\n",
      "-- Comment in J Clin Oncol. 2016 Jun 10;34(17):1973-4.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2016 2016\n",
      "===>> 34(17) 34(17)\n",
      "--->  Jun 10  Jun 10\n",
      "--->  Jun 10\n",
      "---> 2010 1973\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9435 Focus:  Mol Cell 2009  Nov 25 36(4) 620-30 10.1016/j.molcel.2009.09.033\n",
      "-- Comment in Mol Cell. 2009 Nov 25;36(4):539-40.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2009 2009\n",
      "===>> 36(4) 36(4)\n",
      "--->  Nov 25  Nov 25\n",
      "--->  Nov 25\n",
      "---> 620 539\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9442 Focus:  Cancers (Basel) 2020  Jul 17 12(7) 1929 10.3390/cancers12071929\n",
      "-- Comment in Cancer. 2020 Dec 1;126(23):5007.\n",
      "Cancers (Basel)\n",
      "Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9483 Focus:  Clin Cancer Res 2013  Jun 1 19(11) 2873-82 10.1158/1078-0432.CCR-12-3947\n",
      "-- Comment in Clin Cancer Res. 2013 Sep 15;19(18):5255. Clin Cancer Res. 2013 Sep 15;19(18):5254.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2013 2013\n",
      "===>> 19(11) 19(18)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9508 Focus:  Patient Educ Couns 2017  May 100(5) 805-811 10.1016/j.pec.2016.10.026\n",
      "-- Comment in Patient Educ Couns. 2017 May;100(5):793-794.\n",
      "Patient Educ Couns\n",
      "Patient Educ Couns\n",
      "===>> Patient Educ Couns\n",
      "===>> 2017 2017\n",
      "===>> 100(5) 100(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 805 793\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9590 Focus:  Mol Cell 2007  Feb 9 25(3) 331-43 10.1016/j.molcel.2007.01.003\n",
      "-- Comment in Mol Cell. 2007 Feb 23;25(4):487-90.\n",
      "Mol Cell\n",
      "Mol Cell\n",
      "===>> Mol Cell\n",
      "===>> 2007 2007\n",
      "===>> 25(3) 25(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9615 Focus:  Pediatrics 2019  Dec 144(6) e20191031 10.1542/peds.2019-1031\n",
      "-- Comment in Pediatrics. 2019 Dec;144(6):\n",
      "Pediatrics\n",
      "Pediatrics\n",
      "===>> Pediatrics\n",
      "===>> 2019 2019\n",
      "===>> 144(6) 144(6)\n",
      "--->  Dec  Dec\n",
      "--->  Dec\n",
      "---> e20191031 \n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9624 Focus:  Cancer Res 2017  Jul 15 77(14) 3857-3869 10.1158/0008-5472.CAN-16-3079\n",
      "-- Comment in Cell Cycle. 2017 Sep 17;16(18):1635-1636.\n",
      "Cancer Res\n",
      "Cell Cycle\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9638 Focus:  Obstet Gynecol 2020  Mar 135(3) 498-508 10.1097/AOG.0000000000003702\n",
      "-- Comment in Obstet Gynecol. 2020 Mar;135(3):495-497.\n",
      "Obstet Gynecol\n",
      "Obstet Gynecol\n",
      "===>> Obstet Gynecol\n",
      "===>> 2020 2020\n",
      "===>> 135(3) 135(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 498 495\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9654 Focus:  Am J Surg Pathol 2020  Jul 44(7) e15-e29 10.1097/PAS.0000000000001450\n",
      "-- Comment in Eur Urol. 2021 Feb;79(2):318-319.\n",
      "Am J Surg Pathol\n",
      "Eur Urol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9679 Focus:  Cell Cycle 2014  13(13) 2129-37 10.4161/cc.29212\n",
      "-- Comment in Cell Cycle. 2014;13(20):3161-2.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2014 2014\n",
      "===>> 13(13) 13(20)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9692 Focus:  Nucleic Acids Res 2019  Nov 18 47(20) 10662-10677 10.1093/nar/gkz780\n",
      "-- Comment in Trends Cancer. 2020 Apr;6(4):263-265.\n",
      "Nucleic Acids Res\n",
      "Trends Cancer\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9697 Focus:  Fam Cancer 2018  Jan 17(1) 101-111 10.1007/s10689-017-0057-z\n",
      "-- Comment in Fam Cancer. 2018 Jan;17(1):1-3.\n",
      "Fam Cancer\n",
      "Fam Cancer\n",
      "===>> Fam Cancer\n",
      "===>> 2018 2018\n",
      "===>> 17(1) 17(1)\n",
      "--->  Jan  Jan\n",
      "--->  Jan\n",
      "---> 101 1\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9773 Focus:  Eur Urol 2021  Aug 80(2) 134-138 10.1016/j.eururo.2021.04.013\n",
      "-- Comment in Eur Urol. 2021 Aug;80(2):139-141.\n",
      "Eur Urol\n",
      "Eur Urol\n",
      "===>> Eur Urol\n",
      "===>> 2021 2021\n",
      "===>> 80(2) 80(2)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 134 139\n",
      "---> Article 9773 is a commentary and is to be removed\n",
      "\n",
      " 9788 Focus:  Gut 2013  Mar 62(3) 339-47 10.1136/gutjnl-2012-303108\n",
      "-- Comment in Gut. 2015 Aug;64(8):1342-4.\n",
      "Gut\n",
      "Gut\n",
      "===>> Gut\n",
      "===>> 2013 2015\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9789 Focus:  Nature 2011  Jun 8 474(7350) 230-4 10.1038/nature10155\n",
      "-- Comment in Nature. 2011 Jun 9;474(7350):171-2.\n",
      "Nature\n",
      "Nature\n",
      "===>> Nature\n",
      "===>> 2011 2011\n",
      "===>> 474(7350) 474(7350)\n",
      "--->  Jun 8  Jun 9\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9802 Focus:  Cell Cycle 2011  Dec 1 10(23) 4074-82 10.4161/cc.10.23.18170\n",
      "-- Comment in Cell Cycle. 2012 Feb 1;11(3):432-3.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2011 2012\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9803 Focus:  Cell Cycle 2010  Mar 1 9(5) 995-1004 10.4161/cc.9.5.10935\n",
      "-- Comment in Cell Cycle. 2010 Mar 15;9(6):1025.\n",
      "Cell Cycle\n",
      "Cell Cycle\n",
      "===>> Cell Cycle\n",
      "===>> 2010 2010\n",
      "===>> 9(5) 9(6)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9815 Focus:  J Natl Cancer Inst 2006  Oct 4 98(19) 1382-96 10.1093/jnci/djj374\n",
      "-- Comment in J Natl Cancer Inst. 2006 Oct 4;98(19):1350-3. J Natl Cancer Inst. 2007 Mar 21;99(6):487-8; author reply 488-9. J Natl Cancer Inst. 2007 Mar 21;99(6):487; author reply 488-9.\n",
      "J Natl Cancer Inst\n",
      "J Natl Cancer Inst\n",
      "===>> J Natl Cancer Inst\n",
      "===>> 2006 2006\n",
      "===>> 98(19) 98(19)\n",
      "--->  Oct 4  Oct 4\n",
      "--->  Oct 4\n",
      "---> 1382 1350\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9821 Focus:  J Urol 2019  Mar 201(3) 541-548 10.1016/j.juro.2018.09.056\n",
      "-- Comment in J Urol. 2019 Mar;201(3):548.\n",
      "J Urol\n",
      "J Urol\n",
      "===>> J Urol\n",
      "===>> 2019 2019\n",
      "===>> 201(3) 201(3)\n",
      "--->  Mar  Mar\n",
      "--->  Mar\n",
      "---> 541 548\n",
      "---> Article 9821 is a commentary and is to be removed\n",
      "\n",
      " 9824 Focus:  Ann Intern Med 2016  Feb 16 164(4) 279-96 10.7326/M15-2886\n",
      "-- Comment in Ann Intern Med. 2016 Feb 16;164(4):301-2. BMJ. 2016;352:i118.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2016 2016\n",
      "===>> 164(4) 164(4)\n",
      "--->  Feb 16  Feb 16\n",
      "--->  Feb 16\n",
      "---> 279 301\n",
      "---> Article 9824 is a commentary and is to be removed\n",
      "\n",
      " 9826 Focus:  JAMA Oncol 2015  Apr 1(1) 40-49 10.1001/jamaoncol.2014.216\n",
      "-- Comment in JAMA Oncol. 2015 Jul;1(4):541. JAMA Oncol. 2015 Jul;1(4):541-2. JAMA Oncol. 2015 Jul;1(4):542. JAMA Oncol. 2015 Jul;1(4):542-3. JAMA Oncol. 2015 Apr;1(1):19-21.\n",
      "JAMA Oncol\n",
      "JAMA Oncol\n",
      "===>> JAMA Oncol\n",
      "===>> 2015 2015\n",
      "===>> 1(1) 1(4)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9867 Focus:  Cancer Res 2020  Oct 1 80(19) 4172-4184 10.1158/0008-5472.CAN-20-0486\n",
      "-- Comment in Cancer Res. 2020 Oct 1;80(19):4044-4045. Comment on Cancer Res. 2020 Oct 1;80(19):4044-4045.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 80(19) 80(19)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> 4172 4044\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9891 Focus:  J Clin Oncol 2014  Jul 20 32(21) 2224-30 10.1200/JCO.2013.52.8331\n",
      "-- Comment in J Clin Oncol. 2014 Jul 20;32(21):2193-6.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2014 2014\n",
      "===>> 32(21) 32(21)\n",
      "--->  Jul 20  Jul 20\n",
      "--->  Jul 20\n",
      "---> 2224 2193\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9899 Focus:  Eur Urol Oncol 2020  Oct 3(5) 594-611 10.1016/j.euo.2020.07.005\n",
      "-- Comment in Eur Urol Oncol. 2020 Oct;3(5):612-614.\n",
      "Eur Urol Oncol\n",
      "Eur Urol Oncol\n",
      "===>> Eur Urol Oncol\n",
      "===>> 2020 2020\n",
      "===>> 3(5) 3(5)\n",
      "--->  Oct  Oct\n",
      "--->  Oct\n",
      "---> 594 612\n",
      "---> Article 9899 is a commentary and is to be removed\n",
      "\n",
      " 9913 Focus:  JNCI Cancer Spectr 2019  Oct 10 4(1) pkz075 10.1093/jncics/pkz075\n",
      "-- Comment in doi: 10.1093/jncics/pkz076.\n",
      "\n",
      " 9934 Focus:  JAMA Surg 2014  Dec 149(12) 1306-13 10.1001/jamasurg.2014.1081\n",
      "-- Comment in JAMA Surg. 2015 May;150(5):490-1. JAMA Surg. 2015 May;150(5):491-2.\n",
      "JAMA Surg\n",
      "JAMA Surg\n",
      "===>> JAMA Surg\n",
      "===>> 2014 2015\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9962 Focus:  Ann Intern Med 2011  Jul 5 155(1) 10-20 10.7326/0003-4819-155-1-201107050-00003\n",
      "-- Comment in Ann Intern Med. 2011 Jul 5;155(1):58-60. Ann Intern Med. 2011 Oct 18;155(8):566; author reply 566-7.\n",
      "Ann Intern Med\n",
      "Ann Intern Med\n",
      "===>> Ann Intern Med\n",
      "===>> 2011 2011\n",
      "===>> 155(1) 155(1)\n",
      "--->  Jul 5  Jul 5\n",
      "--->  Jul 5\n",
      "---> 10 58\n",
      "---> Article 9962 is a commentary and is to be removed\n",
      "\n",
      " 9972 Focus:  Clin Cancer Res 2019  Jan 1 25(1) 43-51 10.1158/1078-0432.CCR-18-1912\n",
      "-- Comment in Nat Rev Urol. 2018 Dec;15(12):726.\n",
      "Clin Cancer Res\n",
      "Nat Rev Urol\n",
      "---> Article 9972 is a commentary and is to be removed\n",
      "\n",
      " 9973 Focus:  Nat Med 2011  Jun 26 17(7) 875-82 10.1038/nm.2377\n",
      "-- Comment in Nat Rev Clin Oncol. 2011 Sep;8(9):508.\n",
      "Nat Med\n",
      "Nat Rev Clin Oncol\n",
      "---> Received commentary\n",
      "\n",
      "\n",
      " 9974 Focus:  J Clin Oncol 2020  May 10 38(14) 1539-1548 10.1200/JCO.19.03292\n",
      "-- Comment in J Clin Oncol. 2020 Aug 10;38(23):2700-2701. J Clin Oncol. 2020 Aug 10;38(23):2699-2700.\n",
      "J Clin Oncol\n",
      "J Clin Oncol\n",
      "===>> J Clin Oncol\n",
      "===>> 2020 2020\n",
      "===>> 38(14) 38(23)\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9975 Focus:  Cancer Res 2020  Jan 1 80(1) 116-125 10.1158/0008-5472.CAN-19-1847\n",
      "-- Comment in Cancer Res. 2020 Jan 1;80(1):23-24. Comment on Cancer Res. 2020 Jan 1;80(1):23-24.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2020 2020\n",
      "===>> 80(1) 80(1)\n",
      "--->  Jan 1  Jan 1\n",
      "--->  Jan 1\n",
      "---> 116 23\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9977 Focus:  Lancet Oncol 2019  Aug 20(8) 1136-1147 10.1016/S1470-2045(19)30275-X\n",
      "-- Comment in Lancet Oncol. 2019 Aug;20(8):1044-1046. Lancet Oncol. 2019 Sep;20(9):e465.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2019 2019\n",
      "===>> 20(8) 20(8)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 1136 1044\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9979 Focus:  Nat Cell Biol 2018  Aug 20(8) 954-965 10.1038/s41556-018-0140-1\n",
      "-- Comment in Nat Cell Biol. 2018 Aug;20(8):862-863.\n",
      "Nat Cell Biol\n",
      "Nat Cell Biol\n",
      "===>> Nat Cell Biol\n",
      "===>> 2018 2018\n",
      "===>> 20(8) 20(8)\n",
      "--->  Aug  Aug\n",
      "--->  Aug\n",
      "---> 954 862\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9983 Focus:  Clin Cancer Res 2021  Dec 15 27(24) 6677-6686 10.1158/1078-0432.CCR-21-2199\n",
      "-- Comment on Clin Cancer Res. 2021 Dec 15;27(24):6617.\n",
      "Clin Cancer Res\n",
      "Clin Cancer Res\n",
      "===>> Clin Cancer Res\n",
      "===>> 2021 2021\n",
      "===>> 27(24) 27(24)\n",
      "--->  Dec 15  Dec 15\n",
      "--->  Dec 15\n",
      "---> 6677 6617\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9985 Focus:  Lancet Oncol 2019  Apr 20(4) 504-517 10.1016/S1470-2045(18)30902-1\n",
      "-- Comment in Lancet Oncol. 2019 Apr;20(4):463-464. Lancet Oncol. 2019 Jun;20(6):e285. Lancet Oncol. 2019 Jun;20(6):e286.\n",
      "Lancet Oncol\n",
      "Lancet Oncol\n",
      "===>> Lancet Oncol\n",
      "===>> 2019 2019\n",
      "===>> 20(4) 20(4)\n",
      "--->  Apr  Apr\n",
      "--->  Apr\n",
      "---> 504 463\n",
      "---> Received highlight article\n",
      "\n",
      "\n",
      " 9987 Focus:  JAMA Netw Open 2020  Oct 1 3(10) e2021692 10.1001/jamanetworkopen.2020.21692\n",
      "-- Comment in JAMA Netw Open. 2020 Oct 1;3(10):e2021717.\n",
      "JAMA Netw Open\n",
      "JAMA Netw Open\n",
      "===>> JAMA Netw Open\n",
      "===>> 2020 2020\n",
      "===>> 3(10) 3(10)\n",
      "--->  Oct 1  Oct 1\n",
      "--->  Oct 1\n",
      "---> e2021692 e2021717\n",
      "---> Article 9987 is a commentary and is to be removed\n",
      "\n",
      " 9988 Focus:  Cancer Res 2016  Sep 1 76(17) 5103-14 10.1158/0008-5472.CAN-15-2980\n",
      "-- Comment in Cancer Res. 2017 Nov 1;77(21):6045-6046. Cancer Res. 2017 Nov 1;77(21):6042-6044.\n",
      "Cancer Res\n",
      "Cancer Res\n",
      "===>> Cancer Res\n",
      "===>> 2016 2017\n",
      "---> Received comment\n",
      "\n",
      "\n",
      " 9991 Focus:  J Med Genet 2016  May 53(5) 298-309 10.1136/jmedgenet-2015-103529\n",
      "-- Comment in J Med Genet. 2016 May;53(5):296-7.\n",
      "J Med Genet\n",
      "J Med Genet\n",
      "===>> J Med Genet\n",
      "===>> 2016 2016\n",
      "===>> 53(5) 53(5)\n",
      "--->  May  May\n",
      "--->  May\n",
      "---> 298 296\n",
      "---> Received highlight article\n",
      "\n",
      "[10, 25, 32, 38, 40, 44, 48, 58, 59, 63, 68, 82, 86, 100, 104, 111, 113, 121, 122, 136, 137, 140, 146, 150, 153, 161, 168, 174, 187, 191, 192, 193, 196, 200, 209, 210, 219, 220, 222, 223, 227, 231, 236, 237, 239, 241, 242, 255, 256, 259, 260, 261, 275, 280, 282, 283, 288, 291, 292, 293, 294, 296, 298, 299, 302, 307, 346, 358, 359, 360, 366, 367, 373, 377, 378, 385, 386, 387, 393, 395, 401, 406, 407, 414, 415, 416, 419, 425, 427, 432, 433, 435, 436, 440, 441, 446, 448, 450, 453, 471, 486, 488, 492, 509, 518, 528, 531, 542, 551, 552, 572, 602, 610, 611, 641, 673, 698, 713, 724, 735, 740, 753, 763, 765, 817, 845, 868, 908, 981, 1026, 1032, 1044, 1128, 1139, 1184, 1315, 1348, 1375, 1391, 1423, 1424, 1438, 1489, 1504, 1511, 1513, 1575, 1599, 1606, 1628, 1631, 1663, 1666, 1670, 1685, 1687, 1703, 1732, 1741, 1790, 1799, 1830, 1918, 1947, 2014, 2132, 2191, 2242, 2252, 2280, 2292, 2323, 2339, 2394, 2472, 2477, 2606, 2645, 2692, 2732, 2787, 2821, 2865, 2907, 2948, 2949, 2969, 3014, 3017, 3049, 3117, 3143, 3167, 3170, 3171, 3213, 3242, 3252, 3302, 3407, 3412, 3607, 3682, 3695, 3698, 3830, 3967, 4041, 4170, 4307, 4315, 4404, 4567, 4659, 4665, 4681, 4735, 4752, 4830, 4851, 4908, 4939, 4940, 4954, 4986, 5042, 5064, 5166, 5277, 5289, 5375, 5382, 5410, 5425, 5426, 5465, 5478, 5649, 5744, 5879, 5882, 5898, 5935, 5939, 5974, 5991, 5996, 6051, 6068, 6086, 6159, 6163, 6164, 6180, 6181, 6228, 6243, 6262, 6272, 6284, 6285, 6287, 6304, 6329, 6359, 6380, 6387, 6409, 6412, 6415, 6422, 6426, 6449, 6450, 6465, 6466, 6477, 6483, 6500, 6508, 6510, 6517, 6536, 6554, 6555, 6603, 6604, 6605, 6620, 6628, 6629, 6650, 6670, 6671, 6672, 6675, 6676, 6694, 6695, 6732, 6733, 6775, 6776, 6778, 6780, 6794, 6795, 6798, 6814, 6815, 6816, 6820, 6821, 6831, 6834, 6874, 6897, 6898, 6905, 6924, 6926, 6965, 6983, 6999, 7048, 7074, 7101, 7141, 7158, 7205, 7215, 7232, 7255, 7287, 7290, 7298, 7304, 7325, 7398, 7401, 7402, 7417, 7420, 7539, 7559, 7571, 7618, 7660, 7661, 7744, 7807, 7874, 7890, 7909, 7930, 7943, 7989, 8002, 8106, 8118, 8143, 8180, 8231, 8235, 8249, 8291, 8362, 8403, 8405, 8457, 8490, 8528, 8547, 8606, 8608, 8666, 8667, 8681, 8735, 8762, 8895, 8935, 8950, 8992, 9013, 9038, 9051, 9084, 9146, 9175, 9219, 9260, 9261, 9266, 9296, 9309, 9316, 9773, 9821, 9824, 9899, 9913, 9962, 9972, 9987]\n"
     ]
    }
   ],
   "source": [
    "to_remove = []\n",
    "for i, article in enumerate( articles[:] ):\n",
    "    if article and article['comment']:\n",
    "        print('\\n', i, 'Focus: ', article['journal'], article['year'], \n",
    "              article['date'], article['volume'],  \n",
    "              article['pages'], article['doi'])\n",
    "        print('--', article['comment'])\n",
    "        \n",
    "        # Extract info about paper discussed in comment\n",
    "        target = {}\n",
    "        aux = article['comment'].split(';')\n",
    "        if len(aux) == 1:\n",
    "            to_remove.append(i)\n",
    "            continue\n",
    "    \n",
    "        aux = aux[0].split('.')\n",
    "        date_string =  aux[-1].strip()\n",
    "        if len(date_string) < 4:\n",
    "            to_remove.append(i)\n",
    "            continue\n",
    "            \n",
    "        target['year'] = int( date_string[:4] )\n",
    "        target['date'] = date_string[4:]\n",
    "        target['journal'] = aux[-2].strip()\n",
    "        \n",
    "        aux = article['comment'].split(';')[1]\n",
    "        aux = aux.split(':')\n",
    "        target['volume'] = aux[0]\n",
    "        target['pages'] = aux[1].split('.')[0]\n",
    "        \n",
    "        if len(aux) > 2:\n",
    "            target['doi'] = aux[2].split()[0].strip('.')\n",
    "        else:\n",
    "            target['doi'] = None\n",
    "          \n",
    "        # Extract dates of publication\n",
    "        date_focus = extract_publication_date(article)\n",
    "        date_target = extract_publication_date(target)\n",
    "        \n",
    "        # Determine type of comment\n",
    "        #\n",
    "        # Same journal\n",
    "        print(article['journal'])\n",
    "        print(target['journal'].lstrip('Coment').strip().lstrip('ion').strip())\n",
    "        if ( article['journal'] == \n",
    "             target['journal'].lstrip('Coment').strip().lstrip('ion').strip() ):\n",
    "            print('===>>', article['journal'])\n",
    "            print('===>>', article['year'], target['year'])\n",
    "            \n",
    "            # Same year \n",
    "            if article['year'] == target['year']:\n",
    "                print('===>>', article['volume'], target['volume'])\n",
    "            \n",
    "                # Same volume\n",
    "                if target['volume'] and article['volume'] == target['volume']:\n",
    "                    print('--->', article['date'], target['date'])\n",
    "                    \n",
    "                    # Same date\n",
    "                    if article['date'] == target['date']:\n",
    "                        print('--->', article['date'])\n",
    "\n",
    "                        if '-' in article['pages']:\n",
    "                            focus_pages = article['pages'].split('-')[0]\n",
    "                            if focus_pages.isnumeric():\n",
    "                                focus_pages = int(focus_pages)\n",
    "                        else:\n",
    "                            focus_pages = article['pages']\n",
    "                            \n",
    "                        if '-' in target['pages']:\n",
    "                            target_pages = target['pages'].split('-')[0]\n",
    "                            if target_pages.isnumeric():\n",
    "                                target_pages = int(target_pages)\n",
    "                        else:\n",
    "                            target_pages = target['pages']\n",
    "                            \n",
    "                        if type(target_pages) != type(focus_pages):\n",
    "                            target_pages = str(target_pages)\n",
    "                            focus_pages = str(focus_pages)\n",
    "\n",
    "                        print('--->', focus_pages, target_pages)\n",
    "                        \n",
    "                        # Same date, earlier pages\n",
    "                        if focus_pages < target_pages:\n",
    "                            to_remove.append(i)\n",
    "                            print(f\"---> Article {i} is a commentary and is to be removed\")\n",
    "\n",
    "                        # Same date, later pages\n",
    "                        else:\n",
    "                            article['comment'] = ('Received highlight article! ' \n",
    "                                                  + article['comment'])\n",
    "                            print('---> Received highlight article\\n')\n",
    "\n",
    "                    # Same volume, later time\n",
    "                    elif article['date'] > target['date']:\n",
    "                        to_remove.append(i)\n",
    "                        print(f\"---> Article {i} is a comment and is to be removed\")\n",
    "\n",
    "                    # Same volume, earlier time\n",
    "                    elif article['date'] < target['date']:\n",
    "                        article['comment'] = 'Received comment! ' + article['comment']\n",
    "                        print('---> Received comment\\n')\n",
    "\n",
    "                # Same year, volumes that exist, later volume\n",
    "                elif target['volume'] and article['volume'] > target['volume']:\n",
    "                    to_remove.append(i)\n",
    "                    print(f\"---> Article {i} is a comment and is to be removed\")\n",
    "                \n",
    "                # Same year, volumes that exist, earlier volume\n",
    "                elif target['volume'] and article['volume'] < target['volume']:\n",
    "                    article['comment'] = 'Received comment! ' + article['comment']\n",
    "                    print('---> Received comment\\n')\n",
    "\n",
    "                # Same journal, same year, missing volumes \n",
    "                else:\n",
    "                    # Same journal, same year, missing volumes, same date\n",
    "                    if article['date'] == target['date']:\n",
    "                        print('--->', article['date'])\n",
    "\n",
    "                        if '-' in article['pages']:\n",
    "                            focus_pages = article['pages'].split('-')[0]\n",
    "                            if focus_pages.isnumeric():\n",
    "                                focus_pages = int(focus_pages)\n",
    "                        if '-' in target['pages']:\n",
    "                            target_pages = target['pages'].split('-')[0]\n",
    "                            if target_pages.isnumeric():\n",
    "                                target_pages = int(target_pages)\n",
    "\n",
    "                        print('--->', focus_pages, target_pages)\n",
    "\n",
    "                        # Same journal, same year, missing volumes, same date, earlier pages\n",
    "                        if focus_pages < target_pages:\n",
    "                            to_remove.append(i)\n",
    "                            print(f\"---> Article {i} is a commentary and is to be removed\")\n",
    "\n",
    "                        # Same journal, same year, missing volumes, same date, earlier pages\n",
    "                        else:\n",
    "                            article['comment'] = ('Received highlight article! ' \n",
    "                                                  + article['comment'])\n",
    "                            print('---> Received highlight article\\n')\n",
    "        \n",
    "                    # Same journal, same year, missing volumes, later time\n",
    "                    elif article['date'] > target['date']:\n",
    "                        to_remove.append(i)\n",
    "                        print(f\"---> Article {i} is a comment and is to be removed\")\n",
    "\n",
    "                    # Same journal, same year, missing volumes, earlier time\n",
    "                    elif article['date'] < target['date']:\n",
    "                        article['comment'] = 'Received comment! ' + article['comment']\n",
    "                        print('---> Received comment\\n')\n",
    "        \n",
    "            # Same journal, later year \n",
    "            elif article['year'] > target['year']:\n",
    "                to_remove.append(i)\n",
    "                print(f\"---> Article {i} is a comment and is to be removed\")\n",
    "\n",
    "            # Same journal, earlier year\n",
    "            elif article['year'] < target['year']:\n",
    "                article['comment'] = 'Received comment! ' + article['comment']\n",
    "                print('---> Received comment\\n')\n",
    "\n",
    "\n",
    "        # Different journals, later year\n",
    "        elif article['year'] > target['year']:\n",
    "            to_remove.append(i)\n",
    "            print(f\"---> Article {i} is a commentary and is to be removed\")\n",
    "\n",
    "        # Different journals, earlier year\n",
    "        elif article['year'] < target['year']: \n",
    "            article['comment'] = 'Received commentary! ' + article['comment']\n",
    "            print('---> Received commentary\\n')\n",
    "\n",
    "        # Different journals, same year\n",
    "        else:\n",
    "            if date_focus > date_target:\n",
    "                to_remove.append(i)\n",
    "                print(f\"---> Article {i} is a commentary and is to be removed\")\n",
    "            \n",
    "            elif date_focus < date_target:\n",
    "                article['comment'] = 'Received commentary! ' + article['comment']\n",
    "                print('---> Received commentary\\n')\n",
    "                \n",
    "            else:\n",
    "                print('FUCK!!!')\n",
    "\n",
    "print(to_remove)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 229,
   "id": "e90db248",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:28:26.339441Z",
     "start_time": "2024-01-10T16:28:26.310092Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9587\n"
     ]
    }
   ],
   "source": [
    "for i in reversed(to_remove):\n",
    "    articles.pop(i)\n",
    "\n",
    "print(len(articles))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 236,
   "id": "46dc38f9",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:31:57.377952Z",
     "start_time": "2024-01-10T16:31:57.351816Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[144, 200, 362, 385, 387, 390, 393, 395, 401, 467, 478, 639, 676, 997, 1073, 1227, 3344, 3558, 4587, 4790, 5867, 5890, 5933, 6062, 6126, 6261, 6384, 6485, 8747, 8800, 8857, 9017]\n"
     ]
    }
   ],
   "source": [
    "to_remove = []\n",
    "\n",
    "for i, article in enumerate( articles ):\n",
    "    if article is None:\n",
    "        to_remove.append(i)\n",
    "        \n",
    "print(to_remove)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 237,
   "id": "014ec7b2",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:32:12.684812Z",
     "start_time": "2024-01-10T16:32:12.660624Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9523\n"
     ]
    }
   ],
   "source": [
    "for i in reversed(to_remove):\n",
    "    articles.pop(i)\n",
    "\n",
    "print(len(articles))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3c9c7ddf",
   "metadata": {},
   "source": [
    "## Create collections"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 238,
   "id": "a0767a75",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:32:30.332763Z",
     "start_time": "2024-01-10T16:32:30.296636Z"
    }
   },
   "outputs": [],
   "source": [
    "pattern1 = 'review'\n",
    "pattern2 = 'reviewed'\n",
    "\n",
    "\n",
    "erratum_articles = []\n",
    "comment_articles = []\n",
    "review_articles = []\n",
    "no_abstract_articles = []\n",
    "\n",
    "for article in articles:\n",
    "    if not article['retraction']:\n",
    "        if article['erratum']:\n",
    "            erratum_articles.append(article)\n",
    "            continue\n",
    "\n",
    "        if article['comment'] and 'Received comment! ' == article['comment'][:18]:\n",
    "            comment_articles.append(article)\n",
    "            continue\n",
    "\n",
    "        if not article['abstract']:\n",
    "            no_abstract_articles.append(article)\n",
    "        else:\n",
    "            if pattern1 in article['abstract'] or pattern2 in article['abstract']:\n",
    "                review_articles.append(article)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 239,
   "id": "95804a42",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:32:32.620223Z",
     "start_time": "2024-01-10T16:32:32.596600Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "9523\n",
      "8\n",
      "234\n",
      "162\n",
      "599\n",
      "1299\n"
     ]
    }
   ],
   "source": [
    "print(len(articles))\n",
    "print(len(retracted_articles))\n",
    "print(len(erratum_articles))\n",
    "print(len(comment_articles))\n",
    "print(len(no_abstract_articles))\n",
    "print(len(review_articles))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e60ea259",
   "metadata": {},
   "source": [
    "# Save to file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 240,
   "id": "04daabe3",
   "metadata": {
    "ExecuteTime": {
     "end_time": "2024-01-10T16:33:11.045437Z",
     "start_time": "2024-01-10T16:33:10.885010Z"
    }
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Done saving file!\n"
     ]
    }
   ],
   "source": [
    "with open(Path.cwd() / 'articles_clean.json', 'w', encoding = 'utf-8') as f_json:\n",
    "    json.dump(articles, f_json)\n",
    "    \n",
    "print('Done saving file!')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b8b41d99",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:new_base] *",
   "language": "python",
   "name": "conda-env-new_base-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.4"
  },
  "toc": {
   "base_numbering": 1,
   "nav_menu": {},
   "number_sections": true,
   "sideBar": true,
   "skip_h1_title": false,
   "title_cell": "Table of Contents",
   "title_sidebar": "Contents",
   "toc_cell": false,
   "toc_position": {
    "height": "calc(100% - 180px)",
    "left": "10px",
    "top": "150px",
    "width": "200.6px"
   },
   "toc_section_display": true,
   "toc_window_display": true
  },
  "varInspector": {
   "cols": {
    "lenName": 16,
    "lenType": 16,
    "lenVar": 40
   },
   "kernels_config": {
    "python": {
     "delete_cmd_postfix": "",
     "delete_cmd_prefix": "del ",
     "library": "var_list.py",
     "varRefreshCmd": "print(var_dic_list())"
    },
    "r": {
     "delete_cmd_postfix": ") ",
     "delete_cmd_prefix": "rm(",
     "library": "var_list.r",
     "varRefreshCmd": "cat(var_dic_list()) "
    }
   },
   "types_to_exclude": [
    "module",
    "function",
    "builtin_function_or_method",
    "instance",
    "_Feature"
   ],
   "window_display": false
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
